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 Mitochondria play a central role in life and death. Although mitochondrial dysfunction is at 
the core of many diseases, the mechanisms and consequences of mitochondrial targeting and 
dysfunction induced by pathogenic microbes is poorly understood. The vacuolating cytotoxin 
(VacA) of the human gastric pathogen Helicobacter pylori localizes to and disrupts mitochondrial 
function. In order to evaluate mitochondrial targeting of VacA, VacA associated cellular 
compartments were isolated by magnetic based fractionation for proteomic analysis. Several 
proteins were identified to be important for VacA activity, including 14-3-3-G, VPS4B, Rab35, and 
Stx18, with Rab53 being important for VacA localization to mitochondria. Furthermore, all 
constituents of TIM23 and TOM complex were identified, suggesting a potential mechanism of 
VacA import into mitochondria. In order to evaluate the host cellular response to VacA mediated 
mitochondrial dysfunction, cells were treated with VacA, where a robust induction of mitochondria 
dysfunction was observed, then upon removal of VacA, mitochondria dysfunction was observed 
to recover over time, indicating an induction of quality control. Further studies suggest the 
mechanism of recovery is independent of mitophagy. Fluorescence microscopy and in vitro 
assays of purified mitochondria with VacA, revealed VacA to associate with mitochondrial derived, 
VacA containing vesicles, as a means to repair VacA mediated mitochondrial dysfunction. Finally, 
in order to evaluate the effects of VacA in vivo, an intragastric toxin infusion model was 
established and verified, whereby infusion of VacA into the stomachs of mice revealed 
perturbations in gastric mucosal structure, a decrease in gastric mucus production, parietal cell 
vacuolation, and induction of a humoral response to VacA. Altogether, these studies illustrate a 
model that VacA traffics to mitochondria by endosomes, and upon associating with the 
mitochondria and inducing dysfunction, a quality control response is activated. Furthermore, by 
disrupting mitochondrial function, the ability of gastric mucous and parietal cells to function 




 I am beyond proud to dedicate this work to my biggest cheerleader and undoubted 
continual source of support and encouragement, my mother, Patricia Marie Holland. My brother 
and I grew up on a small farm in a small town, and no one in my family was trained professionally 
in the sciences. However, one of the most eye-opening experiences that I obtained was the 
realization that doctoral degrees mean little without the capacity to think. Throughout my studies 
and travels, I have met far too many people with impressive resumes, multiple doctoral degrees 
from top institutions, or from a family of doctors, but I was deeply disheartened by their lack of 
passion, critical eye and engagement, and inability to think beyond what was immediately in front 
of them. At times, I questioned the value of a Ph.D., and what the training I was engaged in 
actually meant. I came to learn that a Ph.D. is simply a title, a title that ideally represents an 
incredible amount of research towards a project that furthers our understanding of a given subject. 
However, the degree itself does not truly represent the actual education one receives, as often 
individuals cheat or pass with little effort, and thus there is simply no degree that represents the 
actual education one receives. I learned this from my mother. My mom grew up in the Poconos 
in Pennsylvania, the daughter of a devoted mother and mechanic father, with three sisters and a 
brother. Her family went through incredible tragedy and pain, but even through their struggles, my 
mom and her sisters grew into remarkable women. As the story goes, when being introduced to 
others, my Aunt Lynn is the smart one, Gloria is the nice organized one, and my mom draws, 
which is truly an understatement. My mom is without a doubt the most passionate person I have 
ever known, in all aspects of her life. When she gets her mind set on something, she chases it, 
and her passion is beautifully translated into her art. While she is most certainly skilled in more 
traditional art, where her skills shine are through illustrations and cartoons. My mom has a 
remarkable ability to intently listen and remember everything that someone tells her. When she 
draws a picture for someone, she puts in an immense amount of detail, little items that only the 
recipient would notice and truly appreciate. My mom went through additional struggles later in life, 
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struggles that no one should be put through, and it is through her response, and how she handled 
those situations, that I learned what it is meant to be strong. I learned from her how to tackle life, 
that no matter what happens, you can always keep moving forward. I remember as a little girl, 
every day before walking down the driveway to get on the bus to go to school, mom and I always 
had the same conversation: “What are you going to do in school today?” and my response “Learn.” 
It is rather heartwarming to look back on that time and what something so simple actually meant. 
Twenty years later, I am still in school, but now my classmates are pursuing doctoral degrees 
instead of learning the alphabet. But what I have observed, is that far too often my classmates 
are not learning. They spend their time memorizing facts for an exam, after which they promptly 
forget those facts. They fail to understand or even enjoy the information that they are being 
presented with, why it is important, what it means, and how they can ultimately use it in their future 
work. Throughout my education from basic sciences in undergraduate to veterinary medicine and 
the wanderings of studies in my Ph.D., I have been at a loss for words of how impressed I have 
been at my mom’s ability to follow along by my side. Without any college education in the 
sciences, simply through her passion to learn and her ability to think, she was able to comprehend 
my work in incredible detail. Before seminars or meetings I would run through my presentation 
with her, and not only was she able to understand my work, but she often asked more complicated 
and fundamental questions than many professors. Even without training in cell biology, my mom 
was able to learn about and understand mitochondrial protein transporters, bacterial toxins, signal 
transduction pathways, and cellular quality control mechanisms, and we had countless 
discussions about how those systems work, what they do for a cell, and how they can ultimately 
lead to human disease. Her repertoire of readings morphed over time, from murder mysteries to 
nonfiction literature on epidemics and major scientific breakthroughs. From my perspective, I am 
continually amazed by my mom’s abilities, all of which stem from her passion and ability to think. 
She may not have an advanced degree with extra letters after her name, but she is truly a brilliant 
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not only because the research of microbial pathogenesis aligned with my scientific interests and 
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science, a dedication to his students, and a continual drive to discover and think critically about 
ones work. As I have learned during my time as a graduate student, different people in lab bring 
different qualities, many of which are good, but some are not. But Steve has a talent for finding 
the good in everyone. Steve learns what good qualities a student possesses, and makes sure to 
give the student ample opportunities for those qualities to thrive. In addition, he fully 
acknowledges our weaknesses and works with us to improve, rather than ignoring the issues and 
just hope they will improve. Over the years I have seen nearly every person in lab change, all for 
the better, because of Steve’s efforts. I have learned that not all change happens overnight. Steve 
has an unparalleled patience for everyone. Through countless individual meetings, Steve never 
gives up on a student. He continues to work with everyone until we improve. And when we did 
improve, he pushed us to be even better. Because of Steve’s efforts, I have no doubt that he 
cultivated a truly exceptional learning and training environment for his students. Not only did he 
train us in basic laboratory skills, but he taught us how to think like a scientist, to communicate 
our work with others, both verbally and written, and mostly importantly, he taught us how to work 
together, to be critical of each other, and how to put forth an honest effort in helping to see each 
other succeed. I am forever grateful for all that Steve has done, for me, and for everyone who is 
lucky enough to pass through his lab.  
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 My committee members, Dr. Steve Blanke, Dr. Gee Lau, Dr. Mark Kuhlenschmidt, and Dr. 
Dongwan Yoo have been a continual source of inspiration for my work. Every year I met with my 
committee, either formally or informally through meetings or departmental events, and they were 
always an excellent source of support. I always appreciate their rigor in questioning my work, and 
proposing new ideas and suggestions to furthering my project. I purposely chose a more diverse 
committee, and by having a virologist, a bacteriologist, and a biochemist, my work was evaluated 
through a perspective that was wonderfully beneficial to the progress of my project. Thanks to Dr. 
Yoo, I am more versed in the intricacies of interferon signaling than I ever anticipated. Thanks to 
Dr. Lau, not only did I gain extensive experience in answering difficult questions in host-microbe 
interactions, but I will never forget his honesty and guidance as a committee mentor, and I will 
never forget his laugh and unmistakable sense of humor. And finally, thanks to Dr. Kuhlenschmidt, 
I will always remember how engaged he was in the science I presented, and his continual 
amazement in how I assembled PowerPoint presentations. I feel rather grateful to have been 
provided such an outstanding group of additional faculty members as my committee over the 
years, as I never dreaded a committee meeting, and always left our meetings with a rekindled 
motivation to try new experiments and chase new ideas.  
 Over the years, I have become rather fortunate to work with various individuals from 
across campus and outside of the university. Drs. Zhao Quing Luo from Purdue University, Gia 
Voeltz from the University of Colorado at Boulder, and Edward Fon from McGill University all 
provided plasmids and cells lines that were instrumental in my work developing new avenues of 
study. Dr. Richard Youle from the NIH NINDS is the world’s leading expert in mitophagy, and I 
was very pleased to speak with him at a Gordon Research Conference, where he volunteered to 
test VacA for us to examine whether it is activating mitophagy. Along with my advisor Dr. Steve 
Blanke, I had the phenomenal opportunity to work with Dr. Timothy Cover at Vanderbilt University 
where we co-authored a chapter on VacA in a Helicobacter pylori book.  
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processing samples for mass spectrometry. Dr. Yau in particular has made a lasting impact. While 
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behind the mass spectrometry that was being used in his lab. Dr. Yau gladly spent hours going 
over the procedure, the rationale behind each step, and what I could do in order to ensure that I 
was preparing my samples in a means that would yield the best results possible. I have fond 
memories of long discussions of not only the science, but also politics (especially during the Brexit 
votes), and veterinary medical school.  I would also like to thank Dr. Barbara Pilas for her expertise 
in flow cytometry analysis, as well as numerous other individuals over the years who helped 
maintain the flow cytometer. At the UIUC Institute for Genomic Biology, Drs. Austin Cyphersmith, 
Glenn Fried, Xudong Guan, Kingsley Boating, and Mayandi Sivaguru were wonderful in teaching 
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Joyce Koeberlein for her administrative assistance. At the Beckman Institute imaging technology 
group, I would like to thank Scott Robinson and Cate Wallace for them assistance in training me 
for transmission electron microscopy. 
 I would like to thank various funding sources for providing me with direct and indirect 
resources for conducting my research, as well as attendance of various scientific meetings, 
conferences, and other training opportunities. I would like to thank the National Institutes of Health 
for overall funding of our laboratory (RO1 AI045928, R21 AI117497), and particular thanks for 
personal funding through a T32 Infection Biology Training Grant (T32 AI078876), and a F30 Ruth 
L. Kirschtein National Research Service Award (F30 OD023012). I would also like to thank the 
Department of Pathobiology in the College of Veterinary Medicine through the Dr. Ed and Mrs. 
Virginia Voss graduate student exposition awards, the University of Illinois College of Veterinary 
Medicine Research Day awards, and the University of Illinois Graduate College for travel awards 
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for me to attend various scientific meetings and conferences. I would also like to thank the 
American Society for Microbiology for the Richard and Mary Finkelstein award to attend the 
Annual American Society for Microbiology meeting in Boston Massachusetts in 2016. Finally, I 
would like to thank the University of Illinois Veterinary Medical Scholar’s program for continued 
funding and support throughout the duration of my education at the University of Illinois. Not only 
was the funding instrumental in my ability to pursue my chosen area of study, but the continued 
support by the numerous faculty members and my fellow students within the program were 
essential to my success.   
 I would also like to thank my family and friends from outside of lab who have always been 
a continual source of support. Although at times we are vastly different in personalities, Dr. 
Kayleigh Bull, Dr. Sarah Reich, and I have been close friends since the start of vet school back 
in 2011. We started our veterinary medical training together, we lived together for 4 years, and all 
through that time we have laughed and cried, through joyous times and hard times. They are my 
proof that I can be social, and that I do indeed go outside and into public every now and then. 
They are a constant source of joy and friendship, and in addition, now they are people to admire 
as I progress into my veterinary training. In addition to Sarah and Kayleigh, I am incredibly grateful 
for other friendships that I have gained through my first veterinary medicine class and now my 
new class of vet students. I would also like to thank a dear friend that I met in a different lab early 
in my PhD training, Jesse Grenz, who ultimately became my wedding officiant. Jesse is an 
absolutely brilliant, caring individual with more talents than he would be open to admit. He has 
always been a reliable a friend, whether it be for a conversation to relieve stress, or to chat about 
cat stories and antics that our pets were getting into. Although I first met them during my 
undergraduate education, I would like to thank my “southern family”, Randell and Marilyn Miller. 
While at Murray State University I met Randell and Marilyn, and they were truly my home away 
from home. They taught me a lot about life, and how one should conduct themselves to live a life 
of respect towards others and to truly value friends and family. I wish we lived closer so I could 
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spend more time with them, but I am forever grateful for how they contributed towards shaping 
my life. I would like to thank my brother, Todd Holland, and his family, Stacy and Layla Schleicher-
Holland (and their somewhat blind but overly lovable dog Maynard). I was privileged enough to 
see this family grow over the years, and I am forever grateful to have all of them in my life. 
Although Todd and I are very different in our career paths, we are both nerds in our own way, and 
I am continually amazed by the career that he has built and the reputation that he has earned. I 
am also rather impressed by his ability to learn about and truly understand intricacies in my 
research to such a high degree. Finally, I would like to thank my husband, Evan Anderson. We 
have gone through many hard times, but he was with me from the beginning, and through it all he 
remained patient and understanding of my idiosyncrasies and at times (or most of the time) over 
dedication to my work with long hours away from home. I am proud of all that he has accomplished 
with his career, and I am grateful for his unwavered dedication to me and our future life that we 
are excited about seeing unfold.  
I have to thank the numerous students who I have had the absolute privilege of working 
with throughout the years. I am grateful for the time and experiences I have gained from past and 
current lab members, including our postdoc Tamilselvam Batcha, graduate students (Brandon 
Banks, Bomy Kim, D’Feau Lieu, Zachary Schaefer, Henry Chen, Hyunjung Anna Kim, and Ik-
Jung Kim), and undergraduate students (Wilhelm Salmen, Shan Shan So, Alexander Rodriguez, 
Whitney Vuong, Aakaash Meduri, Shayaan Nasser, Roche Kapoor, Alondra Diaz, Sally Kim, 
Jeongmin Lee, Mohammad Hamad, Jordan Kryza, Hanlin Mok, Eunji Jeong, Paul Kaminski, 
Lauren O’Keefe, and Jason Yeh. I am grateful for the experience and opportunity to mentor 
various students, including William Riedl (my first undergraduate to mentor), Marianne Koliana (a 
masters student from Sweden), Ami Yamamoto (our newest grad student), Mohammed Hossain, 
Keerthana Hogirala, Jiayi Luo, and Stefan Markovic.  
I would like to make a special thanks to several individuals who have made my time in lab 
even more valuable, by providing me with countless memories that I will never forget. Gregory 
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Harpring and Kristopher Bosi were two of our lab’s most successful undergraduates. Within six 
months after joining lab they both developed projects worthy of attending their first scientific 
conference and presenting their work as a poster at the 2015 Midwest Microbial Pathogenesis 
Conference in Indianapolis Indiana. It was heartwarming to see them so excited about the talks, 
nervous about presenting their first poster, and engaged in speaking with individuals from all 
around the country who shared a similar area of research. Greg went on after graduation to work 
at Eli Lily, apparently the few days in Indianapolis had a lasting impression. Currently, Greg is 
attending medical school at Southern Illinois University. Kris is easily one of the most successful 
undergraduates our lab has ever seen. In addition to winning numerous fellowships and research 
awards through the university, he also received several through the American Society for 
Microbiology. Those awards allowed him to attend the ASM General/Microbe meeting twice, in 
Boston in 2016 and New Orleans in 2017, an opportunity few graduate students gain even once. 
Kris went on to receive a research opportunity through the National Institutes of Health Intramural 
Research Program, where he is pursuing opportunities to further his career goals. Outside of lab, 
Kris and I shared experiences in completing a half marathon, triathalon, and full marathon (where 
I am sad to admit that Kris literally was walking faster than I was jogging at one point, although 
he only finished 30 min faster than I did), as well as countless early morning 13+ mile bike rides, 
runs, and attempts to learn how to swim. Kris is one of those individuals whose excitement and 
passion for life radiates. Although at times he could be slightly overzealous, if ever anyone needed 
help, whether it be a fellow lab member or a homeless man on the street, Kris never hesitated, 
never complained, and never bragged. Kris’s humbleness, honestly, and passion are defining 
characteristics, and I am excited to see which avenue he ultimately pursues for his lifelong career.  
Lab work is difficult, with long hours and countless failed experiments. But what makes 
those trials and tribulations worthwhile is being able to go through them with a good friend. Seung 
Jin Oh (Jay) has been my lab neighbor for nearly the entirety of my time in lab, and every day, I 
can always count on Jay for a smile and a laugh. In addition to being a simply wonderful person 
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with a level of kindness everyone should strive to achieve, Jay is an outstanding scientist with a 
remarkable work ethic. I lost count of the sheer number of mutant bacterial strains Jay made over 
the years, and the number of trials he ran to have confidence in his results. Jay is one of the few 
people who would beat me to lab in the morning, and would often stay later than I in the evening. 
In addition to his simple joy for life, Jay is one of the few graduate students that I know that would 
honestly become excited about experimental results. Jay devoted considerable time to 
establishing a system so that he knew his results were well controlled, and when he collected 
clear and convincing data, his energy in the lab was palpable and infectious. I have no doubt that 
lab dynamics would be considerably different without Jay.  
Finally, I have to thank someone who has given me one of the most long lasting friendships 
I have gained through my interactions with people in lab, that being Amandeep Gargi. Like Jay, 
Aman was always a source of joy, with an admirable balance of optimism with realism. Aman is 
one of the most dedicated people I have ever met regarding how much he cares about people in 
his life, and I recall countless scenarios with Aman where he went out of his way to help someone 
or to simply listen to them when they had a story to tell. Aman never bragged, and he was also 
the first to celebrate any success that anyone achieved in lab, from large successes to small 
victories, Aman was always there to cheer people along. I have yet to find someone who met 
Aman who did not like him, for his dedication to others and sheer optimism and drive to live life to 
the fullest is contagious. Aman goes beyond the norm to meet new people, talk to them, learn 
about them, and stay in touch. He is always there for anyone if they need a smile, someone to 
vent to, or just for a chat over tea. Cheers, Amster, thank you for the memories.  
 There are numerous individuals outside of our laboratory whom I am indebted to. I find 
myself to be in a fortunate position, as a graduate student in the College of Veterinary Medicine 
but completing my research in a lab in the School of Molecular and Cellular Biology (MCB), I was 
able to interact with and experience the wonderful generosity of not one, but two groups of 
individuals. Deb Lebaugh, Shawna Smith, and Diane Tsevelekos in the MCB Department of 
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Microbiology office are wonderfully talented individuals and were fantastic whenever I needed 
help, whether it be with administrative paperwork, or booking travel arrangements to various 
conferences and meetings (where they never really understood my love of travel by train, although 
I learned in recent years how convenient air travel can be). Paula Moxley and Karen Nichols in 
the Department of Pathobiology office were some of the most reliable people I have ever worked 
with. Both Paula and Karen always responded promptly whenever I had questions regarding 
degree requirements (which was frequent at times) or events being held through the department. 
Their tireless efforts have been noticed by many individuals within our department and across 
campus, and we are truly lucky to have them. In addition to administrative staff, I was fortunate 
enough to learn from numerous faculty members in both departments, notably Drs. Jim Slauch, 
Chris Brooks, and Ed Roy, in MCB, and Drs. Dongwan Yoo, Gee Lau, Mark Kuhlenschmidt, Carol 
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the faculty members have also served as advisors and mentors at times over the years, and have 
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while searching for my own route. Finally, I do have to make one special note for my eternal 
gratitude to Dr. Gail Sherba, who passed away unexpectedly in my last year of my PhD training. 
Although Dr. Sherba was not on my committee, and did not study bacteria (I miss our bacteriology 
versus virology banter), she was always my cheerleader. Whenever I saw her she was always 
smiling, she always asked how Steve was doing, and she was always fascinated with my work 
and congratulated me on my successes. She was a beloved member of the Pathobiology 
Department, and she is a constant reminder to me to be optimistic and passionate about your 
work and chase what you enjoy. And more importantly, she taught me to value every person in 
your life, because you never know when that life might be cut short.  
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the provided pages upon pages of comments and suggestions. I recall a Saturday afternoon in 
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Chapter 1: Introduction 
 
1.1 Host-Pathogen Interactions 
Since multicellular organisms first emerged, a dynamic interaction was maintained 
between them and their unicellular ancestors. Organisms engulfed, lysed, or phenotypically 
modulated each other. Given the simplicity and scale of the cellular level, these interactions were 
often mediated through small factors, such as ions, lipids, carbohydrates, peptides, proteins, and 
other small organic molecules. In certain environments, the driving force for these interactions 
was shaped by competition for resources, whereas in other environments, the interactions 
evolved to become mutually beneficial or even innocuous. These originating interactions, and the 
subsequent dynamics that developed, have shaped our current microbiota and fundamental 
mechanisms of host-microbe and host-pathogen interactions. 
Since anatomical humans have existed, and likely well before then, we have been 
colonized by microorganisms, including bacteria, protozoa, viruses, and fungi. Although most 
humans and animals live in a physiological healthy state even with constant inundation of 
microorganisms, certain microorganisms, in certain conditions, are able to bypass or overthrow 
our host defenses. For some pathogens, all hosts are susceptible to infection. Whereas other 
pathogens are only able to cause disease when the host defenses are lowered, whether it be 
through injury, stress, or compromise of the immune system. While the outcomes to infection vary 
between pathogens, ranging from full invasion and systemic infection with Salmonella1,2, Bacillus 
anthracis3,4, and Yersinia pestis5,6, to surface colonization and persistent infection with Candida 
albicans7,8, Staphylococcus aureus9,10, and Lactobacillus acidophilus11, basic strategies of host-
pathogen interactions are found throughout nature. Given the simplicity of most pathogenic 
microorganisms, a common mechanism of interacting with a host organism is mediated through 
the production of protein toxins or non-protein, toxic small molecules. These factors may serve to 
promote colonization in a given niche within a host12, invasion into underlying tissue13, evasion 
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from the host immune system14, or to create a more suitable niche for replication and growth. 
 
1.1.1 Virulence factors and pathogenic effectors 
In order to manipulate and communicate with a host organism, microorganisms have 
evolved a rather diverse repertoire of secreted factors that mediate pathogenesis and host-
microbe interactions. Virulence factors and secreted effectors may facilitate microbe binding to or 
internalization into host tissue, change the extracellular space to create a more hospitable 
environment to grow, or manipulate intracellular cellular processes to favor pathogenesis, whether 
it be signal transduction pathways, immune responses, escape from phagocytosed 
compartments, or induction of cell death. Often, the type of virulence factor or pathogenic effector 
produced is reflective of the specific host environment or the severity of disease. Although much 
is known regarding the identification of pathogenic effectors and characterization of cellular 
responses, a fundamental question that remains in numerous host-pathogen interactions, is why 
a given pathogen makes a given effector; how a specific effector contributes to disease, why it is 
important for the pathogen, and which processes occurred for the evolution of the production of 
the effector. By answering this “holy grail” question in pathogen biology, not only are scientists 
better able to understand the evolution of host-microbe interactions and the development of 
cellular communication dynamics, but we are also better poised to develop countermeasures to 
pathogenic infections, and potentially prevent those illnesses from occurring altogether. 
Virulence factors may facilitate pathogenesis through a wide variety of mechanisms 
(Figure 1.1). For example, to aid in adherence to host tissues, the plague causing bacterium 
Yersinia pestis produces a pH 6 antigen fimbriae (PsaA), a small protein that oligomerizes into 
long fimbrial strands and facilities the binding of the bacterium to pulmonary surfactant and 
respiratory cells (Figure 1.1A)15,16. In order to establish chronic infections, often colonization 
factors are produced in order to modify the extracellular space. To that end, the protein toxin 
urease of H. pylori, which converts gastric urea to ammonia and carbamate, is produced to aid in 
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increasing the pH of the surrounding environment in order to be more favorable for bacterial 
growth and ultimately establishment of a chronic infection (Figure 1.1B)17,18. Some pathogens 
secrete factors that directly inhibit the immune response, including Y. pestis and its secreted 
effector protein YopJ, which inhibits NF-kB and MAPK signaling and subsequent immune 
responses (Figure 1.1C)19,20. Often, micronutrients are in limited abundance; therefore, some 
pathogens produce siderophores, small organic molecules, to scavenge and facilitate the 
transport of iron into a bacterial cell21,22. Yersiniabactin for example, is a siderophore produced by 
several Yersinia species, as well as enteropathogenic E. coli, and acts to scavenge iron within a 
host and facilitates iron uptake by the pathogen (Figure 1.1D)23,24. Altogether, pathogens utilize 
a variety of virulence factors and secreted effectors in order to perturb host cell homeostasis. 
Disruption of a host epithelia may range from slight alterations to facilitate colonization but not 
cause severe damage, to complete subversion of immune responses and invasion into underlying 
tissue with ultimately the death of a host. 
Bacterial endotoxins. Bacterial toxins are generally classified into two main categories, 
endotoxins and exotoxins. Endotoxins are constituents of the outer membrane of Gram-negative 
bacteria, and are comprised of various modifications of lipopolysaccharides (LPS). LPS in and of 
itself serves as a major structural component of the bacterial cell wall, helping to provide stability. 
However, the exact role of LPS, especially in regards to bacterial physiology, remains to be fully 
understood. The molecule itself is composed of three regions: an O-antigen, a long glycan 
polymer which comprises the outermost portion of LPS; the core region, the central “linker” portion 
of LPS that often contains a carbohydrate; and Lipid A, a hydrophobic portion inserted into the 
bacterial membrane, often consisting of numerous fatty acids linked to phosphorylated 
glucosamine disaccharides25. Upon lysis of bacteria, LPS is released, with the Lipid A region 
being the most toxigenic. LPS elicits a strong immune and inflammatory response, where if levels 
are high and sustained, septic shock may ultimately result26,27. At lower levels, LPS is strongly 
pyrogenic, with exposure resulting in fever, and diarrhea26,27.  
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 Bacterial exotoxins: Clostridial neurotoxins. Most bacterial toxins and secreted 
effectors are classified as exotoxins, for they are released from a bacterial cell, either into the 
extracellular environment, or directly inserted into a host cell. Some of the most well characterized 
exotoxins include the botulinum and tetanus toxins, cholera toxin, anthrax toxins, and diphtheria 
toxins. Clostridium botulinum produces the botulinum toxin (Figure 1.2A), which is famously 
known to be the most lethal toxin identified, with only single-digit nanogram amounts of toxin being 
enough to cause death in an adult human28. Eight types of botulinum toxins have been described 
(A-H), all having slightly different conformations and thus different protein targets within a cell28. 
Regardless of the toxin type, all botulinum toxins have the same ultimate effect, whereby they 
target the peripheral nervous system and prevent the release of the major excitatory 
neurotransmitter acetylcholine, thus resulting in a flaccid paralysis28,29. Clostridium tetani, 
however, produces a similar toxin that shares ~35% sequence identity29 to botulinum toxin, the 
tetanus toxin (Figure 1.2A), but instead, tetanus toxin targets the central nervous system, 
preventing the release of major inhibitory neurotransmitters, such as glycine and γ–aminobutyric 
acid, resulting in a spastic paralysis29. The clostridial neurotoxins (tetanus and botulinum) are 
classified as AB toxins, with a toxic (or active) A component, and a cell surface interacting (or 
binding) B component. The clostridial toxins consist of three functional domains: cell surface 
binding, membrane translocation, and proteolysis as a zinc-metalloprotease. The toxic protease 
component cleaves one of several SNARE proteins (soluble NSF (N-ethylmaleimide-sensitive 
factor) attachment protein receptor) mediating the release of neurotransmitters, including VAMP 
(synaptobrevin), SNAP-25, and Syntaxin28,29. Sequence differences in these three domains confer 
neuron cell tropism and severity of disease28.  
Bacterial exotoxins: Cholera toxin. Vibrio cholerae is the causative agent of the disease 
cholera, which is characterized by profuse watery diarrhea. If left untreated and severe, the 
massive fluid loss results in profound dehydration and electrolyte imbalance, and results in death 
in 5-50% of infected individuals. The major pathogenic effector potentiating the disease cholera 
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is the cholera toxin (Figure 1.2B)30. Similar to the clostridial toxins, cholera is an AB toxin, with 
the B component binding to cell surface gangliosides, facilitating the transport of the toxic A 
component into the host cell30,31. Cholera toxin is an ADP-ribosyl transferase, which acts on host 
G protein mediating signaling, resulting in an increase in adenylate cyclase activity, and 
subsequent increase in cAMP and protein kinase A (PKA) activity30,31. Overactive PKA 
phosphorylates the cystic fibrosis transmembrane conductance regulator (CFTR) chloride 
channel, resulting in a massive ATP-dependent efflux of chloride from host cells, followed by the 
secretion of water, resulting in the clinical signs of massive watery diarrhea30,31. Cholera is a 
simple yet elegant example of the direct effects of a pathogenic effector, whereby a simple toxin 
changing a single substrate within a cell, has drastic effects on the health of a host.  
Bacterial exotoxins: Anthrax toxin. Bacillus anthracis is the causative agent of the 
disease anthrax, which may be manifested in four basic forms: cutaneous, pneumonic, 
gastrointestinal, or injection. The clinical presentation of anthrax depends of the route exposure, 
which is also related to the severity of disease, with 20-80% case fatality in the absence of medical 
intervention. Although the pathogenesis and severity of disease of infection with Bacillus anthracis 
is attributed to several virulence factors, the three major pathogenic effectors of Bacillus anthracis 
are lethal factor, edema factor, and protective antigen (Figure 1.2C)32. Protective antigen confers 
cell surface binding of either lethal factor or edema factor32. Upon internalization, lethal factor, a 
zinc dependent endoprotease, cleaves mitogen-activated protein kinase kinases (MAPKK), 
resulting in disruption of central signal transduction pathways, ultimately inducing cell death32,33, 
whereas edema factor, a calcium and calmodulin dependent adenylate cyclase,  increases cAMP, 
resulting in disruption of osmotic homeostasis and additional signal transduction pathways32,34. 
The three toxins act in concert with protective antigen conferring internalization of both edema 
and lethal factor, and edema and lethal factor themselves potentiating the effects of the other 
respective toxin32. The disease anthrax is a clear example of several pathogenic effectors, acting 
by different mechanisms, manipulating host cellular physiology, to ultimate cause severe disease.  
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Bacterial exotoxins: Diphtheria toxin. Finally, Corynebacterium diphtheria causes the 
disease diphtheria, characterized by grey to white patch lesions in the throat and airway 
obstruction in severe cases. Interestingly, the major virulence factor implicated in the disease 
diphtheria, diphtheria toxin (Figure 1.2D), is not encoded within the bacterial genome, but rather 
within a bacteriophage that infects Corynebacterium diphtheria35. Diphtheria toxin is also a 
canonical AB toxin, with the B component binding to heparin-binding epidermal growth factor on 
the cell surface, resulting in endocytosis and the release of the toxic A component, an ADP-ribosyl 
transferase, to the cytoplasm35. Diphtheria toxin then ribosylates host cell elongation factor 2 
(eEF-2), resulting in the blocking of protein synthesis, and ultimately induction of cell death36. 
Diphtheria toxin and its role in the disease diphtheria remain an enigma in toxin biology. Although 
the mechanisms of diphtheria toxin action have been determined in exquisite detail, why 
Corynebacterium diphtheria infected with a bacteriophage produces the toxin is unknown. To add 
more intrigue, the intracellular substrate of diphtheria toxin, eEF-2, is specifically ribosylated on a 
modified histidine residue, termed diphthamide35. This diphthamide residue has no described 
cellular function to date, except to serve as an intracellular target of diphtheria toxin, which raises 
considerable questions regarding the evolution of this host-microbe interaction. 
In summation, pathogenic microorganisms produce a variety of virulence factors and 
pathogenic effectors that modulate host cellular physiology. Even for systems that are intensively 
studied and very well characterized, why pathogens produce some effectors remains unknown. 
What benefit does Clostridium botulinum gain by producing a toxin that renders a host paralyzed, 
even when the bacterium is well past cleared from a host, but only the toxins remain? Why does 
Vibrio cholerae induce a massive watery diarrhea? Does it facilitate transmission and return of 
the bacterium to the environmental reservoir? Or are humans merely accidental victims to the 
bacteria, and cholera toxin fulfills another role in the environment? Why does Bacillus anthracis 
engage two, highly toxic pathogenic effectors? Do the toxins truly facilitate spread and transfer of 
the bacteria between hosts, or do they, potentially like other toxins, fulfill a yet to be identified role 
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for survival in the environment. Why is diphtheria toxin transferred through a bacteriophage, and 
how did diphthamide come to be a residue on eEF-2? Are there more pathogen targets, ligands, 
and receptors that function solely for interaction with pathogens that we have not discovered? 
Although the study of host-microbe interactions is a monumental area of ongoing research, 
considerable unknowns remain in fundamental questions in the nature of these host-microbe 
interactions, how they formed, their dynamics, and ultimately what are the consequences of those 
interactions. 
 
1.1.2 Strategies to intoxication 
In order to mediate cell-to-cell communication, microorganisms are limited in the basic 
number of mechanisms to mediate this process, given the minute scale of the microbial world. 
For example, bacteria may interact with the environment through the direct release or uptake of 
various molecules from the bacterial cell (ions, small and large organic molecules, etc). 
Alternatively, microbial derived signaling molecules and factors may be directly injected into a 
target host cell, whether it be another bacterium, or a eukaryotic cell. Lastly, if a released factor 
requires protection from the extracellular environment, it may be packaged into bacterial derived, 
outer membrane vesicles, to facilitate delivery and internalization of cargo. Of the various secreted 
effectors, protein toxins are the major class of factors that directly modulate a host cell and 
mediate host-microbe interactions. Throughout evolutionary history, pathogens have evolved so 
these toxins are able to cleverly usurp host cell machinery in order to create a desired effect, such 
as disruption of host cell cytoskeleton, signaling systems, or engaging cell death pathways. 
Different pathogens modulate the host cell environment differently; therefore, protein toxins have 
a variety of different targets within a host cell. In order to reach these targets, it is important to 
understand where within a host cell the toxins function, and how the toxins are trafficked within a 
cell in order to reach a given target.  
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Sec system. While some toxins act at the level of the cell surface, the majority of 
described pathogenic effectors are intracellular acting exotoxins. For this class of toxins, the major 
barrier to intoxication is the host cell plasma membrane. In order to circumvent the plasma 
membrane barrier and gain access to the intracellular environment, several secretion systems 
exist37. The different secretion systems are grouped based on their dependence on the general 
Sec secretion system, which consists of an inner membrane SecYEG complex translocon to 
transport proteins across the inner bacterial membrane to the periplasm. Bacterial proteins 
targeted for Sec dependent secretion are guided by cytosolic ushers to the SecYEG complex38,39. 
After accessing the periplasm, different secretion systems are engaged for the various bacterial 
toxins. In contrast to Sec dependent secretion, the Sec independent secretion systems allow for 
direct transport of a bacterial toxin from the bacterial cytosol to the extracellular space without 
passage through a periplasmic intermediate. This direct transport of toxins and pathogenic 
effectors is mediated by large, multi-protein complexes spanning both the inner and outer 
bacterial membranes. By the Sec independent secretion systems, bacterial toxins may either be 
delivered outside of a bacterial cell into the extracellular space, or directly into a host organism’s 
cytosol via injectosome complexes.  
 T1SS. The Type I secretion system (T1SS) is a Sec-independent secretion system 
whereby toxins are delivered in an ATP dependent manner directly from the bacterial cytosol into 
the extracellular space (Figure 1.3)37. The structure and function of T1SSs are similar to ATP-
binding cassette transporters, which hydrolyze ATP in order to transport molecules across a 
biological membrane40,41, and substrates utilizing the T1SS share a C-terminal secretion 
sequence42. T1SSs are comprised of three major functional regions, including the ATP-binding 
cassette transporter on the inner bacterial membrane, an outer membrane factor on the outer 
bacterial membrane, and a membrane fusion protein that connects the inner and outer bacterial 
membranes40,41. When fully assembled and transporting a substrate, the T1SS forms a 
continuous channel connecting the bacterial cytosol to the extracellular space42. Often, effectors 
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and substrates such as proteases and lipases, and those characterized as repeats-in-toxin (RTX), 
which are proteins containing glycine-rich repeats on the C-terminus42,  are secreted via the 
T1SS37,43. One of the most well characterized T1SS effectors is hemolysin A (HlyA) from 
Escherichia coli40,42. HlyA is a pore-forming alpha toxin of approximately 110 kDa in weight42,44 
and is important for E. coli pathogenesis by inducing lysis of erythrocytes45 as well as mediating 
pyelonephritis46. In addition to HlyA, another well characterized T1SS substrate is the 
multifunctional autoprocessing RTX toxin (MARTX) of Vibrio cholerae47. MARTX is a very large 
toxin, with a molecular weight greater than 485 kDa47, and functions by inducing rounding of host 
cells and disruption of cell-to-cell contact at tight junctions through cross-linking of actin and 
inactivation of the Rho GTPases Rac, Rho, and Cdc4247. 
T2SS. The Type II secretion system (T2SS) is a Sec-dependent secretion system, 
whereby a toxin first passes through the Sec translocon before associating with the T2SS 
translocation machinery to also be released into the extracellular space (Figure 1.3)37. The T2SS 
structurally and functionally is similar to the type 4 pilus apparatus and is comprised of 12 factors 
required for functionality, including a cytoplasmic ATPase, an inner membrane transmembrane 
protein, an outer membrane secretin protein, pseudopilins, and proteins for substrate 
recognition30,48,49. Numerous bacteria have been identified to express T2SSs, including E. coli and 
the heat-labile toxin and chitinase, Legionella pneumophila and phospholipase A and C, 
Burkholderia pseudomallei and phospholipase C and lipase, and Pseudomonas aeruginosa and 
exotoxin A and phospholipase C48,50,51. Of the various T2SS substrates, a highly studied and 
prototypical toxin utilizing the T2SS is the cholera toxin from Vibrio cholerae48,51. Cholera toxin is 
an A-B5 complex, with the A component being 28 kDa in size, and each B component monomer 
being 28 kDa in size30. The secretin component of the T2SS of V. cholerae is comprised of a 
dodecamer channel that transports cholera toxin across the outer bacterial membrane52. Although 
the exact mechanism of toxin secretion is unclear, studies support a “piston-driven” model 
whereby a toxin molecule within V. cholerae resides in a periplasmic vestibule of the T2SS, then 
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through the action of the pseudopilus structure, the toxin complex is pushed through the secretin 
channel to the extracellular space52. 
T3SS. The Type III secretion system (T3SS), also referred to as a syringe-like injectosome 
complex, is a Sec-independent secretion system utilizing a structure homologous to bacterial 
flagella, whereby toxins are directly injected into a host cell cytoplasm in an ATP dependent 
manner (Figure 1.3)37,53. The T3SS is very large complex, comprised of over 20 individual 
components assembled into oligomers, multimers and transmembrane structures resulting in a 
final structure sized in the order of mega Daltons53-55. The T3SS structure includes a basal body 
associated with the inner and outer bacterial membranes, an export apparatus including an 
ATPase and protease associated with the inner bacterial membrane, a translocon, an 
extracellular needle filament and tip, and various accessory proteins and chaperones53,55,56. 
Interestingly, the order and process of assembly of the complex is not universal between all of 
the bacterial genera utilizing a T3SS. For example, Salmonella species assemble the T3SS 
complex through an “inside-out” mechanism, whereby the assembly process begins on the inner 
bacterial membrane and subsequent factors are recruited, whereas Yersinia species assemble 
the T3SS complex through an “outside-in” mechanism, whereby the secretin complex forms on 
the outer bacterial membrane first, followed by assembly of the inner bacterial membrane 
complex53. In addition, different bacterial genera utilize different protein factors to control the 
secretion of toxins from the bacteria via the T3SS53. Numerous pathogens have been described 
to utilize a T3SS, including Escherichia coli, Shigella flexneri, Vibrio cholerae, Burkholderia mallei, 
and Pseudomonas aeruginosa37,53,56. Of the various pathogens utilizing the T3SS, different 
Salmonella enterica serovars have been highly investigated and have provided considerable 
insight into the mechanisms of T3SS assembly and effector function56. Salmonella enterica 
utilizes two major pathogenicity islands, namely Salmonella pathogenicity island -1 and -2 (SPI-
1, SPI-2), which encode effectors secreted by the T3SS57. SPI-1 encodes effectors mostly 
required to initiate infection, including proteins mediating actin polymerization57 and activation of 
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MAPK signaling pathways58. SPI-2 encodes effectors mostly required to invade and establish a 
systemic infection57, including disruption of actin networks and host signal transduction pathways, 
and remodeling of and transport of intracellular Salmonella pathogen containing vacuoles58. The 
repertoire of secreted effectors via the T3SS through Salmonella and other genera of bacteria is 
quite elaborate, and considerable research is ongoing to fully characterize the suite of factors that 
are secreted into host cells.  
T4SS. The Type IV secretion system (T4SS) is similar to T3SS in that factors are directly 
injected into the host cell cytosol by an ATP dependent manner via a Sec independent secretion 
system. However, the apparatus for injection by the T4SS is homologous to bacterial conjugation 
pili (Figure 1.3)37,59,60. Like the other secretion systems, the T4SS has been identified in Gram-
negative bacteria, but it has also been identified in Gram-positive bacteria as well37. The class of 
substrates reported to be transported via the T4SS secretion system is quite large, including small 
proteins, large complexes, and even protein-DNA complexes37,61,62. Given the similarity to 
bacterial conjugation pili, the T4SS has been shown to facilitate both the release, as well as the 
uptake, of DNA to and from a bacterial cell37,61,62. In general, the T4SS is comprised of an inner 
bacterial membrane channel structure, ATPases, an outer membrane pore, and an extracellular 
pilus structure37. Numerous pathogens have been described to engage the T4SS for the transport 
of various factors (including proteins, DNA, or protein-DNA complexes), including Escherichia 
coli, Brucella suis, Bordetella pertussis, Legionella pneumophila, Agrobacterium tumefaciens, and 
Neisseria gonorrhoeae, with one of the most well characterized systems being Helicobacter pylori 
and its cytotoxin-associated genes (cag) pathogenicity island (cagPAI)37,59,61,62. The main 
pathogenic effector of the cagPAI is CagA, an oncoprotein which disrupts the actin cytoskeleton 
and host signaling transduction pathways, resulting in inflammatory responses and inhibition of 
cell death63. Although CagA is the only effector identified to be secreted via the H. pylori T4SS, 
studies have indicated that the T4SS alone is sufficient to activate pro-inflammatory responses 
12 
 
independently of CagA63. These findings indicate that other H. pylori T4SS substrates might exist 
and confer activity to facilitate pathogenesis and interaction with host gastric epithelia.  
T5SS. The Type V secretion system (T5SS) is a Sec-dependent secretion system that is 
commonly referred to as the autotransporter secretion system, for proteins secreted by the T5SS 
translocate across the outer bacterial membrane autonomously (Figure 1.3)37,64. T5SS effectors 
are classified into five categories based on the orientation and mechanism of transport through 
the outer membrane transporter65. However, a basic mechanism and structural topology is shared 
amongst T5SS effectors, including an N-terminal signal sequence conferring recognition and 
passage through the Sec secretion system, a passenger domain conferring toxin activity, and a 
β–barrel translocation domain conferring transport across the outer bacterial membrane65,66. The 
different types of T5SSs are designated Type Va-e65. Type Va is the classical autotransporter 
system, which is comprised of monomeric autotransporters with an N-terminal signal sequence 
that are kept unfolded prior to outer membrane insertion and transport of the passenger domain65. 
The Type Vb secretion system is characterized by consisting of two separate peptides, the 
passenger domain and the translocation domain, with the transport process occurring in two 
distinct steps65. The Type Vc secretion system is characterized as a trimeric complex, with the 
passenger domain remaining attached to the outer bacterial membrane (whereas other T5SS 
passenger domain effectors are cleaved and released)65. The Type Vd secretion system is similar 
to the Type Va system, but the C-terminus of the passenger domain is attached to a periplasmic 
polypeptide transport-associated (POTRA) domain65. Finally, the Type Ve secretion system is a 
proposed system whereby proteins are secreted similar to Type Va, but the orientation of the 
passenger domain to the transport domain is reversed, with the C-terminus of the passenger 
domain facing the extracellular space (compared to the N-terminus of the Type Va secretion 
system)65. Similar to other secretion systems, numerous pathogens have been described to utilize 
autotransporters, including Pseudomonas aeruginosa and its PlpD protein67, Neisseria 
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meningitidis and its AspA and IgA protease68,69, and Bordetella pertussis and its Pertactin 
protein70. 
T6SS. The Type VI secretion system (T6SS) is a relatively recently discovered system 
whereby a bacterial cell directly injects pathogenic effectors into a host cell, including either a 
eukaryotic host cell or a bacterial cell (Figure 1.3)37,71,72. Similar to the other direct injection 
secretion systems, the T6SS is a large complex, consisting of more than 13 individual protein 
types73. Interestingly, whereas the T3SS is similar to bacterial flagella and the T4SS is similar to 
bacterial conjugation pili, the T5SS is similar to the T4 bacteriophage tail injection apparatus, with 
the orientation of the machinery reversed by having the tail spike directed towards the 
extracellular space73,74. To add further intrigue regarding the importance and role of the T6SS, 
whereas other secretion systems are commonly associated with human or animal pathogens, the 
T6SS is not, but instead more commonly found in environmental bacteria73. It is therefore 
postulated that the T6SS may function as a means to mediate bacterial cell-to-cell 
communication73,75. To that end, studies have illustrated a “bacterial warfare” scenario whereby 
one bacterium, such as Pseudomonas aeruginosa, responds to direct contact and T6SS mediated 
injection from another bacterium, such as Vibrio cholerae75. The effectors transported through the 
T6SS varies, but mostly are directed towards damaging the recipient cell. T6SS effectors are 
generally classified into three main groups, including effectors that disrupt the host cell wall, 
membrane structure, or target host nucleic acid76,77. For example, Pseudomonas aeruginosa 
utilizes the T6SS to transport Tse1, a protein which degrades peptidoglycan in a recipient host 
cell78. Both Pseudomonas aeruginosa and Vibrio cholerae inject Tle protein effectors that target 
phospholipid head groups on host cell membranes77. Finally, the Rhs proteins of Dickeya dadantii 
contain endonuclease activity and function to degrade host cellular nucleic acid79. Altogether, 
much remains to be elucidated in the T6SS and its role in mediating microbial communities and 
response to a given environment. 
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T7SS.The Type VII secretion system (T7SS) has been described and characterized 
primarily in mycobacteria species, as well as several Gram-positive bacteria. The mycobacterial 
cell wall consists of a plasma membrane of similar composition to that of the inner membrane of 
Gram-negative bacteria, a periplasmic space, and a mycomembrane comprised of long chain 
mycolic acids (Figure 1.3)80. Although the full composition of the T7SS machinery remains to be 
elucidated, several components have been identified with the estimated size of the complex being 
1.5 mega Daltons, including a core channel spanning the plasma membrane, an ATPase subunit, 
a mycosin protease hypothesized to process T7SS substrates, and two cytosolic factors proposed 
to function as a chaperone and ATPase for the T7SS apparatus80. In Gram-positive bacteria, the 
T7SS may serve a role similar to the T6SS in Gram-negative bacteria, whereby effectors are 
target competing bacteria through bacterial cell-to-cell communication. For example, 
Staphylococcus aureus engages a T7SS to transfer a nuclease toxin, EsaD, that, interestingly, is 
neutralized by another S. aureus protein, EsaG81. Studies have evaluated the distribution of S. 
aureus strains producing EsaD and EsaG, and have postulated that the presence of EsaG serves 
as a protective measure against other EsaD producing bacteria, and that by producing EsaD, S. 
aureus is able to compete with either EsaG deficient S. aureus strains, or other bacteria that do 
not express EsaG81. This relatively simple system of encoding a bacterial toxin while also 
producing a neutralizing factor illustrates the elegance of bacterial cell-to-cell communication and 
dynamics, and how one cell is able to protect itself from neighboring microbes.  
Understanding the mechanism of bacterial toxin and pathogenic effector secretion holds 
considerable value in not only deciphering host-microbe interactions, but it also provides an 
important application. Often, bacterial toxins evade immune detection and response due to limited 
contact with immune cells, as the toxins often act intracellularly. If therapeutics may be developed 
to target not the bacterial toxin, but rather the secretion machinery, then the pathogenic effector 
is prevented from ever reaching the extracellular space and the ultimate target within a host cell. 
Although much work has been completed in the study of bacterial secretions systems, much 
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remains to be understood. For example, the T6SS and T7SS are relatively newly described 
mechanisms, which protein factors comprise the secretion systems and what governs the 
apparatus assembly? Given the diversity of secretion systems, why would a pathogen use, and 
more importantly, what does it gain from using one secretion system over another? Considerable 
intrigue remains regarding the origins of the secretion systems, especially the T3SS and its 
similarity to bacterial flagella, the T4SS and its similarity to bacterial conjugation systems, and the 
T6SS and its similarity to the bacteriophage injection machinery. How were microbial machinery 
able to be repurposed into secretion systems? Are the other secretion systems similar to 
machinery yet to be appreciated? And finally, considerable interest arose in the discovery of the 
T6SS, not only because of the sheer size of the structure and how it was evaded observation for 
so many years, but also for the role of the system in bacterial cell-to-cell communication. Do the 
secretion systems merely function to deliver toxic cargo from a bacterium to a host, or are there 
other roles that these systems may fulfill in regards to a bacterium surviving in a given 
environment. 
Intracellular toxin trafficking. Although many toxins exert their biological activity on the 
surface of a host cell, numerous toxins act intracellularly. For intracellular acting exotoxins, a 
major barrier to overcome is the host cell plasma membrane. For toxins that are injected into host 
cells via the T3SS or T4SS, the challenge of bypassing the host plasma membrane is completed 
via the different injectosome apparatuses. However, for toxins that are released into the 
extracellular space by either the T1SS, T2SS, or T5SS, alternative strategies are engaged to 
access the cytosol or other cellular target. Most intracellular acting exotoxins originating from the 
extracellular space enter cells by one of two general mechanisms, either usurping canonical 
retrograde trafficking machinery, or undergoing conformational changes upon exposure to acidic 
intracellular compartments (Figure 1.4). Although the precise mechanism of why a toxin would 
be transported through one pathway versus the other remains yet to be fully appreciated, 
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structural differences and conserved toxin features have been identified, lending insight into the 
characteristics of a toxin being trafficked through either of the two pathways. 
Retrograde trafficking. Retrograde transport is a mechanism whereby extracellular 
material is trafficked opposite of the canonical secretion system, whereby cargo binds to the cell 
surface, is internalized into endosomes, and then further trafficked to the Golgi apparatus with 
ultimate destination in the endoplasmic reticulum (ER) (Figure 1.4). The ER serves as a final 
platform whereby bacterial toxins or viral particles escape into the host cell cytosol. Although 
numerous pathogens have been described to utilize retrograde transport, the exact molecular 
machinery governing the process varies. Classical retrograde trafficked bacterial toxins include 
cholera toxin of Vibrio cholerae, Shiga-like toxins of Shigella dysenteriae and Escherichia coli, 
Pseudomonas exotoxin A of Pseudomonas aeruginosa, and ricin of the castor bean plant Ricinus 
communis82-86. These toxins are A-B toxins, containing and active catalytic domain, and at least 
one binding domain82. Interestingly, toxins that undergo retrograde transport have little to no lysine 
residues, thus providing a clever yet simple means to hijack transporters involved in the unfolded 
protein response while also evade host cellular ubiquitin mediated degradation82,87,88. After 
binding to a cell surface receptor, such as the GM1 ganglioside for cholera toxin84 or low-density 
lipoprotein receptor-related protein for Pseudomonas exotoxin A89, a toxin is then endocytosed 
into caveosomes or endosomal compartments, such as recycling endosomes or early 
endosomes, with the small GTPase Rab5 and often clathrin coated vesicles being an important 
mediator in early transport steps82,83. In order to then traffic to the Golgi apparatus, many toxins 
first pass through the trans-Golgi network, which serves as a final docking and sorting platform 
for secretion vesicles. Toxins may gain access to the trans-Golgi network through a process either 
dependent or independent of the GTPase Rab982. In addition, transport at the level of the Golgi 
apparatus may involve different SNARE (soluble NSF (N-ethylmaleimide-sensitive factor) 
attachment protein receptor) proteins, including VAMP4, Syntaxin 5, and Syntaxin 1682,83. For 
subsequent transport to the ER, toxins may utilize either a KDEL or COP-I dependent or 
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independent transport82. KDEL is an amino acid sequence directing proteins to the ER90, whereas 
COP-I is a protein complex that coats intracellular vesicles and directs the transport of cargo from 
the Golgi apparatus to the ER91. At the level of the ER, translocons exist, including Derlin and 
Sec61β, in order to transport unfolded proteins into the cytosol for degradation by a process 
known as ER associated degradation (ERAD)92,93. As many retrograde trafficked toxins lack lysine 
residues, the toxins pass through the translocons into the cytosol, but do not undergo ubiquitin 
mediated degradation in the proteasome. After gaining access to the cytosol, the various 
pathogenic effectors and toxins are exposed to an abundance of different host factors, and may 
then exert their toxic activity. 
pH mediated trafficking. In contrast to the retrograde trafficking pathway of 
internalization and transport through the Golgi apparatus and endoplasmic reticulum, other 
bacterial toxins take advantage of canonical endosomal transport machinery and physiological 
changes to acidify intracellular compartments (Figure 1.4). Classical toxins that exploit host cell 
endosomal acidification include Toxin B of Clostridium difficile94, anthrax toxins (lethal factor, 
edema factor, and protective antigen) of Bacillus anthracis95-97, the clostridial neurotoxins 
(botulinum toxin of Clostridium botulinum, and tetatus toxin of Clostridium tetani)98,99, binary iota-
toxin of Clostridium perfringens100, and diphtheria toxin of Corynebacteria diphtheria101,102. Similar 
to retrograde transport, the pH triggered pathway begins by an A-B structured toxin binding to a 
cell surface receptor. Binding to the cell surface triggers endocytosis, resulting in the delivery of 
the toxin to early endosomal compartments. Physiologically, early endosomes may be segregated 
into one of two general pathways, either towards recycling endosomes to return to the cell surface 
via the action of the GTPases Rab4 or Rab11, or towards late endosomes for degradation via the 
action of Rab7103,104. Early endosomes that mature into late endosomes subsequently fuse with 
lysosome, with these newly formed degradative compartments containing various proteases, 
hydrolases, and lipases104. In addition, the endolysosomes contain large V-ATPases, which pump 
protons into the endolysosomal lumen via the hydrolysis of ATP, and thus confers a drastic 
18 
 
reduction in lumenal pH, changing from ~6.1-6.8 in early endosomes, to 4.8-6.0 in late 
endosomes, to 4.5 in lysosomes104. Physiologically, this drop in lumenal pH activates lysosomal 
degradative enzymes and thus facilitates the breakdown of lysosomal cargo104. Bacterial toxins 
contained within earlier transport compartments continue unaffected and unchanged, until the 
decrease in pH triggers conformational changes. Often, the conformational change occurs in the 
B component of the toxin complex, forming a membrane spanning translocon. The catalytic A 
component of the toxin complex is subsequently passed through the newly formed translocon, 
and refolds in the host cytosol, where the toxin may exert its toxic activity. Given the medical 
significance of many of the pH mediated transport toxins, the molecular mechanism governing 
the conformational changes to low pH and subsequent transport and escape of the catalytic A 
component have been elucidated in exquisite detail. For example, edema factor (EF) and lethal 
factor (LF) are the catalytic A components of Bacillus anthracis and bind to protective antigen 
(PA), which is produced by B. anthracis and functions as a B component binding platform to 
internalize EF and LF97. PA itself binds to one of two receptors on the host cell surface, recognized 
as anthrax toxin receptor 1 or 2 (ANTXR1, ANTXR2), with ANTXR1 having a lower binding affinity 
for PA97,105,106. After internalization of the entire complex, ANTXR1 and 2 function as a “molecular 
clamp” to prevent PA from forming a pore, but when the pH of the anthrax toxin containing 
compartment reaches 6.0 for ANTXR1 or 5.0 for ANTXR2, residues are protonated in defined 
receptor domains, and PA forms a pore97. The simplicity of a toxin being protonated in order to 
undergo conformation changes to transport a catalytic toxic protein to a host cytosol is a 
remarkable adaptation of bacterial pathogens to usurp physiological processes in order to 
facilitate pathogenesis. 
Outer membrane vesicles. An alternative strategy that some pathogens engage to 
transport and release toxic material is via secreted outer membrane vesicles, or OMVs. Although 
additional studies are needed to fully characterize their function and importance in vivo, OMVs 
have been described to occur as either a quality control response to damaging stimuli, or as a 
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means to release toxins for delivery to host cells. Vesicle transport is most certainly a major means 
to transport cargo within the eukaryotic cell via the endomembrane system. But interestingly, 
extracellular vesicle formation, release, and transport is a field that is gaining considerable 
attention. Relatively recently, a process by which eukaryotic cells release extracellular vesicles, 
termed exosomes, was described. By this process, small vesicles derived from late endosomal 
compartments are contained within larger multivesicular structures that fuse with the plasma 
membrane107. Although the biological function of exosomes in vivo remains to be fully understood, 
the structures have been postulated to mediate cell to cell communication and immune responses 
via the exchange of biological membranes and membrane embedded protein complexes107-109. 
Similarly, Gram-negative bacteria are capable of forming and releasing vesicles from the outer 
bacterial membrane, termed OMVs. OMV formation allows bacteria to release factors in a 
protected state that may not otherwise be functional in the extracellular space, such as factors 
that are easily degraded or are not soluble, such as the hydrophobic quorum-sensing factor PQS 
of Pseudomonas aeruginosa110,111. Bacteria may produce OMVs as means to quickly repair 
damaged cell membranes, including removal of aggregations of unfolded or misfolded proteins, 
proteins damaged by oxidative stress, cell surface bound antibiotics, or bacteriophages110,112,113. 
OMVs may also function to scavenge nutrients by releasing degradative enzymes from 
environmental molecules, or as a means to deliver toxins to host cells undetected but extracellular 
immune response pathways114,115. Many Gram-negative bacteria have been described to form 
OMVs, most notably Escherichia coli112,116,117, Vibrio cholerae, Salmonella species, and 
Pseudomonas aeruginosa110,115. The process of forming vesicles from a cell surface and using 
the vesicles as a means to transport and deliver cargo is shared between bacteria and eukaryotic 
cells, and the vast repertoire of functions of these vesicles continues to be elucidated.   
In conclusion, the mechanisms by which pathogens deliver toxic cargo to a destination on 
or within a host cell are exquisite in their simplicity. By engaging chaperones and small 
transporters, toxins can reach the bacterial periplasm. By assembling large channels, toxins can 
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reach the extracellular space or even the host cytosol directly. By usurping canonical eukaryotic 
cellular trafficking machinery, extracellular toxins gain access to the intracellular environment. 
And by packing cargo into vesicles, pathogens may deliver complex and environmentally sensitive 
toxins to host cells unscathed. Often, these strategies go unnoticed by the host immune system 
defenses, and toxins are released and internalized without recognition. Not until cellular 
physiology is disrupted or cells are damaged, are the alarms sounded and an immune response 
is mounted. The strategies are simple, but the results are often complex, and profound on the 
health of the host.  
 
1.1.3 Organelle targeted pathogenic effectors 
From the perspective of a microbe, a host eukaryotic cell is a vast and massive treasure 
trove of potential targets. Billions of individual molecules, millions of proteins, dozens of signaling 
transduction pathways, and a handful of organelles, all potential targets and substrates for a 
pathogen. While some targets are less likely to hamper cellular physiology if disrupted, especially 
given eukaryotic cellular redundancy and the quantity of various factors, others may have a 
profound effect, as exemplified with Bacillus anthracis lethal factor and edema factor, the 
clostridial neurotoxins, Corynebacterium diphtheria diphtheria toxin, and Vibrio cholerae cholera 
toxin. Enzymatic change of a single substrate in a key signaling transduction pathway may quickly 
potentiate into a massive, pan-cellular response. For many toxins, their action is not defined by 
targeting a cytosolic factor, but rather, an entire organelle. Although organelles are immense in 
size, especially in regards to the endoplasmic reticulum and mitochondria, by-and-large, cells lack 
organellar redundancy and compensatory mechanisms. Often, disruption of even a relatively 
small region of a large organelle potentiates into organelle-wide dysfunction, further spreading to 
global cellular dysfunction. Therefore, the mechanisms by which bacterial toxins target host 
organelles, and the toxic activity at or within an organelle, is an evolved, specific process that 
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ultimately benefits the ability of a pathogen to establish an infection, adapt to its environment, and 
cause disease.  
Nuclear targeting. The control center of a eukaryotic cell lies in the nucleus, an organelle 
that houses a cell’s genetic material and regulates the expression of proteins in response to 
incoming signals. Given the regulation of gene transcription originates in the nucleus and the 
essential protection and maintenance of host DNA, the nucleus serves as an attractive target to 
pathogens for the potential to profoundly disrupt cellular physiology exists even in response to 
relatively mild damage (Figure 1.5). A major mechanism by which a cell regulates gene 
transcription is through the modification of histones118, either through methylation119, 
acetylation120, ubiquitination121, or phosphorylation122. By either inducing or inhibiting histone 
modification, pathogens may directly alter genetic transcriptional profiles. For example, Legionella 
pneumophila produces a T4SS effector known as RomA, or regulator of methylation A123. RomA 
directly localizes to the host cell nucleus via the recognition of a nuclear localization sequence 
(NLS), where it exerts its methyltransferase activity to directly modify a nuclear histone123. 
Interestingly, although histone modification sites have been mapped in exquisite detail, the RomA 
histone methylation site, H3K14, has not been previously described as a physiological methylation 
site, but has been identified as an acetylation site123. This finding indicates that perhaps bacterial 
toxins are able to take advantage of or switch post-translational modifications of histones as a 
means to alter gene regulation. In addition to modulating gene expression through histones 
modifications, pathogens may also directly damage host DNA by producing nucleus localized 
nucleases. Double-stranded DNA breaks have been observed in pathogen infected cells, 
including Helicobacter pylori124, but has also been shown to occur through pathogen derived toxic 
nucleases, with one of the most notable of which being the cytolethal distending toxins (CDT) 
produced by various bacteria, including Escherichia coli, Campylobacter jejuni, Shigella sonnei, 
Shigella dysenteriae, Haemophilus ducreyi, and Actinobacillus actinomycetemcomitans125,126. 
Intoxication of host cells with CDT, which directly localizes to the nucleus, results in cell cycle 
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arrest, cellular distention, and ultimately cell death, and the toxic activity of CDT is attributed to a 
subunit that is functionally similar to the type I deoxyribonuclease125,126. Altogether, targeting of 
the nucleus may allow for subtle changes to transcriptional profiles in order evade immune 
evasion, or it may result in severe, irreversible damage leading to cell death. 
Endoplasmic reticulum targeting. The endoplasmic reticulum (ER) is a massive network 
of tubular cisternae, lending the ER to be the largest organelle within the cell. The ER functions 
as a platform for protein synthesis and sorting of newly formed proteins within a cell as well as 
the site of lipid and hormone synthesis and detoxification127. In addition, the ER is a major sensor 
and signaling hub of cellular stress. By accumulating unfolded, misfolded, or damaged proteins 
and activating the unfolded protein response, or via the release of calcium into the cytosol, ER 
stress may be communicated to the surrounding cell as a means to promote an inflammatory 
response128,129 or to active cell death130. Therefore, given the role of the ER in providing a cell with 
newly formed biomolecules, sorting factors to be specifically trafficked within the cell, and as a 
sensor and communicator of cellular stress, the ER also serves as an attractive target to 
pathogens131 (Figure 1.5). As described previously, the ER may be used during retrograde 
trafficking as means for toxins to gain access to the cytosol via the ER-associated degradation 
(ERAD) translocons, such as with cholera toxin of Vibrio cholerae132 and Shiga toxin of Shigella 
dysenteriae and Escherichia coli133. Other pathogens, however, use the ER as a location for 
replication. Brucella species (most notably B. abortus, B. cais, B. melitensis, B. suis), are zoonotic 
and often foodborne or sexually-transmitted pathogens resulting in fever and weakness, with 
some cases involving the urogenital tract with neurological signs and even death134. Brucella is 
an intracellular pathogen, mostly residing within macrophages, and is able to subvert macrophage 
killing by releasing pathogenic effectors once inside a host cell that prevent the recognition and 
fusion of lysosomes with pathogen containing vacuoles134,135. Interestingly, although the role in 
pathogenesis is unclear, Brucella containing vacuoles are heavily associated with the ER, with 
specific recruitment and fusion of the ER with the Brucella vacuoles through a process that is 
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dependent upon the T4SS effector VirB134-137 with a potential role of the host GTPase Rab2138. 
Similar to Brucella, Legionella pneumophila, the causative agent of the pneumonia Legionnaires’ 
disease, evades cellular defenses by residing within an intracellular pathogen containing 
vacuoles139. Also similar to Brucella, the Legionella containing vacuoles are also composed of 
host ER membranes and this association is important for the ability of L. pneumophila to survive 
within a host cell, replicate, and further pathogenesis139,140. In addition, this process of ER 
recruitment to Legionella containing vacuoles involves the release of the T4SS effectors SidC141, 
SidJ142, and LegK2143. The ER is a massive organelle, comprising a substantial portion of the host 
cell membrane and protein, and thus it is reasonable to ascertain that the ER is an attractive target 
to intracellular pathogens that require host cellular material in order to maintain a replicative niche 
within a host cell. In addition to feeding pathogen-containing vacuoles, the ER serves as a 
signaling platform to cellular stresses, and if pathogens are capable of inhibiting this feedback 
loop, then immune defenses are hampered and the ability of a pathogen to establish an infection 
is heightened.  
Mitochondrial targeting. As the powerhouses of the cell, mitochondria supply a host cell 
with the energy currency of ATP. However, the role of mitochondria in recent years has expanded 
to include sensing and responding to cellular stresses, potentiating cell death pathways, providing 
substrates for the synthesis of other biological molecules within a cell, and immune signaling. 
Interestingly, many pathogens, including bacteria, viruses144-146, and protozoan parasites147, have 
been described to either indirectly affect mitochondrial function, or directly through the action of 
mitochondrial localized pathogenic effectors (Figure 1.5). For bacterial pathogens, classical 
mitochondrial targeted pathogenic effectors include PorB of Neisseria meningitidis and N. 
gonorrhoeae148, LncP of Legionella pneumophila149, Orf19 (Map) and EspF of Escherichia coli150-
152, toxin A of Clostridium difficile153, HopG1 of Pseudomonas syringae154, VacA of Helicobacter 
pylori155, and Ats-1 of Anaplasma phagocytophilum156. While the mechanism of mitochondrial 
targeting for many pathogens, and the ultimate consequences of direct mitochondrial targeting by 
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a pathogenic effector is unknown, for some pathogens, canonical mitochondrial targeting 
sequences have been identified, whereby a toxin exquisitely usurps physiological mitochondrial 
protein transport machinery. For example, EspF is a T3SS effector of E. coli that is important for 
disrupting cell-to-cell tight junctions and ultimately activates host cell death. In order for 
physiological proteins to be transported into mitochondria, they often require an N-terminal 
mitochondrial targeting sequence, or MTS, which is not comprised of a particular sequence of 
residues, but rather a similar biochemical composition, which often includes positively charged or 
hydroxylated residues, such as arginine, serine, alanine, or leucine that form an amphipathic 
helix157. EspF of E. coli not only reaches the mitochondrial matrix, but the first 34 N-terminal 
residues closely resemble a canonical MTS, in that it contains mostly arginine and hydroxylated 
residues and forms an amphipathic helix151. In addition to incorporation of a mitochondrial 
targeting sequence, pathogens may instead mimic protein structures that are recognized for 
mitochondrial import, with the most notable of which being β–barrel proteins158. Neisseria 
gonorrhoeae is the causative agent of the sexually transmitted disease gonorrhea, and an 
important virulence factor of N. gonorrhoeae is a pore-forming toxin called PorB148,159. 
Interestingly, not only is PorB structurally and functionally similar to the mitochondrial channel 
VDAC (voltage-dependent anion channel)160, but by utilizing the TOM20 and TOM40 complex, 
both proteins are inserted into the outer mitochondrial membrane via a similar mechanism160. 
Similar to targeting of the nucleus and endoplasmic reticulum, targeting of the mitochondria by 
pathogens has the potential to result in a multitude of effects, ranging from slight perturbations of 
metabolism to irreversible induction of cell death. While some pathogens indirectly affect 
mitochondrial function, in a remarkable example of adaptation, many produce effectors that mimic 
endogenous mitochondrial targeting sequences or structural motifs in order to achieve localization 
to the mitochondria.  
Endolysosomal targeting. The endolysosomal system is a dynamic series of vesicles 
and transport networks along microtubules that function to move cargo throughout a cell. The 
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endolysosomal system effectively functions in two directions, either away from the cell surface 
during endocytosis, or towards the cell surface during exocytosis. Endocytosis is a process by 
which extracellular material, including recycling of plasma membrane domains, is internalized into 
a host cell. Although pathways might diverge, endocytosis is mostly mediated by the small 
GTPases Rab5, Rab7, and Rab9161. If material is targeted for recycling from early endosomes to 
return to the plasma membrane, then the vesicular cargo passes through recycling endosomes 
mediated by the action of Rab11161. To the contrary, during exocytosis, proteins synthesized in 
the endoplasmic reticulum are packaged into small vesicles and after being processing in the 
Golgi apparatus, fuse with the plasma membrane and release their respective cargo161. Various 
Rab GTPases mediate this process, including Rab1, Rab2, Rab3, and Rab27161. Many pathogens 
have been able to take advantage of the endocytic pathway, as that avenue allows for 
extracellular material to enter a host cell (Figure 1.5). As described earlier, numerous toxins 
undergo endocytosis into endocytic compartments and diverge into trafficking via retrograde 
transport or pH mediated translocation to the cytosol. However, other pathogens use the system 
as a replicate niche within a host cell, whereby an entire pathogen is endocytosed and evades 
immune and host detection by residing within a pathogen containing vacuoles. Two well described 
pathogens utilizing the endocytic pathway for pathogenesis include Salmonella enterica and 
Coxiella burnetii. Salmonella enterica is a Gram-negative bacterium that is mostly notably the 
causative agent of foodborne illnesses, characterized by diarrhea and abdominal cramps. After 
initial interaction with host cells, Salmonella bacteria are internalized into pathogen-containing 
vacuoles that initially contain markers of early endosomes, including EEA1, transferrin receptor, 
and Rab5, which are ultimately lost and the vacuoles mature into non-degradative compartments 
suitable for bacterial replication and survival162-164. This process is mediated by several pathogenic 
effectors, including SopB, SseJ, and SifA, which differentially regulate the maintenance and 
remodeling of the vacuolar membrane162,163,165-167. Coxiella burnetii is a Gram-negative bacterium 
and is the causative agent of Q-fever, a disease characterized by flu-like symptoms, including 
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fever, muscle and joint pain, cough, and diarrhea. Like Salmonella, Coxiella is an intracellular 
pathogen, residing in pathogen-containing vacuoles. However, while other pathogens limit or 
prevent the fusion of degradative machinery with the pathogen-containing vacuoles, Coxiella does 
not, and instead replicates in a rather harsh environment being exposed to acidic pH and 
degradative enzymes168. The pathogen-containing vacuole is indeed formed through the 
endosomal system, with canonical markers including Rab5, Rab7, v-ATPase, VAMP7, LAMP1, 
and LC3168-171. Although not fully understood, this vacuole maturation process and the ability of 
Coxiella to evade intracellular killing is mediated through various effectors, including Cig2 and 
development of a degradative vacuole172, and CvpA and early routing of the vacuole to the 
phagolysosomal pathway173. Altogether, the endosomal system may be manipulated by 
pathogens via two general processes. First, toxins may utilize endosomal routing network as a 
means to gain access to an intracellular target. Also, intracellular pathogens may remodel early 
endosomal compartments to function as a pathogen-containing vacuole to not only evade host 
immune defenses, but also a location to replicate and ultimately disseminate an infection. 
Golgi apparatus targeting. The Golgi apparatus is a complex of cristae, tubules, and 
vesicles that functions to receive proteins from the endoplasmic reticulum, apply post-translational 
modifications such as glycosylation and sulfation, with final preparation and packaging of vesicles 
for transport to the cell surface via exocytosis or to other locations within the cell. In addition, the 
Golgi apparatus is an important platform for synthesizing lipids, especially glycolipids and 
sphingolipids. To that end, pathogens, similar to hijacking of the endosomal system and 
endoplasmic reticulum, utilize the machinery of the Golgi apparatus to remodel physiological 
cellular membrane compartments into suitable replication niches (Figure 1.5). For example, 
Chlamydia trachomatis is a Gram-negative bacterium and the causative agent of the sexually 
transmitted disease chlamydia, a disease manifested as urogenital signs, respiratory distress, or 
ocular disease. Similar to other pathogens discussed, Chlamydia is an intracellular pathogen, 
residing within pathogen-containing vacuoles, termed inclusions, that are derivatives of 
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endosomal compartments and are not degradative in composition. Interestingly, it was observed 
that the membranes of the pathogen-containing vacuoles are enriched in cholesterol and 
sphingomyelin, and through an elegant series of experiments, the importance of the Golgi 
apparatus in the remodeling of the pathogen-containing vacuoles was demonstrated174. In 
addition, Chlamydia bacteria are able to acquire Golgi-derived vesicles in order to maintain the 
pathogen-containing vacuole, whereby the host proteins Rab6, Rab14, and Rab11 are usurped, 
resulting in disruption of Golgi apparatus physiology and structure175-178. Furthermore, the 
remodeling of the pathogen-containing vacuole via the recruitment of host membranes, proteins, 
and lipids, appears to involve the pathogenic effectors Pls1 and Pls2179, IncA180,181 and the Lda 
proteins182. Similar to its interactions with the endosomal system, Salmonella utilizes material from 
the Golgi apparatus in order to remodel the Salmonella pathogen-containing vacuole. As describe 
previously, Salmonella engages two pathogenicity islands upon infection, termed SPI-1 and SPI-
2, with SPI-1 mediating invasion into cells, and SPI-2 mediating systemic infection after 
internalization. Upon entering a host cell and SPI-2 T3SS being activated, effectors are secreted 
into the cytosol, some of which facilitate remodeling of the pathogen-containing vacuoles. Of note, 
SseF and SseG are SPI-2 T3SS effectors that redirect vesicles derived from the Golgi apparatus 
to the pathogen-containing vacuoles with a model that SseF and SseG form a tethering complex 
between the vacuole and the Golgi, and SteA which directly localizes to the Golgi apparatus and 
is important for the formation of the pathogen-containing vacuole183-185. The Golgi apparatus 
serves as a rich resource of protein modification machinery, nascent lipids and proteins, and host 
membranes. By taking advantage of the Golgi apparatus, intracellular pathogens are able to 
harness essential nutrients and factors in order to establish a replicative niche within a host.  
Cytoskeletal targeting. The cytoskeleton is a massive interconnected network of 
filaments and tubules that function not only to provide the shape and structure of a cell, but the 
cytoskeleton also provides the physical pathways by which intracellular vesicles and organelles 
are trafficked and positioned, and the physical force to move material within a cell. The eukaryotic 
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cytoskeleton is comprised of three major divisions: microtubules of α– and β-tubulin, actin 
microfilaments, and intermediate filaments of vimentin, lamin, or keratin186. Given the major 
cellular modulatory roles of the cytoskeleton, numerous pathogens have been described to 
manipulate the cytoskeleton, including Clostridium perfringens via the iota toxin187, Shigella 
flexneri via IpaA and IpaC188, Clostridium botulinum via the C2 toxin189, and Yersinia 
pseudotuberculosis via YopT, YopE, and YopH190. Of the various pathogens that target the host 
cytoskeleton, none do so as effectively and as elegantly as Listeria monocytogenes. L. 
monocytogenes is a Gram-positive bacterium, and the causative agent of the foodborne disease 
listeriosis, which is characterized by diarrhea and may proceed to sepsis or meningoencephalitis. 
One of the most characteristic features of L. monocytogenes, which attributes to it being 
considered highly pathogenic, is its high degree of motility and thus invasiveness through the 
tissue of a host. This ability is mostly mediated via the pathogenic effector ActA, which induces 
actin nucleation near a bacterial cell191,192. This actin nucleation results in the formation of an “actin 
comet” or “actin rocket” which propels L. monocytogenes into a neighboring cell, where the 
process repeats193,194. As described previously, Salmonella is an invasive pathogen that utilizes 
various effectors in order initiate and potentiate pathogenesis within a host. As with Listeria, 
Salmonella also usurps the host cytoskeleton, but rather than using actin as a means of propulsion 
our of one cell and into another, Salmonella uses actin to facilitate internalization by forming 
“ruffles” on the cell surface that are mostly composed of actin. In order to form membrane ruffles, 
Salmonella engages numerous effectors, including SopE, a Cdc42 and Rac GEF resulting in the 
formation of membrane ruffles195, and SipA, a factor which promotes the process of actin 
bundling196-198. Interestingly, although Salmonella infection utilizes a dramatic series of events and 
changes to the cell surface in order to facilitate internalization, cells do not remain in a 
disorganized state in regards to the cytoskeleton. Salmonella also produces the effector SptP, a 
Cdc42 and Rac GAP which works against SopE in order to promote the return of the cytoskeleton 
to a physiological state199,200. This ability of Salmonella to manipulate the cytoskeleton lends an 
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interesting insight into the evolution and adaption of a pathogen to changes in the host cell 
environment, ultimately resulting in a highly invasive pathogen. 
The various organelles within a cell serve a plethora of functions, ranging from basic 
structural components to massive signaling platforms. For nearly all major systems that have 
been described, pathogens have been found to manipulate those systems. However, what lends 
considerable intrigue is how those systems developed over time. Under what set of conditions 
was a bacterial effector first able to traffic to the nucleus, and through what encounters did the 
pathogen develop a toxin to specifically cleave DNA? How was the feedback achieved? Certainly 
pathogens that use a host cell for invasion were easily positively or negatively selected for 
depending on whether or not the bacterium was able to invade, but how did that selection occur 
for pathogens with more subtle manipulation of cellular functions, such as through the nucleus or 
mitochondria? Many pathogens produce effectors with exquisite molecular mimicry, whether it be 
through acquisition of canonical nuclear localization sequences or mitochondrial targeting 
sequences, or usurping the activity of endogenous actin nucleation factors. How did that process 
occur? Were pathogens able to target host factors through other means that were negatively 
selected against due to host defenses? If so, what are they and how did that interaction occur? 
Are there more pathogens that cleverly mimic host factors, motifs, or signal sequences? If so, 
how is it that they were able to go undetected for so long? The simply ability of pathogens to 
manipulate and usurp host cellular physiology is a remarkable demonstration of host-pathogen 
interactions and a dynamic interplay that evolved over time. Furthermore, considerable effort is 
ongoing to understand these interactions and how they themselves might be targeted as a 
countermeasure to prevent infections from occurring altogether.  
 
1.2 Mitochondria and endomembrane system 
The endomembrane system is a highly regulated and complex series of pathways 
connecting various organelles throughout a cell. Depending on the transport cargo and trafficking 
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machinery, membrane bound vesicles and small compartments are transported between the 
endolysosomal system, the endoplasmic reticulum, the Golgi apparatus, the plasma membrane, 
and the nuclear envelope. This process is essential for the ability of cellular material to be 
distributed to the various organelles in order to maintain homeostasis. However, and quite 
interestingly, the mitochondria have not been described to participate in any vesicle trafficking 
whereby membranes traffic to and fuse with the mitochondria. Speculation to this phenomenon 
arises from the origin of mitochondria, in that the organelle was acquired by an ancestral precursor 
to a eukaryotic cell through endocytosis of an organism originating from α-proteobacteria, 
resulting in an endosymbiotic relationship201. Although no reports of membrane fusion have been 
found of vesicles or other cellular compartments being transported to the mitochondria, reports 
have shown mitochondria to form direct contacts and tethers with other organelles through protein 
mediators. Recently, the mechanism of mitochondrial derived vesicles was described202, whereby 
in response to mitochondrial dysfunction, small subdomains of the mitochondria that are 
dysfunctional are selectively removed via vesicles and sent to lysosomes or peroxisomes for 
degradation203-205. To add further intrigue to this newly described pathway, some have postulated 
that perhaps these mitochondrial derived vesicles are reminiscent of bacterial outer membrane 
vesicles, and perhaps our ancient bacterial ancestor retained its ability to respond to extracellular, 
or extra-mitochondrial, stressors, as a means to maintain the functionality of the organism or 
organelle itself. Regardless, the mitochondria are highly dynamic organelles. The structure of the 
mitochondrial network is a key regulator of cellular stresses and maintenance of metabolism. 
Although the mitochondria are relatively isolated from the endomembrane system, in order to 
maintain endosymbiosis, the mitochondria provide signaling factors to the entirety of the cell, most 
notably being the energy currency of ATP, but the mitochondria also require factors from the cell 
itself, including many proteins of which are encoded in the nuclear genome. Finally, the 
mitochondria function, in part, as a major signaling hub of cellular stress responses, whether it be 
oxidative stress, protein misfolding, energy demands, and even pathogen infection. The 
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essentiality of the mitochondria for cellular physiology cannot be understated, and the role of 
mitochondria in health and disease and maintenance of cellular homeostasis is a massive field of 
study lending considerable new insight into the origins and repertoire of functions of the 
powerhouse of our cells.  
 
1.2.1 Mitochondrial dynamics 
 In the early study of mitochondria, the organelle was classically described as separate, 
individual organelles, often resembling a “kidney bean” in structure. However, as imaging 
progressed and the ability to visualize cells and mitochondria in their physiological state 
developed, it was soon realized that the mitochondria were in actuality a heterogenous population 
of long, interconnected, filamentous networks interspersed with small spheroid structures and 
short intermediate bodies. Indeed, this description of the heterogeneity of mitochondria is found 
within the name itself, as the word mitochondrion is Greek for mitos (thread) and chondros (grain 
or granule). In addition to the plasticity of mitochondrial structures, it was discovered that the 
mitochondria are not stagnant, separate organelles, but instead mitochondrial function and 
homeostasis are synchronous, whereby if a small region of the mitochondrial network is damaged, 
the signal is propagated throughout the entire network, illustrating a large-scale interconnected 
network of interorganellar communication and dynamics206. The fundamental mechanisms 
governing mitochondrial dynamics lies in three general processes: fusion, fission, and movement. 
At any snapshot in time, the mitochondria are in a constant state of fusion and fission (Figure 
1.6). Depending on cellular stresses and energy demands, the balance of mitochondria being 
mostly filamentous or mostly fragmented may shift from one direction to the other. Furthermore, 
the precise position of mitochondria within a cell also serves a physiological role, to either directly 
facilitate ATP transfer in areas of higher energy demand, or as a means control signaling 
pathways. Altogether, although the origins of mitochondrial research resided in basic metabolism 
pathways, the field of mitochondrial investigations is massive, intricate, and diverse, as the 
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function and dynamics of mitochondria are continuing to elucidate novel pathways and processes 
that were never before considering aspects of mitochondrial biology. 
 Mitochondrial fusion. Although mitochondria by and large exist as a larger 
interconnected network, at any given moment within a cell, various mitochondrial structures are 
observed, ranging from long branching tubules to small punctate spheres (Figure 1.6). In order 
to facilitate union of any given structures, the mitochondrial fusion machinery is required. As 
mitochondria are comprised of an inner and an outer mitochondrial membrane, different factors 
facilitate the fusion of each respective membrane, including the mitofusins (Mfn1 and Mfn2), which 
are localized on the outer mitochondria membrane207-211, and OPA1, which is localized on the 
inner mitochondrial membrane212,213. Both OPA1 and the mitofusins are large GTPases in the 
dynamin family of proteins, which are often associated with mediating endocytosis and membrane 
dynamics214. During mitochondrial fusion, the process is often more dependent upon OPA1 and 
Mfn1, as Mfn2 holds an additional role in communication with the endoplasmic reticulum212,215-217. 
Often, cells are shifted to a state of enhanced mitochondrial fusion during higher energy demands, 
as a mechanism to increase oxidative phosphorylation. The inner mitochondrial membrane is one 
of the most protein dense locations within a cell, full of various factors in the electron transport 
chain. When energy demand is high, fusion of mitochondria results in increased surface area on 
the inner mitochondrial membrane, and thus higher rates of oxidative phosphorylation and ATP 
production. Often, enhanced mitochondrial fusion is observed when cells are in a state of 
starvation with subsequent inhibition of protein synthesis and autophagy induction via inhibition 
of mTOR (mammalian target of rapamycin)215,218,219. In addition, nutrient stresses and substrate 
availability may alter mitochondrial structure, whereby if media containing glucose is replaced with 
galactose, mitochondrial oxidative phosphorylation is increased and mitochondria increase 
cellular fusion220. OPA1 is an intriguing protein, as it is often argued whether its primary role is 
with mitochondria fission or fusion. Given OPA1 has been shown to be essential for mitochondrial 
fusion to occur, the primary role is by and large attributed to fusion, however, OPA1 is found in 
33 
 
different splice forms, and depending on the predominant form observed, mitochondria may be 
more heavily fragmented213. This observation of OPA1 processing in relation to mitochondrial 
dysfunction has led some to speculate that OPA1, in addition to its primary role of facilitating 
mitochondrial fusion, may also serve as a sensor or indicator of mitochondrial fragmentation. 
OPA1 is found in at least 8 different splice variants, then, depending on subsequent proteolytic 
cleavage by the mitochondrial proteases Yme1L or OMA1, different isoforms of OPA1 may be 
observed (namely the long and short form)213,221. In addition to promoting ATP production, 
mitochondrial fusion has also been speculated to ensure homeostasis by mixing mitochondrial 
contents. For example, over time, different tubules of mitochondria may acquire incorrect ratios 
of electron transport chain complexes, oxidative damage, mitochondria DNA mutations, or other 
heterogeneities. By fusing different mitochondrial tubules, membranes and soluble material mix, 
and with increased fusion rates, the overall distribution of mitochondrial protein and factor 
composition becomes more homogenous throughout a cell. Overall, the process of mitochondrial 
fusion functions beyond simple recovery from fragmentation, hyperfilamentous mitochondria are 
more respiratory active, producing elevated levels of ATP through increased oxidative 
phosphorylation, thus serving an essential role in maintaining cellular homeostasis in response to 
varying energy demands and cellular stresses.  
 Mitochondrial fission. In contrast to fusion, mitochondria may undergo fission, which is 
mediated through an intricate series of factors and assemblies (Figure 1.6). The predominant 
factor mediating mitochondrial fission is the dynamin-related protein Drp1, which is cytosolic in 
distribution, but upon mitochondrial stress, Drp1 is recruited to the mitochondria and binds to the 
mitochondrial receptor Mff222,223. As Drp1 continues to associate with mitochondria, Drp1 forms a 
constrictive ring around a mitochondrial tubule, resulting in the scission of mitochondria from one 
another, and is thus mediating mitochondrial fragmentation222,224,225. Although this relatively 
simplistic model most certainly holds true, in recent years, several interesting facets of 
mitochondrial fission regulation have been deciphered. First, it was observed that the sites of 
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mitochondria fission are not random, but instead machinery are recruited to a particular location. 
Most notably, through a beautiful series of electron micrograph tomography experiments, the 
endoplasmic reticulum was shown to form immensely close contacts with the mitochondria at 
scission sites226. As indicated earlier, a major factor mediating the interaction between the ER and 
mitochondria is mitofusin 2 (Mfn2)227, which is in turn regulated by the mitochondrial ubiquitin 
ligase MITOL228. Physiologically, the ER-mitochondria contact sites serve as a platform for 
calcium signaling between the organelles, as well as direct lipid transfer. However, during periods 
of cellular and mitochondrial stress, ER tubules may envelop the periphery of a mitochondrial 
tubule, thus marking the site of as well as facilitating fission. Also, although Drp1 certainly forms 
rings around mitochondrial tubules, it was unclear what factor was providing the physical force to 
constrict the ring and separate the mitochondria, with work indicating the force was due to GTP 
hydrolysis. As described earlier, the cytoskeleton is a major mediator of cellular dynamics and 
movement, and indeed, actin has been discovered to not only accumulate at sites of mitochondrial 
division and provide the constrictive force to separate the two newly formed mitochondrial tubules, 
but also provides translocation of Drp1 to the mitochondrial fission site229-231, with this process 
involving the ER through the action of the inverted forming 2 (INF2) protein232. Finally, a major 
question in the study of mitochondrial fission is which signals mediate and activate Drp1 
translocation to mitochondria, and two major processes have been characterized. First, Drp1 has 
been shown to undergo post-translational modifications as activation switches, including 
ubiquitination, S-nitrosylation, sumoylation, and phosphorylation233-235. For example, calcineurin 
is a phosphatase that senses a rise in intracellular calcium, and if calcium increase is coupled 
with mitochondrial depolarization, calcineurin directly interacts with and dephosphorylates Drp1, 
facilitating mitochondrial translocation236,237. In accord, the same reside (serine 656) may be 
phosphorylated by cAMP-dependent protein kinase, illustrating a synthesis and balance of cellular 
stress signals regulating mitochondrial structure237. Furthermore, a different residue, serine 585, 
may be phosphorylated by Cdk1/cyclin B, indicating a role for mitochondria being in a fragmented 
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state during mitosis238. In addition, the AMP-activated protein kinase, AMPK, which functions as 
a sensor of cellular ATP levels and metabolic activity, directly phosphorylates the mitochondrial 
receptor of Drp1, Mff239,240, a process which may also involve the ER241,242. Through the concerted 
action of AMPK and Drp1 modifiers, Drp1 is then fully activated and mitochondrial fission is 
initiated. This activation of Drp1 illustrates the role of mitochondrial fission in responding to cellular 
stresses, whether it be via nutrient starvation, or intracellular organelle damage via the release of 
calcium stores. Mitochondrial fragmentation and fission have certainly been shown to occur in 
response to various stressors that damage the mitochondria, and one proposed rationale for 
breaking down the mitochondrial network into smaller fractions is a “separation, segregation, and 
sorting” process. As described earlier, simply through the action of undergoing metabolism, 
mitochondria accumulate damaged material physiologically. While fusion aids in maintaining 
homeostasis, if the damage is widespread, then fragmentation allows a cell to identify severely 
dysfunctional mitochondrial regions that may be subsequently removed by the process of 
mitochondrial selective autophagy, known as mitophagy. Altogether, this balance of mitochondrial 
structure and the ability of cells to mediate mitochondrial fission allows for a sensitive and 
relatively immediate response to cellular stresses. 
 Mitochondrial movement and positioning. Although often depicted as stationary 
structures, mitochondria in reality are highly mobile organelles, travelling along actin or 
microtubule tracks. As the movement of mitochondria in and of itself is an energetically 
unfavorable process, the positioning of mitochondria is not simply random, but rather a process 
with physiological importance. For example, mitochondria are recruited to areas of a cell with 
higher demands for energy, which is exemplified in large, elongated neuronal cells243. In addition, 
the mitochondria in lymphocytes become differentially positioned in order to facilitate adhesion of 
lymphocytes to endothelial cells, followed by migration into the underlying tissue244. Finally, 
mitochondria may be transported to the perinuclear region during times of stress, including 
depolarization of the mitochondrial transmembrane potential and mitophagy induction245,246. This 
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clustering of mitochondria around the nucleus results in a microenvironment that is high in 
oxidants, and is important for signaling to the nucleus for altered gene transcription profiles245. 
Similar to the transport of other cellular cargo throughout a cell, the transport of mitochondria also 
relies on the molecular motors kinesin for anterograde movement towards a cell periphery, and 
dynein for retrograde movement towards the cell nucleus247-249. In order to connect mitochondria 
to a motor protein, the outer mitochondrial membrane GTPase Miro binds to the kinesin binding 
protein Milton250-253, a process that dependents on calcium signaling254. This Miro-Milton complex 
is also a target upon mitochondrial stressors, whereby if mitophagy is activated, Miro is 
phosphorylated, resulting in separation of mitochondria from a microtubule and blocking of 
mitochondrial trafficking250. The assembly of this complex is important for regulating the 
positioning and transport of mitochondria within a cell, and is most often associated with neuronal 
disease. As neurons are large cells with long axonal structures towards a synaptic terminal, 
mitochondria must travel from the cell body, down an axon, in order to reach the synaptic terminal. 
Indeed, in cells deficient in mitochondrial transport machinery, fewer mitochondria are observed 
in the neuronal synapse, and consequentially synaptic transmission of neurotransmitters is 
diminished, thus leading to not only decreased neuronal cell function, but severe neuropathic 
diseases observed in human patients255-257.  
 Mitochondrial diseases. The ability of a cell to regulate mitochondrial dynamics and 
positioning is not only important for the physiology of an individual cell, but it also has profound 
consequences on the health of an individual organism. For example, mutations in the outer 
mitochondrial membrane fusion protein Mfn2 results in Charcot-Marie-Tooth disease in humans, 
a neuropathic condition estimated to affect 1 in 2,500 individuals258-260. Charcot-Marie-Tooth 
disease is manifested by the progressive development of motor and sensory defects due to 
degeneration of nerve fibers, resulting in weakness, loss of reflexes, deformities, and muscle 
atrophy258,259,261,262. Mutations in the inner mitochondrial membrane fusion protein OPA1 results 
in optic atrophy (hence the identification of OPA1, optic atrophy 1) in humans, a disease estimated 
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to affect 1 in 12,000 – 50,000 individuals261,263,264. Optic atrophy is characterized by degeneration 
of retinal ganglion cells and ultimately atrophy the optic nerve axon, resulting in a severe loss of 
vision and ocular pathology261,262. In addition to being important for inner mitochondrial membrane 
fusion, loss of properly functioning OPA1 in patients is also associated with instability of 
mitochondria DNA265 perturbations to mitochondrial structure and function264,266,267. In addition, 
Parkinson’s disease holds origins in mitochondrial function, although not directly due to defects 
in mitochondrial dynamics proteins. A major regulator of mitochondrial selective autophagy, 
mitophagy, is the E3 ubiquitin ligase, called Parkin, which was identified as a factor that is often 
mutated in patients with Parkinson’s disease268,269. In patients with defective Parkin, mitochondria 
are characterized as having elevated levels of Drp1-mediated mitochondrial fission, elevated 
mitochondrial DNA mutations, and impaired mitophagy262,268,270. When these abnormalities are 
present in neuronal cells, the disease is manifested as a neuropathy consisting of rigidity and 
tremors262. 
 Historically, mitochondria, as well as most organelles, are described as stationary 
structures within a cell. However, considerable work has illustrated the complexity of the cellular 
network, with proteins and other cargo undergoing constant movement to and from and within 
various organelles. The understanding of mitochondrial form and function has changed 
considerably in recent decades. At first, mitochondria were “kidney bean” structures that 
generated ATP. But now, mitochondria are expansive networks of fusing and dividing filaments, 
regulating cell death, synthetic processes, and immune responses. The field of mitochondrial 
dynamics and physiology is continuing to grow, with recent studies identifying novel functions of 
mitochondria in vivo. And although early stage studies are promising, the development of an 
effective cure or treatment of mitochondrial based diseases is still relatively distant. But by 
understanding not only how mitochondria are positioned within a cell and the mechanisms of how 
they undergo division and fusion, that distance to reach an effective treatment is becoming all the 
more lessened.  
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1.2.2 Mitochondrial protein import 
Mitochondrial protein import is a highly regulated process, not only controlling which 
proteins enter the mitochondria, but balancing between mitochondrial and nuclear based 
transcription rates. Although mitochondria do indeed contain its own genetic material in the form 
of circular DNA molecules, is estimated that only 1% of mitochondrial proteins are encoded by 
the mitochondrial genome271,272. Therefore, the overwhelming majority of mitochondrial proteins 
are encoded by the nucleus and must be imported into the mitochondria. Various signal 
sequences are used to identify whether a protein is permitted for mitochondrial import, including 
an N-terminal signal sequence, a primarily β-barrel structure, a protein with a high abundance of 
cysteine residues in a relatively small region of a protein, or a protein that functions as a metabolite 
transporter273 (Figure 1.7). Various translocons exist within the inner and outer mitochondrial 
membranes, the intermembrane space, and matrix to sort the different signals for where 
mitochondrial proteins are to be transported (Figure 1.7). The translocon of the outer membrane, 
or TOM complex, is the major mediator of protein import into the mitochondria from the 
cytosol273,274. The sorting and assembly machinery, or SAM complex, is a set of protein machinery 
that recognizes β-barrel proteins and facilitates the insertion of outer mitochondrial membrane 
proteins273,274. The translocon of the inner membrane, or TIM complexes, regulate insertion of 
proteins into the inner mitochondrial membrane, and TIM in conjunction with the pre-sequence 
translocase-associated import motor, or PAM complex, facilitate transport into the cytosol273,274. 
Altogether, the network of translocons and signal sequences allow for selective transport of 
proteins throughout the mitochondria. However, considerable work is ongoing to understand 
whether or not the translocation machinery are constitutively active, or which signals regulate their 
activity. Furthermore, the inner mitochondrial membrane and mitochondrial matrix are considered 
some of the most protein dense locations within a cell; therefore, it is currently unclear how the 
mitochondrial transporters are able to import and shuttle incoming proteins across such a strong 
concentration gradient. Finally, although speculation exists regarding the structure of nuclear 
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encoded mitochondrial proteins, it remains to be fully understood how the mitochondrial import 
machinery developed, and why it was necessary. If mitochondria are ancient bacterial ancestors, 
why were so many genes transferred to the nucleus for transcription versus remaining within the 
mitochondria to retain autonomy? Indeed, if mitochondria are descendent of bacteria, are the 
translocons themselves reminiscent of bacterial transporters, or were the mitochondrial 
translocons obtained via contribution from the eukaryotic host? By understanding the 
mechanisms of mitochondrial protein import, not only will previously not fully understood pathways 
of protein trafficking be elucidated, but how pathogens manipulate mitochondrial targeted 
sequences and protein import pathways will also be understood.  
 
1.2.3 Mitochondrial quality control 
 Although mitochondria are certainly the powerhouses of the cell, generating the energy 
currency of ATP and maintaining cellular homeostasis, the characterized role of mitochondria in 
cell biology is expanding, including involvement in regulating cell death275-278, thermogenesis279-
281, calcium homeostasis282,283, hormone production and signaling284,285, signal transduction 
pathways286, detoxification287, and regulating the innate immune system288-290. In addition, similar 
to the other organelles within a cell, mitochondrial function is maintained through an integrated 
series of quality control measures in order to ensure mitochondrial viability and proper function. 
The mechanisms of mitochondrial quality control range on a spectrum from the molecular to the 
cellular level in response to relatively mild to more severe onslaughts of mitochondrial dysfunction 
(Figure 1.8). Each mechanism functions in response to different degrees of and different types 
of mitochondrial dysfunction, and depending on a particular cell type or tissue, the mechanisms 
of mitochondrial quality control may be differentially regulated. Although the interaction between 
the different mechanisms of mitochondrial quality control are being elucidated, studies have 
indicated that activation of the different levels of mitochondrial quality control may result as a 
sequential order, as a developing response to increasing mitochondrial demand and stressors, or 
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independently, depending on the severity of mitochondrial stress induced. Regardless, numerous 
mechanisms of mitochondrial quality control have been described, each with a unique set of 
machinery that effectively monitors mitochondrial for signals of dysfunction, and is activated to 
return mitochondria to a homeostatic state in order to preserve cellular viability. 
Mitochondrial unfolded protein response. Although the identifier is rather direct, the 
mitochondrial unfolded protein response is somewhat of a misnomer, as the mitochondrial 
unfolded protein response may be activated in the absence of unfolded mitochondrial proteins, 
and likewise, mitochondria may have an accumulation of unfolded proteins, without activation of 
the unfolded protein response. Therefore, considerable effort is gaining ground in recent years to 
understand the nature of the mitochondrial unfolded protein response, and its role in maintaining 
mitochondrial function. The mitochondrial unfolded protein response effectively functions as a 
signaling axis between the mitochondria and the nucleus291-293. Under healthy cellular 
homeostasis, factors that contain both a mitochondrial targeting sequence and nuclear 
localization sequence, such as the activating transcription factor associated with stress (ATFS-1) 
in Caenorhabditis elegans294 or the activating transcription factor 5 (ATF5) of mammalian cells295, 
preferentially localize to the mitochondria. However, when mitochondria stress is induced, the 
protein localization is shifted to the nucleus, inducing the transcription of mitochondrial protective 
genes in order repair mitochondrial dysfunction, with the predominant factors being chaperones 
and proteases. Interestingly, the mitochondrial unfolded protein response is functionally involved 
with other mechanisms of mitochondrial quality control, including mitophagy296 and regulation of 
mitochondrial proteases297. Given the predominant function of mitochondria is oxidative 
phosphorylation, and the core components of the electron transport system are encoded in the 
mitochondrial genome, a balanced regulation between mitochondrial and nuclear gene 
transcription must be communicated through a signaling axis in order to drive efficient ATP 
production and response promptly to changes in energy demand. The mitochondrial unfolded 
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protein response not only functions to repair simple mitochondrial damage, but also serves as a 
signaling platform to respond to increased demands in mitochondrial function and output.  
Mitochondrial proteases. In comparison to other organelles, the mitochondria are unique 
in that the mitochondria are comprised of an inner and outer membrane, with specific translocons 
that mediate protein import. Often, the regulation of mitochondrial protein import is mediated by 
mitochondrial proteases, which cleave mitochondrial targeting sequences as well as degrade 
dysfunctional or misfolded proteins291-293.  For example, in the mitochondrial matrix, the serine 
protease Lon, which interestingly is homologous to the Lon protease of bacteria, degrades 
oxidized or misfolded proteins within the mitochondrial matrix, and is important for maintaining 
the integrity of mitochondrial DNA298-300. On the inner mitochondrial membrane, the m-AAA 
protease is comprised of two subunits, namely paraplegin and AFG3L2, and is involved in 
regulating mitochondrial dynamics and facilitates the degradation of OPA1 and is important for 
regulating the assembly of mitochondrial ribosomes221,301. Also on inner mitochondrial membrane, 
the overlapping with m-AAA protease (OMA1) and the i-AAA protease YME1L function in 
regulating the mitochondrial fusion protein OPA1 through site-specific cleavage302,303. In addition, 
the presenilin-associated rhomboid-like protein (PARL) cleaves the phosphatase and tensin 
homolog-induced putative kinase-1 (PINK1), which is a protein important for regulating the 
induction of mitophagy304-306. In the intermembrane space, the serine protease HtrA1 (Omi) 
degrades XIAP and cytoskeletal proteins, and is important in regulating the induction of apoptosis 
via the activation of caspases307-309. Finally, on the outer mitochondrial membrane, mitochondria 
engage the ubiquitin-protease system, with mitochondrial specific ubiquitin ligases including 
mitochondrial ubiquitin ligase (MITOL)310 and the mitochondrial E3 ubiquitin protein ligase 
(MULAN)311 engaging the proteasome for degradation of ubiquitinated proteins312. Through the 
regulation of individual proteins via the action of mitochondrial localized proteases, endogenous 
mitochondrial dysfunction is controlled and repaired without the engagement of cytoplasmic 
machinery or other organelles. This mitochondrial internal quality control is not only more 
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energetically favorable for a cell, but it has been hypothesized that mitochondrial proteases serve 
as a “first line of defense” to the initial consequences of mitochondrial dysfunction. Then, if 
stressors continue and the proteases are unable to maintain mitochondrial homeostasis, higher 
orders of mitochondrial quality control are engaged. 
Mitochondrial derived vesicles. On the organellar level of quality control in response to 
more severe insults of mitochondrial dysfunction, a recently described phenomenon of 
mitochondrial derived vesicles (MDVs) may form as a means to remove small subdomains of the 
mitochondria that are dysfunctional and are sent to lysosomes or peroxisomes for 
degradation202,203. MDVs are estimated to be approximately 70-100 nm in diameter and may be 
single or double membrane structures313,314, are enriched with oxidized cargo313, and form via a 
process that is not dependent upon the mitochondrial fission factor Drp1314. Although the 
physiological role for transporting mitochondrial derived vesicles to the peroxisomes is uncertain, 
the routing of MDVs to peroxisomes appears to be a specific pathway, as peroxisome targeted 
MDVs contain the MULAN E3 ligase described earlier (also known as mitochondrial-anchored 
protein ligase or MAPL) but lack the outer mitochondrial membrane translocon TOM20, and it has 
been speculated that MDVs may be important for peroxisome biogenesis314.  In addition, the 
vacuolar protein sorting-associated protein 35 (VPS35) is important for the delivery of MULAN 
containing MDVs to peroxisomes203. Lysosomal targeted MDVs, however, are indeed enriched 
with TOM20 and are trafficked to lysosomes, but the formation of lysosomal specific MDVs are 
not dependent upon the autophagic machinery ATG5 and LC3205. MDVs have not only been 
widely observed in cell culture systems, but have also been observed to occur in vivo upon stress 
induced to cardiac tissue315. Interestingly, the mechanism of mitochondrial derived vesicles was 
recently implicated to mediate a process known as mitochondrial antigen presentation, whereby 
mitochondrial antigens are removed via mitochondrial derived vesicles, and are presented on the 
surface of cells via major histocompatibility complex I (MHC-I)316. Similar to other processes of 
mitochondrial quality control, the MDV formation and regulation machinery appears to participate 
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in cross-talk with canonical mitophagic machinery, namely PINK1 and Parkin, which are important 
for the generation of lysosomal targeted MDVs204. Altogether, MDVs function as a “surgical 
excision” approach to mitochondrial quality control, whereby selectively dysfunctional cargo may 
be specifically packaged and sent to lysosomes for degradation. Although the exact machinery 
mediating the formation and transport of MDVs, as well as the physiological importance of MDVs 
has yet to be determined, the process most certainly appears to function as a quality control 
response to aid in maintaining mitochondrial homeostasis. 
Mitophagy. Whereas mitochondrial proteases and mitochondrial derived vesicles function 
as mitochondrial endogenous regulators of quality control, if mitochondrial dysfunction is severe, 
recruitment of extra-mitochondrial machinery may be activated. Generalized autophagy is a 
process by which the formation of an autophagosome encompasses effectively a randomly 
distributed population of cellular material, and upon fusion with a lysosomes, the 
autophagolysosome facilitates the degradation of cellular components for recycling and use as 
building blocks for a cell. However, the process of selective autophagy may also be activated, 
whereby specific intracellular material is tagged the selectively degraded by an autophagosome. 
For example, selective autophagy may include degradation of peroxisomes (pexophagy)317, 
intracellular pathogens (xenophagy)318, protein-aggregates (aggrephagy)319, glycogen 
(glycophagy)320, lipid droplets (lipophagy)321, parts of the nucleus (nucleophagy)322, zymogen 
granules (zymophagy)323, ribosomes (ribophagy)324, and regions of the endoplasmic reticulum 
(reticulophagy, or ER-phagy)325. Of the various mechanisms of selective autophagy, one of the 
most highly studied is that of mitophagy, whereby severely damaged mitochondrial fragments are 
marked for degradation and are removed through fusion with an autophagosome. Whereas the 
mechanism of MDVs can be compared to surgical excision of dysfunctional mitochondria, 
mitophagy is analogous to amputation, whereby entire mitochondrial fragments or larger regions 
of mitochondria are selectively removed. Under conditions activating mitophagy, namely 
depolarization of the mitochondrial transmembrane potential, a loss of cellular ATP, and an 
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increase in mitochondrial ROS production, mitochondria protein transport decreases. The protein 
PINK1, which is normally transported into the inner mitochondrial membrane and quickly 
degraded by the mitochondrial protease PARL, accumulates on the outer mitochondrial 
membrane326,327. Accumulation of PINK on the outer mitochondrial membrane then signals the E3 
ubiquitin like ligase, known as Parkin, to recruit to the damaged mitochondria326,327. Parkin then 
ubiquitinates mitochondrial surface proteins and via the recruitment of the autophagic adaptor 
protein p62328, an autophagosome is subsequently recruited to the marked mitochondrion, 
ultimately leading in degradation and removal of the dysfunctional mitochondrion304,329-331. 
Interestingly, as described previously in regards to the role in regulating mitochondrial dynamics 
via DRP1, AMPK is also involved in mitophagy, as AMPK directly phosphorylates the autophagic 
kinase ULK1332, thus illustrating the regulation of mitochondrial dynamics in response to nutrient 
stress. Although the mechanisms of mitophagy have been relatively well described, it is 
worthwhile to note that debate is ongoing in the field regarding the physiological relevance of 
mitophagy, and whether or not mitophagy occurs in vivo. Often, mitophagy is evaluated via the 
overexpression of Parkin in HeLa cells, which notoriously lack endogenous Parkin. This approach 
has led some to speculate that the phenomenon of mitophagy is highly artificial, and that the 
regulators of the heretofore described mitophagy may be involved in other, currently undescribed 
cellular processes. Regardless, the preponderance of evidence to date support a model that 
mitophagy is a bona fide mitochondrial quality control response, although the exact role in vivo, 
like many aspects of biological study, has yet to be fully elucidated. 
Cell death. The final mechanism of mitochondrial quality control occurs as a means to no 
long maintain the integrity of the mitochondria, but rather the integrity of a larger tissue of interest. 
If the mitochondrial unfolded protein response, mitochondrial derived vesicles, and mitophagy are 
insufficient to repair damaged mitochondria, cell death may be activated. Mitochondrial, in part, 
function as a platform for regulating intrinsic activators of cell death, such as ischemia, hypoxia, 
and reactive oxygen species. Upon induction of mitochondrial stressors, the pro-apoptotic protein 
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Bax is recruited to the outer mitochondrial membrane from the cytosol. Upon interaction with 
another pro-apoptotic protein, Bak, a channel is formed, and the inner mitochondrial membrane 
factor cytochrome c is released, which binds to APAF-1 and activates assembly of the 
apoptosome, resulting in subsequent activation of caspases333-336. The release of cytochrome c 
is often described as a point of no return, or a step that commits a cell to undergo regulated cell 
death. Albeit detrimental to a given afflicted cell, cell death in and of itself serves to maintain the 
integrity of a tissue when lower levels of mitochondrial quality control are insufficient to repair 
dysfunctional mitochondria. Rather than allowing a dysfunctional cell to survive within a given 
tissue, clearance of the dysfunctional cell via mitochondrial regulated cell death is a non-
inflammatory process, whereby a cell may be removed and replaced with a new, functional cell. 
This is in contrast to necrosis, which is a highly pro-inflammatory process, whereby cellular 
contents are leaked into the surrounding interstitium, followed by the production of pro-
inflammatory cytokines and recruitment of neutrophils and inflammatory cells to repair the 
damage that occurred.  
In the context of VacA and infection with H. pylori, the model of activation of mitochondrial 
quality control posits that cell are capable of sensing the initial localization of VacA to the 
mitochondria (Figure 1.8). Although the factor that would facilitate the recognition of VacA by 
mitochondrial proteases is unclear, given that VacA is an exogenous bacterial protein toxin, it 
stands to reason that mitochondrial proteases may recognize VacA and degrade it directly at the 
level of the mitochondria. Next, if mitochondrial-localized VacA molecules increase in number, 
and thus an increase in mitochondrial dysfunction follows, the predicted model is that 
mitochondrial derived vesicles are activated as a means to selective package VacA into 
dysfunctional subdomains of mitochondria, and subsequently transport VacA within mitochondrial 
derived vesicles for lysosomes for degradation and removal from a cell. Furthermore, if the VacA 
insult continues and mitochondrial derived vesicles are insufficient to repair VacA mediated 
mitochondrial dysfunction, the mechanism of mitophagy is predicted to be activated. By this 
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process, it is anticipated that the recognition of mitochondrial domains to be degraded will not be 
based on the absence or presence of VacA specifically, but rather the degree of mitochondrial 
damage induced by VacA. And finally, if mitophagy is insufficient to repair dysfunctional 
mitochondria, then mitochondrial based cell death would be activated as a means to maintain the 
integrity of an entire tissue. For this model to be supported, not only would each of the levels of 
mitochondrial quality control need to be observed, but it is also predicted that inhibition of one 
level would subsequently result in the activation of the next higher order in mitochondrial quality 
control. If substantiated, this model would serve to elucidate the mechanisms by which a host cell 
is able to detect and respond to the toxic insults of VacA at the level of the mitochondria, which 
would address a fundamental gap in knowledge in the study of VacA and H. pylori infection as a 
whole. 
Altogether, the mechanisms of mitochondrial quality control serve to constantly patrol and 
monitor the mitochondria in an effort to ensure homeostasis. Mitochondria are highly dynamic, 
complex organelles that fulfill a variety of roles in maintaining cellular physiology, and are thus 
essential for cellular viability. To any degree, the loss of mitochondrial function yields severe 
consequences to the physiology of a cell. By engaging one or more of a variety of quality control 
measures, a cell may repair mitochondrial dysfunction with minimal input of energy or other 
cellular factors. Such a regulation process allows for a more controlled system so resources are 
not wasted while mitochondria are undergoing repair. Furthermore, a multi-step regulation 
approach is important for ensuring that cells do not “overreact” to relatively minor insults to 
mitochondrial dysfunction. Although the machinery governing mitochondrial quality control 
processes have been relatively well described, the physiological importance of mitochondrial 
quality in vivo remains to be fully appreciated. Certainly, dysfunction in the mitophagic regulator 
PARKIN has been very well described to be a predisposing factor for the development of 
Parkinson’s disease, but the degree to which mitochondrial quality control is engaged in healthy 
tissue is unclear. Furthermore, which insults active the different levels of mitochondrial quality 
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control? Are there thresholds of dysfunction that will lead to one pathway being activated over 
another? To what degree are the pathways interconnected, and how many one pathway regulate 
another? By understanding the basic mechanisms of mitochondrial quality control, not only will 
applications be used to counter mitochondrial based diseases, but understanding the 
fundamentals of organelle quality control lends deep insight into the development of cellular 
dynamics and maintenance of homeostasis.  
In order to maintain cellular viability, cells engage a variety of quality control measures 
that act on various levels in order to achieve homeostasis. The necessity of patrolling cellular 
functions is probably best illustrated within the nucleus, for maintenance of genetic material is 
essential in order to control the degree of mutations which occur and may be passed on to 
subsequent generations. Quality control mechanisms exist in a variety of pathways and regulation 
networks, depending on a particular system. However, the basics of cellular quality control, at its 
essence, may be distilled to detection of non-functional or dysfunctional proteins or organelles, 
then removal of those structures from a cell. Often, lower order processes engage proteases, as 
a means to remove single proteins. Then, if dysfunction accumulates, higher order processes 
engage degradative organelles, such as autophagolysosomes, in order to remove larger 
structures or complexes of proteins. The mitochondria fall into an interesting category of 
regulation, which is in part due to the organelle being canonically considered independent of the 
endomembrane system, but also due to the fact that mitochondria are proposed to originate from 
an endosymbiotic event of an α-proteobacteria. The regulation of mitochondria is further 
complicated that the vast majority of the mitochondrial genome has been transferred to the 
nucleus for transcription. As mitochondria originated as effectively an exogenous material, why 
were nascent eukaryotic detection systems unable to degrade or remove mitochondrial ancestors 
from the cell? How did the mitochondrial quality control mechanisms arise? Is mitophagy a 
modified version of xenophagy (or vice versa)? Interestingly, do pathogens perhaps manipulate 
the mechanisms of mitochondrial quality control? Numerous pathogens have been described to 
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target the mitochondria with the subsequent induction of mitochondrial-based cell death, but are 
those the true phenotypes of the pathogens? Are host cells capable of activating mitochondrial 
quality control in response to the pathogens in order to limit the damage being induced? 
Elucidation of the host-microbe interactions at the level of the mitochondria will yield fundamental 
new insight into not only the development of how pathogens have evolved to manipulate host 
cellular systems, but also provide potential opportunities for strategies to combat pathogenic 
infections through medical intervention. 
 
1.3 Helicobacter pylori and vacuolating cytotoxin A (VacA) 
The vacuolating cytotoxin of Helicobacter pylori was first identified in 1988 when culture 
supernatants from the then Campylobacter pylori clinical isolates were used to treat cultured 
cells337. Exposure of cells in culture resulted in the formation of large, membrane bound vacuolar 
structures337. From the initial observation in 1988, thorough evaluation of the content of the culture 
supernatants and secreted factors, and isolation of different bacterial factors coupled with genetic 
analyses, resulted in the identification of the vacuolating cytotoxin, aptly named VacA. Since the 
discovery of VacA, and more importantly, since the development of a purification method of VacA 
from H. pylori directly, a plethora of studies have been conducted to elucidate the functionality of 
VacA. While VacA has often been described as a multifunctional toxin, as many consequences 
have been attributed to VacA, many questions remain unanswered. Interestingly, although VacA 
has been shown to induce a variety of cellular outcomes, the actual biological toxic activity is a 
single event, in that VacA is a pore-forming toxin, with no catalytic activity of VacA being identified 
to date. To add further intrigue, the VacA pore is relatively small, often only allowing the passage 
of single anion molecules, whereas other bacterial toxins form massive pores resulting in the 
release of large quantities of cellular contents upon formation. Therefore, numerous questions 
have arisen and remain in the study of VacA, including how VacA is assembles on the cell surface, 
what the exact mechanism of biological activity is of VacA, which host factors VacA directly 
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interacts with within a cell, how the different phenotypes of VacA exposure are interrelated, how 
VacA is trafficked throughout a cell, and most importantly, why H. pylori secretes VacA and how 
VacA contributes to H. pylori colonization and persistence within a human host. VacA is unique, 
in that to date no homologous proteins or toxins have been identified that are similar to VacA. 
Furthermore, although there are certainly numerous other Helicobacter species that colonize the 
stomachs of other organisms, such as H. suis from swine338, and H. felis, H. bizzozeronii, and H. 
salomonis in felines and canines339,340, no other Helicobacter species have been described to 
secrete VacA or a similar pore-forming toxin. In addition, although proposals have been 
hypothesized341, to date, no environmental reservoir for H. pylori has been conclusively identified. 
Therefore, the only location where VacA is known to exist in nature, is within the stomachs of 
humans. Certainly an argument may be made that the study of VacA is esoteric with limited 
applications to other systems. However, VacA in and of itself serves as an exquisite example of 
a bacterial toxin with relatively simple biological activity, yet is able to exert and large variety of 
cellular effects. By understanding the host-microbe interactions of H. pylori through the lens of 
VacA, researchers gain considerable insight into how pathogens developed their respective 
systems in order manipulate host cell physiology in order to establish an infection and colonize a 
host environment. 
 
1.3.1 Helicobacter pylori and human health 
Helicobacter pylori chronically infects approximately half of the world’s population, with 
approximately 1% of those infected developing gastric cancer, the second leading cause of 
cancer related death worldwide342-344. While other virulence factors of H. pylori have been 
implicated in the severity of gastric disease, a correlation between the toxic alleles of VacA and 
human gastric disease has been observed. To examine the role of VacA in human disease, a 
common approach is to compare the severity of gastric disease from clinical isolates to the 
different alleles of VacA present in the H. pylori infected human. Genetic analysis has shown 
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VacA to have two regions of allelic diversity, termed the s-region (s1a, s1b, and s2 alleles) and 
m-region (m1, m2a, m2b alleles)345. Studies have shown that humans infected with strains of H. 
pylori harboring the s1/m1 alleles are at a greater risk for peptic ulceration and gastric epithelial 
damage compared to s2/m2 strains346. Additionally, by histologically examining gastric biopsies 
of H. pylori infected humans, those who were infected with the more toxic s1/m1 strains displayed 
elevated levels of dysfunctional autophagy (identified by increased levels of p62), indicating that 
VacA is disrupting host responses to limit H. pylori infection347. While animal models implicate 
VacA to be involved in initial infection, it is uncertain if that holds true in humans, for little is known 
about the initial stages of H. pylori infection. For infection with H. pylori alone, it has been observed 
that colonization is associated with gastric ulceration, gastritis, gastric adenocarcinoma, gastric 
mucus and gastric acid depletion, parietal cell hyperplasia, and infiltration of the gastric mucosa 
with neutrophils and lymphocytes348-352 (Figure 1.9). However, in vivo studies are lacking that 
ascribe the various phenotypes to particular pathogenic effectors. Regardless, the data thus far 
indicate that VacA is associated with more severe gastric disease, perhaps by perturbing host 
cell responses to limit the infection and colonization with H. pylori. 
 
1.3.2 Helicobacter pylori virulence strategies 
Numerous virulence factors of Helicobacter pylori have been identified. Besides VacA, the 
most well characterized virulence factor of H. pylori is the Cag pathogenicity island (PAI). The 
CagPAI encodes a total of approximately 31 genes that form a T4SS to deliver the toxin CagA 
into the cytosol of host cells353. H. pylori isolates have been found that either produce, or do not 
produce CagA, indicating that is not an essential factor for pathogenesis. The presence of CagA 
has been associated with severity of gastric disease, including gastritis and gastric 
adenocarcinoma, and has thus been described as a bacterial derived oncogene354. OipA is an 
outer membrane protein of H. pylori and has been implicated in the initiation of an inflammatory 
response given mutagenesis studies have indicated that OipA is important for the induction of IL-
51 
 
8 secretion355,356. NAP, appropriately termed the neutrophil activating protein, is important for 
initiating the infiltration of neutrophils and mast cells into the gastric mucosa upon H. pylori 
infection357. And although NAP is structurally similar to bacterioferritins, it does not function 
similarly, as NAP binds to TLR-2 and induces a potent IL-12 response and is thus subsequently 
a major regulator in innate immune responses358. BabA and SabA function as an adhesin and are 
implicated in binding to cell surface sialic acid, with BabA binding to Lewis B antigens, and SabA 
binding to sialyl-Lewis A antigens359,360. DupA has been associated with duodenal ulcers, 
however, the molecular function and host cell targets of DupA is currently unknown361,362. 
Altogether, although H. pylori produces several virulence factors that have individually been 
shown to be important for regulating gastric disease, the exact role of the various factors, and 
more importantly the cooperativity of the factors with one another, remains an area of research in 
need of further investigation. 
 
1.3.3 VacA structure and allelic diversity 
VacA is a T5SS protein, whereby the protoxin within a bacterium is approximately 140 
kDa in size (Figure 1.10). In order to be secreted from the bacterium, an N-terminal signal 
sequence is cleaved, and the C-terminal autotransporter is removed363. The remaining passenger 
domain of 88 kDa toxin is the secreted form of VacA, which is comprised of effectively 2 putative 
domains, termed p33 and p55363. Two major allelic forms of VacA have been described, term the 
s and m alleles, with the s1/m1 allelic form of VacA being associated with the greatest severity of 
gastric disease, and the s2m2 allele being associated with lesser forms of disease363,364.  
Currently, the crystal structure of the p55 domain has been resolved, illustrating a right-
handed β-helix365. Given the predicted globular nature of p33, the crystal structure has not been 
solved. In order to evaluate the quaternary structure of VacA, cryo electron microscopy has been 
performed. While various oligomers have been described in regards to the number of monomers 
and the distribution of the structure, the most common form of the toxin was a hexamer in 
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shape366,367. The oligomers were approximately 25-30 nm in diameter, with a center cavity about 
12 – 14 nm in width366. The pores formed by VacA are anion-selective and bidirectional 
channels368, although it is unclear whether the observed central cavity structure of the VacA 
oligomer is indeed the anion pore. Currently, it is not clear how the VacA channel oligomerizes 
and assembles on the surface, although it is known that VacA associates with the abundant lipid 
sphingomyelin on the cell surface369 and VacA forms channels on the plasma membrane368. 
Current models of VacA assembly being internalization of monomers with assembly occurring 
within an intracellular compartment, association of dimer or trimer intermediates on the cell 
surface with pore formation either on the cell surface or within the cell, and finally the entire VacA 
oligomer forming in solution then docking on the plasma membrane. Given VacA is observed as 
oligomeric structures in solution, there does not appear to be any limitation to VacA forming 
complexes with or without a membrane to interact with. Altogether, much remains to be fully 
understood in regards to the structure of VacA and its association with cells. However, to date, 
the only known biological activity of VacA is its ability to form membrane spanning channels within 
a host cell. By understanding the initial interactions of VacA with the surface of cells, then perhaps 
the downstream intracellular trafficking and routing of VacA within a cell could be fully elucidated.  
 
1.3.4 VacA intracellular trafficking 
Since its discovery, VacA was described as an intracellular acting toxin, but the 
mechanism by which VacA entered cells remained elusive for many years. In early studies of 
VacA and its initial endocytosis into cells, researchers described an association with cholesterol 
and GPI-anchored proteins, indicating lipid rafts, but clathrin-mediated endocytosis was quickly 
excluded370,371. In 2005, the mechanism was finally uncovered, where researchers described an 
association of VacA on the cell surface on detergent resistant membranes above areas enriched 
in actin, which were dependent on Rac1 (a small GTPase involved in regulating the cytoskeleton 
and cell growth), and the entry of VacA was dependent on Cdc42, but independent of dynamin, 
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all indicative of GEECs372. Given the CLIC/GEEC pathway is not commonly used in physiological 
endocytosis, it stands to reason that by VacA utilizing this pathway, it is gaining access to cellular 
machinery that is necessary for it to exert its intracellular activity, perhaps at the level of the 
mitochondria. Alternatively, if VacA was endocytosed by another mechanism in order to gain 
access to the intracellular environment, the required machinery for VacA biological activity would 
not be present and cells would likely not be sensitive to VacA. 
After internalization, intracellular VacA has been shown to localize to one of two 
predominant locations, either the mitochondria or vacuoles (Figure 1.11). The molecular basis 
for this differential sorting is currently unknown, but given a key determining factor in where and 
how a toxin traffics throughout a cell is initial contact at the plasma membrane, it is possible the 
nature of the receptor and how VacA binds might mediate to which of the two destinations VacA 
is sent.  
After it was discovered that VacA is internalized into GEECs, the same group sought to 
characterize the trafficking of VacA throughout a cell373. It was shown that after trafficking to 
GEECs (within 10 min), VacA then localizes with early endosomes (30 min), and finally late 
endosomes (120 min). If cells are treated with an actin poison (such as cytochalasin D or 
latrunculin B) prior to VacA reaching late endosomes, the toxin remains halted at the GEEC stage, 
indicating that actin is necessary for VacA trafficking. These data correlate with previously 
published data that vacuolation induction by VacA is also dependent on actin374.  High resolution 
fluorescence microscopy revealed the characterization of so called “actin comets,” with VacA on 
the leading edge and linked to an actin tail through the protein CD2AP (which regulates the actin 
cytoskeleton), indicating that actin is providing a motive force to drive VacA trafficking. It was 
previously established that while trafficking through the endosomal system, VacA would 
eventually target vacuoles, where it has been reported to localize to the vacuolar boundaries375,376. 
While the nature of the vacuoles has been debated, it is clear they contain markers of late 
endosomal vesicles376,377, however, also considering the vacuoles are acidic, it has been 
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hypothesized that they are derivatives of autophagosomes378. To this date, the role of vacuoles 
in H. pylori pathogenesis remains poorly understood. 
In addition to forming and localizing to vacuoles, VacA has also been shown to localize to the 
mitochondria (Figure 1.11). This mitochondrial localization was first demonstrated by ectopically 
expressing VacA within cells, then it was observed that VacA localized with mitochondria both by 
fluorescence microscopy, as well as electron microscopy155. Mitochondrial localization was further 
confirmed by exposing cells to purified VacA toxin by fluorescence microscopy379, and 
biochemical fractionation380. Interestingly, it was recently reported that exposure to VacA results 
in endosomes containing the toxin being brought into close proximity to the mitochondria380, 
indicating that perhaps VacA trafficking to the mitochondria, like vacuoles, is also mediated 
through the endosomal system. As reviewed earlier, while the physiological role of vacuole 
formation is uncertain, there is a large body of evidence clearly showing that VacA induces 
mitochondrial damage and dysfunction, and furthermore that metabolic homeostasis is perturbed. 
A clear link between mitochondrial damage and the ability of H. pylori to colonize has not been 
established, and no in vivo role of VacA mediated mitochondrial dysfunction has been 
demonstrated, but it has been hypothesized that VacA exposed cells might be severely limited in 
their ability to respond to a pathogen effectively; therefore, the pathogen has created a suitable 
niche in order to establish an infection through the production of toxins. 
 
1.3.5 VacA biological activity 
The molecular effects of VacA exposure to host cells have been well characterized in vitro, 
however, less is known about its role in vivo. Being Helicobacter pylori is a human specific 
pathogen, the experiments needed to determine the role of VacA in H. pylori pathogenesis simply 
cannot be conducted. Therefore, researchers study VacA in a multifaceted approach, by 
collecting retrospective data from humans with confirmed H. pylori infection, and comparing 
phenotypes to what has been described in cell culture and animal model systems. 
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To best reciprocate in vivo conditions, standard experimental cell lines (HeLa, MEF, HEK) 
have been studied in addition to human gastric specific cell types (AZ-521, AGS). Although there 
are varying degrees of sensitivity to VacA amongst the different cell lines, the major cellular effects 
appear to be universal. In cell culture, VacA has been shown to directly target and disrupt 
mitochondria, perturb autophagy, and induce vacuolation347,381,382. At the level of the mitochondria, 
upon treatment of VacA, researchers have observed the release of cytochrome c by fluorescence 
microscopy379. Cytochrome c is an inner membrane hemeprotein involved in the electron transport 
chain, and is a potent activator of apoptosis if released from the mitochondria into the cytosol. To 
also monitor mitochondrial damage, the transmembrane potential of the mitochondria is easily 
measured by the potential sensitive dye TMRE (tetramethylrhodamine ethyl ester perchlorate), 
where healthy mitochondria take up TMRE, while depolarized mitochondria do not (and 
hyperpolarized mitochondria can take up more dye). Upon treatment with VacA, cells take up less 
stain (shown by both fluorescence microscopy and flow cytometry), indicating that VacA 
depolarizes the mitochondrial membrane379. Additionally, VacA has been shown to induce 
mitochondrial fragmentation by activating the mitochondrial fission regulator Drp1383. This 
mitochondrial damage has direct effects on cellular metabolism, where it was shown that VacA 
treatment results in lower levels of cellular ATP, an inhibition of oxygen consumption, and a slight 
increase in the number of cells found in the G0/G1 phase of the cell cycle384. All of these data 
suggest that VacA is capable of disrupting metabolic homeostasis, which may facilitate the ability 
of Helicobacter pylori to establish an infection, for the host epithelium is unable to respond 
effectively.  
Another prominent cellular effect of VacA is its role in autophagy. Autophagy is a physiological 
process by which a cell degrades its own components, and is also an innate immune response to 
pathogens by participating in a selective form known as xenophagy385. The literature to date 
indicate that VacA is capable of both inducing, as well as disrupting, autophagy in exposed cells, 
depending on the length of exposure. While examining early exposure to both VacA and H. pylori, 
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researchers observed an induction of autophagy as indicated by LC3 accumulation in puncta and 
conversion of LC3 I to LC3 II (LC3 being a ubiquitous protein that is recruited to autophagosomes 
upon autophagy induction)381. When the autophagosomes were examined over prolonged 
exposure times, researchers observed that the autophagosomes were defective, as confirmed by 
the presence of elevated levels of p62347. In addition to disrupting metabolic homeostasis, these 
studies suggest that VacA perturbs a physiological response to pathogen exposure, in order to 
disrupt the host epithelial barrier.  
Perhaps the most striking phenotype of VacA exposure is what the toxin was named after, 
vacuolation. One of the first observations of this phenomenon was described in 1988, when 
cultured cells exposed to culture filtrates of, at the time, Campylobacter pylori (now Helicobacter 
pylori), resulted in the formation of large intracellular vacuoles, observed by both light and electron 
microscopy337. Although this was the first cellular effect attributed to the vacuolating cytotoxin, in 
the subsequent decades, the physiological role of these vacuoles remains uncertain and highly 
debated. While it is unknown why the vacuoles form, more is known regarding how they form. 
Through extensive immunofluorescence microscopy of different cellular markers, vacuoles 
appear to be derivatives of late endocytic compartments, due to staining by Lucifer yellow (fluid 
phase marker indicative of endocytosis), and localization with Rab7 (a Rab GTPase regulating 
vesicular trafficking and is localized to late endosomes)377. Additionally, the formation of vacuoles 
is enhanced by co-exposing cells to VacA and ammonium chloride376. Regardless of the 
physiological role of vacuole formation, this phenotype has served as a reliable indicator of VacA 
activity and entry into exposed cells. Altogether, it has been well described that VacA induces 
mitochondrial dysfunction in addition to autophagy induction and disruption to cell to cell junction, 
but an underlying question is how those phenotypes benefit H. pylori colonization and ultimate 





1.3.6 VacA interactions with mitochondria 
The earliest reports of VacA interactions with the mitochondria occurred almost a decade 
after the discovery of VacA, where it was observed that VacA intoxication results in a depletion of 
cellular ATP and inhibition of oxygen consumption384. Soon after, it was observed that the N-
terminal domain of VacA directly localizes to the mitochondria, resulting in the release of 
cytochrome c and mitochondrial specific cell death155. Although the N-terminal domain of VacA 
has been described to be important for the pore formation of VacA, it was uncertain whether 
exogenously added VacA, similar to natural intoxication, would induce a similar phenotype. 
Indeed, after the purification of VacA was determined, it was observed that exogenously added, 
intact VacA was able to localize to the inner mitochondria membrane, depolarize the inner 
mitochondrial membrane potential, and also induce the release of cytochrome c379,386-388. More 
recent studies have illustrated that the cell death activity by VacA is related to the ability of VacA 
to induce mitochondrial fission through the action of the dynamin related protein Drp1383. Although 
it was proposed that the N-terminus of VacA functions as a novel mitochondrial targeting 
sequence387, given the N-terminus is also essential for VacA channel formation, the only known 
activity of VacA, it stands to reason that the N-terminus is not a true mitochondrial signal 
sequence, but rather it confers the biological activity necessary for VacA mediated mitochondrial 
localization. While the induction of mitochondrial dysfunction and structural perturbations have 
been determined, the mechanism, and consequences of targeting the mitochondria of host cells 
by VacA are not fully understood. 
 
1.4 Gap in knowledge 
VacA has been well described to localize to host cell mitochondria and induce 
mitochondrial dysfunction and cellular vacuolation due to the pore forming ability of VacA. 
However, three major underlying gaps in knowledge remain in the study of VacA and H. pylori 
pathogenesis and the interactions with host cells. First, the mechanism of mitochondrial targeting 
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by VacA is unclear. VacA is a membrane embedded, pore-forming toxin, yet VacA is capable of 
translocating from the extracellular environment and the cell surface into the mitochondria. This 
route of trafficking of a protein from the cell surface to the mitochondria is challenging, as there 
are no mechanisms described to date of vesicle mediated transport to and fusion with the 
mitochondria. A considerable challenge lies in the fact that as VacA is a pore-forming toxin with 
all biological activity attributed to ability of VacA to form channels in the membranes of host cells; 
therefore, it is predicted that VacA would remain associated with membranes for the duration of 
its intracellular trafficking. Because of the complicated nature of VacA and its intracellular 
trafficking, the ability of VacA to localize to mitochondria has remained poorly understood. A 
second gap in knowledge is whether host cells are able to detect and repair VacA mediated 
mitochondrial dysfunction. Mitochondria are essential for cellular viability, however, numerous 
quality control measures exist to ensure mitochondria are functioning properly. Currently, it is not 
clear whether the level of damage that VacA induces at the mitochondria is irreversible, or if VacA 
is capable of circumventing host responses in order to respond to and repair dysfunctional 
mitochondria. Furthermore, if the physiological importance of VacA was to induce cell death, it 
would be predicted that the severity of and incidence of gastric disease would be higher in H. 
pylori infected individuals. However, the rates of gastric disease are rather low, indicating that 
VacA is not inducing massive cell death in vivo. Therefore, much remains to be understood in 
regards to how a host cell senses and responds to VacA action at the level of the mitochondria. 
Finally, the role of VacA in vivo is a major gap in knowledge that seeks to address numerous 
aspects of H. pylori and VacA biology. All clinical isolates of H. pylori harbor the VacA gene, and 
most H. pylori isolates express VacA, however, it is unknown how production of a mitochondrial 
toxin facilitates H. pylori pathogenesis. Given the multifaceted gaps in knowledge described, 
numerous approaches were employed in order to investigate the questions posed. First, 
intracellular compartments containing VacA were isolated and characterized via an unbiased 
proteomics analysis for identification of trafficking machinery. Second, several mechanisms of 
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mitochondrial quality control were evaluated in VacA intoxicated cells, in addition to evaluating 
generalized host responses to VacA mediated mitochondrial dysfunction. And finally, an in vivo 
model for the intragastric infusion of VacA was established and implemented in order to evaluate 
the specific effects that VacA is exerting on gastric tissue. The approaches described and 
comprised within the presented work directly address three seemingly disparate, but 




In summation, the culmination of these studies will address critical gaps in knowledge in 
the study of VacA and its interactions with host cells. By understanding the mechanisms 
governing VacA trafficking to the mitochondria, not only will a previously undescribed pathway 
and molecular machinery be elucidated, but the knowledge of this pathway will be the first 
characterized pathway of any extracellular, membrane associated protein being directly 
transported to the mitochondria. This has particular medical implications given mitochondrial 
based diseases have no known cure or effective therapy. The development of site directed drug 
therapy has profound implications in the understanding any potential treatment in mitochondrial 
disorders. In addition, while general mechanisms governing mitochondrial targeting by pathogens 
are known, the overwhelming majority of mitochondrial targeted pathogenic effectors have 
unidentified mechanisms of mitochondrial localization. By understanding VacA mediated 
mitochondrial targeted, that knowledge may be used to further the understanding of strategies 
that other pathogens use to target the mitochondria. Furthermore, the reports of mitochondrial 
quality control being activated in response to pathogen mediated mitochondrial dysfunction is 
limited to a small number of studies. Even more so, few studies characterize the nature of 
pathogen targeting mitochondrial function, as the physiological importance of pathogen mediated 
mitochondrial dysfunction is often to induce cell death. Identification and characterization of a host 
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cell detecting and responding to pathogen mediated mitochondrial dysfunction will yield 
fundamental insight into not only the mechanisms governing mitochondrial quality control, but 
also sensing signals allowing for the detection of pathogen mediated mitochondrial dysfunction. 
In addition, characterization of mitochondrial derived VacA containing vesicles will be the first 
described mechanism of MDVs being formed in response to a pathogenic effector. Finally, the 
implementation of an intragastric infusion model in VacA exposure will provide the best and most 
representative model of VacA exposure in vivo. To date, oral gavage of animals with VacA is the 
most commonly used modality to evaluate the role of VacA in vivo. However, oral gavage has 
considerable limitations to reproducing the natural intoxication with VacA. The intragastric infusion 
model will provide the most representative model to date of in vivo VacA exposure. Altogether, 
these studies address major areas in not only the study of VacA and H. pylori pathogenesis, but 
the approaches and methodologies are representative of strategies that may be applied to any 
investigation of host-pathogen interactions, and the role that a particular pathogenic effector of 






Figure 1.1: Virulence factors and pathogenic effectors. Bacteria toxins and pathogenic 
effectors modulate the host environment through various mechanisms. For example, A) Yersinia 
pestis adheres to host epithelial surfaces via the pH 6 antigen (PsaA), B) Helicobacter pylori 
increases the surrounding media through the action of urease, C) Yersinia pestis modulates 
intracellular signaling cascades through YopJ, and D) Escherichia coli scavenges iron through 
the siderophore Yersiniabactin. These systems illustrate various mechanisms by which 





Figure 1.2: Classic bacterial virulence factors and pathogenic effectors. Although various 
bacterial toxins have been identified and characterized as important for the pathogenesis of a 
given bacterium, several systems have been intensively studied and are considered key classical 
examples of virulence factors and pathogenic effectors. A) Clostridium botulinum and Clostridium 
tetani produce the botulinum and tetanus toxins, respectively, which are proteases that cleave 
intracellular SNARE proteins, resulting in inhibition of neurotransmitter release. B) Vibrio cholerae 
produces the cholera toxin, an ADP-ribosyl transferase targeting G-proteins, resulting in 
increased adenylate cyclase activity, cAMP, PKA, and increased efflux of chloride ions and water 
from the cell. C) Bacillus anthracis produces lethal and edema factor, and protective antigen, 
whereby edema factor, a calcium and calmodulin dependent adenylate cyclase, increases cAMP 
resulting in edema, and lethal factor, a protease, cleaves MAPKK, resulting in cell death. D) 
Corynebacterium diphtheria, via a bacteriophage, produces the diphtheria toxin, an ADP-ribosyl 
transferase, which acts on host eEF-2, resulting in inhibition of protein synthesis and ultimately 





Figure 1.3: Bacterial secretion systems. In order to deliver pathogenic effectors to the 
extracellular space or directly into a host cell, bacteria engage any of seven different secretion 
systems. The Type 1 secretion system (T1SS) spans the inner and outer Gram-negative bacterial 
membranes as a channel. The Type 2 secretion system (T2SS) is a Sec-dependent secretion 
system with an outer bacterial membrane secretin channel. The Type 3 secretion system (T3SS) 
is similar to bacterial flagella and forms a multi-membrane spanning injectosome apparatus to 
secrete effectors directly in the host cytosol. The Type 4 secretion system (T4SS) is similar to 
bacterial conjugation pilus and forms a multi-membrane spanning channel to also secrete 
effectors directly into the host cytosol. The Type 5 secretion system (T5SS) is a Sec-dependent 
secretion system utilizing an autotransporter domain for transport across the outer bacterial 
membrane. The Type 6 secretion system (T6SS) is similar to the T4 bacteriophage injection 
apparatus and directly injects effectors into a host cell, including both bacterial and eukaryotic 
targets. The Type 7 secretion system (T7SS) is primarily characterized in mycobacterium and 
Gram-positive bacteria, and utilizes an inner bacterial membrane channel before secretion to the 




Figure 1.4: Bacterial toxin import. Bacteria toxins secreted into the extracellular space with 
biological activity in the host cell cytosol often undergo trafficking by one of two general 
mechanisms. The pH triggered mechanism (left) involves the host cellular endocytic pathway, 
whereby extracellular material is internalized into endosomes, which then acidify in order to 
facilitate lysosomal mediated degradation. Bacterial toxins utilizing this pathway, however, 
undergo a conformational change in response to the low pH, often resulting in the formation of a 
membrane channel and transport of the active A component of the toxin into the cytosol.  
Alternatively, the retrograde trafficking pathway (right) involves host cellular retrograde trafficking, 
whereby cell surface material is package into endosomal compartments, and trafficked to the 
Golgi apparatus then the endoplasmic reticulum (ER) via the recognition of lysine residues. Upon 






Figure 1.5: Organelle targeted pathogenic effectors. The eukaryotic host cell is a massive 
complex of potential factors for targeting by pathogenic microorganisms. Depending on the 
mechanism of pathogenesis, bacteria have evolved to usurp different intracellular organelles. For 
nuclear targeting, pathogens may alter host gene expression profiles. For endoplasmic reticulum, 
Golgi apparatus, and endosomal targeting, pathogens may sequester host membranes, lipids, 
and proteins in order to create a replication niche within a host cell. For mitochondrial targeting, 
pathogens may activate cell death pathways and manipulate metabolism. For cytoskeletal 
targeting, pathogens may use the actin motor as a means to propel a bacterium from a cell, or as 
a means of gaining access and internalization into a host cell. These various organelle targeting 
processes by pathogens are often mediated by direct acting effectors that either localize to a 
given target by mimicking host translocation machinery, or mimic the activity of factors canonically 





Figure 1.6: Mitochondrial dynamics. Mitochondria exist in a dynamic state balanced between 
fusion and fission. In physiologically homeostatic cells, mitochondria are constantly cycling 
between mitochondrial fission and fusion. However, when cells undergo various stressors, the 
dynamics are shifted. When energy demand is low and severe mitochondrial stress is induced, 
mitochondria are predominantly fragmented. When energy demand is elevated, mitochondria 




Figure 1.7: Mitochondrial protein import. The import of mitochondrial proteins into the outer 
mitochondrial membrane, the intermembrane space, the inner mitochondrial membrane, and the 
matrix is governed through the recognition of different signal sequences and transfer through 
different translocons. Several bacterial toxins have taken advantage of these trafficking 
processes, including PorB of N. gonorrhoeae, LncP of L. pneumophila, MAP of E. coli, and VacA 





Figure 1.8: Model of VacA mediated induction of mitochondrial quality control. The studies 
investigated the model that subsequent to VacA mediate mitochondrial dysfunction, mitochondrial 
quality control is activated in an effort to repair VacA mediated mitochondrial dysfunction. The 
model posits that in response to low levels of VacA and/or shorter times of intoxication, lower level 
quality control will be activated as a “first line of defense” to maintain mitochondrial homeostasis, 
comprising the mitochondrial unfolded protein response. As toxin exposure increases in 
concentration and time, and if low level mitochondrial quality control is insufficient to repair VacA 
damaged mitochondria, the model posits a stepwise engagement in higher levels of mitochondrial 
quality control activation, including activation of mitochondrial derived vesicles and mitophagy. If 
all molecular and organellar levels of mitochondrial quality control are insufficient to repair VacA 





Figure 1.9: Gastric anatomy and the effects of Helicobacter pylori infection in vivo. The 
gastric pits of the stomach is comprised of mucus secreting neck cells on the apical surface, 
gastric hydrochloric acid secreted parietal cells midway into the gastric pit, pepsinogen secreting 
Chief cells and somatostatin secreting D cells deeper within the gastric pit, followed by gastric 
secreting G cells in the terminal aspects of the gastric pits. Infection with Helicobacter pylori is 
associated with a depletion of gastric mucus, parietal cell hyperplasia, a decrease in gastric acid 





Figure 1.10: VacA structure. The protoxin of VacA is a 140 kDa protein. Upon secretion via the 
T5SS, the signal sequence and autotransporter domains of VacA are cleaved, leaving an 88 kDa 




Figure 1.11: VacA intracellular trafficking. Current literature suggests that VacA binds to the 
cell surface, is internalized into endosomal compartments indicative of GEECs, in routed into 
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Chapter 2: Intracellular trafficking of VacA 
2.1 Introduction 
The mitochondria of mammalian organisms contain a genome separate from the nucleus, 
and encodes a total of 13 proteins1,2. However, the mitochondrial proteome consists of over 1500 
proteins1-3; therefore, the overwhelming majority of proteins are encoded in the nucleus and 
require import in order to localize to the mitochondria and carry out their biological function. 
Mitochondrial protein import is a highly regulated process, whereby various translocons and 
transporters recognize different signals to traffic a given protein to the outer mitochondrial 
membrane, intermembrane space, inner mitochondrial membrane, or the matrix2,3. The TOM 
complex is the major translocon of the outer mitochondrial membrane, and is the primary gate for 
the transport of proteins into the mitochondria, regardless of the targeting signal3-5. If a protein 
has a canonical mitochondrial targeting sequence, often an N-terminal run of positively charged 
or hydroxylated residues forming an amphipathic α-helix, the protein is transported through TOM 
to the inner mitochondrial translocon complex TIM232-4. If the protein is integral to the inner 
mitochondrial membrane, it is directly shuttled into the membrane via TIM23, whereas if the 
protein is matrix localized, it is further transported through a PAM complex (pre-sequence 
translocase-associated import motor)3,4. Proteins containing cysteine-rich signals are often 
transported to the intermembrane space, and require the complex termed MIA (mitochondrial 
intermembrane space import and assembly)2,3,6. Hydrophobic, inner mitochondrial membrane 
metabolite carrier proteins are transported through TOM, and upon interaction with small TIM 
chaperones, are shuttled to the TIM22 inner mitochondrial membrane translocon, whereby the 
proteins are directly inserted into the inner mitochondrial membrane2,3,6. Finally, proteins that are 
a β-barrel in shape are also imported through TOM and interact with the small TIM chaperones, 
but rather than being targeted to the inner membrane, they are trafficked to the SAM complex 
(sorting and assembly machinery) on the outer mitochondrial membrane via the recognition of a 
“β-signal”, consisting of polar residues (often lysine or glutamine), a glycine residue, and 2 
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hydrophobic residues2-4. Similarly, proteins that are α-helical in nature are also trafficked to the 
outer mitochondrial membrane2. However, it has been reported that α-helical proteins main gain 
access to the outer mitochondrial membrane in the absence of TOM, but rather utilize the 
mitochondrial import complex (MIM)2. 
Interestingly, numerous pathogens have been described to take advantage of canonical 
mitochondrial transport machinery and pathways in order to gain access to the mitochondria7. 
Neisseria meningitides and gonorrhoeae produce the pore-forming toxin PorB. PorB is a β–barrel 
in structure, and is structurally similar to the outer mitochondrial channel VDAC (voltage-
dependent anion channel)8. In order to be inserted into the outer mitochondrial membrane, PorB 
is transported through the TOM complex, interacts with the small TIM chaperones, and is 
transported to the SAM complex for membrane insertion8-10. Legionella pneumophila produces 
LncP, an ATP carrier protein that is transported through the TOM complex, also interacts with the 
small TIM chaperones, and is transported to the TIM22 complex for membrane insertion, similar 
to how endogenous mitochondrial carrier proteins and transported11. 
Helicobacter pylori secretes VacA into the extracellular space via a Type 5 secretion 
system12,13. Upon contact with the host cell surface, VacA has been shown to bind to the abundant 
lipid sphingomyelin, which is also important for conferring biological acitivty14, as well as the 
proteins RPTPα and RPTPβ15,16. Upon internalization, VacA localizes to clathrin-independent 
carrier/GPI-anchored protein enriched endosomal compartments (CLIC/GEECs) (Figure 2.1), a 
process dependent on the actin cytoskeleton, Rac1, and Cdc4217. As toxin exposure progresses, 
VacA localizes to early endosomes, then to late endosomes18, ultimately reaching vacuoles19 or 
mitochondria20 (Figure 2.1).  
Given VacA is a membrane embedded, pore forming toxin, it is reasonable to ascertain 
that the toxin remains associated with membranes throughout its trafficking; therefore, trafficking 
is most likely to be mediated through vesicular transport. Additionally, no published data to date 
have shown VacA localization with the cytosol when cells are exposed to the purified toxin 
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extracellularly. While the targeting and formation of vacuoles is reasonable, considering VacA-
induced alterations in membrane dynamics, the targeting of the mitochondria is more perplexing. 
To date, no physiological process has been described of vesicular transport of cargo to and fusion 
of vesicles with the mitochondria; therefore, a pathogen producing a mitochondrial targeted 
effector must harness and reprogram physiological vesicular transport machinery in order to 
reroute vesicles to deliver cargo to the mitochondria (Figure 2.1).  
The discovery of the mechanism of VacA mediated mitochondrial targeting will be a new 
and undescribed phenomenon, not only to bacterial pathogenesis, but to cell biology as well. 
Elucidating the mechanism will also yield significant benefit to the medical field, for transport of 
an extracellular protein to mitochondria provides an exciting opportunity for site-directed drug 
therapy to combat a large number of mitochondrial based diseases with no known cure or effective 
treatment21. 
In recent years, an understanding of mitochondrial dynamics and communication with 
other organelles is beginning to be described22,23, including interactions with the plasma 
membrane24, endoplasmic reticulum25-27, and the endolysosomal system28-30. Although pathways 
have been described of vesicles forming from the mitochondria and trafficked to peroxisomes and 
lysosomes30-32, to date no pathways have been described of vesicular transport to and fusion with 
the mitochondria. Phenomena have been reported of endosomal and lysosomal compartments 
coming into direct contact and juxtaposition with the mitochondria28, but whether vesicular 
transport pathways exist to traffic to and deliver cargo to the mitochondria remains poorly 
understood.  
Here, I report the approach to isolate and characterize the temporal remodeling of the 
VacA enriched compartments (VEC) proteome prior to delivery of VacA to the mitochondria. 
Furthermore, I report the identification of several proteins that are important for VacA activity, 
namely 14-3-3-G, VPS4B, Rab35, and Stx18, with Rab35 specifically being important for VacA 
localization to host cell mitochondria. Altogether, these studies provide not only an effective 
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strategy to evaluate the intracellular trafficking of a bacterial toxin, but it also provides new insight 
into the molecular machinery governing the trafficking of VacA within host cells in order to 
ultimately localize to the mitochondria. 
 
2.2 Materials and methods 
Bacterial strains. Helicobacter pylori 60190 (cag PAI+, vacA s1/m1; 49503; ATCC) was 
cultured in biphasic media (3 ml of liquid media on top of solid agar media) in bisulfite- and sulfite-
free Brucella broth (BSFB) on Ham’s F-12 (Sigma) agar plates supplemented with 5 µg/ml 
vancomycin (Sigma) and 10% fetal bovine serum (Sigma) for 48 h at 37ºC under microaerophilic 
conditions (5% CO2, 10% O2). Plate supernatants were collected as a starter culture inoculum 
and diluted 1:100 in fresh BSFB supplemented with 5 µg/ml vancomycin and incubated on a 
shaker platform for 48 h at 37ºC under microaerophilic conditions. 
Mammalian cells. AZ-521 (HuTu-80) human duodenal adenocarcinoma derived cells 
were obtained from Riken Japan Health Science Foundation (3940), HeLa human cervical 
adenocarcinoma derived cells were obtained from ATCC (CCL-2), and AGS human gastric 
adenocarcinoma derived cells were obtained from ATCC (CRL-1739). AZ-521 and HeLa cells 
were maintained in MEM (Fisher Scientific), and AGS cells were maintained in DMEM (Fisher 
Scientific), each supplemented with glutamine (2 mM, Fisher Scientific), fetal bovine serum (FBS) 
(10%, Sigma-Aldrich), penicillin (100 U/ml, Fisher Scientific), and streptomycin sulfate (1 mg/ml, 
Fisher-scientific). All cell lines were maintained at 37ºC, 5% CO2, in humidified atmosphere, and 
passaged with trypsin (0.05%, Corning) for 5 min at 37ºC after cells reached approximately 80% 
confluency.  
Chemicals, reagents and primary antibodies. Unless otherwise noted, all chemicals 
and reagents were purchased from Sigma-Aldrich. Primary antibodies against TOM20 (rabbit 
polyclonal, SC-11415), EEA1 (rabbit polyclonal, SC-33585), and LAMP1 (mouse monoclonal, 
SC-20011) were obtained from Santa Cruz Biotechnology; 14-3-3-G (rabbit monoclonal, AB-
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137048), Rab35 (rabbit polyclonal, AB-105762), VPS4B (rabbit polyclonal, AB-102687), and 
Stx18 (rabbit monoclonal, AB-156017); and β-actin (rabbit monoclonal, CS-4970) was obtained 
from Cell Signaling Technology. The anti-VacA antibody was raised in lab from New Zealand 
White rabbits immunized with purified VacA.  
Purification of VacA. (Figure 2.2) Culture supernatants were obtained by centrifuging 48 
h H. pylori bacterial cultures (8, 2 liter Erlenmeyer flasks each containing 200 ml of culture) at 
7,000 x g for 30 min at 4ºC. Culture supernatants were precipitated at 90% ammonium sulfate 
(Fisher Scientific) at room temperature for 1 h, then centrifuged at 7,000 x g for 30 min. 
Precipitated protein pellets were resuspended in phosphate buffer (10 mM Na2HPO4 (Sigma), pH 
7.0), then dialyzed in 50,000 MWCO dialysis membrane (Spectrum Laboratories) 1:200 in 
phosphate buffer at 4ºC for 5 h with 4 buffer changes. Dialyzed culture extracts were filter 
sterilized through 0.22 µm pore PES filters (Millipore), and loaded onto a 35 ml bed volume 
diethylaminoethyl (DEAE)-sephacel anion exchange column (GE, Sigma-Aldrich) pre-equilibrated 
with 2 bed volume washes phosphate buffer. The culture extract bound column was washed with 
2 bed volumes of phosphate buffer, then eluted with phosphate buffer containing elution salt (10 
mM Na2HPO4, 200 mM NaCl (Fisher scientific), pH 7.0). Column eluates were evaluated by SDS-
PAGE and Coomassie staining, and eluates containing pure VacA (as defined by the 88 kDa 
VacA band comprising >95% of total lane bands) were combined and dialyzed in a 50,000 MWCO 
dialysis membrane (Spectrum Laboratories) 1:200 in PBS pH 7.4 at 4ºC for 5 h with 3 buffer 
changes. PBS dialyzed, purified VacA was filtered sterilized through a 0.22 µm pore syringe filter 
(Millipore), aliquoted into single use vials, and stored at -20ºC. The concentration of purified VacA 
was determined by the BCA protein concentration assay with bovine serum albumin (BSA) 
standards prepared in PBS pH 7.4, VacA activity was determined by the neutral red vacuolation 
assay with only purified VacA batches yielding activity within one standard deviation of previously 
established Vac50 values (the concentration of VacA yielding vacuolation in 50% of intoxicated 
cells) being used for experimentation, and the identify of purified VacA was confirmed by 
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immunoblotting purified VacA batches separated on a 10% gel by SDS-PAGE and transferred to 
PVDF with detection using rabbit anti-VacA antibodies. 
Protein concentration assay. The concentration of PBS pH 7.4 dialyzed, filter sterilized, 
purified VacA was determined by the bicinchoninic acid (BCA) protein concentration assay kit 
(Thermo Fisher Scientific) by the manufacturer’s instructions. In brief, standards of 0, 25, 125, 
250, 500, 750, 1000, and 1500 μg/ml of bovine serum albumin (BSA) were prepared in PBS pH 
7.4 from 2 mg/ml BSA ampules provided by the kit provided. Standards and VacA samples were 
plated 25 μl per well in a 96 well non-tissue culture treated plate (Fisher Scientific) in triplicate. 
The BCA working reagent was prepared fresh for each concentration assay, consisting of a 50:1 
dilution of Reagent A to Reagent B in a volume sufficient for 0.2 ml of working reagent for each 
well. After addition of the working reagent, plates were incubated in a 37ºC incubator, followed by 
absorbance measurement at 562 nm on a plate reader (BioTek Synergy 2, Gen5 software version 
1.02.8). A standard curve was plotted as absorbance at 562 nm versus the concentration of BSA 
protein (μg/ml) and fitted as a 3rd order polynomial.  
Acid activation of VacA. Immediately prior to experimentation, single use aliquots of PBS 
pH 7.4 dialyzed, filter sterilized, purified VacA was thawed and acid activated by incubating VacA 
10:1 in 0.3 M HCl (Fisher) for 30 min at 37ºC in a hot water bath, followed by neutralization with 
an equal volume of 0.3 M NaOH (Fisher) to the volume of 0.3 M HCl used. The acid activated 
VacA was diluted with cell culture media for cell culture treatments and immediately used. 
VacA fluorophore labeling. Purified VacA was directly labeled with Alexa Fluor 488 
sulfodichlorophenol (5-SDP) ester (Thermo Fisher) by the manufacturer’s protocol. In brief, 
purified VacA was concentrated using a 15,000 MWCO centrifugal filter unit (Amicon) to 
approximately 1 mg of protein. The pH of the VacA solution was increased by adding a 1:10 
dilution of 1M NaHCO3 (final concentration of 0.1 mM NaHCO3). Added into the solution of VacA 
was 0.5 – 1 mg of Alexa Fluor 488 5-SDP ester. The labeling solution was incubated at room 
temperature for 1 h protected from light. The reaction was quenched by adding a 1:100 dilution 
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of 2M Tris, pH 8.5 (final concentration of 0.02 M Tris), and further incubated at room temperature 
for 10 min. The solution was transferred to a 3500 MWCO dialysis cassette (Thermo Fisher) and 
dialyzed in a 1000X volume of PBS pH 7.4 at 4ºC for 6 h with 3 buffer changes. The degree of 
VacA labeling was confirmed by SDS-PAGE and imaging using a ChemiDoc XRS+ system using 
an Alexa Fluor 488 filter. In order to determine the concentration of labeled VacA, densitometry 
analysis was performed by comparing coomassie staining of purified, unlabeled VacA to labeled 
VacA by SDS-PAGE. Quantification was performed using ImageLab. 
Intracellular trafficking of VacA. AZ-521, AGS, and HeLa cells were seeded in 8 well 
chambered microscope slides (Lab Tek) and were incubated with VacA directly labeled with Alexa 
Fluor 488 (250 nM) for 30 min at 4ºC to allow for binding to the cell surface. After binding, cells 
were washed and the media was replaced with an equal concentration of unlabeled VacA (250 
nM) and incubated at 37ºC for 0.25, 0.5, 1, 2, 4, or 8 h. Following incubation, cells were fixed in 
5% formaldehyde at 37ºC for 15 min, washed with PBS pH 7.4 three times, permeabilized in 0.1% 
Triton-X 100 in PBS pH 7.4 at room temperature for 15 min, washed with PBS pH 7.4 three times, 
and blocked with 5% bovine serum albumin (BSA; Sigma-Aldrich) in PBS for 1 h at room 
temperature. Cells were then washed with 0.1% Tween-20 in PBS pH 7.4 three times, and probed 
for the mitochondrial marker TOM20 with an anti-TOM20 rabbit polyclonal antibody at a 1:1000 
dilution (Santa Cruz Biotechnology), the early endosome marker EEA1 with an anti-EEA1 rabbit 
polyclonal antibody at a 1:1000 dilution (Santa Cruz Biotechnology), and a lysosomal marker 
LAMP1 with an anti-LAMP1 mouse polyclonal antibody at a 1:500 dilution (Santa Cruz 
Biotechnology) in 1% BSA in PBS pH 7.4 overnight at 4ºC. Following primary antibody incubation, 
cells were washed with 0.1% Tween-20 in PBS pH 7.4 three times, followed by Alexa Fluor-555 
conjugated goat anti-mouse and Alexa Fluor-555 conjugated donkey anti-rabbit secondary 
antibody  at a 1:1000 dilution (Life Technologies) in 1% BSA in PBS pH 7.4 at room temperature 
for 2 h and then counterstained with DAPI (0.5 µg/ml in PBS pH 7.2, room temperature, 15 min), 
washed with 0.1% Tween-20 in PBS pH 7.4 three times, then mounted in ProLong Gold Antifade 
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Reagent (Life Technologies) overnight and sealed. At least 10 cells per experimental treatment 
and individual replicate were imaged by DIC epifluorescence microscopy using a DAPI, FITC, 
and RD-TR-PE filter on a Delta Vision RT microscope. VacA association with mitochondria, early 
endosomes, and lysosomes was measured by Pearson’s coefficient of correlation in the FITC 
and RD-TR-PE channels. Data from 3 independently performed biological replicates were 
compiled after the data from each independent biological replicate performed with 3 technical 
replicates were relativized to the respective untreated control. 
Analysis of cellular vacuolation. AZ-521, AGS, and HeLa cells were cultured in 96 well 
plates at a density of 2.5 x 105 cells per ml of culture volume and allowed to adhere overnight at 
37ºC, 5% CO2, in humidified atmosphere. Cells received the designated experimental treatment 
in cell culture medium containing 5 mM NH4Cl (Sigma) with an experimental set (including 
technical replicates) being performed in duplicate on the same plate for total protein 
measurement. For routine quality control testing of purified VacA, neutral red vacuolation assays 
were performed for 4 h. Following experimentation, cells were imaged for visual vacuole formation 
by light microscopy. Following imaging, all cells were washed twice at room temperature with PBS 
pH 7.4. The plate was incubated at 37ºC for 4 min with experimental set for vacuolation 
measurement staining in 100 µl per well of Neutral Red solution (Sigma-Aldrich) (diluted 1:5 with 
PBS pH 7.4) and the experimental set for total protein measurement in 100 µl per well of PBS pH 
7.4. Following staining, all cells were washed three times with PBS pH 7.4 to remove residual 
neutral red and control for washing and cell loss. The experimental set of cells for vacuolation 
measurement were lysed in 100 µl per well of acid alcohol (3.7% HCl, 70% ethanol, in diH2O), 
and the experimental set of cells for total protein measurement were lysed in 25 µl per well of 
RIPA buffer (Thermo Fisher). The plate was incubated for 10 min at room temperature on a shaker 
platform for cell lysis. Subsequently, 200 µl of BCA working reagent (Thermo Fisher) was added 
per well for the total protein measurement experimental set. The entire plate was incubated at 
37ºC for 30 min for BCA development. For total protein measurement, a set of standards from 
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1500 µg/ml bovine serum albumin (BSA) in RIPA buffer to 25 µg/ml were prepared with 25 μl per 
well on a separate, non-tissue culture treated 96 well plate (Fisher Scientific) in triplicate. Neutral 
red uptake was measured at 530 nm and 410 nm on a plate reader (Bio Tek Synergy 2, Gen5), 
and total protein was measured at 562 nm. Data from 3 independently performed biological 
replicates were compiled after the data from each independent biological replicate performed with 
3 technical replicates were normalized to the respective total protein measurement under the 
same experimental treatment and relativized to the respective untreated control. 
Analysis of mitochondrial fragmentation. Following experimental treatments in 8 well 
chambered microscope slides (Lab Tek), AZ-521, AGS, and HeLa cells were fixed in 5% 
formaldehyde at 37ºC for 15 min, washed with PBS pH 7.4 three times, permeabilized in 0.1% 
Triton-X 100 in PBS pH 7.4 at room temperature for 15 min, washed with PBS pH 7.4 three times, 
blocked with 5% bovine serum albumin (BSA; Sigma-Aldrich) in PBS for 1 h at room temperature, 
washed with 0.1% Tween-20 in PBS pH 7.4 three times, and probed for the mitochondrial marker 
TOM20 with an anti-TOM20 rabbit polyclonal antibody at a 1:1000 dilution (Santa Cruz 
Biotechnology) in 1% BSA in PBS pH 7.4 overnight at 4ºC, washed with 0.1% Tween-20 in PBS 
pH 7.4 three times, followed by Alexa Fluor-488 conjugated goat anti-rabbit secondary antibody  
at a 1:1000 dilution (Life Technologies) in 1% BSA in PBS pH 7.4 at room temperature for 2 h 
and counterstained with DAPI (0.5 µg/ml in PBS pH 7.2, room temperature, 15 min), washed with 
0.1% Tween-20 in PBS pH 7.4 three times, then mounted in ProLong Gold Antifade Reagent (Life 
Technologies) overnight and sealed. At least 10 cells per experimental treatment and individual 
replicate were imaged by DIC epifluorescence microscopy using a DAPI and FITC filter on a Delta 
Vision RT microscope. Mitochondrial filament lengths were measured manually using the Imaris 
imaging processing software and recorded in micrometers. Data from 3 independently performed 
biological replicates were compiled after the data from each independent biological replicate 




RNAi knockdown. AZ-521, AGS, and HeLa cells were cultured in antibiotic free media, 
then transfected with 50 nM RNAi against NC1 (scrambled control), 14-3-3-G, Rab35, VPS4B, 
and Stx18 (IDT) with Lipofectamine (Invitrogen) by the manufacturer’s instructions for 48 h prior 
to experimentation. In brief, cells were cultured in 6 well cell culture plates in antibiotic free media 
and allowed to reach approximately 80% confluency prior to transfection. Each RNAi transfection 
reagent for each cell type and protein target was prepared by diluting RNAi in 50 µl OptiMEM, 
and Lipofectamine 2000 in 50 µl OptiMEM and incubating at room temperature for 5 min. After 
initial incubation, the diluted Lipofectamine was added to the RNAi, and the complex was further 
incubated at room temperature for 25 min. The 100 µl mixture was added directly into a single 
well of a 6 well plate. Cells were exposed to the transfection reagents for 24 h, then washed twice 
with PBS pH 7.4 and replaced with fresh cell culture medium lacking antibiotics. Cells were re-
transfected using the same method described. Approximately 4-6 h after the second transfection, 
cells were washed twice with PBS pH 7.4 then collected by trypsinization (0.05% trypsin, 5 min, 
37ºC), and collected in antibiotic free cell culture medium. Cells were re-seeded into the needed 
cell culture plates (e.g. 96 well plate, 24 well plate, 8 well chamber slide), at a density of 2.5 x 105 
cells per ml of cell culture medium and incubated overnight at 37ºC, 5% CO2, humidified atm. 
Approximately 48 h after the initial transfection, an experiment was begun. Immunoblotting 
against each protein with a β-actin loading control was performed to confirm knockdown for every 
transfection and experiment conducted. 
Ferrofluid labeling of VacA. Immediately following acid activation, purified VacA in 10 
mM Na2HPO4 pH 7.0 was incubated in a 1:50,000 dilution of ferrofluid (EMG 607, Ferrotec USA) 
to final culture medium volume at room temperature for 1 h under gentle agitation. Labeled VacA 
was brought up to the final volume and desired concentration with cell culture medium. 
VEC isolation. AZ-521 cells were cultured in four, 15 cm cell culture plates to obtain 
sufficient yield of VECs for mass spectrometry analysis. Cells were incubated in purified VacA 
directly labeled with ferrofluid in cell culture medium at 4ºC for 30 min to allow for binding. Cells 
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were washed three times with PBS pH 7.4 to remove unbound labeled VacA. PBS pH 7.4 was 
replaced with an equal volume and concentration of unlabeled VacA (250 nM) pre-warmed to 
37ºC as a chase medium. Following incubation at 37ºC, cells were washed 3 times with cold PBS 
pH 7.4, then collected with a cell scraper. Cells in suspension were centrifuged at 500 x g for 5 
min at 4ºC, and supernatant decanted. Cell pellets were resuspended in a hypo-osmotic swell 
solution (10 mM NaCl, 1.5 mM  MgCl2, 10 mM Tris-HCl, pH 7.5) and incubated on ice for 10 min 
to facilitate mechanical lysis. Tonicity was restored by adding 2.5X lysis buffer (525 mM mannitol, 
175 mM sucrose, 12.5 mM Tris-HCl, 2.5 mM EDTA, pH 7.5) to 1X, followed by immediate lysis of 
cells by 20 passages through a 25 gauge needle and syringe on ice. Unlysed cells, nuclei, and 
heavy membrane debris were pelleted at 500 x g for 10 min at 4ºC. Supernatants were applied 
to a magnetic column (µMACS, Miltenyi Biotec) held in a magnetic field pre-equilibrated with PBS 
pH 7.4. Flow through was collected and the column was washed with 20 ml of cold sterile PBS 
pH 7.4. The column was removed from the magnetic field and 60 µl of eluates were collected. 
VECs were isolated in 3 independent replicates at 0, 0.25, 0.5, 1, 2, and 4 h of VacA intoxication. 
Yield of VEC isolation was determined by immunoblotting against VacA, BCA for total protein in 
the eluate, and krypton staining of eluate samples.  
VEC mass spectrometry. VEC samples were analyzed by HPLC-MS/MS at the Roy J. 
Carver Biotechnology Center at the University of Illinois within the Proteomics Core Facility. The 
samples were processed by solubilization in a mild detergent and residual buffer components, 
salts, detergents, and lipids were removed by the G-Biosciences Perfect Focus kit. The VEC 
proteins were digested with proteomics grade trypsin, lyophilized, and 1-2 µg of digested peptides 
were analyzed by tandem HPLC-MS/MS. The raw proteomics data were collected using the 
Xcalibur software and peptide sequences were compared against the SwissProt protein database 
for human proteins. Resultant proteins with an ion score (probability that an observed match is a 
random event) less than 10 were discarded, and relative protein content was quantified by the 
exponentially modified protein abundance index (emPAI). 
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Immunoblotting. Upon completion of an experimental treatment, cells were washed with 
PBS pH 7.4 twice then collected in lysis buffer (100 mM Tris-Cl, 4% SDS, 0.2% Bromophenol 
Blue, 20% glycerol, 10% β-mercaptoethanol, and 50 mM dithiothreitol) or samples were prepared 
in 2X Laemmli sample buffer (BioRad). Samples were boiled at 100ºC for 10 min on a heating 
block, then aliquoted and stored at -20ºC, or used immediately for electrophoresis. Following 
denaturation, samples were centrifuged at 1000 x g for 15 sec to collect condensation. Depending 
on the molecular weight of the protein target, samples were separated on 6-12% polyacrylamide 
gels at 80-120V for 60-120 min at room temperature via SDS-PAGE. Following electrophoresis, 
samples were immunoblotted to polyvinylidene fluoride (PVDF) membranes activated with 
methanol by wet transfer at 60-80V for 30-60 min at 4ºC. PVDF membranes were blocked with 
5% milk in Tris-Buffered Saline + Tween (TBS-T: 137 mM NaCl, 100 mM Tris-base, 0.5% Tween-
20, pH 7.6) at room temperature for 1 hour, then incubated in the given primary antibody in 1% 
milk in TBS-T overnight at 4ºC. Membranes were washed with TBS-T, then incubated in 
secondary antibodies conjugated to horseradish peroxidase (HRP) (Cell Signaling) at room 
temperature for 60 min. Membranes were washed with TBS-T, then developed with SuperSignal 
West Femto/Pico Maximum Sensitivity Substrate (ThermoFisher). Images were acquired using a 
ChemiDoc XRS+ system and data were processed with ImageLab software. 
Statistical analysis. All experiments were performed in three independent replicate with 
at least three technical replicates. For pairwise comparisons, significance was determined using 
a 2-tailed distribution, paired t test. For multiple comparisons, significance was determined using 
a one-way ANOVA with Tukey correction for multiple comparisons. Unless otherwise indicated, 
statistical significance was signified by an alpha level threshold of 0.05. Error bars from 
quantification datasets represent standard error of the mean (SEM). For all statistical analyses, 





2.3  Results 
2.3.1  Model of VacA intracellular trafficking  
 Previous reports have shown VacA to bind on the cell surface to the abundant lipid 
sphingomyelin14, with internalization into GEECs17. Subsequent to internalization, VacA 
associates with the endolysosomal system, as well as mitochondria18,20,33-36. To date, no reports 
have detected exogenously added VacA to localize to the cytoplasm. It is worthwhile to note, 
however, that VacA overexpressed in the cell cytosol is capable of mitochondrial localization34, 
although numerous concerns are raised regarding the association of VacA with cellular 
membranes upon endogenous expression. Given VacA is a membrane embedding, pore-forming 
toxin37-39, it is hypothesized that VacA is associated with membranes throughout its intracellular 
trafficking. Multiple models have been proposed for the mechanism underlying VacA trafficking to 
the mitochondria. One model posits that a direct contact and transfer of VacA containing 
endosomes with the mitochondria occurs, with subsequent transport of VacA through the TOM 
complex40. A second model proposes that, like other canonical AB toxins, VacA is indeed released 
into the cytosol, with domains of VacA then gaining access to the mitochondria, also via 
mitochondrial transporters. The final model ascertains that VacA containing early uptake vesicles 
fuse with the mitochondria, although no biological process has been described illustration such a 
possibility. Given the reported association of VacA with the endosomal system as well as the 
mitochondria, a model of VacA intracellular trafficking and localization to the mitochondria which 
fulfills requirements for all three of the models just described consists of a dynamic remodeling of 
VacA containing vesicles from the endosomal system in order to become functionally competent 
to traffic to and/or fuse with the mitochondria (Figure 2.1). However, as described earlier, to date 
no studies have identified a pathway of vesicle transport to and fusion with the mitochondria. 
Alternatively, vesicles may become within close proximity to the mitochondria, and VacA may be 
directly transferred between compartments. Regardless, all models of VacA intracellular 
trafficking share a common early uptake compartment to which VacA is localized. Therefore, it is 
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hypothesized that these early uptake compartments, and the components contained within them, 
are important for directing and mediating the trafficking of VacA to the mitochondria. By 
performing an unbiased characterization of early uptake VacA containing vesicles, molecular 
factors previously unknown to be important for VacA activity, may then be identified. 
 
2.3.2  VacA association with endosomes and mitochondria 
 Previous reports have shown VacA to associate with the endosomal system18,33 as well 
as the mitochondria33,36. In order to evaluate the temporal association of VacA with different 
compartments within a cell, a pulse-chase fluorescence microscopy approach was used. For this 
approach, in order to track the “front wave” of VacA entering a cell, purified VacA was directly 
labeled with a fluorophore (Figure 2.2), and cells were incubated with labeled VacA at 4ºC for 30 
min to allow for cell surface binding of the pulse population of VacA. Excess, unbound VacA was 
washed and removed, and subsequently replaced with an equal concentration of unlabeled toxin. 
Cells were incubated at 37ºC along a timeseries, and the association of VacA with the different 
organelles was measured by fluorescence microscopy. Upon examination of the colocalization 
data, VacA first associates with early endosomes, peaking in association within 30 min, then 
decreasing by 1 h and reaching steady-state levels (Figure 2.3A). Similarly, VacA rather quickly 
is detected to associate with the mitochondria, also at 30 min (Figure 2.3B). However, the peak 
of association of VacA with the mitochondria occurs at 2 h, and interestingly, subsequent to 2 h, 
the association of VacA with the mitochondria decreases to be no longer significant by 8 h of 
intoxication (Figure 2.3B). As a control, no significant change in VacA association with the 
general cellular marker actin was detected over time (Figure 2.3C), indicating that the observed 
increase in VacA association with endosomes and mitochondria was not background of VacA 
entering a cell, but rather is a specific association with the organelle. The trends of VacA peaking 
in association with either endosomes or mitochondria indicate that the pulse population of VacA 
is transiting through the given organelle, with ultimate localization to another compartment. Upon 
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examination of the structure of VacA with endosomes and mitochondria, a very strong and 
complete overlay of VacA with early endosomes was apparent, as indicated by an overlap of the 
EEA1 and VacA channels with each other (Figure 2.3D). However, the association with the 
mitochondria was more sparse, with VacA positive puncta being within a closer proximity or 
adjacent to mitochondria, rather than a complete overlay of the two structures (Figure 2.3E). 
Given VacA was not observed to completely localize to the mitochondria, this finding supports a 
model that VacA is further trafficked from the mitochondria over time, which is illustrated by a 
detectable decrease in VacA association with the mitochondria by 8 h after internalization (Figure 
2.3B). Furthermore, this finding may illustrate a relatively quick and dynamic phenomenon, 
whereby VacA associates with the mitochondria, but is quickly trafficked to another location. 
Altogether, these data support a model that VacA associates with endosomal compartments prior 
to associating with the mitochondria. 
 Examination of the VacA signal alone across a timecourse of intoxication illustrates that 
VacA associates with punctate structures (Figure 2.4). When bound to the cell surface under 
conditions not permitting internalization (incubation at 4°C), the VacA signal appears to coincide 
with the cell surface and binding to plasma membrane projections (Figure 2.4). Following 
internalization, the VacA signal appeared more punctate, and never was a signal detected 
indicative of mitochondrial tubules, indicating that VacA associates with vesicular structures 
during trafficking, including while associated with the mitochondria. In addition, VacA was not 
detected in a diffuse pattern within the cell cytosol, further illustrating that VacA is unlikely to 
release a functional domain into the cytosol for biological activity. Altogether, these data indicate 
that VacA associates with vesicular compartments throughout the duration of VacA intracellular 






2.3.3  VacA enriched compartment (VEC) isolation 
 Subsequent to internalization, VacA has previously been shown to localize to early 
endocytic compartments, prior to localization to mitochondria33. Although there are reports of 
intracellular vesicles coming in close contact with mitochondria28,33, there are no reports to date 
of intracellular vesicles localizing to and fusing with the mitochondria. Given there are no known 
mechanisms of vesicle transport to the mitochondria, to investigate the trafficking of VacA to the 
mitochondria, it was hypothesized that intracellular compartments containing VacA are remodeled 
from canonical early uptake compartments to vesicles rendered competent for trafficking to and 
fusion with the mitochondria via the recruitment of host protein factors. To address this 
hypothesis, VacA enriched compartments (VECs) were directly isolated and characterized in 
order to evaluate protein based changes in the VacA enriched compartments. Recently, a report 
was published detailing the isolation and characterization of intracellular compartments containing 
VacA from T cells41. The group approached the VacA intracellular compartment isolation using 
an immuno-magnetic based isolation, which is limited in regards to resolution given all intracellular 
compartments containing VacA were collected, yielding significant background. Furthermore, 
immuno-based approaches often confer a large degree of background signal, and depending on 
the sensitivity of the mass spectrometry analysis, that background may mask significant biological 
findings.  
In order to isolate the most representative class of VECs at a given temporal stage post-
intoxication, a magnetic based pulse-chase isolation approached was used. In brief, purified VacA 
was directly labeled with ferromagnetic nanoparticles, rendering VacA capable of being retrieved 
upon exposure to a magnetic field without interfering with the ability of VacA to exert its biological 
activity within a host cell. AZ-521 cells were exposed to a pulse of magnetically labeled VacA, 
followed by a chase of an equal concentration of unlabeled VacA. VECs were collected by 
applying cellular lysates to a magnetic field (Figure 2.5). This approach allowed for the isolation 
of the most mature stage of intracellular compartments containing VacA, limiting the background 
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of all compartments containing VacA, at any given time. Furthermore, this approach provides the 
best resolution for the composition of a VEC population at any given time post intoxication, by 
enriching for the pulse, VacA-labeled population of VECs. 
 VacA is routinely purified using an anion exchange resin42 (Figure 2.2). Given anionic 
resins attract negatively charged molecules, a cationic based ferrofluid was utilized. Following 
acid activation, purified VacA was incubated with cationic ferrofluid, then passed through a column 
exposed to a magnetic field. The flow through was collected, the column was washed extensively 
with sterile PBS pH 7.4, then eluates were collected upon removal of the column from the 
magnetic field. After coomassie staining, the data indicate that incubation of VacA with ferrofluid 
rendered VacA to be magnetically retained, as indicated by the absence of VacA in washes, but 
presence of VacA in eluates when VacA is incubated with ferrofluid (Fe-VacA) (Figure 2.6). 
Passage of VacA that was not incubated with ferrofluid yielded no detectable VacA in the eluates, 
indicating that VacA was not non-specifically associating with the magnetic column (Figure 2.6). 
It is also worthwhile to note that coomassie positive material was detected in the wells of the SDS-
PAGE gel, indicating that a 10 min boiling of samples at 100°C was not sufficient to fully separate 
VacA from the ferrofluid nanoparticles, illustrating the strength of the association and labeling of 
VacA with ferrofluid. Altogether, these data indicate that VacA is successfully labeled with 
ferromagnetic nanoparticles, resulting in the ability to recovery VacA specifically from a magnetic 
field.  
 In order to evaluate whether the ferrofluid label affects VacA activity, or cell viability, cells 
were treated with VacA, VacA labeled with ferrofluid (Fe), or ferrofluid alone, and cells were 
examined for the ability of VacA to induce cellular vacuolation, as well as the viability of cells 
overall. Upon evaluating VacA mediated vacuolation using visual assessment of vacuole 
formation coupled with quantification using a neutral red assay, both VacA and ferrofluid labeled 
VacA (Fe-VacA) resulted in comparable levels of vacuolation and neutral red uptake, whereas 
untreated cells or cells treated with ferrofluid alone, did not yield detectable vacuolation (Figure 
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2.7A, B). It is worthwhile to note that during the labeling of pure VacA alone, some VacA is 
detected in the column flow through (Figure 2.6), indicating that the labeling of VacA is not 
complete. However, given there is no detectable loss in VacA mediated vacuolation (Figure 2.7A, 
B), it is interpreted that all VacA is contributing to VacA mediated vacuolation, and not only the 
non-labeled population of VacA. In addition, no visible cytotoxicity was observe upon exposure of 
cells to either rerrofluid alone, or to ferrofluid labeled VacA (such as cell shrinkage or detachment) 
(Figure 2.7A, B). Upon measuring cell viability by a trypan blue exclusion assay, no significant 
induction of cell death was observed in any of the VacA, control, or ferrofluid only treatments, 
whereas the positive control of ethanol treatment yielded complete uptake of trypan blue (Figure 
2.7C). Altogether, these data indicate that the ferrofluid does not negatively interfere with VacA 
activity, and the internalization of ferrofluid does not overtly negatively impact the viability of cells.  
 In order to evaluate whether VacA can be magnetically retained from complex cellular 
material, cells were treated with purified VacA labeled with ferrofluid, VacA alone, or ferrofulid 
alone (Figure 2.8). Isolation of VECs by application of post-nuclear supernatants to a magnetic 
field after extensive washing indicated that VacA immuno-reactive material was obtained only in 
the samples treated with VacA that was directly labeled with ferrofluid, as indicated by the 
presence of VacA bands in the eluates of the Fe-VacA treated cells (identified as lanes 8-11) 
(Figure 2.8). These data indicate that the wash conditions used are sufficient as no detectable 
VacA material was observed in later washes (identified as lanes 6 and 7), that VacA alone is not 
retained in the magnetic column and is thus unlikely to yield detectable background in VEC 
isolations. It is also worthwhile to note that VacA bands are detected in the flow through (lane 4) 
and first washes (lane 5) of the elution profile (Figure 2.8), which are interpreted to represent the 
“chase” population of VacA that is not labeled with ferrofluid. Given VacA is detected in the 
eluates, not only does this illustrate that VacA is able to be collected from complex cellular 
material, but this observation illustrates that the ferrofluid label does not dissociate from VacA 
over time while VacA is trafficking within cells. 
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 In order to submit a VEC sample for analysis by mass spectrometry, each individual 
preparation underwent a series of quality control evaluations. All VECs obtained in the eluate 
sample were stained for total protein by the highly sensitive Krypton stain to observe detectable 
proteins, and the protein yield was determined by BCA for measurement of total protein (Figure 
2.9A). In addition, all samples collected through the VEC isolation were analyzed for western 
blotting in order to confirm the presence of VacA within the eluate, and the presence or absence 
of other cellular markers predicted to be associated with VacA enriched compartments, such as 
the early endosome protein EEA1, and the mitochondrial protein TIM23 (Figure 2.9B). The 
absence of any detectable protein in the final wash before elution confirmed that the washing 
steps were thorough and removed any background protein (Figure 2.9B). Only samples yielding 
at least 10 µg of total protein, confirmed with a detectable krypton signal, with detectable VacA in 
the eluate fraction, and absence of VacA in the last wash were submitted for mass spectrometry 
analysis. Any samples that did not meet these criteria were discarded and isolations were 
repeated. 
 
2.3.4 VEC interaction with the endoplasmic reticulum 
 Prior to submission and analysis by mass spectrometry and proteomics, isolated VEC 
samples were immunoblotted for various cellular markers (Figure 2.10). After a 2 h incubation 
with magnetically labeled VacA, whereby given previous data (Figure 2.3) it is anticipated that 
VacA is predominantly associated with the mitochondria and no longer associated with 
endosomes, indeed, there were no datable early or late endosomal proteins within the isolated 
VacA containing compartments (Figure 2.10). Actin was observed on the isolated VECs, which 
is in support of previous findings that actin is important for VacA mediated transport within cells 
via the formation of “actin comets”18. In support of previous microscopy findings, indeed, a 
mitochondrial marker (TIM23) was found to be highly enriched with the isolated VECs (Figure 
2.10). However, interestingly, the isolated VECs also displayed a substantial signal in two proteins 
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canonically localized with the endoplasmic reticulum (ER), namely calnexin and calreticulin 
(Figure 2.10). Given mitofusin 2 (Mfn2) was also detected within the isolated VEC samples, it 
stands to reason that the 2 h isolated VECs are comprised of the mitochondrial associated 
membrane, or MAM. The MAM is a specialized region of the endoplasmic reticulum that forms 
direct connections with the mitochondria, and are important sites for mediating mitochondrial 
division, lipid transfer, and calcium signaling43,44. In order to visualize the potential association of 
VECs with the ER, AZ-521 cells overexpressing the Sec61β ER translocon fused to GFP were 
treated with VacA directly labeled with Alexa Fluor 555 and imaged by fluorescence microscopy 
(Figure 2.11). Similar to previous reports45, the VECs appeared to be within close contact with 
the ER membranes (Figure 2.11). This observed association of VECs with the ER proposes 
interesting models regarding the trafficking of VacA to the mitochondria. First, the ER might be 
directing the transport of VECs to the mitochondria. Alternatively, the ER-mitochondria contact 
sites may serve as a platform by which VacA targets in order to gain access to the mitochondria. 
And finally, the association of the ER with VECs may simply be background, as it has been 
reported that the ER is often difficult to remove from mitochondria and other closely associated 
structures46. Regardless, it is important to note the association of the ER with the isolated VECs 
as well as VacA within intact cells, as the endoplasmic reticulum is intimately involved in many 
cellular processes and may very well be important for VacA mediated transport to the 
mitochondria. 
 
2.3.5  Proteomics of VacA enriched compartments 
Isolated VECs were processed by ESI-TRAP mass spectrometry and rendered using the 
MASCOT database and Swiss Protein Databank. All proteomes at a given VEC temporal stage 
were compared using a Bioinformatics and Evolutionary Genomics software, and proteins 
common to all independent VEC isolations at a given temporal stage were annotated using the 
PANTHER gene ontology program. Relative abundance of each protein was calculated by 
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averaging the molar protein content (using the exponentially modified protein abundance index, 
emPAI) between the different VEC isolations. Proteomes were characterized by annotated protein 
subcellular localization and molecular function. 
 A total of 18 samples were analyzed for mass spectrometry, consisting of 6 timepoints 
with 3 individual sample preparations for each timepoint. An ion score cutoff of 21 was applied, 
yielding an average of 524 unique proteins identified for each preparation. In order to identify 
proteins that are most representative of a given temporal stage of VCVs, the data from all 
replicates of a given time point were overlaid (Figure 2.12), yielding an average of 188 proteins 
that are representative of each temporal stage. In order to evaluate whether the collection of 
proteins of a given temporal stage by the VEC isolation approach is truly representative of all 
proteins present within a given temporal stage, all datasets were combined and rarefaction 
analysis was performed (Figure 2.13). For most of the VEC isolation timepoints, the additional 
technical replicates for a VEC isolation yielded little in regards to new proteins identified, indicating 
that the sampling size for the VEC isolation was sufficient to obtain the most representative 
population of VECs at a given timepoint (Figure 2.13). All temporal stage proteomes were 
overlaid in order to identify proteins that were unique to a given timepoint, those proteins common 
to all timepoints, and those proteins shared between different relative temporal stages (early: 0 
and 15 min, mid: 30 and 60 min, and late: 120 and 240 min) (Figure 2.14). Of all of the proteins 
identified throughout the mass spectrometry analysis, 334 proteins were common to all VEC 
datasets, which represent a “core” proteome. It is interpreted that the core proteome, in part, 
represents background proteins that are identified regardless of time. In addition, it is anticipated 
that some of the proteins represent molecular cargo that is either directly associated with VacA, 
or is associated with VECs throughout the duration of the experimental timeseries, and these 
proteins may or may not be facilitating the transport of VacA to the mitochondria and throughout 
a cell.   
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 In order to determine temporal changes is VEC proteomes over time, all proteins were 
annotated for molecular function and subcellular localization. The relative protein abundance for 
each protein within a given dataset was calculated. Proteins were categorized by subcellular 
localization (vacuole, nucleus, lysosome, endosome, plasma membrane, mitochondrial, Golgi 
apparatus, cytoskeleton, peroxisome, ER and cytoplasm) and molecular function (membrane 
trafficking/vesicle mediated transport) (Figure 2.15). The data indicate that proteins canonically 
associated with the nucleus and cytoplasm remained effectively unchanged over time, while 
endosome, lysosome, and vacuole associated proteins peaked in relative abundance at 120 min 
of VacA intoxication (Figure 2.15). Mitochondrial associated protein abundance fluctuated over 
time, with the lowest abundance being at 0 min and highest abundance at 30 min (Figure 2.15). 
Altogether, these data illustrate temporal changes in relative abundances of protein classes over 
time, with the 120 min VEC stage appearing to have the greatest enrichment in proteins 
canonically associated with endosomal compartments. However, it is important to note that 
abundance of protein factors does not correlate to molecular function. If an increase in a particular 
protein abundance is observed, it is interpreted that the data are suggestive that VacA is 
contained within a particular compartment, or perhaps the protein is recruited to a VEC for 
transport. However, it is important to understand that even a relatively low abundance of a protein 
may confer significant biological activity, and thus it is important to consider other factors when 
determining whether or not a protein is potentially important for VacA mediated intracellular 
trafficking. 
  
2.3.6  Verification of VEC proteomics 
 In the study of VacA, several proteins have been reported to either associate with VacA, 
or to be important for VacA activity. In order to verify whether those proteins were identified in the 
VEC proteomes obtained at the expected timepoints, the databases were searched for the 
presence or absence of various proteins previously identified to be important for VacA activity. 
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 At the level of the plasma membrane, receptor tyrosine phosphatase (RPTP) was 
identified as a putative receptor for VacA through co-immunoprecipitation experiments47. RPTP 
is important for the regulation of cell surface adherence junctions through E-cadherin48.  A total of 
21 protein tyrosine phosphatase receptor types have been identified, and in the VEC isolations, 
type Z was identified in all VEC isolations, indicating that the protein co-traffics with VacA 
throughout its intracellular trafficking (Figure 2.16). The data collected are not clear whether or 
not RPTP is directly associated with VacA throughout the trafficking timecourse, but the results 
do reflect that VacA remains associated with early uptake machinery. 
 VacA has been described to be internalized via a clathrin independent type of endocytosis 
known as the GEEC-CLIC pathway (GPI-anchored protein enriched early endosomal 
compartment clathrin independent compartment), and through this process the proteins Rac1 and 
Cdc42 are important17,49. Rac1 and Cdc42 are important for mediating actin dynamics at the level 
of the cell surface and facilitating phagocytosis50. In the VEC isolations, Cdc42 was also identified 
in all temporal stages, and Rac1 was identified in all stages except for the 15 min VEC isolations 
(Figure 2.16). These data also indicate that Rac1 and Cdc42 remain associated with VECs 
through trafficking. 
 Upon internalization into host cells, VacA has been described to associate with early 
endosomal compartments, with a major identifier of early endosomes being early endosome 
antigen 1 (EEA1)18. EEA1 has been shown to be important for mediating endosome docking and 
ultimately membrane fusion through interactions with Rab551,52. In the VEC isolations, EEA1 was 
only identified in the 30 min stage proteome, which aligns with previous data indicating that VacA 
peaks in association with EEA1 at 30 min during intracellular trafficking (Figures 2.3, 2.16). 
 An interesting observation reported in VacA intoxication in 2010 reported that the pro-
apoptotic protein Bax is mislocalized to endosomes33. Canonically, Bax is a cytosolic protein, and 
upon a pro-apoptotic stimuli, Bax is targeted to and localizes to the mitochondria, where the 
protein assembles with another pro-apoptotic protein, Bak, to form pores on the outer 
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mitochondrial membrane53. By isolating early endosomes, late endosomes, and mitochondria, 
Bax was detected in the early endosome fraction as early as 2.5 h after VacA intoxication33. In 
the VEC isolation data, Bax was indeed identified, but only in the 15 min VEC proteome, indicating 
that like EEA1, the association of VacA with Bax might be transient (Figure 2.16). 
 At the level of the mitochondria, VacA has been shown to potentially associate with the 
outer mitochondrial translocon TOM2033,34. The TOM complex serves as a major translocon for 
all proteins entering the mitochondria to be transported3. Although various subunits of the TOM 
complex were identified in all VEC proteomes, the greatest abundance was observed at 30 min 
(Figure 2.16). Throughout the timeseries, all known subunits of the TOM complex were identified 
in the VEC proteomics data, including TOM5, 6, 7, 20, 22, 40, and 70. These data support 
previous indications that the TOM complex is important for VacA activity. In addition, nearly all 
subunits of the inner mitochondrial translocation TIM23 complex were identified, including TIM16, 
23, 44, and 50 (Figure 2.16). Interestingly no proteins of another major inner mitochondrial 
translocation complex, TIM22, and the outer mitochondria membrane protein sorting machinery 
of the SAM complex were identified. Finally, all subunits of the TIM chaperone complex, namely 
TIM9 and TIM10 were identified in VEC proteomics data. Altogether, the mitochondrial proteomics 
data illustrate a model that the outer mitochondrial translocation machinery of the TOM complex, 
and the inner mitochondrial translocation machinery of the TIM23 complex with the small TIM 
chaperones are associated with intracellular compartments containing VacA, and might illustrate 
a potential pathway by which VacA enters the mitochondria. 
 Finally, VacA has been shown to associate with late endosomes and lysosomes, with the 
proteins Rab7 and LAMP1 as major indicators of late endosomal and lysosomal association54,55. 
Rab7 is a major mediator in regulating vesicle transport in the endosomal system as well as 
autophagosome formation56,57. LAMP1 is a canonical marker of lysosomes, and is important for 
binding carbohydrates for selectin presentation58,59. In the VEC proteomics data, Rab7 was 
identified in all VEC proteomes, and LAMP1 was identified in the 0, 60, and 120 min proteomes 
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(Figure 2.16). These data indicate at association with late endosomal and lysosomal 
compartments occurs through VacA trafficking. 
 
2.3.7  Membrane trafficking proteins 
 Given VacA is a membrane embedded, pore-forming toxin, and to date no reports have 
identified VacA associating with the cytosplasm after exogenous administration, it was predicted 
that proteins important for VacA trafficking are likely to be proteins that mediate membrane 
trafficking. In order to identify and characterize proteins mediating membrane trafficking in the 
VEC proteomics data, all proteins annotated to be important for mediating membrane trafficking 
were identified, compiled, and overlaid between the different VEC timepoints (Figure 2.17). A 
total of 33 proteins were identified to be common to all VEC proteomes, including Rab GTPases 
(Rab10, Rab1A,B, Rab5C, Rab11A, and Rab14) and two SNARE proteins (Snp23 and Stx4) 
(Figure 2.18). To evaluate whether any proteins are common to different temporal stages, 
proteins were identified to associate with either early stage (0 and 15 min), intermediate stage (30 
and 60 min) and late stage (120 and 240 min) VECs (Figure 2.19). Only 5 proteins were identified 
as early stage, 2 proteins as intermediate stage, and 0 proteins as late stage membrane trafficking 
proteins (Figure 2.19). Finally, proteins annotated to mediate membrane trafficking were 
identified to be unique to each VEC stage (Figure 2.20). Similar to other proteomes, this consisted 
of Rab GTPases (Rab18 at 0 min, Rab6 at 30 min, Rab9 and 240 min), and SNARE proteins 
(Snp20 and Stx6 at 0 min, Stx18 at 30 min) (Figure 2.20). The identification of proteins present 
in different stages in VECs is important for determining candidate proteins that might be important 
for VacA trafficking. 
 
2.3.8  Proteins identified as potential mediators in VacA activity 
 Through analysis of the VEC proteomic data, proteins were identified as potential 
candidates important for VacA activity. Candidate proteins were chosen based on subcellular 
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localization (priority to vesicle, endosomal, and/or mitochondrial associated proteins), and 
molecular function (important for membrane trafficking or vesicle-mediated transport). From the 
proteomics characterization, 4 candidate proteins were identified. 14-3-3-G (YWHAG) was 
identified to localize to the mitochondria and cytoplasmic vesicle membranes, and mediate the 
insertion of proteins into the mitochondria membrane (UniProt). Canonically, 14-3-3-G is an 
adaptor protein that is implicated in a wide variety signaling processes and interactions with a 
large number of factors60. Vacuolar protein sorting-associated protein 4B (VPS4B) is important 
for the multivesicular body pathway and mediates membrane dynamics61. Rab35 has been 
indicated to associate with mitochondria as well as endosomal membranes (UniProt), and is 
important for early stages of endocytosis and the recycling endosome pathway62. Syntaxin 18 
(Stx18) is an endoplasmic reticulum (ER) SNARE that is important for Golgi to ER membrane 
transport63,64. 
 In order to evaluate the importance of 14-3-3-G, VPS4B, Rab35, and Stx18 in VacA 
intoxicated cells and VacA biological activity, the expression of each protein was knocked down 
using RNAi, and VacA activity was measured by vacuolation with neutral red staining. After 4 h 
of intoxication, in comparison to cells treated with VacA in the absence of RNAi specific to a VEC 
protein of interest, knockdown of all four proteins resulted in a significant decrease in vacuolation 
(Figure 2.21A). One protein, VPS4B, decreased the level of vacuolation to the same degree as 
the untreated control, whereas 14-3-3-G, Rab35, and Stx18 decreased vacuolation further by an 
additional approximately 25%. This finding indicates that 14-3-3-G, Rab35, and Stx18 may be 
important for regulating endogenous acidification of intracellular compartments. Upon 
visualization of cells, few vacuoles are observed in the knockdown cells, with the most vacuoles 
being observed in the VPS4B knockdown condition, supporting the finding that knockdown of 
VPS4B also has higher levels of neutral red uptake (Figure 2.21B). It is worthwhile to note, 
however, that the transfection reagent (Lipofectamine) alone has been reported to induce cellular 
vacuolation. Therefore, these data neither support nor do not support whether or not the visually 
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observed vacuoles are due to VacA biological activity, or if the vacuoles are a manifestation of 
increased cellular sensitivity to transfection upon knockdown of the protein of interest. 
Regardless, these data indicate that all of the proteins identified, to varying degrees, are important 
for the biological activity of VacA and the interaction of VacA with host cells. However, vacuolation 
is a relatively downstream phenotype of VacA activity and may be the consequence of other VacA 
mediated cellular activity, and thus it is unclear from these data at which level 14-3-3-G, VPS4B, 
Rab35, and Stx18 function. But these findings do support the identification of four proteins 
previously unknown to be important for VacA biological activity. 
 In order to evaluate the level by which 14-3-3-G, VPS4B, Rab35, and Stx18 function in 
regards to VacA biological activity, cells were next assessed for the ability of VacA to induce 
mitochondrial fragmentation. After 4 h of intoxication, in comparison to cells treated with VacA in 
the absence of RNAi specific to a VEC protein of interest, knockdown VPS4B yielded no 
detectable difference in mitochondrial length upon intoxication with VacA as visualized by 
mitochondria being fragmented, indicating that VPS4B may function downstream of the 
mitochondrial disruption by VacA, and is likely important for VacA mediated vacuole biogenesis 
(Figure 2.22). Knockdown of Stx18 yielded a slight reduction in the ability of VacA to induce 
mitochondrial fragmentation, as mitochondria appeared fragmented, but the fragments were 
longer in size compared to the wild-type cells treated with VacA (Figure 2.22). Although 
promising, it is not clear whether or not Stx18 is important for VacA mediated mitochondrial 
dysfunction. However, it is clear that Stx18, like VSP4B, is important for the ability of vacuoles to 
form in response to VacA intoxication (Figure 2.21). Finally, knockdown of 14-3-3-G and Rab35 
yielded a complete inhibition of the ability of VacA to induce mitochondrial fragmentation, as 
indicated by mitochondria retaining a filamentous structure upon exposure to VacA (Figure 2.22). 
Besides the identification of Drp1 and its involvement in VacA mediated biological activity, 14-3-
3-G and Rab35 are the only proteins identified to date that are important for the ability of VacA to 
induce mitochondrial fragmentation, indicating that perhaps the proteins function upstream of 
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VacA trafficking to mitochondria. It is worthwhile to note that under all knockdown conditions, the 
mitochondria of cells appeared in the expected dynamic state, with a combination of mostly 
filamentous, but also intermediate sized mitochondrial fragments (Figure 2.22). This observation 
indicates that knockdown of 14-3-3-G, VPS4B, Rab35, and Stx18 alone do not negatively impact 
mitochondrial architecture. 
 Finally, in order to evaluate the importance of 14-3-3-G, VPS4B, Rab35, and Stx18 in the 
ability of VacA to localize to the mitochondria, the expression of each protein was knocked down 
and VacA colocalization with the mitochondrial marker TOM20 was measured by fluorescence 
microscopy. In support of the mitochondrial fragmentation findings, knockdown of neither VPS4B 
nor Stx18 resulted in a detectable difference in VacA association with the mitochondria, indicating 
that the proteins function, in part, to regulate post-mitochondrial activities and trafficking of VacA 
within a host cell (Figure 2.23). This finding is an important validation of the fragmentation data, 
further supporting the interpretation that VSP4B and Stx18 are not important for VacA biological 
activity prior to or at the level of the mitochondria. Interestingly, knockdown of 14-3-3-G resulted 
in a nearly 2-fold increase in VacA association with the mitochondria (Figure 2.23). This 
observation indicates that perhaps 14-3-3-G may function as either a negative regulator of VacA 
trafficking to mitochondria, and thus removal of 14-3-3-G enhances VacA translocation to the 
mitochondria, or 14-3-3-G functions as a downstream regulator of VacA localization to the 
mitochondria. As described earlier, the association of VacA with mitochondria decreases over 
time (Figure 2.3B, E), perhaps 14-3-3-G is important for the downstream trafficking of VacA from 
the mitochondria, and thus removal of 14-3-3-G results in an accumulation of VacA with the 
mitochondria. 
 Altogether, evaluation of the importance of 14-3-3-G, VPS4B, Rab35, and Stx18 at varying 
levels of VacA biological activity indicate that VPS4B and Stx18 function in post-mitochondrial 
VacA activity, with an indicated localized role in forming intracellular vacuoles (Figure 2.24). In 
addition, both 14-3-3-G and Rab35 function at the level of the mitochondria, and may be important 
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for either the delivery of, or the removal of VacA from the mitochondria (Figure 2.24). In addition, 
14-3-3-G and Rab35 are important for the ability of VacA to induce mitochondrial dysfunction 
(Figure 2.24). Altogether, these studies have identified four novel proteins in regards to the 
biological activity of VacA and the interaction of VacA with host cells. While all proteins are 
important for the well described ability of VacA to induce cellular vacuolation, more thorough 
analyses were able to further identify that two proteins are specifically important for the ability of 
VacA to act at the level of the mitochondria, which is a fundamentally new insight into the study 
of VacA and its host-toxin interactions. 
 
2.4 Discussion 
 The endomembrane system consists of a dynamic, yet highly regulated series of 
membrane interactions connecting all membrane bound organelles inside of the cell. Depending 
on the recruitment of select membrane trafficking machineries, membrane bound compartments 
may transit through the plasma membrane, endosomes, lysosomes, endoplasmic reticulum, Golgi 
apparatus, peroxisomes, and nuclear envelope65-67. While the endomembrane system is complex 
and involves a wide variety of intracellular compartments, the mitochondria remains isolated. The 
only reports indicating an involvement of the mitochondria with other membrane bound 
compartments involves direct contact sites between the mitochondria and endoplasmic 
reticulum23,25-27,68, juxtaposition of endosomes with the mitochondria28, and the transport of 
mitochondrial derived vesicles to either peroxisomes or lysosomes31,32. However, to date, no 
mechanisms or pathways have been described of vesicular carriers transporting material to the 
mitochondria.  
 VacA of Helicobacter pylori is a membrane-embedded, pore-forming toxin39. The only 
known activity of VacA is its ability to form a pore, for no catalytic activity of VacA has been 
described. Furthermore, the trafficking of VacA and localization to the mitochondria is dependent 
upon its ability to form a functional channel33,34,38. Therefore, it is unlikely that VacA acts at the 
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level of the mitochondria by releasing a mitochondrial targeted subunit into the cytosol to be 
imported into the mitochondria. One class of AB toxins takes advantage of the endolysosomal 
system, whereby acidification of vesicles triggers a conformational change of a toxin, resulting in 
the release of a catalytically active subunit into the cytosol69. To date, no reports have been made 
of any portion of VacA being released from the holotoxin. The preponderance of evidence 
accumulated thus far support a model that VacA is continually associated with membranes, which 
raises the question of how a membrane-embedded, pore-forming toxin is able to traffic from the 
cell surface, into the mitochondria.  
 Given no physiological pathways have been described of vesicular transport of cargo to 
and fusion with the mitochondria, the approach of direct isolation and characterization of VacA 
enriched compartments provides a robust and highly selective modality for the identification and 
characterization of proteins potentially mediating VacA transport to the mitochondria. The studies 
performed were successful in isolating and characterizing the proteomes of VacA enriched 
intracellular compartments over time. Although preliminary, initial studies indicated that perhaps 
VECs are associated with or comprised of regions of the endoplasmic reticulum, and that the 
endoplasmic reticulum might be important for direct VacA transport to the mitochondria. From the 
proteomics data, numerous candidate proteins were identified to either comprise VacA enriched 
compartments and contribute to the remodeling of canonical early uptake compartments with 
VacA, or the identified candidate proteins may directly facilitate the transport of VacA to 
mitochondria. Of the candidate proteins, four proteins new to the field of VacA biology were 
specifically characterized and were identified to be important for the ability of VacA to induce 
cellular vacuolation, namely 14-3-3-G, VPS4B, Rab35, and Stx18. Furthermore, additional 
studies illustrated that two of the proteins, 14-3-3-G and Rab35, function specifically at the level 
of host mitochondria and are important for the ability of VacA to not only induce mitochondrial 
dysfunction, but to also localize VacA to the mitochondria. If validated, these host factors will be 
the first identified to mediate the trafficking of VacA to the mitochondria, which not only contributes 
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to the understanding of pathogen targeting of host mitochondria and usurping of host factors for 
toxin trafficking, but this process also identifies potential modalities for intervention, in order to 






Figure 2.1: Model of VacA trafficking to mitochondria. The studies investigated the 
intracellular trafficking of VacA. Given previous studies detailed the subcellular localization of 
VacA, and identification of proteins implicated to be important for VacA trafficking, the model being 
tested is that VacA binds to the cell surface, is internalized into endosomal compartments, which 
over time, due to the pore forming ability of VacA, become remodeled from canonical endosomal 





Figure 2.2: VacA purification. Purified VacA is test for purity, yield, and activity before 
experimental use. Following elution from anion exchange column chromatography, eluates are 
resolved via SDS-PAGE and stained with Coomassie Blue. Only eluates containing pure VacA 
are combined (eluates 2-11 in the example gel) (A). Yield of purified VacA is measured by BCA 
protein concentration assay with bovine serum albumin standards fitted to a 3rd order polynomial 
curve (B). The activity of VacA is determined by the neutral red vacuolation assay, consisting of 
a two-fold serial dilution of acid activated, purified VacA that is treated to cells in cell culture media 
containing 5 mM NH4Cl. The amount of vacuolation is observed visually, and quantified after 
staining of neutral red normalized to total protein (C, D). Images are representative of, and 
quantified data are compiled from three independent purifications with quality control 






Figure 2.3: Association of VacA with early endosomes and mitochondria.  AZ-521 cells were 
exposed to VacA (250 nM) directly labeled with Alexa Fluor 488 under pulse conditions (4ºC for 
30 min, washed with PBS pH 7.4) then incubated at 37ºC with unlabeled VacA (250 nM) in MEM 
for 0, 0.25, 0.5, 1, 2, 4, and 8 h post-internalization, then fixed and processed for microscopy. The 
association of VacA with endosomes or mitochondria was measured by fluorescence microscopy 
with indirect immunofluorescence staining with EEA1, appreciated quantitatively (A) and 
qualitatively (D) or TOM20, appreciated quantitatively (B) and qualitatively (E), respectively, with 
secondary antibodies conjugated to Alexa Fluor 555. The association of VacA with actin was 
measured by fluorescence microscopy with staining of actin with phalloidin conjugated to Alexa 
Fluor 555 (C). Colocalization was determined by Pearson’s coefficient of correlation. Images are 
representative of and quantitative data are compiled from 3 independent experiments performed 
in triplicate, with each experimental treatment consisting of 30 cells imaged. Error bars represent 
standard error of the mean. Statistical significance was determined by one way ANOVA with an 





Figure 2.4: Structure of VacA within cells. AZ-521 cells were exposed to VacA (250 nM) directly 
labeled with Alexa Fluor 488 under pulse conditions (4ºC for 30 min, washed with PBS pH 7.4) 
then incubated at 37ºC with unlabeled VacA (250 nM) in MEM for 0, 0.25, 0.5, 1, 2, 4, and 8 h 
post-internalization, then fixed and processed for microscopy. Images are representative of 3 
independent experiments performed in triplicate, with each experimental treatment consisting of 




Figure 2.5: Model of VEC isolation. Purified VacA was directly labeled with ferromagnetic 
nanoparticles.AZ-521 cells were exposed to pulse of magnetically labeled VacA (250 nM), 
followed by a chase with an equal concentration of unlabeled VacA. Cells were incubated for 0, 
0.25, 0.5, 1, 2, and 4 h, then cell lysates were collected and post-nuclear supernatants were 
applied to a column in a magnetic field. Non-magetically retained material was washed 





Figure 2.6: Retention of pure VacA in magnetic field. Purified VacA (1 µM) was directly labeled 
with or without cationic ferrofluid by incubation at room temperature for 1 h at a 1:50,000 dilution 
of ferrofluid to VacA. Samples (lanes 2, 9) were passed through a column exposed to a magnetic 
field, flow throughs were collected (lanes 3, 10), and columns were washed extensively with PBS 
pH 7.4 (lanes 4 and 5, 11 and 12). Eluates were collected upon removal of the column from the 





Figure 2.7: Fe does not affect VacA stability/activity. AZ-521 cells were treated with control 
(PBS pH 7.4), purified VacA (250 nM), ferrofluid (1:50,000), or purified VacA directly labeled with 
ferrofluid (250 nM VacA and 1:50,000 dilution of ferrofluid in solution). Vacuolation was 
appreciated qualitatively (A), and quantifed by neutral red uptake normalized to total protein (B). 
Cell viability was assessed by trypan blue exclusion assay. Data are representative of 3 
independent experiments performed in triplicate, and quantitative data were made relative to the 
untreated control. Error bars represent standard error of the mean. Statistical significance was 





Figure 2.8: Retention of VacA in magnetic field from cell lysates. AZ-521 cells were treated 
with purified VacA (250 nM), ferrofluid (1:50,000), or purified VacA directly labeled with ferrofluid 
(250 nM VacA and 1:50,000 dilution of ferrofluid in solution) for 4 h. VECs were collected by 
applying post-nuclear cellular lysates to a magnetic field. Samples were immunoblotted against 






Figure 2.9: Quality control of VEC preparations for mass spectrometry analysis. AZ-521 
cells were treated with purified VacA directly labeled with ferrofluid (250 nM VacA and 1:50,000 
dilution of ferrofluid in solution) at 4ºC for 30 min to allow for binding, followed by extensive 
washing with PBS pH 7.4 and subsequent incubation of cells in an equal concentration of 
unlabeled VacA at 37ºC for 2 h. VECs were collected by applying post-nuclear cellular lysates to 
a magnetic field. The eluate sample containing VECs was stained with krypton, and isolation 
samples were immunoblotted against the early endosomal marker EEA1, VacA, the cytosolic 






Figure 2.10: Immunoblot of isolated VECs. AZ-521 cells were treated with purified VacA 
directly labeled with ferrofluid (250 nM VacA and 1:50,000 dilution of ferrofluid in solution) at 4ºC 
for 30 min to allow for binding, followed by extensive washing with PBS pH 7.4 and subsequent 
incubation of cells in an equal concentration of unlabeled VacA at 37ºC for 2 h. VECs were 
collected by applying post-nuclear cellular lysates to a magnetic field. The eluate sample 
containing VECs was immunoblotted against an early endosome marker (EEA1, Rab5), late 
endosome and lysosome marker (LAMP1), actin, endoplasmic reticulum markers (calnexin, 





Figure 2.11: VCV association with endoplasmic reticulum. AZ-521 cells were transfected with 
pAcGFP-Sec61β for 24 h then treated for 30 min with 250 nM VacA directly labeled with Alexa 
Fluor 555. Cells were fixed and processed for immunofluorescence microscopy with DAPI 





Figure 2.12: VEC proteomics distribution by temporal stage. Proteomics data were obtained 
from the MASCOT server and proteins were identified by the huan SwissProt protein database. 
An ion score cutoff of 21 was applied and databases were overlaid to identify protein 
commonalities for each given temporal stage of VEC. Data were overlaid for 0 min (000M), 15 
min (015M), 30 min (030M), 60 min (060M), 120 min (120M), and 240 min (240M) with 3 technical 





Figure 2.13: Rarefaction curve for protein collection. The total number of new proteins 
identified from the addition of a technical VEC sample replicate was measured for each temporal 





Figure 2.14: Total VEC protein distribution. The proteomes of each temporal stage (0, 15, 30, 
60, 120, and 240 MIN) were overlaid for commonalities. Proteins common to, or unique to all 





Figure 2.15: VEC protein distribution by subcellular localization and molecular function. 
The relative protein abundance of all proteins was determined using the empirically modified 
protein abundance index (emPAI), annotated for subcellular localization and molecular function 
and categorized for different protein classes. The relative abundance of proteins common to a 





Figure 2.16: VEC proteins previously identified as important for VacA activity. VEC protein 
databases were searched for proteins previously identified to be associated with VacA, or to be 
important for VacA activity. Identified proteins include PTPRT, Rac1, Cdc42, EEA1, Bax, TOM, 






Figure 2.17: Membrane trafficking proteins overlay. All proteins that were functionally 
annotated to be involved in membrane trafficking and vesicle mediated transport were overlaid to 
identify commonalities amongst the different VEC temporal stages. Proteins common to, or 




Figure 2.18: Membrane trafficking proteins common to all VEC proteome timepoints. 
Proteins identified in all VEC temporal stages annotated to be involved in membrane trafficking 





Figure 2.19: Membrane trafficking proteins common to early, intermediate and late stage 
VEC proteomes. Proteins identified as common to early stage VECs (common to 0 and 15 min), 
intermediate stage (30 and 60 min) and late stage (120 and 240 min) annotated to be involved in 






Figure 2.20: Membrane trafficking proteins unique to each VEC proteomes. Proteins 
identified as unique to each stage VECs annotated to be involved in membrane trafficking were 





Figure 2.21: VEC proteins and VacA mediated vacuolation. AZ-521 cells were treated with 
RNAi against NC1 scrambled control (NC1) (RNAi -), 14-3-3-G (14), VPS4B (VP), RAB35 (R35), 
or STX18 (S18) for 48 h to allow for protein knockdown. Cells were incubated in the absence or 
presence of VacA (250 nM) at 37ºC for 4 h in the presence of 5 mM NH4Cl. Vacuolation was 
quantified by neutral red staining and normalization to total protein, determined by BCA assay (A) 
and visualized by light microscopy (B). Data are representative of 3 independent experiments 
performed in triplicate. Quantified vacuolation data were made relative to the non-VacA, non-
RNAi treated control. Error bars represent standard error of the mean. Statistical significance was 
determined by one way ANOVA with an alpha level of 0.001 with Tukey correction for multiple 
comparisons against the non-VacA, non-RNAi treated control. Statistical significance is identified 





Figure 2.22: VEC proteins and VacA mediated mitochondrial fragmentation. AZ-521 cells 
were treated with RNAi against NC1 scrambled control (NC1) (untreated), 14-3-3-G, VPS4B, 
RAB35, or STX18 for 48 h to allow for protein knockdown. Cells were incubated in the absence 
or presence of VacA (250 nM) at 37ºC for 4 h, then fixed and processed for fluorescence 
microscopy. Mitochondria were stained using anti-TOM20 primary antibodies with goat anti-rabbit 
antibodies conjugated to Alexa Fluor 488, and mitochondrial structure was visualized using 






Figure 2.23: VEC proteins and VacA localization to mitochondria. AZ-521 cells were treated 
with RNAi against NC1 scrambled control (NC1), 14-3-G, VPS4B, RAB35, or STX18 for 48 h to 
allow for protein knockdown. AZ-521 cells were exposed to VacA (250 nM) directly labeled with 
Alexa Fluor 488 under pulse conditions (4ºC for 30 min, washed with PBS pH 7.4) then incubated 
at 37ºC with unlabeled VacA (250 nM) in cell culture media for 2 h post-internalization, then fixed 
and processed for fluorescence microscopy. The association of VacA with mitochondria was 
measured by fluorescence microscopy with indirect immunofluorescence staining with anti-
TOM20 primary antibodies, and secondary antibodies conjugated to Alexa Fluor 555. 
Colocalization was determined by Pearson’s coefficient of correlation. Quantitative data are 
compiled from 3 independent experiments performed in triplicate, with each experimental 
treatment consisting of 30 cells imaged. Error bars represent standard error of the mean. 
Statistical significance was determined by one way ANOVA with an alpha level of 0.001 and Tukey 
correction for multiple comparisons against the untreated condition. Statistical significance is 





Figure 2.24: Summary of the importance of VEC proteins in VacA biological activity. The 
importance of the VEC identified proteins 14-3-3-G, VPS4B, RAB35, and STX18 were assessed 
by individually knocking down their expression and measuring the ability of VacA to induce cellular 
vacuolation, mitochondrial fragmentation, and the ability of VacA to localize to the mitochondria. 
Proteins being important for the biological activitiy, as interpreted by a reduction in VacA activity 
upon knockdown of protein expression, are signified by checkmarks (). Proteins not important 
for the biological activity, as interpreted by no detectable or significnat change in VacA activity 
upon knockdown of protein expression, are signified by dashes (-). Proteins that are important for 
VacA activity upon knockdown of protein expression, but exhibit directionality as illustrated by an 
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Chapter 3: VacA and mitochondrial quality control  
3.1 Introduction 
In addition to maintaining metabolic homeostasis and controlling cell death, mitochondria 
are intimately involved in a large number of other cellular processes, including synthesis of iron 
sulfur clusters1-4, purines and pyrimidines5, amino acids6, and heme2,7; maintaining calcium 
homeostasis8-11, production of hormones12-14, and regulation of innate immunity15-18. Such a large 
number of cellular processes illustrate the vitality of this organelle to ensure cellular homeostasis. 
Therefore, it stands to reason that quality control mechanisms exist to ensure the functionality of 
the mitochondria. Indeed, numerous quality control measures have been described, ranging in a 
spectrum from the molecular to the cellular level, in response to more mild and mitochondrial 
specific, to more severe and widespread mitochondrial and cellular dysfunction. These 
mechanisms of mitochondrial quality control include the mitochondrial unfolded protein response 
and mitochondrial proteases, mitochondrial derived vesicles, mitophagy, and cell death.   
The mechanism of mitochondrial quality control utilizing the least amount of energy and 
activates in response to relatively mild insults of mitochondrial dysfunction is the mitochondrial 
unfolded protein response (UPRmt)19-22. Mitochondria contain endogenous proteases which 
recognize and degrade dysfunctional or misfolded proteins22. These proteases are specific to the 
different mitochondrial compartments, such as the ClpXp and Lon proteases of the matrix, PARL, 
YME1L, OMA1, and different AAA proteases of the inner mitochondrial membrane, and Omi of 
the intermembrane space23-26. To repair damaged proteins on the outer membrane, the 
mitochondria utilize the cellular ubiquitin system, whereby damaged or misfolded proteins are 
tagged with ubiquitin and degraded in the proteasome27. If endogenous mitochondrial proteases 
are insufficient to remove unfolded or other dysfunctional proteins and mitochondrial output 
begins to decrease, the retrograde transcription response is activated, whereby signals are 
released from the mitochondria and are detected within the nucleus to upregulate the expression 
of genes important for maintaining mitochondrial output and recovery of proteostasis20,21,28.  
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A second mechanism of mitochondrial quality control was recently characterized, by which 
small vesicles of damaged mitochondrial domains are selectively removed from mitochondria and 
sent to the lysosomes for degradation or to peroxisomes29,30. Although the physiological important 
of peroxisomal targeting of mitochondrial derived vesicles (MDVs) is unclear, the peroxisome 
population of MDVs appear to have specific cargo (membrane anchored protein ligase, MAPL)31, 
and given the function of peroxisomes, it is predicted that they might serve to aid in fatty acid 
oxidation or removal of ROS. Interestingly, these MDVs were the first described vesicular 
transport with the mitochondria. However, to date, no vesicles have been shown to traffic to the 
mitochondria. While the cellular machinery which is driving MDV formation and trafficking is just 
beginning to be described, whereby the proteins Rab9, Rab7, Snx9, and Stx17 appear to be 
involved in MDV formation and trafficking32, it is clear that the formation of MDVs is quickly 
induced (within 10-60 min) in response to mitochondrial damage, and is independent of and 
precedes mitophagy, a third type of mitochondrial quality control33.  
Mitophagy is a selective form of autophagy. Autophagy utilizes the formation of a double 
membrane autophagosome to engulf cellular material and upon fusion with a lysosomes, 
degrades the autophagolysosomal contents, thus providing basic biological molecules for use 
within a cell, such as amino acids, nucleic acids, lipids, and monomeric carbohydrates. In addition 
to generalized autophagy, autophagy may be specifically targeted to a given structure within a 
cell, with mitochondrial selective autophagy being identified as mitophagy. During conditions of 
mitophagy activation, such as mitochondrial damage or nutrient deprivation34,35, mitochondrial 
protein import is halted, and the protein PINK1 accumulates on the outer mitochondrial 
membrane, resulting in the recruitment of the ubiquitin ligase PARKIN and subsequent 
recruitment of an autophagosome to degrade an entire mitochondrion36-39. The process of 
mitophagy in and of itself is more energetically disfavorable compared to the other mechanisms 
of mitochondrial quality control; however, it is also in response to more severe cellular or 
mitochondrial damage.  
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If mitochondrial damage or a cellular stress is too severe, then the last type of quality 
control is induced: cell death. Mitochondria are the regulators of cell death through the localization 
of the pro-apoptotic BCL-2 proteins Bax and Bak, which form channels on the outer mitochondrial 
membrane resulting in the release of cytochrome c from the mitochondria, and induction of 
mitochondrial mediated apoptosis and assembly of the apoptosome40-43. Induction of cell death is 
mitochondrial quality control at a cellular level, where to maintain the integrity of the surrounding 
cells or tissue, a damaged cell initiates programmed cell death and is removed.  
From a pathogen’s perspective, it is one challenge to have a toxin localize to the 
mitochondria, but once localization is achieved, the toxin faces a second daunting challenge: to 
evade or harness the mitochondrial quality control machinery. Understanding the role of 
mitochondrial quality control in pathogenic infection explores an intriguing possibility for how 
pathogens are able to subvert host responses to limit infection. Not only are mitochondria 
essential for metabolic processes, but increasing evidence implicates the organelle as a major 
regulator of the innate immune system, whereby signaling at the mitochondria triggers a 
surveillance system to detect and control an initial infection16,44. By perturbing mitochondrial 
quality control measures, a pathogen is able to subvert this machinery, thus creating an 
advantageous situation to establish a chronic infection. 
The human gastric pathogen Helicobacter pylori negatively impacts host mitochondrial 
function through the action of its secreted toxins CagA and VacA45-47. VacA is one of the first and 
most well described mitochondrial targeted pathogenic effectors, where upon internalization into 
a host cell, VacA directly localizes to the mitochondria, and due to the pore-forming ability of 
VacA, VacA induces mitochondrial dysfunction, including mitochondrial fragmentation48, 
depolarization46, and cytochrome c release47,49. Although mitochondrial quality control responses 
have been reported in response to exogenous stimuli inducing mitochondrial fragmentation and 
depolarization29,35,50, it has not been identified whether a quality control response is activated to 
mitigate VacA mediated mitochondrial dysfunction. The vacA gene has been identified in all 
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clinical isolates of H. pylori infection and as a major contributor to the severity of gastric disease51-
54, however, only about 10% of Hp colonized humans are estimated to progress to the 
development of gastric ulcer disease 55,56. Given the low incidence of gastric disease in chronic 
H. pylori infection, we hypothesized that a host mitochondrial quality control response is activated 
to limit the severity of VacA induced mitochondrial dysfunction, and subsequent damage to a host 
epithelial barrier.  
Here, I report that VacA mediated mitochondrial dysfunction is detected by a host cell and 
is repaired over time through the formation of mitochondrial derived VacA containing vesicles 
(MDVCVs). The formation of MDVCVs serves to remove VacA from the mitochondria and 
relocalize VacA to lysosomal-like compartments. The removal of VacA from the mitochondria 
resulted in recovery of mitochondrial structure, transmembrane potential, and ATP levels, and 
limited the induction of downstream consequences of VacA intoxication, namely cell death and 
conversion of oxidative phosphorylation to glycolysis. In contrast to mitophagy, where entire 
mitochondrial fragments are degraded through autophagosomes, MDVCVs allow for selective 
excision of a membrane embedded mitochondrial toxin from the healthy network for degradation 
and ultimately mitochondrial repair, a more energetically favorable and faster response to initial 
insults to mitochondrial physiology. The studies completed illustrate that VacA activity relies on 
proteins previously shown to be important for MDV formation. Furthermore, by isolating MDVCVs, 
we were able to characterize the full proteome, identifying factors that might be important for 
MDVCV formation and trafficking.  
 
3.2 Materials and methods 
Bacterial strains. Helicobacter pylori 60190 (cag PAI+, vacA s1/m1; 49503; ATCC) was 
cultured in biphasic media (3 ml of liquid media on top of solid agar media) in bisulfite- and sulfite-
free Brucella broth (BSFB) on Ham’s F-12 (Sigma) agar plates supplemented with 5 µg/ml 
vancomycin (Sigma) and 10% fetal bovine serum (Sigma) for 48 h at 37ºC under microaerophilic 
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conditions (5% CO2, 10% O2). Plate supernatants were collected as a starter culture inoculum 
and diluted 1:100 in fresh BSFB supplemented with 5 µg/ml vancomycin and incubated on a 
shaker platform for 48 h at 37ºC under microaerophilic conditions. 
Mammalian cells. AZ-521 (HuTu-80) human duodenal adenocarcinoma derived cells 
were obtained from Riken Japan Health Science Foundation (3940), HeLa human cervical 
adenocarcinoma derived cells were obtained from ATCC (CCL-2), and AGS human gastric 
adenocarcinoma derived cells were obtained from ATCC (CRL-1739). AZ-521 and HeLa cells 
were maintained in MEM (Fisher Scientific), and AGS cells were maintained in DMEM (Fisher 
Scientific), each supplemented with glutamine (2 mM, Fisher Scientific), fetal bovine serum (FBS) 
(10%, Sigma-Aldrich), penicillin (100 U/ml, Fisher Scientific), and streptomycin sulfate (1 mg/ml, 
Fisher-scientific). All cell lines were maintained at 37ºC, 5% CO2, in humidified atmosphere, and 
passaged with trypsin (0.05%, Corning) for 5 min at 37ºC after cells reached approximately 80% 
confluency.  
Chemicals, reagents and primary antibodies. Unless otherwise noted, all chemicals 
and reagents were purchased from Sigma-Aldrich. Primary antibodies against TOM20 (rabbit 
polyclonal, SC-11415), LC3 (rabbit polyclonal, SC-28266), EEA1 (rabbit polyclonal, SC-33585), 
SNX9 (rabbit polyclonal, SC-99027), Rab9 (mouse monoclonal, SC-74482), VAMP8/Endobrevin 
(mouse monoclonal, SC-166820), Rab5 (mouse monoclonal, SC-46692), LAMP1 (mouse 
monoclonal, SC-20011), Rab7 (rabbit polyclonal, SC-10767), and PINK1 (rabbit polyclonal, SC-
33796) were obtained from Santa Cruz Biotechnology; OPA1 (mouse monoclonal, BD-612606), 
TIM23 (mouse monoclonal, BD-611222), DRP1 (mouse monoclonal, BD-611112), and 
cytochrome c (mouse monoclonal, BD-556432) were obtained from BD Biosciences; STX17 
(rabbit polyclonal, AB-116113), and STX12 (rabbit polyclonal, AB-215355) were obtained from 
Abcam; and β-actin (rabbit monoclonal, CS-4970) were obtained from Cell Signaling Technology. 




Purification of VacA (Figure 3.1). Culture supernatants were obtained by centrifuging 48 
h H. pylori bacterial cultures (8, 2 liter Erlenmeyer flasks each containing 200 ml of culture) at 
7,000 x g for 30 min at 4ºC. Culture supernatants were precipitated at 90% ammonium sulfate 
(Fisher Scientific) at room temperature for 1 h, then centrifuged at 7,000 x g for 30 min. 
Precipitated protein pellets were resuspended in phosphate buffer (10 mM Na2HPO4 (Sigma), pH 
7.0), then dialyzed in 50,000 MWCO dialysis membrane (Spectrum Laboratories) 1:200 in 
phosphate buffer at 4ºC for 5 h with 4 buffer changes. Dialyzed culture extracts were filter 
sterilized through 0.22 µm pore PES filters (Millipore), and loaded onto a 35 ml bed volume 
diethylaminoethyl (DEAE)-sephacel anion exchange column (GE, Sigma-Aldrich) pre-equilibrated 
with 2 bed volume washes phosphate buffer. The culture extract bound column was washed with 
2 bed volumes of phosphate buffer, then eluted with phosphate buffer containing elution salt (10 
mM Na2HPO4, 200 mM NaCl (Fisher scientific), pH 7.0). Column eluates were evaluated by SDS-
PAGE and Coomassie staining, and eluates containing pure VacA (as defined by the 88 kDa 
VacA band comprising >95% of total lane bands) were combined and dialyzed in a 50,000 MWCO 
dialysis membrane (Spectrum Laboratories) 1:200 in PBS pH 7.4 at 4ºC for 5 h with 3 buffer 
changes. PBS dialyzed, purified VacA was filtered sterilized through a 0.22 µm pore syringe filter 
(Millipore), aliquoted into single use vials, and stored at -20ºC. The concentration of purified VacA 
was determined by the BCA protein concentration assay with bovine serum albumin (BSA) 
standards prepared in PBS pH 7.4, VacA activity was determined by the neutral red vacuolation 
assay with only purified VacA batches yielding activity within one standard deviation of previously 
established Vac50 values (the concentration of VacA yielding vacuolation in 50% of intoxicated 
cells) being used for experimentation, and the identify of purified VacA was confirmed by 
immunoblotting purified VacA batches separated on a 10% gel by SDS-PAGE and transferred to 




Protein concentration assay (Figure 3.1). The concentration of PBS pH 7.4 dialyzed, 
filter sterilized, purified VacA was determined by the bicinchoninic acid (BCA) protein 
concentration assay kit (Thermo Fisher Scientific) by the manufacturer’s instructions. In brief, 
standards of 0, 25, 125, 250, 500, 750, 1000, and 1500 μg/ml of bovine serum albumin (BSA) 
were prepared in PBS pH 7.4 from 2 mg/ml BSA ampules provided by the kit provided. Standards 
and VacA samples were plated 25 μl per well in a 96 well non-tissue culture treated plate (Fisher 
Scientific) in triplicate. The BCA working reagent was prepared fresh for each concentration 
assay, consisting of a 50:1 dilution of Reagent A to Reagent B in a volume sufficient for 0.2 ml of 
working reagent for each well. After addition of the working reagent, plates were incubated in a 
37ºC incubator, followed by absorbance measurement at 562 nm on a plate reader (BioTek 
Synergy 2, Gen5 software version 1.02.8). A standard curve was plotted as absorbance at 562 
nm versus the concentration of BSA protein (μg/ml) and fitted as a 3rd order polynomial.  
Acid activation of VacA. Immediately prior to experimentation, single use aliquots of PBS 
pH 7.4 dialyzed, filter sterilized, purified VacA was thawed and acid activated by incubating VacA 
10:1 in 0.3 M HCl (Fisher) for 30 min at 37ºC in a hot water bath, followed by neutralization with 
an equal volume of 0.3 M NaOH (Fisher) to the volume of 0.3 M HCl used. The acid activated 
VacA was diluted with cell culture media for cell culture treatments and immediately used. 
VacA fluorophore labeling (Figure 3.1). Purified VacA was directly labeled with Alexa 
Fluor 488 sulfodichlorophenol (5-SDP) ester (Thermo Fisher) by the manufacturer’s protocol. In 
brief, purified VacA was concentrated using a 15,000 MWCO centrifugal filter unit (Amicon) to 
approximately 1 mg of protein. The pH of the VacA solution was increased by adding a 1:10 
dilution of 1M NaHCO3 (final concentration of 0.1 mM NaHCO3). Added into the solution of VacA 
was 0.5 – 1 mg of Alexa Fluor 488 5-SDP ester. The labeling solution was incubated at room 
temperature for 1 h protected from light. The reaction was quenched by adding a 1:100 dilution 
of 2M Tris, pH 8.5 (final concentration of 0.02 M Tris), and further incubated at room temperature 
for 10 min. The solution was transferred to a 3500 MWCO dialysis cassette (Thermo Fisher) and 
186 
 
dialyzed in a 1000X volume of PBS pH 7.4 at 4ºC for 6 h with 3 buffer changes. The degree of 
VacA labeling was confirmed by SDS-PAGE and imaging using a ChemiDoc XRS+ system using 
an Alexa Fluor 488 filter (Figure 3.1). In order to determine the concentration of labeled VacA, 
densitometry analysis was performed by comparing coomassie staining of purified, unlabeled 
VacA to labeled VacA by SDS-PAGE. Quantification was performed using ImageLab. 
Analysis of mitochondrial transmembrane potential. AZ-521, AGS, and HeLa cells 
were grown in 24 cell culture plates at 2.5 x 105 cells per ml of culture volume and allowed to 
adhere overnight at 37ºC, 5% CO2, in humidified atmosphere. Thirty min prior to completion of 
experimentation, cells were incubated in tetramethylrhodamine ethyl ester perchorate (TMRE) 
(10 nM, Life Technologies) at 37ºC, 5% CO2, in humidified atmosphere, protected from light. 
Following staining, the cells were gently washed with PBS pH 7.4 three times, detached in 50 µl 
of 0.05% trypsin per well at 37ºC for 5 min, and collected in 100 µl of 10% FBS in PBS pH 7.4 on 
ice. Relative TMRE fluorescence intensity was measured by flow cytometry using the FL2 channel 
(575/30-nm bandpass filter) on a BD FACSCanto II flow analyzer (BD Biosciences). For each 
individual replicate, 10,000 events were collected at a medium flow rate. Data from 3 
independently performed biological replicates were compiled after the data from each 
independent biological replicate performed with 3 technical replicates were relativized to the 
respective untreated control. 
Analysis of cellular vacuolation (Figure 3.1). AZ-521, AGS, and HeLa cells were 
cultured in 96 well plates at a density of 2.5 x 105 cells per ml of culture volume and allowed to 
adhere overnight at 37ºC, 5% CO2, in humidified atmosphere. Cells received the designated 
experimental treatment in cell culture medium containing 5 mM NH4Cl (Sigma) with an 
experimental set (including technical replicates) being performed in duplicate on the same plate 
for total protein measurement. For routine quality control testing of purified VacA, neutral red 
vacuolation assays were performed for 4 h. Following experimentation, cells were imaged for 
visual vacuole formation by light microscopy. Following imaging, all cells were washed twice at 
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room temperature with PBS pH 7.4. The plate was incubated at 37ºC for 4 min with experimental 
set for vacuolation measurement staining in 100 µl per well of Neutral Red solution (Sigma-
Aldrich) (diluted 1:5 with PBS pH 7.4) and the experimental set for total protein measurement in 
100 µl per well of PBS pH 7.4. Following staining, all cells were washed three times with PBS pH 
7.4 to remove residual neutral red and control for washing and cell loss. The experimental set of 
cells for vacuolation measurement were lysed in 100 µl per well of acid alcohol (3.7% HCl, 70% 
ethanol, in diH2O), and the experimental set of cells for total protein measurement were lysed in 
25 µl per well of RIPA buffer (Thermo Fisher). The plate was incubated for 10 min at room 
temperature on a shaker platform for cell lysis. Subsequently, 200 µl of BCA working reagent 
(Thermo Fisher) was added per well for the total protein measurement experimental set. The 
entire plate was incubated at 37ºC for 30 min for BCA development. For total protein 
measurement, a set of standards from 1500 µg/ml bovine serum albumin (BSA) in RIPA buffer to 
25 µg/ml were prepared with 25 μl per well on a separate, non-tissue culture treated 96 well plate 
(Fisher Scientific) in triplicate. Neutral red uptake was measured at 530 nm and 410 nm on a plate 
reader (Bio Tek Synergy 2, Gen5), and total protein was measured at 562 nm. Data from 3 
independently performed biological replicates were compiled after the data from each 
independent biological replicate performed with 3 technical replicates were normalized to the 
respective total protein measurement under the same experimental treatment and relativized to 
the respective untreated control. 
Analysis of mitochondrial fragmentation. Following experimental treatments in 8 well 
chambered microscope slides (Lab Tek), AZ-521, AGS, and HeLa cells were fixed in 5% 
formaldehyde at 37ºC for 15 min, washed with PBS pH 7.4 three times, permeabilized in 0.1% 
Triton-X 100 in PBS pH 7.4 at room temperature for 15 min, washed with PBS pH 7.4 three times, 
and blocked with 5% bovine serum albumin (BSA; Sigma-Aldrich) in PBS for 1 h at room 
temperature. Following blocking, cells were washed with 0.1% Tween-20 in PBS pH 7.4 three 
times, and probed for the mitochondrial marker TOM20 with an anti-TOM20 rabbit polyclonal 
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antibody at a 1:1000 dilution (Santa Cruz Biotechnology) in 1% BSA in PBS pH 7.4 overnight at 
4ºC. Following primary antibody incubation, cells were washed with 0.1% Tween-20 in PBS pH 
7.4 three times, followed by Alexa Fluor-488 conjugated goat anti-rabbit secondary antibody  at a 
1:1000 dilution (Life Technologies) in 1% BSA in PBS pH 7.4 at room temperature for 2 h and 
counterstained with DAPI (0.5 µg/ml in PBS pH 7.2, room temperature, 15 min), washed with 
0.1% Tween-20 in PBS pH 7.4 three times, then mounted in ProLong Gold Antifade Reagent (Life 
Technologies) overnight and sealed. At least 10 cells per experimental treatment and individual 
replicate were imaged by DIC epifluorescence microscopy using a DAPI and FITC filter on a Delta 
Vision RT microscope. Mitochondrial filament lengths were measured manually using the Imaris 
imaging processing software and recorded in micrometers. Data from 3 independently performed 
biological replicates were compiled after the data from each independent biological replicate 
performed with 3 technical replicates were relativized to the respective untreated control. 
Analysis of ATP synthesis, membrane permeability, and total protein. Analysis of 
ATP synthesis was performed by using the Mitochondrial ToxGlo Assay Kit (Promega) by the 
manufacturer’s protocol. AZ-521, AGS, and HeLa cells were cultured and adapted in glucose free, 
galactose (10 mM; Fisher) containing medium for 2 days prior to experimentation. Experiments 
were performed in a 96 well, black walled cell culture plate (Corning), with an experimental set 
(including technical replicates) being performed in duplicate on the same plate for total protein 
measurement.  Following the completion of experimentation, the experimental set designated for 
ATP measurement was washed twice with PBS pH 7.4, then incubated in 50 µl of serum free 
media for 30 min at 37ºC in the MitoTox cytotoxicity reagent, and the experimental set designated 
for total protein measurement was washed twice with PBS pH 7.4, then cells were lysed by 
incubating in 25 µl of RIPA buffer (Thermo Fisher) at 37ºC for 5 min, followed by a 25 min 
incubation at 37ºC after adding 200 µl per well of BCA reagent (Thermo Fisher). For total protein 
measurement, a set of standards from 1500 µg/ml bovine serum albumin (BSA) to 25 µg/ml 
prepared in RIPA buffer were used. Cell permeability fluorescence was measured on a plate 
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reader at 485 nm for excitation and 520-530 nm for emission. The MitoTox ATP detection reagent 
was added to the same experimental set receiving the cytotoxicity reagent, mixed on an orbital 
shaker for 1 min, then ATP levels were measured on a plate reader for luminescence. Total 
protein was measured at 562 nm. Data from 3 independently performed biological replicates were 
compiled after the data from each independent biological replicate performed with 3 technical 
replicates were normalized to the respective total protein measurement under the same 
experimental treatment and relativized to the respective untreated control. 
Analysis of oxygen consumption and glycolysis. Oxygen consumption and glycolysis 
were analyzed using the Oxygen Consumption/Glycolysis Dual Assay Kit (Cayman Chemical) by 
the manufacturer’s protocol. AZ-521, AGS, and HeLa cells were cultured and adapted in glucose 
free, galactose (10 mM; Fisher) containing medium for 2 days prior to experimentation. 
Experiments were performed in a 96 well, black walled cell culture plate (Corning), with an 
experimental set (including technical replicates) being performed in duplicate on the same plate 
for total protein measurement. Following the completion of experimentation, culture supernatants 
were transferred to a fresh plate to perform the glycolysis assay, whereby culture supernatants 
were combined with assay buffer, incubated at room temperature for 30 min, then absorbance 
measured at 490 nm. Lactate standards were included to determine extracellular lactate produced 
in experimental treatments. The experimental set designated for oxygen measurement was 
washed twice with PBS pH 7.4, then placed serum free media containing MitoXpress Xtra 
solution. Wells were overlaid with mineral oil and measurements were obtained at 380 nm for the 
excitation, and 650 nm for the emission at 37ºC. The experimental set designated for total protein 
measurement was washed twice with PBS pH 7.4, then cells were lysed by incubating in 25 µl of 
RIPA buffer (Thermo Fisher) at 37ºC for 5 min, followed by a 25 min incubation at 37ºC after 
adding 200 µl per well of BCA reagent (Thermo Fisher). For total protein measurement, a set of 
standards from 1500 µg/ml bovine serum albumin (BSA) to 25 µg/ml prepared in RIPA buffer were 
used. Total protein was measured at 562 nm. Data from 3 independently performed biological 
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replicates were compiled after the data from each independent biological replicate performed with 
3 technical replicates were normalized to the respective total protein measurement under the 
same experimental treatment and relativized to the respective untreated control. 
Immunoblotting. Upon completion of an experimental treatment, cells were washed with 
PBS pH 7.4 twice then collected in lysis buffer (100 mM Tris-Cl, 4% SDS, 0.2% Bromophenol 
Blue, 20% glycerol, 10% β-mercaptoethanol, and 50 mM dithiothreitol) or samples were prepared 
in 2X Laemmli sample buffer (BioRad). Samples were boiled at 100ºC for 10 min on a heating 
block, then aliquoted and stored at -20ºC, or used immediately for electrophoresis. Following 
denaturation, samples were centrifuged at 1000 x g for 15 sec to collect condensation. Depending 
on the molecular weight of the protein target, samples were separated on 6-12% polyacrylamide 
gels at 80-120V for 60-120 min at room temperature via SDS-PAGE. Following electrophoresis, 
samples were immunoblotted to polyvinylidene fluoride (PVDF) membranes activated with 
methanol by wet transfer at 60-80V for 30-60 min at 4ºC. PVDF membranes were blocked with 
5% milk in Tris-Buffered Saline + Tween (TBS-T: 137 mM NaCl, 100 mM Tris-base, 0.5% Tween-
20, pH 7.6) at room temperature for 1 hour, then incubated in the given primary antibody in 1% 
milk in TBS-T overnight at 4ºC. Membranes were washed with TBS-T, then incubated in 
secondary antibodies conjugated to horseradish peroxidase (HRP) (Cell Signaling) at room 
temperature for 60 min. Membranes were washed with TBS-T, then developed with SuperSignal 
West Femto/Pico Maximum Sensitivity Substrate (ThermoFisher). Images were acquired using a 
ChemiDoc XRS+ system and data were processed with ImageLab software. 
Analysis of cytochrome c release. Following experimental treatments in 8 well 
chambered microscope slides (Lab Tek), AZ-521, AGS, and HeLa cells were fixed in 5% 
formaldehyde at 37ºC for 15 min, washed with PBS pH 7.4 three times, permeabilized in 0.1% 
Triton-X 100 in PBS pH 7.4 at room temperature for 15 min, washed with PBS pH 7.4 three times, 
and blocked with 5% bovine serum albumin (BSA; Sigma-Aldrich) in PBS for 1 h at room 
temperature. Following blocking, cells were washed with 0.1% Tween-20 in PBS pH 7.4 three 
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times, and probed for the mitochondrial marker TOM20 with an anti-TOM20 rabbit polyclonal 
antibody at a 1:1000 dilution (Santa Cruz Biotechnology) and anti-cytochrome c mouse 
monoclonal antibody at a 1:500 dilution (BD Biosciences) in 1% BSA in PBS pH 7.4 overnight at 
4ºC. Following primary antibody incubation, cells were washed with 0.1% Tween-20 in PBS pH 
7.4 three times, followed by Alexa Fluor-488 conjugated goat anti-mouse and Alexa Fluor-555 
conjugated donkey anti-rabbit secondary antibody  at a 1:1000 dilution (Life Technologies) in 1% 
BSA in PBS pH 7.4 at room temperature for 2 h and counterstained with DAPI (0.5 µg/ml in PBS 
pH 7.4, room temperature, 15 min), washed with 0.1% Tween-20 in PBS pH 7.4 three times, then 
mounted in ProLong Gold Antifade Reagent (Life Technologies) overnight and sealed. At least 10 
cells per experimental treatment and individual replicate were imaged by DIC epifluorescence 
microscopy using a DAPI, FITC, and RD-TR-PE filter on a Delta Vision RT microscope. 
Cytochrome c release was identified as a cytoplasmic distribution of cytochrome c, rather than 
strong mitochondrial association. Data from 3 independently performed biological replicates were 
compiled after the data from each independent biological replicate performed with 3 technical 
replicates were relativized to the respective untreated control. 
Analysis of Drp1 association with mitochondria. Following experimental treatments in 
8 well chambered microscope slides (Lab Tek), AZ-521, AGS, and HeLa cells were fixed in 5% 
formaldehyde at 37ºC for 15 min, washed with PBS pH 7.4 three times, permeabilized in 0.1% 
Triton-X 100 in PBS pH 7.4 at room temperature for 15 min, washed with PBS pH 7.4 three times, 
and blocked with 5% bovine serum albumin (BSA; Sigma-Aldrich) in PBS for 1 h at room 
temperature. Following blocking, cells were washed with 0.1% Tween-20 in PBS pH 7.4 three 
times, and probed for the mitochondrial marker TOM20 with an anti-TOM20 rabbit polyclonal 
antibody at a 1:1000 dilution (Santa Cruz Biotechnology) and anti-Drp1 mouse monoclonal 
antibody at a 1:500 dilution (BD Biosciences) in 1% BSA in PBS pH 7.4 overnight at 4ºC. Following 
primary antibody incubation, cells were washed with 0.1% Tween-20 in PBS pH 7.4 three times, 
followed by Alexa Fluor-488 conjugated goat anti-mouse and Alexa Fluor-555 conjugated donkey 
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anti-rabbit secondary antibody  at a 1:1000 dilution (Life Technologies) in 1% BSA in PBS pH 7.4 
at room temperature for 2 h and counterstained with DAPI (0.5 µg/ml in PBS pH 7.4, room 
temperature, 15 min), washed with 0.1% Tween-20 in PBS pH 7.4 three times, then mounted in 
ProLong Gold Antifade Reagent (Life Technologies) overnight and sealed. At least 10 cells per 
experimental treatment and individual replicate were imaged by DIC epifluorescence microscopy 
using a DAPI, FITC, and RD-TR-PE filter on a Delta Vision RT microscope. Drp1 association with 
mitochondria was measured by Pearson’s coefficient of correlation in the FITC and RD-TR-PE 
channels. Data from 3 independently performed biological replicates were compiled after the data 
from each independent biological replicate performed with 3 technical replicates were relativized 
to the respective untreated control. 
Analysis of autophagy induction. Following experimental treatments in 8 well 
chambered microscope slides (Lab Tek), AZ-521, AGS, and HeLa cells were fixed in 5% 
formaldehyde at 37ºC for 15 min, washed with PBS pH 7.4 three times, permeabilized in 0.1% 
Triton-X 100 in PBS pH 7.4 at room temperature for 15 min, washed with PBS pH 7.4 three times, 
and blocked with 5% bovine serum albumin (BSA; Sigma-Aldrich) in PBS for 1 h at room 
temperature. Following blocking, cells were washed with 0.1% Tween-20 in PBS pH 7.4 three 
times, and probed for anti-LC3 rabbit polyclonal antibody at a 1:500 dilution (Santa Cruz 
Biotechnology) in 1% BSA in PBS pH 7.4 overnight at 4ºC. Following primary antibody incubation, 
cells were washed with 0.1% Tween-20 in PBS pH 7.4 three times, followed by Alexa Fluor-488 
conjugated goat anti-mouse secondary antibody at a 1:1000 dilution (Life Technologies) in 1% 
BSA in PBS pH 7.4 at room temperature for 2 h and counterstained with DAPI (0.5 µg/ml in PBS 
pH 7.4, room temperature, 15 min), washed with 0.1% Tween-20 in PBS pH 7.4 three times, then 
mounted in ProLong Gold Antifade Reagent (Life Technologies) overnight and sealed. At least 10 
cells per experimental treatment and individual replicate were imaged by DIC epifluorescence 
microscopy using a DAPI and FITC filter on a Delta Vision RT microscope. Bax activation was 
identified as a localization of Bax to the mitochondria, rather than distribution in the cytosol. Data 
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from 3 independently performed biological replicates were compiled after the data from each 
independent biological replicate performed with 3 technical replicates were relativized to the 
respective untreated control. 
Intracellular trafficking of VacA. AZ-521, AGS, and HeLa cells seeded in 8 well 
chambered microscope slides (Lab Tek) were incubated with VacA directly labeled with Alexa 
Fluor 488 (250 nM) for 30 min at 4ºC to allow for binding to the cell surface. After binding, cells 
were washed and media was replaced with an equal concentration of unlabeled VacA (250 nM) 
and incubated at 37ºC for 0.25, 0.5, 1, 2, 4, or 8 h. Following incubation, cells were fixed in 5% 
formaldehyde at 37ºC for 15 min, washed with PBS pH 7.4 three times, permeabilized in 0.1% 
Triton-X 100 in PBS pH 7.4 at room temperature for 15 min, washed with PBS pH 7.4 three times, 
and blocked with 5% bovine serum albumin (BSA; Sigma-Aldrich) in PBS for 1 h at room 
temperature. Following blocking, cells were washed with 0.1% Tween-20 in PBS pH 7.4 three 
times, and probed for the mitochondrial marker TOM20 with an anti-TOM20 rabbit polyclonal 
antibody at a 1:1000 dilution (Santa Cruz Biotechnology), the early endosome marker EEA1 with 
an anti-EEA1 rabbit polyclonal antibody at a 1:1000 dilution (Santa Cruz Biotechnology), and a 
lysosomal marker LAMP1 with an anti-LAMP1 mouse polyclonal antibody at a 1:500 dilution 
(Santa Cruz Biotechnology) in 1% BSA in PBS pH 7.4 overnight at 4ºC. Following primary 
antibody incubation, cells were washed with 0.1% Tween-20 in PBS pH 7.4 three times, followed 
by Alexa Fluor-555 conjugated goat anti-mouse and Alexa Fluor-555 conjugated donkey anti-
rabbit secondary antibody  at a 1:1000 dilution (Life Technologies) in 1% BSA in PBS pH 7.4 at 
room temperature for 2 h and counterstained with DAPI (0.5 µg/ml in PBS pH 7.4, room 
temperature, 15 min), washed with 0.1% Tween-20 in PBS pH 7.2 three times, then mounted in 
ProLong Gold Antifade Reagent (Life Technologies) overnight and sealed. At least 10 cells per 
experimental treatment and individual replicate were imaged by DIC epifluorescence microscopy 
using a DAPI, FITC, and RD-TR-PE filter on a Delta Vision RT microscope. VacA association with 
mitochondria, early endosomes, and lysosomes was measured by Pearson’s coefficient of 
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correlation in the FITC and RD-TR-PE channels. Data from 3 independently performed biological 
replicates were compiled after the data from each independent biological replicate performed with 
3 technical replicates were relativized to the respective untreated control. 
MDV mass spectrometry. MDV samples were analyzed by HPLC-MS/MS at the Roy J. 
Carver Biotechnology Center at the University of Illinois within the Proteomics Core Facility. The 
samples were processed by solubilization in a mild detergent and residual buffer components, 
salts, detergents, and lipids were removed by the G-Biosciences Perfect Focus kit. The MDV 
proteins were digested with proteomics grade trypsin, lyophilized, and 1-2 µg of digested peptides 
were analyzed by tandem HPLC-MS/MS. The raw proteomics data were collected using the 
Xcalibur software and peptide sequences were compared against the SwissProt protein database 
for mouse proteins. Resultant proteins with an ion score (probability that an observed match is a 
random event) less than 10 were discarded, and relative protein content was quantified by the 
exponentially modified protein abundance index (emPAI). 
RNAi knockdown. AZ-521, AGS, and HeLa cells were cultured in antibiotic free media, 
then transfected with 50 nM RNAi against NC1 (scrambled control), Rab7, Rab9, Snx9, Stx17, 
Vamp8, Stx12, Rab32, and Rab5C (IDT) with Lipofectamine (Invitrogen) by the manufacturer’s 
instructions for 48 h prior to experimentation. In brief, cells were cultured in 6 well cell culture 
plates in antibiotic free media and allowed to reach approximately 80% confluency prior to 
transfection. Each RNAi transfection reagent for each cell type and protein target was prepared 
by diluting RNAi in 50 µl OptiMEM, and Lipofectamine 2000 in 50 µl OptiMEM and incubating at 
room temperature for 5 min. After initial incubation, the diluted Lipofectamine was added to the 
RNAi, and the complex was further incubated at room temperature for 25 min. The 100 µl mixture 
was added directly into a single well of a 6 well plate. Cells were exposed to the transfection 
reagents for 24 h, then washed twice with PBS pH 7.4 and replaced with fresh cell culture medium 
lacking antibiotics. Cells were re-transfected using the same method described. Approximately 4-
6 h after the second transfection, cells were washed twice with PBS pH 7.4 then collected by 
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trypsinization (0.05% trypsin, 5 min, 37ºC), and collected in antibiotic free cell culture medium. 
Cells were re-seeded into the needed cell culture plates (e.g. 96 well plate, 24 well plate, 8 well 
chamber slide), at a density of 2.5 x 105 cells per ml of cell culture medium and incubated 
overnight at 37ºC, 5% CO2, humidified atm. Approximately 48 h after the initial transfection, an 
experiment was begun. Immunoblotting against each protein with a β-actin loading control was 
performed to confirm knockdown for every transfection and experiment conducted. 
Animal Care. All experiments involving the use of live vertebrate animals were conducted 
with the approval of the University of Illinois at Urbana-Champaign Institutional Animal Care and 
Use Committee. Animal populations were composed of C57BL/6J mice (Jackson Laboratory, Bar 
Harbor ME) bred in-house. Animals were housed in a climate-controlled (23ºC, 55% humidity) 
University of Illinois at Urbana-Champaign animal care unit with a 12h/12h light:dark cycle. 
Animals were fed a standard commercial rodent diet (Envigo, Indianapolis, IN) and allowed 
access to food and water ab libitum. Animals were sib-mated in trios (2 females and 1 male) and 
were weaned at 22 days of age.  
MDVCV isolation. MDVCVs were isolated as previously reported 57. In brief, mouse livers 
were collected following euthanasia of 4, 6-8 week old C57BL/6 mice by CO2 asphyxiation. Livers 
were immediately homogenized in mitochondrial isolation buffer (220 mM mannitol, 68 mM 
sucrose, 80 mM KCl, 0.5 mM EGTA, 2 mM magnesium acetate, 20 mM HEPES, pH 7.4) using a 
mortar and pestle on ice. Mitochondria were isolated following 3 centrifugations at 1000 x g for 10 
min at 4ºC to remove heavy debris, then 7000 x g for 10 min at 4ºC to pellet mitochondria. The 
cytosol was isolated by ultracentrifugation of the post-mitochondrial supernatant at 250,000 x g 
for 90 min at 4ºC using a Beckman SW 50.1 rotor. Crude mitochondrial pellets were washed 3 
times in mitochondrial isolation buffer, and total protein of mitochondria and cytosol were 
measured by the Bradford protein concentration assay (Pierce) with bovine serum albumin 
standards prepared in mitochondria isolation buffer. Mitochondrial pellets were combined with 
cytosol at a 1:4 ratio of mitochondrial protein to cytosol protein with 250 nM acid activated VacA 
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in MDVCV budding reaction buffer (220 mM mannitol, 68 mM sucrose, 80 mM KCl, 0.5 mM EGTA, 
2 mM magnesium acetate, 20 mM HEPES pH 7.4, 1 mM ATP, 5 mM succinate, 80 µM ADP, 2 
mM K2HPO4) at 37ºC for 2 h. Intact mitochondria were pelleted at 10,000 x g for 10 min at 4ºC, 
and MDVCVs were collected in the post-mitochondrial supernatant and processed for density 
gradient ultracentrifugation or trypsin digestion. All experiments were conducted in accordance 
with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were 
approved by the University of Illinois at Urbana-Champaign Institutional Animal Care and Use 
Committee. 
MDVCV density gradient ultracentrifugation. Post-mitochondrial supernatants from the 
MDVCV isolation were made to 50% sucrose in mitochondrial isolation buffer, then layered in a 
30%, 40%, and 50% sucrose in mitochondrial isolation buffer step gradient. Gradients were 
ultracentrifuged at 250,000 x g in a SW50.1 rotor for 2 h at 4ºC. Samples were collected from 
each layer and interface and processed for western blotting. 
MDVCV trypsin digestion. Post-mitochondrial supernatants from the MDVCV isolation 
were treated with 0.5 mg/ml trypsin at 4ºC for 10 min. Immediately following incubation samples 
were processed for western blotting. 
Statistical analysis. All experiments were performed in three independent replicate with 
at least three technical replicates. For pairwise comparisons, significance was determined using 
a 2-tailed distribution, paired t test. For multiple comparisons, significance was determined using 
a one-way ANOVA with Tukey correction for multiple comparisons. Unless otherwise indicated, 
statistical significance was signified by an alpha level threshold of 0.05. Error bars from 
quantification datasets represent standard error of the mean (SEM). For all statistical analyses, 







3.3  Results 
3.3.1  Model of VacA induction of mitochondrial quality control 
Previous studies have shown VacA to induce mitochondrial dysfunction, including a 
dissipation of the mitochondrial transmembrane potential and induction of mitochondrial 
fragmentation48, cytochrome c release46, and decrease in cellular ATP levels and increase in 
reactive oxygen species (ROS) production47,58. Given mitochondria are essential for cellular 
viability, numerous mitochondrial quality control measures exist to maintain mitochondrial and 
cellular homeostasis in response to mitochondrial damaging agents and stimuli24,59. Given VacA 
induces mitochondrial dysfunction, I hypothesized that a host cell would respond to mitochondrial 
dysfunction by activing a stepwise series of mitochondrial quality control from the molecular to 
the cellular level (Figure 3.2). On the molecular level, the mitochondrial unfolded protein response 
(UPRmt) serves to control endogenous mitochondrial protein dysfunction, with communication of 
mitochondrial dysfunction to nuclear gene transcription to upregulate mitochondrial chaperones, 
proteases, and repair machinery19. On the organellar level, subdomains of oxidized cargo or 
dysfunctional regions of mitochondria are removed via vesicular carriers, termed mitochondrial 
derived vesicles, and transported to either peroxisomes31 or lysosomes29 for degradation. 
Additionally, mitophagy serves as a selective form of autophagy, whereby dysfunctional 
mitochondrial fragments are marked for degradation by directly associating with 
autophagolysosomes34. Finally, the activation of cell death via mitochondrial damage serves as a 
cellular level of quality control, in order to maintain the integrity of a population of cells or a tissue40. 
The model of VacA induction of mitochondrial quality control posits that in response to low levels 
of VacA and/or shorter times of intoxication, the molecular level quality control responses will be 
activated as a “first line of defense” to the initial onslaughts of mitochondrial dysfunction. If the 
UPRmt is insufficient to repair mitochondrial dysfunction, the model posits that higher orders of 
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mitochondrial quality control will be activated until cells either return to homeostasis, or ultimately 
undergoes cell death.  
Given VacA is a membrane embedded, pore forming toxin60,61, I hypothesized that the 
trafficking of VacA within a cell is mediated by membrane transport, and that in response to VacA 
mediated mitochondrial dysfunction, the organellar level quality control mechanism of 
mitochondrial derived vesicles is activated. The model posits that dysfunctional subdomains of 
mitochondria containing VacA are removed via vesicular carriers that transport VacA from the 
mitochondria to LAMP1 enriched, lysosomal-like compartments (Figure 3.3). Subsequent to 
removal from the mitochondria, lysosome associated VacA induces an osmotic imbalance due to 
the VacA pore, resulting in lysosomes to swell into large vacuoles. 
 
3.3.2  Recovery of mitochondrial structure in VacA intoxicated cells 
Mitochondria exist in a constant state of division and fusion62. Fragmentation of the 
mitochondrial network occurs in response to depolarization of the mitochondria transmembrane 
potential34,63 whereby the mitochondrial fission factor Drp1 is recruited to mitochondrial scission 
sites and facilitates the separation of mitochondrial tubules64. Mitochondrial fragmentation is 
important  during cell division in order to distribute mitochondria between nascent cells, and also 
functions as a quality control measure to isolate depolarized mitochondrial segments from the 
functional network63. Through the action of mitochondrial membrane fusion machinery, namely 
Mfn1 and Mfn2 for the outer membrane and OPA1 for the inner membrane, mitochondrial 
fragments may refuse with the intact network as a means to enhance oxidative phosphorylation 
or dilute the relatively small dysfunctional mitochondrial segment with the functional network63. If 
mitochondria remain fragmented and depolarized, a cell may ultimately undergo programmed cell 




Drp1 mediated mitochondrial fragmentation has been reported in VacA intoxicated cells48. 
In order to evaluate whether host cells are capable of detecting and responding to perturbations 
in mitochondrial structure by VacA over time, cells were exposed to VacA (250 nM) under either 
a pulse or continuous condition (Figure 3.4). If cells are capable of activating mitochondrial quality 
control as a means to maintain homeostasis, it was hypothesized that the ability the detect 
mitochondrial recovery will be based on the rate of VacA inducing mitochondrial dysfunction 
balanced with the rate by which host cells repair the mitochondria. Therefore, by treating cells 
under a pulse condition where cells received an initial robust induction of mitochondrial 
dysfunction by VacA, the design of the experiment allows for the host cell’s recovery response to 
repair VacA medicated mitochondrial dysfunction to a detectable level, if indeed the process is 
occurring. For the pulse versus continuous treatments, cells were first incubated with VacA under 
conditions nonpermissive to internalization, but permissive to binding (4ºC, 30 min). Cells were 
then washed with PBS pH 7.4 twice to remove unbound VacA, then the PBS pH 7.4 was replaced 
with 37ºC VacA deficient media for pulse conditions, or 37ºC VacA containing media for 
continuous conditions, then further incubated at 37ºC for 1, 4 or 24 h.  
In order to first evaluate whether cells are capable of repairing the dysfunction induced at 
the level of the mitochondria, the mitochondrial structure in AZ-521 cells treated with either a pulse 
or continuous exposure to VacA for 1, 4, or 24 h was analyzed by fluorescence microscopy with 
staining against the outer mitochondrial membrane translocon subunit TOM20. Under these 
conditions, mitochondria appeared fully fragmented by 1 h, as indicated by mitochondria existing 
as small, non-filamentous structures, in both the VacA pulse and continuous exposure conditions, 
with no appreciable differences observed between each VacA treatment (Figure 3.5). However, 
by 4 h under pulse conditions, the mitochondrial network appeared to regain the filamentous 
structure, although mitochondria under continuous VacA exposure remained fragmented (Figure 
3.5). By 24 h post-intoxication, all mitochondria appeared filamentous across treatments, with the 
continuously VacA exposed cells mitochondria appearing slightly shorter in length (Figure 3.5). 
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These findings indicate that over time, if VacA levels are limited, cells are able to repair the 
mitochondrial network, providing the first evidence that cells may be capable of sensing VacA 
mediated mitochondrial dysfunction. 
In order to validate the phenomenon of mitochondrial fragmentation recovery in VacA 
intoxicated cells, the mitochondrial structure was evaluated under pulse and continuous VacA 
exposure in AGS and HeLa cells (Figure 3.6). In support of the findings in AZ-521 cells, 
mitochondria were initially fragmented upon exposure to VacA, then within 4 h the mitochondrial 
structure returned filamentous when VacA exposure was limited, and by 24 h, all mitochondria 
regained the healthy filamentous network (Figure 3.6). These data indicate that the recovery of 
VacA mediated mitochondrial fragmentation is not idiosyncratic to a single cell line, and that 
indeed different cells are capable of detecting and responding to VacA mediated mitochondrial 
stressors.  
In order to evaluate the degree of mitochondrial fragmentation occurring within VacA 
intoxicated cells, the length of mitochondria were quantified in AZ-521 cells exposed to VacA by 
measuring the length of mitochondrial structures from fluorescence microscopy images. The total 
length of filaments were traced for the full length of a mitochondrion, and for small fragments 
where no apparent longitudinal direction was appreciated, the diameter was measured. The 
lengths of all mitochondria measured in a given experimental condition were then averaged. The 
observed trend of recovery of mitochondrial structure in VacA intoxicated AZ-521, AGS, and HeLa 
cells (Figures 3.5, 3.6) was appreciated quantitatively, whereby the length of mitochondria were 
compiled from a total of 8,553 mitochondria measured (Figure 3.7). As a complementary 
modality, in order to account for different mitochondrial structural states, mitochondria at various 
lengths were also categorized as either “fragmented” (less than 2 µm in length), “intermediate” 
(between 2 and 8 µm in length), or “tubular” (greater than 8 µm in length), and quantified as 
percent abundance of total mitochondria within a given category within a cell (Figure 3.8). Similar 
to the mitochondrial length measurements, whereby within 1 h of intoxication the length of 
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mitochondria decreased by approximately 70% in both VacA treatments (Figure 3.7), a near 
equal percentage of mitochondria were predominantly in the fragmented state in both VacA 
exposure conditions (Figure 3.8). At 4 h post-intoxication, the length of mitochondria in pulse 
intoxicated cells was equivalent to untreated cells (Figure 3.7), and the distribution of 
mitochondria in the pulse exposed VacA cells was equivalent to the respective control (Figure 
3.8), indicating a return to mitochondrial structural homeostasis. By 24 h post-intoxication, the 
continuously VacA intoxicated cells displayed an increase in tubular mitochondria (Figure 3.8) 
with the length quantified to be approximately 80% that of unaffected mitochondria (Figure 3.7). 
Interestingly, although the average mitochondrial length in VacA intoxicated cells approaches that 
of the control cells (Figures 3.7, 3.8), a fraction of the remaining mitochondria remain in a 
fragmented state, indicating that either recovery is not complete within 24 h, or that the remaining 
smaller mitochondrial structures are isolated and will not re-fuse with the remaining mitochondrial 
network. Finally, in order to evaluate the shift in mitochondrial populations over time, the length 
of mitochondria were plotted as histograms and compared between the different treatments 
(Figure 3.9). Altogether, the histograms illustrate the same trend, whereby upon initial exposure 
of cells to VacA, mitochondria exist in predominantly a fragmented state of equal composition 
(Figure 3.9). These data also illustrate that the degree of fragmentation induced by VacA in both 
the pulse and continuous VacA exposures is near identical, lending support that the pulse VacA 
exposure mediated recovery is not occurring simply because VacA is inducing less mitochondrial 
dysfunction. Then, upon removal of VacA via the pulse condition, the mitochondrial structure 
population shifts to that of the control cells, with an intermediate stage being observed at 4 h 
(Figure 3.9). By 24 h post intoxication, all three profiles nearly overlap entirely, with the continuous 
VacA treatment yielding a slight increase in the population of fragmented mitochondria (Figure 
3.9). Overall, these data indicate that cells are capable of responding to and repairing dysfunction 




3.3.3  Intracellular VacA levels 
   Previous studies have indicated that VacA associates with the lysosomal associated 
membrane protein 1, or LAMP1 during intoxication. Given LAMP1 is a marker of lysosomes65, 
and that lysosomes are a degradative compartment66,67, it was predicted that VacA levels should 
decrease over time. Therefore, in order to determine whether the recovery of VacA mediated 
mitochondrial fragmentation is simply due to a complete removal of VacA within a cell due to 
fewer VacA molecules entering via the pulse exposure, the intracellular levels of VacA were 
evaluated. First, cells treated with VacA under pulse and continuous conditions were 
immunoblotted for VacA (Figure 3.10). Although cell-associated VacA levels were approximately 
50% lower in the pulse VacA treated cells compared to the continuous VacA treated cells, the 
relative levels over time remained steady (Figure 3.10). This finding indicates that over time, 
VacA is not being actively degraded by host cell protein degradation machinery; therefore, the 
phenotype observed of a recovery in mitochondrial structure is occurring in presence of an 
equivalent amount of VacA within a cell. Furthermore, analysis of the degree of mitochondrial 
fragmentation (Figure 3.7), indicated that VacA exposure in both pulse and continuous treatments 
yielded the same degree of mitochondrial dysfunction, further illustrating that the amount of VacA 
entering cells during the pulse exposure is sufficient to induce the same amount of cellular toxicity 
as compared to the continuous exposure. In addition to blotting VacA levels, intracellular VacA 
was evaluated by fluorescence microscopy using indirect immunofluorescence with an antibody 
against VacA in addition to imaging the pulse VacA that was directly labeled with Alexa Fluor 488. 
After exposing cells to a pulse of VacA directly labeled with Alexa Fluor 488 followed by a chase 
of unlabeled VacA for 8 h, and cells were stained total VacA, a complete co-localization of pulse 
VacA with total VacA was observed (Figure 3.11). Furthermore, additional punctate signals were 
detected in the total VacA staining and not the pulse, thus representing the chase population of 
VacA. Given a positive immuno-reactive signal was detected in the pulse VacA channel, the data 
are suggesting that VacA is indeed localized within cells during a timecourse of intoxication and 
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that by 8 h VacA is not completely removed from a cell via degradation. Furthermore, these data 
illustrate that VacA is indeed localized within cells under conditions where recovery of 
mitochondrial function is observed.  
  
3.3.4  VacA and OPA1 splice isoforms 
Mitochondrial dynamics is regulated through the action of different proteins in the dynamin 
family63. Under conditions promoting mitochondrial division or fragmentation, the mitochondrial 
fission factor Drp1 localizes to the mitochondria, and forms a constrictive ring, thus facilitating 
scission of mitochondrial filaments63,64,68,69. Under conditions of mitochondrial fusion, the outer 
mitochondrial membrane fusion factors (Mfn1 and Mfn2) and inner mitochondrial membrane 
fusion factor (OPA1) facilitate the reconnection of mitochondrial membranes63,70,71. While the 
mitofusins are tethered to the mitochondrial membranes and function to promote membrane 
fusion, the state of mitochondria may be assessed by examining different splicing isoforms of 
OPA172-74. Currently, eight different splice variants of OPA1 have been described, with all sharing 
a mitochondrial targeting sequence, and mitochondrial processing peptidase cleavage site, a 
transmembrane domain, and a shared cleavage site identified as S174. Under physiological 
conditions, OPA1 is observed as a long form (L-OPA1) and a short form (S-OPA1) by 
immunoblotting74. The processing of L-OPA1 to S-OPA1 is mediated through several 
mitochondrial proteases, including PARL, paraplegin, and Yme1L74,75. Upon mitochondrial 
depolarization and fragmentation, loss of mitochondrial ATP levels, and induction of apoptosis, 
OPA1 is cleaved to the short form, indicative of mitochondrial stresses76.  
Given VacA induces reversible mitochondrial fragmentation, in order to evaluate the 
severity of mitochondrial damage and the ability of cells to engage the mitochondrial fusion 
machinery, the isoform status of OPA1 was evaluated. AZ-521, AGS, and NCI-N87 cells were 
incubated in the absence or presence of VacA (250 nM), CCCP (10 µM), or both, for 1, 12, or 24 
h. Samples were collected and processed for immunoblotting against OPA1 and β-actin as a 
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loading control. Mitochondrial dysfunction represented by OPA1 is indicated by a loss of L-OPA1 
(upper OPA1 band) and accumulation of S-OPA1 (lower OPA1 band). Primarily, the data illustrate 
disparities between cell types (Figure 3.12). In NCI-N87 cells, no detectable changes in OPA1 
splice forms were observed over time for all of the conditions used (Figure 3.12). In AGS cells, 
OPA1 cleavage was observed in 1 h with CCCP treatment alone, but interestingly, in combination 
with VacA the cleavage of OPA1 appeared limited, indicating that the presence of VacA was 
perhaps protecting CCCP mediated mitochondrial damage (Figure 3.12). By 12 and 24 h of 
exposure in AGS cells however, OPA1 was fully cleaved in both CCCP and VacA/CCCP 
combined treatments (Figure 3.12). Finally, in AZ-521 cells, OPA1 cleavage was only observed 
in the 12 hr CCCP and VacA/CCCP treated cells, although it is to be noted that like AGS cells, 
co-incubation of VacA with CCCP resulted in the retention of a faint L-OPA1 band, indicating that 
perhaps VacA confers protection to severe insults to mitochondrial dysfunction (Figure 3.12). In 
addition, by 24 h treatment of AZ-521 cells, the L-OPA1 forms return, indicating that perhaps AZ-
521 cells are better able to undergo mitochondrial dysfunction recovery upon insults to 
mitochondrial dysfunction. Finally, it is to be noted that a slight reduction in L-OPA1 was observed 
in the 1 h CCCP treatment in AZ-521 cells, indicating that like AGS cells, CCCP mediated 
mitochondrial damage and dysfunction may be a rapid phenomenon (Figure 3.12). It is also to 
be noted, however, that all cells types tested (AGS, AZ-521, HeLa) for mitochondrial 
fragmentation are capable of undergoing recovery in response to VacA (Figures 3.5, 3.6). 
Altogether, these data indicate that NC-N87 cells are resistant to OPA1 cleavage, AGS cells are 
the most sensitive, with VacA providing possible protection against CCCP mediated OPA1 
cleavage, and AZ-521 cells are capable of recovering from OPA1 cleavage. Furthermore, these 
data indicate that VacA intoxication, although inducing robust mitochondrial fragmentation, does 
not result in OPA1 cleavage. 
In order to evaluate whether the lack of detecting OPA1 cleavage in VacA intoxicated cells 
was due to low doses of VacA, cells were exposed to VacA up to 1000 nM (Figure 3.13). Under 
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the experimental conditions performed (2 h treatment with VacA (1000, 250, 10 nM), CCCP (10, 
5, 2.5 µM), oligomycin (10 µM), Antimycin A (50 µM), or chloramphenicol (50 µM)) in NCI-N87, 
AGS, and AZ-521 cells, OPA1 cleavage was only detected in 10 µM CCCP in NC1-N87 and AGS 
cells, with only a slight decrease in L-OPA1 in AZ-521 cells under 10 μM CCCP treatment (Figure 
3.13). These data indicate that VacA independent, severe mitochondrial dysfunction is needed 
for OPA1 cleavage in the cell lines tested, and further support the observation that VacA, even at 
high concentrations, is not capable of inducing OPA1 cleavage.  
In order to evaluate whether the lack of detecting OPA1 cleavage in VacA intoxicated cells 
was due to the length of incubation with VacA, AZ-521 cells were exposed to VacA (250 nM), 
CCCP (10 µM), CCCP in combination with chloroquine, chloroquine alone, or NAD or 1, 4, 12, or 
24 h (Figure 3.14). These data further illustrate that the only experimental conditions yielding 
cleavage of OPA1 from L-OPA1 to S-OPA1 is treatment with CCCP (Figure 3.14). Interestingly, 
cleavage of OPA1 in response to CCCP was observed rather rapidly, as quickly of 1 h after 
treatment, illustrating that OPA1 processing is not an inherently resistant phenotype to insults of 
mitochondrial stress. If OPA1 were to be a process that requires extensive incubation in order to 
undergo cleavage, it is reasonable to ascertain that perhaps an explanation for not observing 
OPA1 cleavage in VacA intoxicated cells is simply due to the degree of exposure not being severe 
enough. However, OPA1 cleavage is certainly a relatively rapid response, and although VacA is 
inducing robust mitochondrial dysfunction within 1 h of intoxication, it is an interesting 
phenomenon that no cleavage of OPA1 is observed during VacA intoxication. 
Finally, in order to examine whether the lack of OPA1 cleavage in VacA intoxicated cells 
was due lower mitochondrial respiration activity, cells were cultured in glucose media (promoting 
glycolytic activity) or galactose media (promoting mitochondrial oxidative phosphorylation) by 
engaging the Warburg effect6. After 4 h of exposure to VacA (250 nM), CCCP (10 µM), or 
Antimycin A (50 µM) in glucose or galactose containing media, AZ-521, AGS, and HeLa cells 
appeared more sensitive to OPA1 cleavage in galactose media (Figure 3.15). Under the 
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experimental conditions used, AZ-521 cells underwent OPA1 cleavage with CCCP and Antimycin 
A treatment in the galactose medium only, whereas AGS, HeLa, and Cos7 cells all underwent 
OPA1 cleavage in glucose media with CCCP treatment (Figure 3.15). These data, in combination 
with the previous studies, indicate that under no conditions tested did VacA intoxication result in 
OPA1 cleavage. This finding suggests that VacA mediated mitochondrial dysfunction is not as 
severe compared to CCCP or Antimycin A treatments, suggesting that higher order level of 
mitochondrial quality control may not be engaged in order to repair the dysfunctional 
mitochondria. Furthermore, these findings suggest that the mitochondrial fusion machinery 
remains intact in VacA intoxicated cells, even under continuous exposure conditions, indicating 
that VacA intoxicated mitochondria are functionally capable of undergoing mitochondrial fusion 
subsequent to fragmentation. 
 
3.3.5  Drp1 association with mitochondria in VacA intoxicated cells 
Finally, in order to evaluate whether the mitochondrial fission machinery is fully 
disengaged during mitochondrial dysfunction recovery, the association of Drp1 with mitochondria 
was measured. Under conditions promoting mitochondrial fission, cytoplasmic Drp1 is recruited 
to mitochondrial scission sites upon binding to the mitochondrial receptor Mff68. Furthermore, Drp1 
mediated mitochondrial fragmentation has been reported to occur in VacA intoxicated cells48. 
Upon exposure of AZ-521 cells to a pulse or continuous condition of VacA (250 nM) for 1, 4, or 
24 h, Drp1 was observed to associate with both VacA exposure conditions within 1 h, then by 4 
h the association decreased in the pulse VacA exposed cells, with complete dissociation of Drp1 
with mitochondria by 24 h in the pulse VacA exposed cells, but not the continuously exposed cells 
(Figure 3.16). These data indicate that mitochondrial structural repair in VacA intoxicated cells 
includes the disassociation of the mitochondrial fission machinery Drp1 from the mitochondria, 
further illustrating the reversibility of VacA mediated mitochondrial dysfunction. 
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These data altogether indicate that when VacA exposures are limited, host cells are able 
to recover mitochondrial structure. It has been reported that if cells are undergoing metabolic 
stress, induced by inhibitions of autophagy or protein synthesis63, mitochondrial fusion is induced 
to increase oxidative phosphorylation. The observed phenotype of recovery of mitochondria 
structure in pulse VacA intoxicated cells may indicate simple recovery and return to baseline 
homeostasis, or activation of fusion to enhance mitochondrial energy output. 
 
3.3.6  Recovery of mitochondrial potential in VacA intoxicated cells 
The mitochondrial transmembrane potential is an electrochemical gradient established on 
the inner mitochondrial membrane by the transport of protons through the electron transport 
chain77,78. Perturbations in any complexes within the electron transport may consequently impact 
the ability of protons to translocate across the inner mitochondrial membrane, thus resulting in 
mitochondrial membrane depolarization. Depolarized mitochondria are significantly less able to 
generate ATP, and if the potential does not recover, cells may ultimately undergo cell death40. 
Previous studies have shown VacA to mediate mitochondrial depolarization46,48 and ultimately 
induce cell death46,48,58. Given the observation of recovery in mitochondrial structure in pulse VacA 
exposed cells, I next sought to evaluate whether the recovery phenotype is functionally relevant 
to restore mitochondria to homeostasis.  
In order to evaluate mitochondrial function, the integrity of the inner mitochondrial 
membrane was evaluated by measuring the mitochondrial transmembrane potential. The 
mitochondrial transmembrane potential is an electrochemical gradient established on the inner 
mitochondria membrane via the electron transport chain and its regulation is implicated in overall 
mitochondrial function and the induction of cell death79,80. Given the electron transport chain 
functions to transfer electrons through the transport of protons across the inner mitochondria 
membrane, the mitochondrial matrix carries a net negative charge, and can thus be stained with 
lipophilic cationic fluorescent molecules such as tetramethylrhodamine ethyl ester (TMRE)78.  
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In order to first assess the dynamics of mitochondrial depolarization, AZ-521 cells were 
treated with either VacA or CCCP under a variety of conditions (Figure 3.17). Upon exposure of 
cells to a dose range of VacA (from 1 to 1000 nM VacA) for 4 h, the first significant decrease in 
mitochondrial transmembrane potential was observed at 10 nM VacA (Figure 3.17A). 
Interestingly, the degree of depolarization induced by VacA was not observed to continually 
decrease, but rather plateau at 35 nM VacA with approximately 50% depolarization (Figure 
3.17A). These data indicate that a threshold of depolarization is reached within VacA intoxicated 
cells, and the mitochondrial transmembrane potential is not depleted during VacA intoxication. 
For CCCP treatment, a sharp transition was observed, whereby mitochondrial transmembrane 
potential decreased by greater than 70% from 2.5 μM to 20 μM CCCP (Figure 3.17B). In 
comparison of 20 μM CCCP treatment to 250 nM VacA treatment at 4 h, CCCP was able to induce 
a further approximately 60% loss in mitochondrial potential compared to VacA, indicating that 
mitochondrial depolarization induced by VacA may be further decreased upon exposure to more 
damaging insults.  
In order to evaluate the ability of cells to recover mitochondrial function after exposing 
cells to the same pulse or continuous VacA conditions described previously, mitochondrial 
potential by TMRE staining and detection using flow cytometry was performed (Figure 3.18). In 
support of a recovery in mitochondrial structure, the data revealed a recovery in mitochondrial 
transmembrane potential over time in pulse VacA exposed conditions (Figure 3.18). Within 1 h 
post-intoxication, both VacA exposure conditions yielded an approximately 20% decrease in 
mitochondria potential, and by 4 h the transmembrane potential in continuously VacA exposed 
cells continued to further decrease to approximately 40%, while the pulse VacA exposed cells 
began to return to baseline (Figure 3.18). By 24 h post-intoxication, only an approximately 5% 
loss in mitochondrial potential was observed in the pulse VacA exposed cells, while the 
continuously VacA exposed cells remained depolarized at approximately 40% (Figure 3.18). In 
support of these findings, a similar trend was observed in both AGS and HeLa cells (Figure 3.19), 
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further illustrating that the response and recovery to VacA mediated mitochondrial dysfunction is 
not idiosyncratic to a single cell line. In conjunction with the recovery in mitochondrial structure, 
these data illustrate the disparity between mitochondrial fragmentation and depolarization, 
whereby recovery in mitochondrial structure appears to be a relatively rapid response, and 
recovery in potential is a more delayed response. Interestingly, these findings also illustrate the 
nature of the recovery process. It has been hypothesized that one means to repair mitochondrial 
dysfunction is by activing mitochondrial fusion, resulting in a mixing of damaged, depolarized 
mitochondria, with mitochondrial filaments of full potential. The findings observed with VacA 
indicate that perhaps a detection in full mitochondrial structure recovery if functioning to facilitate 
the eventual recovery of the depolarized mitochondrial transmembrane potential. 
 
3.3.7  Recovery of cellular ATP levels in VacA intoxicated cells 
In order to evaluate whether the recovery in mitochondrial structure and transmembrane 
potential further translate to metabolically active mitochondria, total ATP levels were measured, 
which has previously been shown to decrease in VacA intoxicated cells47. When intracellular ATP 
levels are depleted, cells respond to either recover ATP levels by shifting from mitochondrial 
oxidative phosphorylation to anaerobic glycolysis81, or if severe cells may undergo cell death. ATP 
is the energy currency of the cell; therefore, various cellular processes are sensitive to even slight 
perturbations in ATP level, and there is considerable pressure to maintain cellular ATP 
homeostasis.  
In order to investigate whether the recovery of VacA mediated mitochondrial dysfunction 
correlates to a recovery in ATP levels, cells were exposed to VacA under the same pulse and 
continuous VacA exposure conditions described previously. Within 1 h of intoxication, a 
comparable level of decrease (approximately 20%) of total cellular ATP was observed under both 
the pulse and continuous VacA exposures, which remained low through 4 h (Figure 3.20). By 24 
h post-intoxication, continuously VacA exposed cells remained depleted of cellular ATP, whereas 
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the pulse exposure returned to comparable levels as the untreated control (Figure 3.20). These 
data support the model that not only does mitochondrial structure recover over time, but this 
recovery leads to a repletion of mitochondrial energy output. The delay in observed recovery of 
ATP levels supports the interpretation that mitochondrial structural recovery occurs as a primary 
mechanism to initiate the subsequent recovery of mitochondrial membrane potential and 
ultimately mitochondrial function. Furthermore, it is interesting to note that whereas the continuous 
exposure yielded a recovery in mitochondrial structure by 24 h post-intoxication (Figure 3.7), ATP 
levels remained depleted (Figure 3.20). This finding is in support of the observation that 
mitochondrial potential remains depolarized in the 24 h continuous VacA treatment (Figure 3.18). 
These observations indicate that although structurally mitochondria have recovered, functionally 
the membrane potential and ATP levels have not, indicating that either recovery is not complete 
and requires more time, or that the insults being induced by VacA continue to hamper 
mitochondrial function. 
 
3.3.8  Oxygen consumption and glycolysis in VacA intoxicated cells 
In order to evaluate whether the recovery in mitochondrial energy output is associated 
with functional mitochondria, oxygen consumption and glycolysis were measured. One report 
indicated an inhibition of oxygen consumption in VacA intoxicated cells, whereby oxygen levels 
decreased over time but to a lesser extent compared to untreated cells47. Upon treatment of cells 
to VacA under pulse or continuous conditions for 1, 4, or 24 h, oxygen levels also appeared to 
decrease over time, to a greater extent in the continuous VacA exposure, and to a lesser extent 
in the pulse VacA exposure. These data indicate that the pulse exposure of VacA limits the degree 
of respiratory stress (Figure 3.21). Furthermore, under the identical conditions, glycolysis was 
measured as the presence of lactate in the extracellular medium, whereby greater levels of 
glycolysis was detected in continuous VacA exposed cells, and to a lesser degree in pulse VacA 
exposed cells (Figure 3.22). Altogether, these data indicate recovery of mitochondrial function in 
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VacA intoxicated cells limits disruptions in cellular respiration and the shift from mitochondrial 
oxidative phosphorylation to glycolysis. As the shift from oxidative phosphorylation to glycolysis 
may occur as a compensatory mechanism in order to maintain cellular levels of ATP, it is 
hypothesized that under the pulse exposure to VacA, the recovery of mitochondrial dysfunction 
by cells limits the necessity of cells to undergo a compensatory response to restore cellular ATP 
levels. As glycolysis is not as energetically favorable, it stands to reason that the shift from 
oxidative phosphorylation to glycolysis would not occur unless ATP demands are severe. 
Therefore, the minimal shift to glycolysis in pulse VacA intoxicated cells indicates that the recovery 
phenotype is occurring, and the recovery of cellular ATP levels is sufficient to limit the induction 
of glycolysis from oxidative phosphorylation. 
 
3.3.9  Cell death in VacA intoxicated cells 
 Previous studies have shown VacA to induce cell death, including apoptotic like cell death 
as measured by DNA fragmentation82,83, caspase-3, -7, -8, and -9 activation83-85, cytochrome c 
release49,86,87, activation of the pro-apoptotic proteins Bax and Bak86,88 and poly(ADP-
ribose)polymerase (PARP) activation58,83,86, as well as necrosis like cell death as measured by 
lactate dehydrogenase release58. In order to examine the viability of cells exposed to pulse and 
continuous VacA conditions, the plasma membrane permeability and total protein levels of cells 
were measured. Using the MitoTox Glo ATP determination kit, the cell plasma membrane 
permeability was measured as an indirect indication of cellular viability. AZ-521 cells were treated 
with pulse or continuous VacA for 1, 4, or 24 h, and under all conditions tested there was no 
detectable change in membrane permeability (Figure 3.23). These data support a model of 
apoptotic like cell death, whereby the cellular membrane does not become permeable. Upon 
measurement of total protein after exposure of cells to pulse or continuous VacA, by 24 a 
significant decrease in total protein in both VacA exposures was observed (Figure 3.24). These 
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data indicate that either cells underwent cell death and detached during the processing of the 
experiment, or cell growth was decreased and therefore less total protein was obtained.  
 
3.3.10 Mitochondrial activation of cell death in VacA intoxicated cells 
 Previous studies have reported that VacA induced cell death is mediated through 
mitochondrial dysfunction48,82,83,86,88. Given the collected data indicate that mitochondria 
dysfunction recovers over time in pulse VacA exposed cells, even with comparable levels of 
mitochondrial dysfunction early in VacA intoxication compared to 1 h continuously VacA exposed 
cells, I next sought to examine whether the recovery limited the activation of mitochondrial 
mediated cell death. Cytochrome c is a small protein essential in the electron transport chain, 
mediating the transfer of electrons between Complex III and Complex VI89. Upon induction of a 
pro-apoptotic stimuli, proteins in the BCL-2 family mediated mitochondrial outer membrane 
permeabilization, resulting in the release of cytochrome c from the mitochondria into the 
cytoplasm41. Cytosolic cytochrome c binds to apoptotic protease activation factor-1 (APAF-1), 
resulting in the assembly of a large multi-subunit complex termed the apoptosome, subsequently 
activating procaspases and ultimately leading to cell death90,91.  
Numerous studies have reported cytochrome c release upon VacA exposure48,49,86,87; 
therefore, I first sought to examine whether recovery in mitochondrial dysfunction limits the 
induction of mitochondrial mediated cell death activation. Upon incubation of cells in the absence 
or presence of VacA (250 nM) under pulse and continuous conditions for 1, 4, or 24 h, a complete 
overlap of the mitochondria (stained with TOM20) was observed with cytochrome c for all 
conditions except for 24 h of continuous VacA exposure (Figure 3.25). These data support 
previous temporal studies indicating that cytochrome c release is a downstream phenotype of 
VacA intoxication. Furthermore, these experiments supported previous findings in that 
mitochondrial structure appeared fragmented in both 1 h VacA exposures, then only in the 4 h 
continuous VacA exposure. It is to be noted, however, that a relatively small population of cells 
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appeared to undergo cell death at 24 h under the continuous exposure, with approximately 60% 
of cells remaining viable (Figure 3.25). Therefore, a possible explanation is that 24 h is slightly 
premature to evaluate widespread VacA mediated cell death. Altogether, these data support a 
model that recovery of VacA mediated mitochondrial dysfunction limits the induction of 
downstream cell death activation pathways. 
 
3.3.11  Autophagy and cell death in VacA intoxicated cells 
Previous reports have indicated the involvement of autophagy in VacA intoxicated cells. 
Upon exposure of cells to VacA, a conversion of LC3-I to LC3-II85,92 and autophagosome 
formation92,93, are observed. Although the mechanism connecting autophagy induction to VacA 
mediated mitochondrial dysfunction is unclear, it is reasonable to ascertain that dysfunctional 
mitochondria leads to energy stress, and thus a shift towards autophagy. Reports have connected 
mitochondrial function and autophagy, including autophagy being important for  maintaining 
mitochondrial homeostasis94, autophagy being induced through mitochondrial dysfunction 
resulting in ROS production and ATP loss95, and a major regulator of autophagy termed mTOR 
(mammalian target of rapamycin) controls mitochondrial biogenesis in order to maintain cellular 
ATP96. 
In order to evaluate whether recovery in VacA mediated mitochondrial dysfunction results 
in reversal of autophagy induction in VacA intoxicated cells, cells were treated with VacA under 
the same pulse and continuous VacA exposures as described previously for 1, 4, and 24 h. 
Imaging of LC3 puncta by fluorescence microscopy indicated that strong puncta were apparent 
initially upon VacA intoxication at 1 h (Figure 3.26). By 4 h, cells with LC3 puncta were apparent 
under both pulse and continuous VacA exposures as well, but to a greater extent in continuous 
VacA exposure. At 24 h post-intoxication, LC3 puncta were only observed only in the continuously 
VacA exposed cells. These data indicate that autophagy induction was apparent throughout 
continuous VacA intoxication, but recovery of mitochondrial function in pulse VacA exposed cells 
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resulted in a lessening of autophagy induction. These data do not lend evidence that autophagy 
is a mechanism of mitochondrial quality control, but these findings illustrate that the additional 
effects of VacA on host cells, including autophagy, are reversible phenotypes. 
 
3.3.12  VacA association with endosomes prior to mitochondrial localization 
Previous studies have shown VacA to localize to endosomes prior to associating with the 
mitochondria or vacuoles87,88,97,98. Given my data support a model of recovery in VacA mediated 
mitochondrial dysfunction, and that the only known activity of VacA is its ability to form a pore, I 
hypothesized that this recovery might be mediated through the removal of VacA from the 
mitochondria. Removal of proteins from the mitochondrial network may occur by three 
mechanisms. First, dysfunctional or foreign proteins may be directly degraded within the 
mitochondria by various mitochondrial proteases27,50,99,100. These proteases include Lon and 
ClpXP in the matrix, PARL, i-AAA protease YME1L1, and m-AAA protease paraplegin on the 
inner mitochondrial membrane, Omi in the intermembrane space, and the ubiquitin-proteasome 
system on the outer mitochondrial membrane23. Second, proteins may be excised in membrane 
containing vesicles from the mitochondria via mitochondrial derived vesicles59, which are either 
trafficked to lysosomes29,  or peroxisomes31.  Finally, entire dysfunctional mitochondrial fragments 
may be degraded by the selective form of autophagy, mitophagy 35, whereby severely damaged 
mitochondria are ubiquitinated by the E3 ubiquitin ligase Parkin, and are degraded subsequent to 
fusion with an autophagosome. 
In order to evaluate whether VacA is trafficking from the mitochondria, the intracellular 
trafficking of VacA was monitored over time using pulse-chase fluorescence microscopy. AZ-521 
cells were incubated with purified VacA (250 nM) directly labeled with an Alexa Fluor dye at 4ºC 
for 30 min to allow for labeled VacA to bind to the cell surface without being internalized. Then 
the excess, unbound VacA was removed and cells were washed extensively with PBS pH 7.2. 
Finally, the media was replaced with an equal concentration (250 nM) of unlabeled toxin, and the 
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cells were warmed to 37ºC. After various times along a timecourse of intoxication, cells were fixed 
and processed for fluorescence microscopy, and the colocalization of VacA with different 
subcellular markers was measured. In alignment with previous publications97, VacA was detected 
to associate with endosomes within 30 min post-internalization, and the association of VacA with 
endosomes decreased after 30 min, illustrating a passage of VacA through the structure (Figure 
3.27). In addition, in support of previous publications46,48,87,88,101, VacA was detected to associate 
with the mitochondria. However, the pulse-chase method revealed that after 2 h post-
internalization, VacA association with the mitochondria decreased, and by 8 h there was no 
detectable association of VacA with the mitochondria compared to the bound state (Figure 3.27). 
These data suggest that VacA associates with endosomal compartments prior to association with 
the mitochondria, then VacA is further trafficked from the mitochondria.  
 
3.3.13  VacA association with lysosomes 
In addition to mitochondrial localization, VacA has been shown to associate with late 
endosomal and lysosomal like compartments as indicated by an increased colocalization of VacA 
with LAMP1 (lysosomal associated protein 1)97,98,102, Rab798,103, vacuolar V-ATPase104, Lgp110103, 
and lysobisphosphatidic acid (LBPA)88. The VacA associated lysosomal like compartments, 
however, are lacking some canonical late endosomal and lysosomal proteins, including CI-
M6PR103 and cathepsin D105. 
By examining VacA association with other cellular markers, VacA was detected to 
associate with the lysosomal protein marker LAMP1 (Figure 3.28). This association of VacA with 
LAMP1 was delayed in comparison to VacA association with early endosomes or mitochondria, 
with the first significant association not occurring until 0.5 – 1 h. In addition, unlike VacA 
association with endosomes and mitochondria, which peaked at one timepoint then decreased 
over time, VacA appeared to accumulate in the LAMP1 enriched compartments as indicated by 
no apparent loss of VacA association with LAMP1, and a complete overlap of the two channels 
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with each other. These data indicated that VacA associates with early endocytic compartments 
prior to associating with the mitochondria, then after localizing to the mitochondria, VacA is further 
trafficking to intracellular compartments enriched in the protein LAMP1. 
 
3.3.14  Mitochondria association with LAMP1 
 If VacA is being trafficked from the mitochondria to LAMP1 enriched compartments, either 
by recruitment of LAMP1 compartments to the mitochondria, or by dysfunctional mitochondrial 
regions being trafficked to LAMP1 compartments, it is predicted that mitochondrial markers might 
co-traffic with VacA to LAMP1 compartments. In order to test this prediction, the association of 
mitochondria (with TOM20 staining) with LAMP1 was measured upon VacA intoxication. Upon 
exposure to VacA, an increase in the association of TOM20 with LAMP1 was quantitatively 
detected (Figure 3.29), indicating that either mitochondrial regions are trafficking to LAMP1 
compartments, or that LAMP1 compartments are recruited to mitochondria. Examination of the 
structure of TOM20 association with LAMP1, the associate appears to consist of larger structures, 
with regions of LAMP1 staining material engulfing regions of mitochondria (Figure 3.29). 
 
3.3.15  VacA mediated vacuolation 
 VacA was discovered because of its ability to induce intracellular vacuolation106. However, 
since the identification of VacA in 1988106, the origin of VacA mediated vacuoles, their role in 
VacA intoxication and Helicobacter pylori pathogenesis, and the involvement in VacA mediated 
mitochondrial dysfunction remains poorly understood. The VacA vacuoles have been described 
to be derived from late endosomal or lysosomal compartments98,105, although the functionality of 
the lysosomal components remains to be characterized. 
 Given the data indicate that VacA associates with lysosomal markers after associating 
with mitochondria, it was predicted that the lysosomal association of VacA observed might be 
VacA localization to vacuoles. In order to test this prediction, cells were treated with VacA and 
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imaged by DIC as well as staining for VacA, LAMP1, and Rab7. The data illustrate that VacA, 
LAMP1, and Rab7 are all localized on the vacuolar membranes (Figure 3.30).  
Furthermore, a timecourse of VacA intoxication was performed in order to examine 
whether vacuolation is a downstream or terminal consequence of VacA intoxication. Upon 
exposure of cells to VacA for various amounts of time, it was observed that vacuolation is detected 
later in intoxication, and that vacuolation levels remain high until very late timepoints where cell 
death is expected (Figure 3.31). Furthermore, under pulse versus continuous exposures to VacA, 
vacuolation was continually observed in VacA intoxicated cells (Figure 3.32), further indicating 
that although mitochondrial function may recovery in VacA intoxicated cells, vacuolation is in and 
of itself a downstream consequence of VacA mediated cellular intoxication. Altogether, these 
data, in conjunction with the previous findings of a delayed association of VacA with LAMP1 
compartments and VacA leaving the mitochondria, support a model that vacuolation is a 
downstream consequence of VacA mediated mitochondrial dysfunction. 
 
3.3.16  Vacuolation and mitochondrial dysfunction 
 One hypothesis in the association of VacA mediated vacuolation with mitochondrial 
dysfunction, is that vacuolation in and of itself is a physiological response to mitochondrial 
damage. Therefore, cells were treated with various mitochondrial damaging agents, and the 
degree of vacuolation was assessed visually and quantitatively by neutral red uptake (Figure 
3.33). Treatment of cells with VacA induced the expected robust vacuolation phenotype as what 
has been previously described (Figure 3.33). However, treatment with neither the proton gradient 
uncoupler CCCP, the ATP synthase inhibitor oligomycin, the ubiquinone inhibitor Antimycin A, 
nor the mitochondrial protein synthesis inhibitor chloramphenicol, resulted in visual vacuolation 
or quantitative increase in neutral red uptake (Figure 3.33). This finding indicates that vacuolation 
induced by VacA is a VacA specific process, and that vacuolation of cells is not a ubiquitious host 
response to mitochondrial stressors.  
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Finally, the ability of VacA to induce vacuolation in the presence of mitochondrial inhibitors 
was evaluated. Cells were incubated in the presence or absence of VacA, co-incubated with either 
CCCP, oligomycin, Antimycin A, or chloramphenicol (Figure 3.34). In support of the previously 
described finding, each mitochondrial inhibitor did not result in an increase in neutral red uptake 
(Figure 3.34), although treatment with CCCP and oligomycin did result in a decrease in neutral 
red uptake (Figure 3.34), indicating that mitochondrial function is important for the ability of cells 
to create acidic compartments. Interestingly, in comparison to VacA alone, co-treatment of VacA 
with either CCCP, Antimycin A, or Oligomycin resulted in a significant decrease in neutral red 
uptake (Figure 3.34). These data indicate that at least, in part, VacA mediated vacuolation 
requires the presence of intact mitochondria. This observation of mitochondrial dependent 
vacuolation may be explained by either vacuolation being an energy dependent phenomenon, 
and that mitochondrial function is indirectly important for the generation of vacuoles, or, especially 
given CCCP is a protonophore, the mitochondrial inhibitors may be indirectly acting at the level 
of vacuoles, thereby reducing vacuole formation. 
 
3.3.17  Vacuolation and mitochondrial dynamics 
 Major regulators of mitochondrial dynamics include the proteins Rab32, OPA1, and Drp1. 
Therefore, in order to evaluate whether the proteins are important for the ability of VacA to mediate 
vacuole formation, the relative expression of each protein was knocked down and the ability of 
VacA to induce vacuolation was measured. Upon knockdown of Rab32, OPA1, and Drp1, all 
proteins resulted in a significant decrease in vacuolation (Figure 3.35). OPA1 knockdown cells 
exhibited relatively strong levels of vacuolation, however, knockdown of either Rab32 or OPA1 
resulted in a complete loss in VacA mediated vacuolation. These data indicate that regulation of 
mitochondrial dynamics is important for VacA mediated vacuolation. In addition, knockdown of 
both Rab32 and Drp1 resulted in a blockage of VacA mediated mitochondrial fragmentation 
(Figure 3.35). However, it is to be noted that as Rab32 and Drp1 are regulators of mitochondrial 
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division, knockdown of their expression resulted in mitochondrial phenotypically displaying a 
hyperfilamentous mitochondrial network (Figure 3.36). Likewise, as OPA1 is a major regulator of 
mitochondrial fusion, knockdown of OPA1 protein expression resulted in mitochondria 
phenotypically displaying a fragmented network (Figure 3.36). Finally, the ability of VacA to 
associate with the mitochondria was assessed in cells lacking Rab32, Drp1, and OPA1 (Figure 
3.37). Upon knockdown of Rab32, Drp1, and OPA1, a significant loss in the ability of VacA to 
localize to the mitochondria was observed in Rab32 and Drp1 deficient cells (Figure 3.37), 
indicating that the mitochondrial dynamics regulators are important for the ability of VacA 
associate with mitochondria.  
Interestingly, one final experiment was conducted whereby mitochondria were removed 
from cells via the hyperactivation of mitophagy. Cells overexpressing PARKIN were treated with 
the mitochondrial damaging agents oligomycin and Antimycin A, followed by treatment with VacA. 
Interestingly, within PARKIN expressing cells, all mitochondrial were cleared as visualized by a 
lack of TOM20 signal (Figure 3.38). Furthermore, in cells lacking mitochondria, vacuoles were 
not observed, whereas cells containing mitochondria exhibited robust vacuolation (Figure 3.38). 
Altogether, these data indicate that functional mitochondria are important for the ability of VacA 
to not only associate with mitochondria themselves, but also to induce cellular vacuolation. 
 
3.3.18  Mitochondrial mass during VacA intoxication 
 The studies conducted indicate that VacA induces severe mitochondrial dysfunction; 
therefore, it was predicted that mitochondrial mass might decrease in an effort to remove 
dysfunctional mitochondrial. Mitophagy is a selective form of autophagy, whereby dysfunctional 
mitochondrial fragments are marked for degradation and are cleared through delivery to 
autophagolysosomes34,35. Although measurement of mitochondrial mass relies on a flux of 
mitochondrial degradation and clearance with mitochondrial biogenesis, the rate of mitochondrial 
degradation generally occurs at a faster rate than the generation of new mitochondria107,108. Given 
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mitochondrial fragmentation, ATP loss, and depolarization of the inner mitochondrial membrane 
are well described activators of mitophagy, in addition to reports of VacA activating autophagy92,93, 
it was predicted that VacA would induce mitophagy.  
Although there are several mechanism by which mitophagy may progress34,35, a common 
feature is a loss of mitochondrial mass. A challenge in measuring mitochondrial mass lies in the 
measurement of a mitochondrial feature that is neither selectively degraded as part of 
physiological regulatory process, nor dependent upon the mitochondrial transmembrane 
potential. In order to measure mitochondrial mass, a mitochondrial potential insensitive stain was 
used and fluorescence intensity was measured by flow cytometry. Upon exposure of cells to VacA 
continuously and under conditions where a robust depolarization of the mitochondria was 
observed with either VacA (250 nM) alone, CCCP (10 µM) alone, or combined, only when CCCP 
was incubated was a decrease in mitochondrial mass observed (Figure 3.39). Interestingly, the 
combination of CCCP and VacA resulted in a larger depolarization of the mitochondrial inner 
membrane, but no further loss in mitochondrial mass was detected relative to CCCP alone 
(Figure 3.39). Furthermore, no loss of mitochondrial mass was detected upon a timecourse of 
exposure to VacA (Figure 3.40). However, intoxication of AZ-521 with VacA indicate that perhaps 
mitochondrial mass increases upon longer intoxication timepoints (Figure 3.40A). Altogether, 
these data indicate that VacA intoxication does not result in a global loss in mitochondrial mass. 
This might be explained either by a concurrent activation of mitochondrial biogenesis, or that the 
degree of VacA mediated mitochondrial dysfunction is not sufficient to activate mitophagy.  
 
3.3.19  PINK1 levels in VacA intoxication and mitochondrial stress 
 Mitophagy involves the activation of various proteins that are recruited to the mitochondria. 
PTEN-induced putative kinase protein 1 (PINK1) is a protein that is constantly imported into the 
mitochondria and upon localization to the inner membrane, rapidly undergoes multiple steps of 
proteolytic cleavage, including removal of the mitochondrial targeting sequence (MTS) by the 
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mitochondrial processing peptidase (MPP)38,109 and further cleavage by Presenilin associated 
rhomboid-like protein (PARL)109,110 and Lon protease38,109. Under conditions of damaged or 
depolarized mitochondria, translocation of PINK1 through the outer and inner mitochondrial 
translocons (TOM and TIM complexes, respectively) is inhibited, and PINK1 accumulates on the 
outer mitochondrial membrane34,109. Accumulation of PINK1 on the outer membranes recruits the 
E3 ubiquitin ligase Parkin, which in turn ubiquitinates substrates on the outer mitochondrial 
membrane, resulting in recruitment of an autophagosome and ultimately degradation of a 
mitochondrial fragment34,107. PINK1 and Parkin have therefore been used as markers of 
mitophagy activation.  
 In order to evaluate whether PINK1 levels and processing changes under VacA mediated 
or chemically induced mitochondrial stresses, different cell lines (AZ-521, AGS, HeLa, and Cos7) 
were grown in glucose media, which predominantly undergoes glycolytic metabolism, and 
galactose media, which predominantly undergoes oxidative phosphorylation. After 4 h of 
exposure of cells to VacA, CCCP, or Antimycin A, changes in PINK1 levels were observed in 
VacA and CCCP exposure, but only in galactose grown cells (Figure 3.41). The data illustrated 
a slight molecular weight shift in response to VacA or CCCP, indicating a release of the 
mitochondrial targeting sequence. Interestingly, previous data indicate that VacA intoxication 
does not result in a loss in mitochondrial mass, suggesting that PINK1 is capable of achieving 
mitochondrial import and initial processing, but further degradation is not detected (Figure 3.41). 
These data suggest that the mitochondrial dysfunction induced by VacA is not severe enough to 
engage mitophagy.  
 
3.3.20  PARKIN activation in VacA intoxicated cells 
 A major regulator in mitophagy is the E3 ubiquitin ligase PARKIN109, which is recruited to 
the mitochondrial surface upon depolarization or severe induction of mitochondria damage. In 
order to evaluate whether VacA intoxication is activating mitophagy via PARKIN, cells 
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overexpressing PARKIN were treated with either VacA or the positive controls for mitophagy 
activation oligomycin and Antimycin A. Upon examination of fluorescence microscopy images, 
oligmycin and Antimycin A induced a robust activation or PARKIN, as illustrated by a complete 
association of TOM20 with PARKIN aggregates within the cytoplasm of cells (Figure 3.42). 
However, no association was observed upon exposure to VacA, as PARKIN retained a 
predominantly cytoplasmic distribution (Figure 3.42). As a negative result cannot be proven, only 
supported by a preponderance of evidence, a thorough series of experiments were next 
conducted in order to evaluate whether the lack of detection of PARKIN in VacA intoxicated cells 
is due to idiosyncracies in a particular cell line, concentration of VacA used, or timepoint of 
exposure evaluated (Figure 3.43). Through an in-depth evaluation of PARKIN activation of a wide 
range of doses of VacA (from 1 nM to 500 nM) (Figure 3.43A-C), timepoints of exposure (Figure 
3.43D-F), as well as treatments in AZ-521 (Figure 3.43A, D), AGS (Figure 3.43B, E), or HeLa 
cells (Figure 3.43C, F), under no conditions of VacA intoxication was an activation of mitophagy 
observed as indicated by the recruitment of PARKIN to mitochondria. However, under dose 
responses and timecourses in various cell lines with Oligmycin and Antimycin A treatment, robust 
mitophagy activation was observed (Figure 3.43), indicating that most certainly the various cells 
tested are capable of undergoing mitophagy induction. These data are indicating that, at least 
through the wide series of conditions tested, VacA does not activate PINK1/PARKIN dependent 
mitophagy. 
 One final question in the study of VacA and mitophagy remains is whether or not VacA is 
simply not activating mitophagy, or if VacA is inhibiting the activation of mitophagy. In order to 
address these possibilities, cell overexpressing PARKIN were pre-treated with VacA for 4 h, 
followed by treatment with Oligomycin and Antimycin A (Figure 3.44). In support of previous 
findings, VacA treatment alone was unable to activate detectable mitophagy, whereas treatment 
with Oligomycin and Antimycin A resulted in robust mitophagy activation (Figure 3.44). 
Interestingly, pretreatment of cells with VacA did not inhibit the ability of Oligomycin and Antimycin 
223 
 
A to activate mitophagy, as indicated by a robust recruitment of PARKIN to aggregated 
mitochondria (Figure 3.44). Altogether, these data indicate that VacA does not activate detectable 
mitophagy, and that VacA in and of itself in not inhibiting the ability of cells to activate mitophagy. 
 
3.3.21  Mitochondrial derived vesicles in VacA intoxication 
A mechanism of mitochondrial quality control that functions in part to remove damaged 
subdomains from the mitochondria through the process of vesicular carriers to lysosomes or 
peroxisomes for degradation is known as mitochondrial derived vesicles (MDVs)29,59. These 
MDVs form rapidly relative to mitophagy as a quality control response, and are activated in 
response to oxidative stress29,31. MDVs may form as either single, or double membrane structures, 
and formation is suggested to be dependent upon selective cargo59. After formation, MDVs are 
trafficked to either peroxisomes31, or lysosomes29, serving as a means to degrade the 
mitochondrial compartments.  
In order to evaluate whether VacA induces MDVs, cells were treated with VacA and 
imaged for the formation of small (~120 nm diameter), punctate structures positively staining with 
mitochondrial markers. The data indicated that upon VacA exposure, the number of MDVs 
detected per cell were approximately 2 to 3 fold higher (Figure 3.45) compared to untreated 
controls. The MDVs detected were positively stained for TOM20, indicating that the MDVs were, 
in part, comprised of the outer mitochondrial membrane. In addition, the VacA induced MDVs 
were observed in the presence of vacuoles, as well as overexpression of PARKIN (Figure 3.46). 
Finally, an apparent cargo selectivity was observed as VacA induced MDVs were positively 
stained for TOM20, but excluded cytochrome c staining (Figure 3.47). 
In order to determine whether VacA directly associates with MDVs, purified mitochondria 
were incubated with VacA in an MDV budding reaction57, and post-mitochondrial supernatants 
were applied to either a sucrose gradient or protease degradation. Of note, previous publications 
have treated purified mitochondria with VacA and VacA was successfully imported into the 
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mitochondria101,111. Sucrose density gradient ultracentrifugation indicated that upon exposure of 
purified mitochondria to VacA, VacA associated with buoyant compartments that were derived 
from the mitochondria, as observed by VacA associating with higher levels in a sucrose gradient, 
whereas VacA alone remained in the densest layer of the gradient (Figure 3.48). Previous studies 
utilizing the in vitro reconstitution of MDVs indicated that MDVs present in more dense layers of 
the sucrose gradient (between 20 and 30% sucrose) were predominantly double membrane 
structures, whereas lighter vesicles (separating at the 2 and 20% sucrose interface) were single 
membrane57. The VacA treated mitochondrial sample indicate that VacA is associated with heavy, 
double membrane MDVs, which supports previous findings that VacA associates with the inner 
mitochondrial membrane101. 
 In order to evaluate whether VacA was associated within a membrane bound 
compartment, or peripherally associated with MDVs, a protease protection assay was performed. 
Treatment of post-mitochondrial supernatants with a protease such as trypsin, would illustrate 
whether a protein of interest was contained within a membrane bound compartment because the 
membrane itself will protect internal proteins from protease degradation57. In the presence or 
absence of cytosol, VacA also was equally susceptible to protease degradation (Figure 3.49). 
Incubation of VacA with mitochondria conferred protection of post-mitochondrial supernatant 
containing VacA from degradation, more notably in cytosol treated mitochondria, indicating that 
VacA was contained with a membrane bound compartment (Figure 3.49). Altogether, these data 
indicate that VacA induces the formation of MDVs, and associates with protease resistant, 
buoyant vesicles that are derived from the mitochondria. 
 
3.3.22  MDV formation machinery 
 Previous reports have identified major proteins mediating the formation and trafficking of 
MDVs32. Sorting nexin 9 (Snx9) and Rab9 localize to the mitochondria and function to facilitate 
the budding and formation of MDVs at the level of the mitochondria32. Syntaxin 17 (Stx17) and 
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Rab7 localize to the late-stage MDVs and function to facilitate the trafficking and fusion of MDVs 
with lysosomes32. Prior to being identified as being important in MDV formation, Snx9 was 
characterized to be involved in endocytosis and regulation of actin dynamics112-114, Rab9 to 
mediate vesicle transport between the endosomes and trans-Golgi network115,116, Stx17 to 
mediate autophagosomal formation and association with the endolysosomal system117,118, and 
Rab7 to mediate lysosome and late endosome, and autophagosome formation119,120. Although it 
has yet to be determined whether Stx17, Rab7, Snx9, and Rab9 constitute core MDV formation 
and trafficking machinery, common to all classes of MDVs, or if they are only important for a 
single, or a subset of MDVs. 
 Given Stx17, Rab7, Snx9, and Rab9 were reported to be important for MDV formation and 
trafficking, those proteins were tested for their importance in VacA activity. The expression of 
Stx17, Snx9, Rab7, and Rab9 was knocked down using RNAi, and VacA activity was measured 
by vacuolation with neutral red staining. The data indicate that most of the currently identified 
MDV machinery proteins were important for VacA mediated vacuolation, including Snx9, Stx17, 
and Rab7 (Figure 3.50). These data indicate that, in part, some of the MDV formation and 
trafficking machinery are important for VacA activity.  
  
3.3.23  Proteomics of VacA mediated mitochondrial derived vesicles 
 Previous reports have indicated different classes of MDVs to form in response to different 
stimuli, including double membrane MDVs containing oxidized cargo for transport to lysosomes, 
single membrane MDVs, and double membrane MDVs for transport to peroxisomes59. Given no 
reports of pathogen induced mitochondrial derived vesicles have been made to date, it is 
reasonable to ascertain that VacA mediated mitochondrial derived vesicles may not contain or 
utilize factors that have previously been shown to be important for MDV formation. Therefore, 
there is a need to characterize VacA mediated MDVs. 
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 In order to determine the composition of VacA mediated MDVs, MDVs were isolated as 
described previously, whereby purified mitochondria were treated with VacA and/or the cytosol, 
then post-mitochondrial supernatants were applied to a sucrose density gradient. Following 
ultracentrifugation, samples were collected from each layer and interface and processed for 
immunoblotting against VacA. The data indicated that VacA positive signal was detected at the 
30-40% sucrose interface (Figure 3.51). Furthermore, treatment with the cytosol contained a 
slight signal in actin and the endosomal marker EEA1, but the weakness of the signal indicated 
that the cytosol preparation was sufficient to remove endosomal and cytoskeletal material (Figure 
3.51). These data indicated that the MDV preparation was clean and in support of previous 
experiments, VacA associated with buoyant compartments derived from the mitochondria. 
Given the VacA protein band intensity at the 30-40% interface was enriched, whereas a 
lesser signal was observed within the 30% and 40% layers, the 30-40% interface MDV sample 
was processed for mass spectrometry (Figure 3.51). The proteomics dataset consisted of post-
mitochondrial supernatants obtained from mitochondria treated with A) cytosol, B) VacA, or C) 
cytosol and VacA. An ion score cutoff of 21 was applied, yielding 352 proteins for cytosol, 318 
proteins for VacA, and 328 proteins for VacA and cytosol treated mitochondria. A total of 215 
proteins were common to all preparations (Figure 3.52, Table 3.1A), and 44 proteins were unique 
to the cytosol treated mitochondria (Figure 3.52, Table 3.1B), 44 proteins were unique to the 
VacA treated mitochondria (Figure 3.52, Table 3.1C), and 39 proteins were unique to the VacA 
and cytosol treated mitochondria (Figure 3.52, Table 3.1D). Proteins identified as localizing to 
the mitochondria were further characterized as associating with the inner mitochondria membrane 
(IMM), outer mitochondrial membrane (OMM), or matrix. By comparing sub-mitochondrial 
localization in addition to relative protein abundance, the data indicate that mitochondria treated 
with VacA yielded MDVs enriched in inner mitochondrial membrane proteins, relative to outer 
mitochondrial membrane proteins (Figure 3.53). These data support a model the VacA MDVs are 
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heavy, double membrane structures consisting of inner and outer mitochondrial membranes. 
These findings support the literature that VacA localizes to the inner mitochondrial membrane101.  
Given the process of mitochondrial derived vesicles is a pathway governed by membrane 
and vesicle transport, proteins involved in vesicle-mediated transport were identified by 
annotation for molecular function. Of note, various proteins canonically involved in membrane 
trafficking were identified, including Rab GTPases, syntaxins, synaptosomal-associated proteins 
(SNAP), and vesicle-associated membrane proteins (VAMP), as well as other SNARE (soluble 
NSF attachment protein receptor) proteins (Table 3.2). All of the proteins identified represent 
possible mediators of VacA mediated MDV formation.  
 
3.3.24  VacA mediated MDV machinery 
  Of the various vesicle-mediated transport proteins identified in the MDV mass 
spectrometry, three were chosen to test for importance in VacA activity. Vesicle associated 
membrane protein 8 (VAMP8/endobrevin) is important for membrane dynamics and vesicle fusion 
at late endosomes, lysosomes, and autophagosomes, and has been shown to form complexes 
with STX17117,118. Syntaxin 12 is a SNARE that mediates vesicle transport between the late 
endosomes and trans-Golgi network121, and Rab5C is a major regulator of the endosomal 
system122, but has recently been reported to mediate mitochondrial dynamics through 
mitochondrial clearance123. 
 In order to evaluate the importance of VAMP8, STX12, and Rab5C in VacA intoxicated 
cells, the expression of VAMP8, STX12, and Rab5C was knocked down using RNAi, and VacA 
activity was measured by vacuolation with neutral red staining. The data indicate that of the 
proteins tested, Rab5C was important for VacA activity (Figure 3.54). Given the reported 
involvement of Rab5C with mitochondrial clearance123, it is hypothesized that perhaps Rab5C 
participates in the formation of MDVs from the mitochondria, and when lacking within cells, MDVs 




 Mitochondrial quality control has been a well described series of pathways in response to 
physiological stressors of mitochondrial function24,35,50,59,99. Mitochondria are essential for 
maintaining overall cellular homeostasis, including the maintenance of energy and ATP 
levels69,124, governing calcium homeostasis10,11, regulating programmed cell death10,40, and also 
playing a critical role in regulating the innate immune system15. Given the importance of 
mitochondria, it stands to reason that numerous quality control measures would exist to ensure 
organelle homeostasis. The processes of the unfolded protein response19-21, mitochondrial 
derived vesicles31,59, mitophagy34,35,109, and mitochondrial mediated cell death10,40,41, function to 
maintain the integrity of an entire cell, or a tissue, by detecting and responding to insults of 
mitochondrial function. 
Interestingly, numerous pathogens have been described to disrupt mitochondrial function, 
either indirectly through invasion into a host cell by a pathogen or disruption of extra-mitochondrial 
factors125-127, or directly by producing pathogenic effectors that directly localize to and disrupt the 
mitochondria44,128-136. Although numerous pathogens have been described to target the 
mitochondria, an understanding of why a pathogen would produce a mitochondrial localized 
pathogenic effector remains poorly understood. Currently, insights have been made in investing 
innate immune responses. Given mitochondrial ROS and overall metabolic state are important 
factors in controlling the clearance of intracellular pathogens in immune cells, it is hypothesized 
that targeting of mitochondria limits the ability of host cell to respond to a pathogenic infection15.   
Given the essentiality of mitochondria for cellular function, it stands to reason that host 
mitochondrial quality control would be activated in response to pathogen mediated mitochondrial 
dysfunction. Indeed, a few reports have supported this idea, whereby the mitochondrial unfolded 
protein response137 and mitophagy138 served to protect C. elegans from Pseudomonas 
aeruginosa infection. Interestingly, some pathogens have been described to subvert host 
mitochondrial immune defenses, including Vibrio cholerae inhibition of mitochondrial dynamics 
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and induction of immune responses44. These findings indicate that host cells are indeed capable 
of detecting and responding to pathogen mediated mitochondrial dysfunction, and that 
mitochondrial quality control is an important mediator in maintaining cellular homeostasis.  
VacA has been well described to target the mitochondria of host cells46,48,87,101,111, resulting 
in perturbations to mitochondrial physiology and dynamics46-49,94. However, the reasoning 
proposed regarding why a pathogen such as H. pylori would produce a toxin that damages the 
mitochondria was that by disrupting mitochondria, VacA was activating programmed cell death 
and thus providing nutrients available for H. pylori growth139,140. However, this model fails to 
connect the pathophysiology of H. pylori infection with the findings of VacA intoxication.  
Current estimates indicate that 1% of humans infected with H. pylori will ultimately develop 
severe gastric disease, including gastric adenocarcinoma55,56,141,142. If the driving strategy of H. 
pylori production of VacA is to produce a toxin that ultimately kills host epithelial cells, then one 
would predict that humans infected with H. pylori would suffer severe disease due to damage of 
the gastric mucosa. However, given a rather small percentage of humans report for clinical 
symptoms of gastric disease and even fewer develop gastric cancer, it is likely that H. pylori is 
actually causing very little active damage at the level of the pathogen-host interface. Furthermore, 
current evidence indicates that high levels of VacA initiates an form of cell death most closely 
related to apoptosis, as indicated by fragmented DNA, annexin V staining, cytochrome c release, 
caspase activation, and Bax activation82,83,88,143. In contrast to lytic types of cell death resulting in 
a massive pro-inflammatory release of intracellular material such as with necrosis, apoptosis 
progresses through cell shrinkage, and membrane blebbing, with ultimate clearance by 
phagocytic immune cells such as macrophages and dendritic cells144,145. Therefore, the type of 
cell death associated with VacA intoxication does not yield a large release of intracellular 
contents. If H. pylori were to require host cell lysis for survival and acquisition of nutrients, the 
bacterium would also encounter an onslaught of proteases, nucleases, hydrolases, and other 
degradative factors, as well as pro-inflammatory cytokines, all of which would likely be harmful to 
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the bacterium. Altogether, it is to be argued that the role of VacA in vivo with H. pylori infection is 
unlikely to induce cell death as a means to provide nutrients for H. pylori. 
Although H. pylori is the major bacterial colonizer of the human stomach, H. pylori is not 
an acidophile146,147. Rather, H. pylori colonizes the gastric mucosa surface, at the interface 
between the mucus and underlying epithelial cells where the pH is maintained near neutral148,149. 
Two cell types that are important in mediated gastric physiology are mucus cells and parietal 
cells150,151. Mucus cells are located at the most apical regions of the gastric mucus, and are 
primarily responsible for the production of mucus152-154. Parietal cells are located approximately 
midway between the most apical and basal aspects of the gastric mucosa, and are primarily 
responsible for the production of gastric acid155,156. In order for mucus cells and parietal cells to 
be functioning properly in order to maintain output of mucus and gastric acid, respectively, 
mitochondrial function is critical.  
Taking into account gastric physiology, as well as the known activities of VacA and the 
colonization of H. pylori, it is predicted that the role of VacA in vivo in H. pylori infection is to aid 
in persistence of H. pylori in the colonized human stomach. By dampening the ability of parietal 
cells to produce acid, the stomach becomes less acidic, and is thus more favorable for H. pylori 
growth. By dampening the ability of mucus cells to produce mucus, there is less physical force 
moving H. pylori from the surface of the gastric mucosa, and is also thus more favorable for H. 
pylori persistence in the stomach. Previous in vivo models of the importance of VacA in H. pylori 
colonization and pathogenesis indicate that VacA is important, but not necessary for 
colonization157. Altogether, the proposed model is that by producing a mitochondrial targeted 
bacterial toxin, where a host mitochondrial quality control response is activated as a means to 
limit toxin mediated mitochondrial dysfunction, intoxicated cells do not undergo cell death, but are 
rather in a constant state of dysfunction, where acid and mucus are not being produced effectively. 
This dampening of host cellular function by mitochondrial toxin serves to promote persistence of 
H. pylori infection and colonization in the human stomach.  
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The studies performed detail the recovery of organelle level dysfunction in response to a 
mitochondrial targeted pathogenic effector. The data presented confirm previous findings that 
VacA induces mitochondrial fragmentation48, depolarization46, ATP depletion47, and cytochrome 
c release49. However, the studies illustrated that if the residual, extracellular pool of toxin is 
removed, although a comparable level of mitochondrial dysfunction is induced compared to a 
continual exposure to VacA, mitochondria become repaired over time. Not only was it observed 
that mitochondrial structure recovers, but mitochondrial function and metabolic output recovery 
as well. Furthermore, the recovery of mitochondrial function in VacA intoxicated cells served to 
limit the induction of mitochondrial specific cell death, and conversion from oxidative 
phosphorylation to glycolysis for energy production. The results indicated that host cells are able 
to detect, respond to, and repair mitochondrial dysfunction induced by a bacterial toxin.  
The studies performed characterize the mechanism by which mitochondrial dysfunction is 
repaired over time in response to a bacterial toxin. Given the levels of mitochondrial dysfunction 
induced by VacA, it remains interesting that VacA was insufficient to activate detectable 
mitophagy. The inability to activate mitophagy by VacA might be explained by two potential 
means: 1) the level of VacA mediated mitochondrial dysfunction is below a threshold of 
mitochondrial damage needed to activate mitophagy, or 2) VacA intoxication is actively 
suppressing the activation of mitophagy. Although mitophagy was not detected, the pathway of 
mitochondrial derived vesicles gained supporting evidence in VacA intoxication. The studies 
conducted yielded a detection in the number of MDVs present in VacA intoxication, and VacA 
was shown to associate with MDVs in vitro. Furthermore, knockdown of the expression of proteins 
either previously reported to be important for MDV formation, or proteins identified through 
isolation and characterization of VacA mediated MDVs by mass spectrometry, were shown to be 
important for VacA cellular activity. Altogether, the data obtained support a model that in response 
to VacA localization to mitochondria, and VacA induction of mitochondrial dysfunction, a host cell 
activates a mitochondrial quality control response whereby VacA is selectively removed via 
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mitochondrial derived vesicles, then transported to lysosomes for removal from the cell. I propose 
that this activation of mitochondrial quality control serves to limit the severe, negative 
consequences of VacA mediated mitochondrial dysfunction, thus dampening the ability of gastric 






3.5 Figures and tables 
 
Figure 3.1: VacA purification. Purified VacA is tested for purity, yield, and activity before 
experimental use. Following elution from anion exchange column chromatography, eluates are 
resolved via SDS-PAGE and stained with Coomassie Blue. Only eluates containing pure VacA 
are combined (eluates 2-11 in the example gel) (A). Yield of purified VacA is measured by BCA 
protein concentration assay with bovine serum albumin standards fitted to a 3rd order polynomial 
curve (B). The activity of VacA is determined by the neutral red vacuolation assay, consisting of 
a two-fold serial dilution of acid activated, purified VacA that is treated to cells in cell culture media 
containing 5 mM NH4Cl. The amount of vacuolation is observed visually, and quantified after 
staining of neutral red normalized to total protein (C, D). Following labeling with Alexa Fluor 488, 
purified and labeled VacA is resolved by SDS-PAGE and imaged for fluorescence and stained for 
coomassie (E). Images are representative of, and quantified data are compiled from three 
independent purifications with quality control measurements each performed in triplicate. Error 




Figure 3.2: Model of VacA mediated induction of mitochondrial quality control. The studies 
investigated the model that subsequent to VacA mediate mitochondrial dysfunction, mitochondrial 
quality control is activated in an effort to repair VacA mediated mitochondrial dysfunction. The 
model posits that in response to low levels of VacA and/or shorter times of intoxication, lower level 
quality control will be activated as a “first line of defense” to maintain mitochondrial homeostasis, 
comprising the mitochondrial unfolded protein response. As toxin exposure increases in 
concentration and time, and if low level mitochondrial quality control is insufficient to repair VacA 
damaged mitochondria, the model posits a stepwise engagement in higher levels of mitochondrial 
quality control activation, including activation of mitochondrial derived vesicles and mitophagy. If 
all molecular and organellar levels of mitochondrial quality control are insufficient to repair VacA 






Figure 3.3: Model of VacA mediated induction of mitochondrial derived vesicles. The 
studies investigated the model that subsequent to VacA mediate mitochondrial dysfunction, VacA 
is removed from mitochondria into small vesicular carriers, designated mitochondrial derived 
VacA containing vesicles (MDVCVs), and are transported to lysosomal-like, LAMP1 containing 
vesicles. Given the pore forming activity of VacA, the lysosomal-like compartments then swell into 
large vacuolar structures. The model tested posits that MDVCVs serve as innate sensing and 






Figure 3.4: Pulse versus continuous exposure to VacA. For the experiments evaluating the 
host response to VacA mediated mitochondrial dysfunction, a pulse versus continuous exposure 
apparoach was used. For both designs, VacA molecules were allowed to bind to the cell surface 
and internalize into host cells. However, for the pulse design, the extracellular pool of VacA was 
removed in order to limit the continual internalization of VacA into cells and subsequent induction 




Figure 3.5: Time-dependent changes in mitochondrial structure within VacA intoxicated 
cells.  AZ-521 cells were incubated in the absence or presence of VacA (250 nM) under pulse 
conditions (4 ºC for 30 min, then washed with PBS pH 7.4) or continuous conditions (4 ºC for 30 
min), followed by further incubation at 37 ºC for 1, 4, or 24 h. Mitochondria were strained with anti-
TOM20 antibodies, then the mitochondrial structure was imaged by fluorescence microscopy. For 
each experimental condition, images are representative of three independent experiments where, 
in each, all mitochondria were analyzed from a single focal plane within 5 separate cells (~63 





Figure 3.6: Time-dependent changes in mitochondrial structure within VacA intoxicated 
cells.  AGS and HeLa cells were incubated in the absence or presence of VacA (250 nM) under 
pulse conditions (4 ºC for 30 min, then washed with PBS pH 7.4) or continuous conditions (4 ºC 
for 30 min), followed by further incubation at 37 ºC for 1, 4, or 24 h. Mitochondria were strained 
with anti-TOM20 antibodies, then the mitochondrial structure was imaged by fluorescence 
microscopy. For each experimental condition, images are representative of three independent 






Figure 3.7: Time-dependent changes in mitochondrial structure within VacA intoxicated 
cells.  AZ-521 cells were incubated in the absence or presence of VacA (250 nM) under pulse 
conditions (4 ºC for 30 min, then washed with PBS pH 7.4) or continuous conditions (4 ºC for 30 
min), followed by further incubation at 37 ºC for 1, 4, or 24 h. Mitochondria were strained with anti-
TOM20 antibodies, then the mitochondrial structure was imaged by fluorescence microscopy and 
mitochondrial length was measured in µm and expressed relative to the 1 h untreated cells. For 
each experimental condition, data were combined from three independent experiments where, in 
each, all mitochondria were analyzed from a single focal plane within 5 separate cells (~63 
mitochondria per cell, total of 8598 mitochondria analyzed). Error bars represent standard error 
of the mean. Statistical significance was determined by one way ANOVA with an alpha level of 






Figure 3.8: Quantification of the recovery in VacA mediated mitochondrial fragmentation 
by mitochondrial filament length categorization.  AZ-521 cells were incubated in the absence 
or presence of VacA (250 nM) under pulse conditions (4 ºC for 30 min, then washed with PBS pH 
7.4) or continuous conditions (4 ºC for 30 min), followed by further incubation at 37 ºC for 1, 4, or 
24 h. Mitochondria were strained with anti-TOM20 antibodies, then the mitochondrial structure 
was imaged by fluorescence microscopy. Mitochondrial filaments less than 2 µm in length were 
classified as fragmented, between 2 and 8 µm in length were classified as intermediate, and 
greater than 8 µm in length were classified as tubular. The distribution of fragmented, 
intermediate, and tubular mitochondria was determined as a percentage of mitochondria filaments 
designated as a given structure over the total mitochondrial filaments measured. Mitochondrial 
filament percent composition was measured and are representative of 3 independent experiments 






Figure 3.9: Quantification of the recovery in VacA mediated mitochondrial fragmentation 
by histogram analysis.  AZ-521 cells were incubated in the absence or presence of VacA (250 
nM) under pulse conditions (4 ºC for 30 min, then washed with PBS pH 7.4) or continuous 
conditions (4 ºC for 30 min), followed by further incubation at 37 ºC for 1, 4, or 24 h. Mitochondria 
were strained with anti-TOM20 antibodies, then the mitochondrial structure was imaged by 
fluorescence microscopy. The distribution of mitochondrial filament length was plotted 
continuously as proportions of the total mitochondrial population length. Black lines represent 
untreated cells, blue lines represent pulse VacA treated cells, and red lines represent continuously 





Figure 3.10: Intracellular levels of VacA in pulse versus continuous VacA exposures. AZ-
521 cells were incubated in the absence or presence of VacA (250 nM) under pulse conditions (4 
ºC for 30 min, then washed with PBS pH 7.4) or continuous conditions (4 ºC for 30 min), followed 
by further incubation at 37 ºC for 1, 4, or 24 h. Whole cell lysates were collected and 
immunoblotted against VacA and β–actin. Relative protein abundances were quantified by 
normalizing VacA band intensities to β–actin and made relative to the 1 h untreated condition (A) 
and appreciated visually (B). Error bars represent standard error of the mean. Statistical 
significance was determined by one way ANOVA with an alpha level of 0.001 and Tukey 





Figure 3.11: Detection of pulse labeled VacA with anti-VacA antibodies.  AZ-521 cells were 
exposed to VacA (250 nM) directly labeled with Alexa Fluor 488 under pulse conditions (4ºC for 
30 min, washed with PBS pH 7.2) then incubated at 37ºC with unlabeled VacA (250 nM) in MEM 
for 8 h post-internalization. Total VacA levels associated with pulse VacA was measured by 
indirect immunofluorescence staining of VacA with anti-VacA antibody and secondary antibody 
conjugated to Alexa Fluor 555. Images are representative of 3 independent experiments 






Figure 3.12: Time-dependent changes in OPA1 forms in response to mitochondrial stress.  
AZ-521 , AGS, and NCI N87 cells were incubated in the absence or presence of VacA (250 nM) 
or CCCP (10 µM)  at 37 ºC for 1, 12, or 24 h. Cell lysates were processed for immunoblotting with 







Figure 3.13: OPA1 forms in response to doses of mitochondrial stress.  AZ-521 , AGS, and 
NCI N87 cells were incubated in the absence or presence of VacA (1000, 250, 10 nM), CCCP 
(10, 5, 2.5 µM), oligomycin (10 µM), Antimycin A (50 µM), or chloramphenicol (50 µM)  at 37 ºC 
for 2 h. Cell lysates were processed for immunoblotting with anti-OPA1, anti-TIM23, and anti-actin 





Figure 3.14: OPA1 forms in response to timecourses of mitochondrial stress. AZ-521 cells 
were incubated in the absence or presence of VacA, CCCP, CCCP in combination with 
chloroquine, chloroquine alone, or NAD  at 37 ºC for either 1, 4, 12, or 24 h. Cell lysates were 
processed for immunoblotting with anti-OPA1, anti-TIM23, and anti-β-actin antibodies. Images 






Figure 3.15: OPA1 forms in response to mitochondrial stress in glucose and galactose 
adapted cells.  AZ-521, AGS, HeLa, and Cos7 cells adapted to grow in glucose or galactose 
containing media were incubated in the absence or presence of VacA (250 nM), CCCP (10 µM), 
or Antimycin A (50 µM) at 37 ºC for 4 h. Cell lysates were processed for immunoblotting with anti-





Figure 3.16: Time-dependent changes in Drp1 association with mitochondria in VacA 
intoxicated cells.  AZ-521 cells were incubated in the absence or presence of VacA (250 nM) 
under pulse conditions (4 ºC for 30 min, then washed with PBS pH 7.4) or continuous conditions 
(4 ºC for 30 min), followed by further incubation at 37 ºC for 1, 4, or 24 h. Drp1 association with 
the mitochondria was measured by fluorescence microscopy and indirect immunofluorescence 
staining against TOM20 and Drp1 and analyzed quantitatively (A) and qualitatively (B). 
Colocalization was determined by Pearson’s coefficient of correlation. Images are representative 
of and quantitative data are compiled from 3 independent experiments performed in triplicate, with 
each experimental treatment consisting of 5 cells imaged. Error bars represent standard error of 
the mean. Statistical significance was determined by one way ANOVA with an alpha level of 0.001 






Figure 3.17: Measurement of mitochondrial transmembrane potential. AZ-521 cells were 
incubated in the presence of VacA (0 nM, 1 nM, 10 nM, 35 nM, 100 nM 250 nM, 500 nM, or 1000 
nM) for 4 h (A), or VacA (250 nM) or CCCP (0.04 μM, 0.07 μM, 0.15 μM, 0.32 μM, 0.62 μM, 1.25 
μM, 2.5 μM, 5 μM, 10 μM, or 20 μM) for 4 h (B). Mitochondrial transmembrane potential measured 
by TMRE and flow cytometry with 10,000 events collected for each experimental condition with 
the median TMRE fluorescence intensity measured. Error bars represent standard error of the 
mean. Statistical significance was determined by one way ANOVA with an alpha level of 0.001 
and Tukey correction for multiple comparisons against the untreated control within a given 




Figure 3.18: Time-dependent changes in mitochondrial transmembrane potential in VacA 
intoxicated cells.  AZ-521 cells were incubated in the absence or presence of VacA (250 nM) 
under pulse conditions (4 ºC for 30 min, then washed with PBS pH 7.4) or continuous conditions 
(4 ºC for 30 min), followed by further incubation at 37 ºC for 1, 4, or 24 h. Mitochondrial 
transmembrane potential measured by TMRE and flow cytometry with 10,000 events collected 
for each experimental condition. Median TMRE fluorescence intensities were made relative to the 
1 h untreated control and are representative of 3 independent experiments performed in triplicate. 
Error bars represent standard error of the mean. Statistical significance was determined by one 
way ANOVA with an alpha level of 0.001 and Tukey correction for multiple comparisons against 





Figure 3.19: Time-dependent changes in mitochondrial transmembrane potential in VacA 
intoxicated AGS and HeLa cells.  AGS and HeLa cells were incubated in the absence or 
presence of VacA (250 nM) under pulse conditions (4 ºC for 30 min, then washed with PBS pH 
7.4) or continuous conditions (4 ºC for 30 min), followed by further incubation at 37 ºC for 1, 4, or 
24 h. Mitochondrial transmembrane potential measured by TMRE and flow cytometry with 10,000 
events collected for each experimental condition. Median TMRE fluorescence intensities were 
made relative to the 1 h untreated control and are representative of 3 independent experiments 
performed in triplicate. Error bars represent standard error of the mean. Statistical significance 
was determined by one way ANOVA with an alpha level of 0.001 and Tukey correction for multiple 





Figure 3.20: Time-dependnet changes in cellular ATP levels in VacA intoxicated cells.  AZ-
521 cells were adapted in glucose free, galactose containing media incubated in the absence or 
presence of VacA (250 nM) under pulse conditions (4 ºC for 30 min, then washed with PBS pH 
7.4) or continuous conditions (4 ºC for 30 min), followed by further incubation at 37 ºC for 1, 4, or 
24 h. Total ATP levels were measured using the MitoTox Glo ATP determination kit (Promega). 
ATP levels were normalized to total protein (in µg) measured by BCA, then made relative to the 
untreated control at each timepoint. Data are representative of 3 independent experiments 
performed in triplicate. Error bars represent standard error of the mean. Statistical significance 
was determined by one way ANOVA with an alpha level of 0.001 and Tukey correction for multiple 





Figure 3.21: Time-dependent changes in oxygen consumption in VacA intoxicated cells.  
AZ-521 cells were adapted in glucose free, galactose containing media incubated in the absence 
or presence of VacA (250 nM) under pulse conditions (4 ºC for 30 min, then washed with PBS pH 
7.4) or continuous conditions (4 ºC for 30 min), followed by further incubation at 37 ºC for 1, 4, or 
24 h. Oxygen consumption was measured using the Oxygen Consumption/Glycolysis Dual Assay 
Kit (Cayman Chemical). Oxygen consumption levels were normalized to total protein (in µg) 
measured by BCA, then made relative to the untreated control at each timepoint. Data are 
representative of 3 independent experiments performed in triplicate. Error bars represent 
standard error of the mean. Statistical significance was determined by one way ANOVA with an 
alpha level of 0.001 and Tukey correction for multiple comparisons against the untreated control 






Figure 3.22: Time-dependent changes in glycolysis in VacA intoxicated cells.  AZ-521 cells 
were adapted in glucose free, galactose containing media incubated in the absence or presence 
of VacA (250 nM) under pulse conditions (4 ºC for 30 min, then washed with PBS pH 7.4) or 
continuous conditions (4 ºC for 30 min), followed by further incubation at 37 ºC for 1, 4, or 24 h. 
Glycolysis was measured using the Oxygen Consumption/Glycolysis Dual Assay Kit (Cayman 
Chemical). Glycolysis levels were normalized to total protein (in µg) measured by BCA, then made 
relative to the untreated control at each timepoint. Data are representative of 3 independent 
experiments performed in triplicate. Error bars represent standard error of the mean. Statistical 
significance was determined by one way ANOVA with an alpha level of 0.001 and Tukey 





Figure 3.23: Measurement membrane permeability in pulse and continuous VacA 
intoxications.  AZ-521 cells were adapted in glucose free, galactose containing media incubated 
in the absence or presence of VacA (250 nM) under pulse conditions (4 ºC for 30 min, then 
washed with PBS pH 7.4) or continuous conditions (4 ºC for 30 min), followed by further incubation 
at 37 ºC for 1, 4, or 24 h. Membrane permeability was measured using the MitoTox Glo ATP 
determination kit (Promega). Membrane permeability luminescence were normalized to total 
protein (in µg) measured by BCA, then made relative to the untreated control at each timepoint. 
Data are representative of 3 independent experiments performed in triplicate. Error bars represent 
standard error of the mean. Statistical significance was determined by one way ANOVA with an 
alpha level of 0.001 and Tukey correction for multiple comparisons against the untreated control 







Figure 3.24: Measurement of total protein in pulse and continuous VacA intoxications.  AZ-
521 cells were exposed to 250 nM VacA under pulse (4ºC for 30 min, washed with PBS pH 7.4, 
incubated at 37ºC with MEM) or continuous (4ºC for 30 min, incubated at 37ºC with VacA in MEM) 
for 1, 4, 24 hrs post-internalization. Total protein was measured by BCA with standards against 
bovine serum albumin. Total protein values were normalized to the 1 h untreated control and are 
representative of 3 independent experiments performed in triplicate. Error bars represent 
standard error of the mean, and statistical significance was determined using one way ANOVA 





Figure 3.25: Cytochrome c release in VacA intoxicated cells.  AZ-521 cells were incubated in 
the absence or presence of VacA (250 nM) under pulse conditions (4 ºC for 30 min, then washed 
with PBS pH 7.4) or continuous conditions (4 ºC for 30 min), followed by further incubation at 37 
ºC for 1, 4, or 24 h. Cytochrome c release was measured by fluorescence microscopy and indirect 
immunofluorescence staining against TOM20 (555) and cytochrome c (488). Within each 
experimental treatment, the percentage of cells that were viable, displayed cytoplasmic 
cytochrome c, or appeared dead, were counted. Images are representative of (A) and quantitative 
data (B) are compiled from 3 independent experiments performed in triplicate, with each 
experimental treatment consisting of 5 cells imaged. Error bars represent standard error of the 
mean. Statistical significance was determined by one way ANOVA with an alpha level of 0.001 





Figure 3.26: LC3 puncta in VacA intoxicated cells.  AZ-521 cells were incubated in the absence 
or presence of VacA (250 nM) under pulse conditions (4 ºC for 30 min, then washed with PBS pH 
7.4) or continuous conditions (4 ºC for 30 min), followed by further incubation at 37 ºC for 1, 4, or 
24 h. Autophagy induction was measured by fluorescence microscopy and indirect 
immunofluorescence staining against LC3. Images are representative of 3 independent 
experiments performed in triplicate, with each experimental treatment consisting of 5 cells 




Figure 3.27: Association of VacA with early endosomes and mitochondria.  AZ-521 cells 
were exposed to VacA (250 nM) directly labeled with Alexa Fluor 488 under pulse conditions (4ºC 
for 30 min, washed with PBS pH 7.4) then incubated at 37ºC with unlabeled VacA (250 nM) in 
MEM for 0, 0.25, 0.5, 1, 2, 4, and 8 h post-internalization. The association of VacA with 
endosomes or mitochondria was measured by fluorescence microscopy with indirect 
immunofluorescence staining with EEA1 (A) or TOM20 (B), respectively, with secondary 
antibodies conjugated to Alexa Fluor 555. Colocalization was determined by Pearson’s coefficient 
of correlation. Images are representative of and quantitative data are compiled from 3 
independent experiments performed in triplicate, with each experimental treatment consisting of 
30 cells imaged. Error bars represent standard error of the mean. Statistical significance was 
determined by one way ANOVA with an alpha level of 0.001 and Tukey correction for multiple 





Figure 3.28: Association of VacA with lysosomes.  AZ-521 cells were exposed to VacA (250 
nM) directly labeled with Alexa Fluor 488 under pulse conditions (4ºC for 30 min, washed with 
PBS pH 7.2) then incubated at 37ºC with unlabeled VacA (250 nM) in MEM for 0, 0.25, 0.5, 1, 2, 
4, and 8 h post-internalization. The association of VacA with lysosomes was measured by 
fluorescence microscopy with indirect immunofluorescence staining with LAMP1, with secondary 
antibodies conjugated to Alexa Fluor 555. Data were analyzed quantitatively (A) and qualitatively 
(B). Colocalization was determined by Pearson’s coefficient of correlation. Images are 
representative of and quantitative data are compiled from 3 independent experiments performed 
in triplicate, with each experimental treatment consisting of 30 cells imaged. Error bars represent 
standard error of the mean. Statistical significance was determined by one way ANOVA with an 





Figure 3.29: Mitochondria association with lysosomes in VacA intoxicated cells. AZ-521 
cells were exposed to VacA (250 nm) for 4 h. The association of mitochondria with lysosomes 
was measured by fluorescence microscopy with indirect immunofluorescence staining with 
LAMP1, with secondary antibodies conjugated to Alexa Fluor 555, and TOM20 (mitochondria) 
with secondary antibodies conjugated to Alexa Fluor 488. Colocalization was determined by 
Pearson’s coefficient of correlation. Quantitative data are compiled from 3 independent 
experiments performed in triplicate, with each experimental treatment consisting of 30 cells 
imaged. Error bars represent standard error of the mean. Statistical significance was determined 
by one way ANOVA with an alpha level of 0.001 and Tukey correction for multiple comparisons 








Figure 3.30: VacA mediated vacuole formation.  AZ-521 cells were exposed to VacA (250 nM) 
for 8 h. VacA was detected by fluorescence microscopy and DIC imaging using indirect 
immunofluorescence staining of VacA with anti-VacA, lysosomes with anti-LAMP1 antibody, and 
Rab7 with anti-Rab7 antibodies with secondary antibodies conjugated to Alexa Fluor 488, 555, or 
488, respectively. Images are representative of 3 independent experiments performed in triplicate, 





Figure 3.31: Timecourse of VacA mediated vacuolation.  AZ-521 cells were incubated in the 
absence or presence of VacA (250 nM) for 0.5, 1, 2, 4, 8, 12, 16, or 24 h. Vacuolation was 
measured by neutral red uptake normalized to total protein. Error bars represent standard error 





Figure 3.32: Timecourse of VacA mediated vacuolation under pulse versus continuous 
VacA intoxication. AZ-521 cells were incubated in the absence or presence of VacA (250 nM) 
under pulse conditions (4 ºC for 30 min, then washed with PBS pH 7.4) or continuous conditions 
(4 ºC for 30 min), followed by further incubation at 37 ºC for 1, 4, or 24 h. Cells were visually 




Figure 3.33: Cellular vacuolation upon mitochondria stress. AZ-521 cells were incubated in 
the absence or presence of VacA (250 nM), CCCP (10 µM), Oligomycin A (10 µM), Antimycin A 
(50 µM), or chloramphenicol (50 µM) at 37°C for 4 h. Vacuolation was measured by neutral red 
uptake normalized to total protein, and visualized by light microscopy. Error bars represent 
standard error of the mean. Statistical significance was determined by one way ANOVA with an 





Figure 3.34: Inhibition of VacA mediated vacuolation with mitochondrial toxicants. AZ-521 
cells were incubated in the absence or presence of VacA (250 nM), CCCP (10 µM), Oligomycin 
A (10 µM), Antimycin A (50 µM), or chloramphenicol (50 µM), or in combination with each of the 
mitochondrial inhibits, at 37°C for 4 h. Vacuolation was measured by neutral red uptake 
normalized to total protein. Error bars represent standard error of the mean. Statistical 
significance was determined by one way ANOVA with an alpha level of 0.001 and Tukey 






Figure 3.35: Mitochondrial dynamics proteins and VacA mediated vacuolation. The 
expression of Rab32, OPA1, and DRP1 was knocked down using RNAi and AZ-521 cells were 
allowed to incubate for 48 h to allow for complete knockdown of each protein. Cells were 
subsequently treated with VacA (250 nM) for 4 h in the presence of 5 mM NH4Cl. Vacuolation 
was assessed quantitatively by neutral red uptake (A) or qualitatively by light microscopy (B). 
Error bars represent standard error of the mean. Statistical significance was determined by one 
way ANOVA with an alpha level of 0.001 and Tukey correction for multiple comparisons against 





Figure 3.36: Mitochondrial dynamics proteins and VacA mediated mitochondrial 
fragmentation. The expression of Rab32, OPA1, and Drp1 was knocked down using RNAi and 
AZ-521 cells were allowed to incubate for 48 h to allow for complete knockdown of each protein. 
Cells were subsequently treated with VacA (250 nM) for 4 h. VacA mediated mitochondrial 
fragmentation was assessed by fluorescence microscopy with anti-TOM20 staining of 






Figure 3.37: Mitochondrial dynamics proteins and VacA mediated mitochondrial 
localization. The expression of Rab32, OPA1, and DRP1 was knocked down using RNAi and 
AZ-521 cells were allowed to incubate for 48 h to allow for complete knockdown of each protein. 
Cells were subsequently treated with VacA directly labeled with Alexa Fluor 488 (250 nM) for 4 h. 
The association of VacA with mitochondria was measured by fluorescence microscopy with 
indirect immunofluorescence staining with TOM20 with secondary antibodies conjugated to Alexa 
Fluor 555. Colocalization was determined by Pearson’s coefficient of correlation. Quantitative 
data are compiled from 3 independent experiments performed in triplicate, with each experimental 
treatment consisting of 10 cells imaged. Error bars represent standard error of the mean. 
Statistical significance was determined by one way ANOVA with an alpha level of 0.001 and Tukey 






Figure 3.38: Importance of mitochonria for VacA mediated vacuolation. AZ-521 cells 
overexpressing mCherry-PARKIN were treated with a combination of oligmycin and Antimycin A 
(50 μM each) for 8 hr to facilitate the clearance of mitochondria from cells via overactivated 
mitophagy. Cells were then treated with VacA (250 nM) at 37°C for 4 h in media containing 5 mM 
NH4Cl to induce vacuolation. Cells were fixed and processed for fluorescence microscopy with 






Figure 3.39: Mitochondrial mass in response to mitochondrial stressors.  HeLa cells were 
incubated in the absence or presence of VacA (250 nM) for 12 h. Mitochondrial transmembrane 
potential measured by TMRE staining and mitochondria mass was measured by MitoTracker 
Deep Red staining and flow cytometry with 10,000 events collected for each experimental 
condition. Median TMRE or MitoTracker Deep Red fluorescence intensities were made relative 
to the untreated control and are representative of 3 independent experiments performed in 
triplicate. Error bars represent standard error of the mean. Statistical significance was determined 
by one way ANOVA with an alpha level of 0.001 and Tukey correction for multiple comparisons 




Figure 3.40: Mitochondrial mass during VacA timecourse intoxication.  AZ-521 or AGS cells 
were incubated in the absence or presence of VacA (250 nM) for 1, 4, or 12 h. Mitochondrial mass 
was measured by MitoTracker Deep Red staining and flow cytometry with 10,000 events collected 
for each experimental condition. Median MitoTracker Deep Red fluorescence intensity was made 
relative to the untreated control and are representative of 3 independent experiments performed 
in triplicate. Error bars represent standard error of the mean. Statistical significance was 
determined by one way ANOVA with an alpha level of 0.001 and Tukey correction for multiple 







Figure 3.41: PINK1 levels upon mitochondrial stress.  AZ-521, AGS, HeLa, and Cos7 cells 
were adapted to grow in glucose or galactose containing media, then treated with VacA (250 nM), 
CCCP (10 µM), or Antimycin A (50 µM) for 4 h. Whole cell lysates were collected and processed 
for immunoblotting against PINK1 and actin. Blots are representative of 3 independent 





Figure 3.42: PARKIN activation in VacA intoxicated cells. HeLa cells overexpressing PARKIN-
mCherry for 24 h were incubated in the absence or presence of VacA (250 nM) and oligomycin 
(Oligo, 10 μM) or antimycin A (AntiA, 10 μM) at 37°C for 12 h. Mitochondria were stained with 







Figure 3.43: PARKIN activation in VacA intoxicated AGS, AZ-521, and HeLa cells along 
timecourses and dose responses. HeLa cells overexpressing PARKIN-mCherry for 24 h were 
incubated in the absence or presence of VacA (250 nM) and oligomycin (Oligo, 10 μM) or 
antimycin A (AntiA, 10 μM) at 37°C for 12 h. Mitochondria were stained with anti-TOM20 






Figure 3.44: Activation of mitophagy during VacA intoxication. HeLa cells overexpressing 
PARKIN-mCherry for 24 h were incubated in the absence or presence of VacA (250 nM) or 
oligomycin (Oligo, 10 μM) and antimycin A (AntiA, 10 μM) at 37°C for 4 h, followed by additional 
treatment of Oligomycin and Antimycin A for another 4 h. Mitochondria were stained with anti-








Figure 3.45: MDV formation.  HeLa cells were exposed to VacA (250 nM) for 12 h. Mitochondria 
were imaged by fluorescence microscopy using indirect immunofluorescence staining of TOM20 
with secondary antibodies conjugated to Alexa Fluor 488. The number of MDVs formed were 
quantified by counting the number of MDVs observed per cell. Images are representative of and 
quantitative data were compiled from 3 independent experiments performed in triplicate, with each 






Figure 3.46: MDV formation. HeLa cells overexpressing mCherry-PARKIN for 24 h were 
exposed to VacA (250 nM) for 12 h. Mitochondria were imaged by fluorescence microscopy using 
indirect immunofluorescence staining of TOM20 with secondary antibodies conjugated to Alexa 
Fluor 488. MDVs were visualized as small mitochondria puncta. Images are representative of 3 





Figure 3.47: Cargo selectivity in VacA mediated MDVs.  AZ-521 cells were exposed to VacA 
(250 nM) for 12 h. Mitochondria were imaged by fluorescence microscopy using indirect 
immunofluorescence staining of TOM20 with secondary antibodies conjugated to Alexa Fluor 555, 
or cytochrome c with secondary antibodies conjugated to Alexa Fluor 488. MDVs were visualized 
as small mitochondria puncta. Images are representative of 3 independent experiments 





Figure 3.48: VacA association with MDVs.  Mitochondria were purified from a bovine heart, and 
in the presence of an energy regenerating buffer that facilitates MDV formation, mitochondria 
were incubated at 37ºC for 2 h with or without VacA, or cytosol, then post-mitochondrial 
supernatants were separated on a 4 step sucrose gradient and centrifuged at 200,000 x g for 6 
h. Samples were collected from each layer and interface and immunoblotted against VacA. 
Images are representative of 3 independent experiments performed from mitochondria purified 





Figure 3.49: VacA association with MDVs.  Mitochondria were purified from a bovine heart, and 
in the presence of an energy regenerating buffer that facilitates MDV formation, mitochondria 
were incubated at 37ºC for 2 h with or without VacA, or cytosol, then post-mitochondrial 
supernatants were treated with trypsin at 4ºC for 10 min then processed for immunoblotting 
against VacA. Images are representative of 3 independent experiments performed from 





Figure 3.50: MDV formation machinery. AZ-521 cells were treated with RNAi against NC1 
scrambled control (NC1), syntaxin 17 (S17), sorting nextin 9 (S9), Rab7 (R7), and Rab9 (R9) for 
48 h to allow for protein knockdown. Cells were incubated in the absence or presence of VacA 
(250 nM) at 37ºC for 4 h in the presence of 5 mM NH4Cl. Vacuolation was measured by neutral 
red staining and normalization to total protein, determined by BCA assay. Data are representative 
of 3 independent experiments performed in triplicate, and were made relative to the untreated 
control. Error bars represent standard error of the mean. Statistical significance was determined 
by one way ANOVA with an alpha level of 0.001 and Tukey correction for multiple comparisons 







Figure 3.51: MDV isolation for mass spectrometry.  Mitochondria were purified from mouse 
livers, and in the presence of an energy regenerating buffer that facilitates MDV formation, 
mitochondria were incubated at 37ºC for 2 h with or without VacA, or cytosol, then post-
mitochondrial supernatants were separated on a 3 step sucrose gradient and centrifuged at 
200,000 x g for 6 h. Samples were collected from each layer and interface and immunoblotted 
against VacA. Images are representative of 3 independent experiments performed from 





Figure 3.52: MDV proteomics distribution.  Proteomics data were obtained from the MASCOT 
server and proteins were identified by the mouse SwissProt protein database. An ion score cutoff 









Figure 3.53: MDV proteome: Mitochondrial protein distribution.  Proteins annotated using the 
PANTHER protein annotation software were identified by subcellular localization and molecular 
function. Proteins were identified to localize to the mitochondria, inner mitochondrial membrane 
(IMM), outer mitochondrial membrane (OMM), or the matrix. Relative protein abundance was 
determined by dividing the empirically modified protein abundance index (emPAI) value obtained 
from the MASCOT server by the sum of all emPAI values in a given dataset. The emPAI values 
for all proteins in a given category (mitochondria, IMM, OMM, matrix) were summed and plotted 







Figure 3.54: MDV proteome: Vesicle-mediated transport proteins.  AZ-521 cells were treated 
with RNAi against NC1 scrambled control (NC1), vesicle associated membrane protein 8 
(VAMP8), syntaxin 12 (Stx12), and Rab5C for 48 h to allow for protein knockdown. Cells were 
incubated in the absence or presence of VacA (250 nM) at 37ºC for 4 h in the presence of 5 mM 
NH4Cl. Vacuolation was measured by neutral red staining and normalization to total protein, 
determined by BCA assay. Data are representative of 3 independent experiments performed in 








Table 3.1 A. Proteins common to all preparations: MITO + CYTO, MITO + VACA, MITO + VACA + CYTO 
Gene ID Protein Name  Gene ID Protein Name 
A1AT3 ALPHA-1-ANTITRYPSIN-RELATED   K1C10 KERATIN, TYPE I CYTOSKELETAL 10  
AAAD ARYLACETAMIDE DEACETYLASE   K1C15 KERATIN, TYPE I CYTOSKELETAL 15  
ABCA6 ATP-BINDING CASSETTE SUB-FAMILY A MEMBER 6   K22E KERATIN, TYPE II CYTOSKELETAL 2 EPIDERMAL  
ABCB6 
ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 6, 
MITOCHONDRIAL  
 
K2C5 KERATIN, TYPE II CYTOSKELETAL 5  
ACBP ACYL-COA-BINDING PROTEIN   K2C73 KERATIN, TYPE II CYTOSKELETAL 73  
ACSL1 LONG-CHAIN-FATTY-ACID--COA LIGASE 1   K2C79 KERATIN, TYPE II CYTOSKELETAL 79  
ACSL5 LONG-CHAIN-FATTY-ACID--COA LIGASE 5   KAD2 ADENYLATE KINASE 2, MITOCHONDRIAL  
ACTB ACTIN, CYTOPLASMIC 2   KMO KYNURENINE 3-MONOOXYGENASE  
AIFM1 APOPTOSIS-INDUCING FACTOR 1, MITOCHONDRIAL   KNG1 KININOGEN-1  
AL3A2 FATTY ALDEHYDE DEHYDROGENASE   LAMP2 LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEIN 2  
ALBU SERUM ALBUMIN   LDLR LOW-DENSITY LIPOPROTEIN RECEPTOR  
ALDOB FRUCTOSE-BISPHOSPHATE ALDOLASE B  
 
LICH 






LMAN1 PROTEIN ERGIC-53  
ANGT ANGIOTENSINOGEN  
 
LRP1 
PROLOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED 
PROTEIN 1  
ANT3 ANTITHROMBIN-III   LTOR1 RAGULATOR COMPLEX PROTEIN LAMTOR1  




MANNOSIDASE IA  
APOA1 APOLIPOPROTEIN A-I   MA2A1 ALPHA-MANNOSIDASE 2  
APOA2 APOLIPOPROTEIN A-II   MAL2 PROTEIN MAL2  
APOA5 APOLIPOPROTEIN A-V   MARC1 MITOCHONDRIAL AMIDOXIME-REDUCING COMPONENT 1  
APOB APOLIPOPROTEIN B-100   MET7B METHYLTRANSFERASE-LIKE PROTEIN 7B  





APOE APOLIPOPROTEIN E   MGST1 MICROSOMAL GLUTATHIONE S-TRANSFERASE 1  
ASGR1 ASIALOGLYCOPROTEIN RECEPTOR 1   MIA3 MELANOMA INHIBITORY ACTIVITY PROTEIN 3  
ASSY ARGININOSUCCINATE SYNTHASE   MTCH2 MITOCHONDRIAL CARRIER HOMOLOG 2  
AT11C PHOSPHOLIPID-TRANSPORTING ATPASE IG  
 
MTP 
MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN 
LARGE SUBUNIT  
AT1A1 
SODIUM/POTASSIUM-TRANSPORTING ATPASE SUBUNIT 
ALPHA-1  
 
MUG1 MURINOGLOBULIN-1-RELATED  
ATPA ATP SYNTHASE SUBUNIT ALPHA, MITOCHONDRIAL   MUP2 MAJOR URINARY PROTEIN 1-RELATED  
ATPB ATP SYNTHASE SUBUNIT BETA, MITOCHONDRIAL   NB5R3 NADH-CYTOCHROME B5 REDUCTASE 3  
ATPO ATP SYNTHASE SUBUNIT O, MITOCHONDRIAL   NCEH1 NEUTRAL CHOLESTEROL ESTER HYDROLASE 1  
CAB45 45 KDA CALCIUM-BINDING PROTEIN   NCPR NADPH--CYTOCHROME P450 REDUCTASE  
CAH3 CARBONIC ANHYDRASE 3  
 
NHRF3 
NA(+)/H(+) EXCHANGE REGULATORY COFACTOR NHE-
RF3-RELATED  
CALR CALRETICULIN   NICA NICASTRIN  
CALX CALNEXIN   NTCP SODIUM/BILE ACID COTRANSPORTER  
CATA CATALASE   NUCB1 NUCLEOBINDIN-1  
CATB CATHEPSIN B   PCYOX PRENYLCYSTEINE OXIDASE 1  
CATD CATHEPSIN D   PDIA1 PROTEIN DISULFIDE-ISOMERASE  
CATH PRO-CATHEPSIN H   PDIA3 PROTEIN DISULFIDE-ISOMERASE A3  
CES1D LIVER CARBOXYLESTERASE 1-RELATED   PDIA4 PROTEIN DISULFIDE-ISOMERASE A4  
CLH1 CLATHRIN HEAVY CHAIN 1   PDIA6 PROTEIN DISULFIDE-ISOMERASE A6  
CLUS CLUSTERIN  
 
PG12B 
GROUP XIIB SECRETORY PHOSPHOLIPASE A2-LIKE 
PROTEIN  
CNPY2 PROTEIN CANOPY HOMOLOG 2 
 
PGRC1 
MEMBRANE-ASSOCIATED PROGESTERONE RECEPTOR 
COMPONENT 1  
CO3 COMPLEMENT C3   PIGR POLYMERIC IMMUNOGLOBULIN RECEPTOR  
COX5A CYTOCHROME C OXIDASE SUBUNIT 5A, MITOCHONDRIAL   PON1 SERUM PARAOXONASE/ARYLESTERASE 1  
CP17A STEROID 17-ALPHA-HYDROXYLASE/17,20 LYASE   PPIB PEPTIDYL-PROLYL CIS-TRANS ISOMERASE B  
CP1A2 CYTOCHROME P450 1A2   PRDX1 PEROXIREDOXIN-1  
CP237 CYTOCHROME P450 2C37-RELATED   PRDX4 PEROXIREDOXIN-4  
CP240 CYTOCHROME P450 2C40-RELATED  RAB10 RAS-RELATED PROTEIN RAB-10  
CP270 CYTOCHROME P450 2C70   RAB14 RAS-RELATED PROTEIN RAB-14  
CP2AC CYP2A22 PROTEIN-RELATED   RAB1A RAS-RELATED PROTEIN RAB-1A  
CP2CT CYTOCHROME P450 2C9   RAB1B RAS-RELATED PROTEIN RAB-1B-RELATED  
CP2DA CYTOCHROME P450 2D10-RELATED   RAB6A RAS-RELATED PROTEIN RAB-6A  
CP2DQ CYTOCHROME P450 2D26-RELATED   RAB7A RAS-RELATED PROTEIN RAB-7A  
CP2E1 CYTOCHROME P450 2E1   RALA RAS-RELATED PROTEIN RAL-A  
CP2F2 CYTOCHROME P450 2F1   RAP1A RAS-RELATED PROTEIN RAP-1A  
CP341 CYTOCHROME P450 3A11-RELATED   RDH11 RETINOL DEHYDROGENASE 11  
CP341 CYTOCHROME P450 3A11-RELATED   RDH7 RETINOL DEHYDROGENASE 16  
CP3AB CYTOCHROME P450 3A11-RELATED   REEP6 RECEPTOR EXPRESSION-ENHANCING PROTEIN 6  
CP3AD CYTOCHROME P450 3A7   RET4 RETINOL-BINDING PROTEIN 4  
CPT1A 
CARNITINE O-PALMITOYLTRANSFERASE 1, LIVER 
ISOFORM  
 
RGN REGUCALCIN  
CREG1 PROTEIN CREG1   RL6 60S RIBOSOMAL PROTEIN L6  
CY1 CYTOCHROME C1, HEME PROTEIN, MITOCHONDRIAL   RLA1 60S ACIDIC RIBOSOMAL PROTEIN P1  




GLYCOSYLTRANSFERASE SUBUNIT 1  
CYB5 CYTOCHROME B5   RS27A POLYUBIQUITIN-B  
CYB5B CYTOCHROME B5 TYPE B   RS7 40S RIBOSOMAL PROTEIN S7  
CYC CYTOCHROME C   RSSA 40S RIBOSOMAL PROTEIN SA  
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Table 3.1 A (cont.). Proteins common to all preparations: MITO + CYTO, MITO + VACA, MITO + VACA + CYTO 
DHI1 
CORTICOSTEROID 11-BETA-DEHYDROGENASE ISOZYME 
1  
 
S20A2 SODIUM-DEPENDENT PHOSPHATE TRANSPORTER 2  
DNJC3 DNAJ HOMOLOG SUBFAMILY C MEMBER 3   S27A2 VERY LONG-CHAIN ACYL-COA SYNTHETASE  
DPP4 DIPEPTIDYL PEPTIDASE 4   S27A5 BILE ACYL-COA SYNTHETASE  
EF1A1 ELONGATION FACTOR 1-ALPHA-LIKE 3-RELATED   SC22B VESICLE-TRAFFICKING PROTEIN SEC22B  
ENPL ENDOPLASMIN-RELATED  
 
SCAM1 
SECRETORY CARRIER-ASSOCIATED MEMBRANE 
PROTEIN 1  
EST1 LIVER CARBOXYLESTERASE 1-RELATED  
 
SCAM3 
SECRETORY CARRIER-ASSOCIATED MEMBRANE 
PROTEIN 3  
EST1C CARBOXYLESTERASE 1C-RELATED   SCRB2 LYSOSOME MEMBRANE PROTEIN 2  
EST1E CARBOXYLESTERASE 1E   SCRIB PROTEIN SCRIBBLE HOMOLOG  




ALPHA-2,3-SIALYLTRANSFERASE 1  
EST2E PYRETHROID HYDROLASE CES2E   SIAT1 BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE 1  
EST3A CARBOXYLESTERASE 3   SIAT9 LACTOSYLCERAMIDE ALPHA-2,3-SIALYLTRANSFERASE  
EST3B CARBOXYLESTERASE 3   SODC SUPEROXIDE DISMUTASE [CU-ZN]  
FABPL FATTY ACID-BINDING PROTEIN, LIVER   SPA3K SERINE PROTEASE INHIBITOR A3A-RELATED  
FADS1 FATTY ACID DESATURASE 1   STX8 SYNTAXIN-8  
FETUA ALPHA-2-HS-GLYCOPROTEIN   SUOX SULFITE OXIDASE, MITOCHONDRIAL  
FIBA FIBRINOGEN ALPHA CHAIN   SURF4 SURFEIT LOCUS PROTEIN 4  
FIBB FIBRINOGEN BETA CHAIN   SYEP BIFUNCTIONAL GLUTAMATE/PROLINE--TRNA LIGASE  
FIBG FIBRINOGEN GAMMA CHAIN   TFR2 TRANSFERRIN RECEPTOR PROTEIN 2  
FMO1 
DIMETHYLANILINE MONOOXYGENASE [N-OXIDE-
FORMING] 1  
 
TM205 TRANSMEMBRANE PROTEIN 205 
FMO3 
DIMETHYLANILINE MONOOXYGENASE [N-OXIDE-
FORMING] 3  
 
TMED9 
TRANSMEMBRANE EMP24 DOMAIN-CONTAINING 
PROTEIN 9  
FMO5 
DIMETHYLANILINE MONOOXYGENASE [N-OXIDE-
FORMING] 5  
 
TMEDA 
TRANSMEMBRANE EMP24 DOMAIN-CONTAINING 
PROTEIN 10  
FRIL1 FERRITIN LIGHT CHAIN   TPP1 TRIPEPTIDYL-PEPTIDASE 1  
G3P GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE   TRFE SEROTRANSFERRIN  
G6PE GDH/6PGL ENDOPLASMIC BIFUNCTIONAL PROTEIN   TTHY TRANSTHYRETIN  
GANAB NEUTRAL ALPHA-GLUCOSIDASE AB   TXND5 THIOREDOXIN DOMAIN-CONTAINING PROTEIN 5  
GGLO L-GULONOLACTONE OXIDASE   UD11 UDP-GLUCURONOSYLTRANSFERASE 1-1  
GLCM GLUCOSYLCERAMIDASE   UD2A3 UDP-GLUCURONOSYLTRANSFERASE 2A1  
GLMP GLYCOSYLATED LYSOSOMAL MEMBRANE PROTEIN   UDB17 MCG131371-RELATED 
GLTD2 
GLYCOLIPID TRANSFER PROTEIN DOMAIN-CONTAINING 




GLUCOSYLTRANSFERASE 1  
GLU2B GLUCOSIDASE 2 SUBUNIT BETA   UK114 RIBONUCLEASE UK114  
GOGA5 GOLGIN SUBFAMILY A MEMBER 5   VA0D1 V-TYPE PROTON ATPASE SUBUNIT D 1  
GOLI4 GOLGI INTEGRAL MEMBRANE PROTEIN 4   VAMP8 VESICLE-ASSOCIATED MEMBRANE PROTEIN 8  
GRP78 78 KDA GLUCOSE-REGULATED PROTEIN   VATA V-TYPE PROTON ATPASE CATALYTIC SUBUNIT A  
GSTA3 GLUTATHIONE S-TRANSFERASE A3   VATB2 V-TYPE PROTON ATPASE SUBUNIT B, BRAIN ISOFORM  
HA1B 
HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-68 ALPHA 
CHAIN  
 
VATE1 V-TYPE PROTON ATPASE SUBUNIT E 1  
HBE HEMOGLOBIN SUBUNIT EPSILON  
 
VDAC1 
VOLTAGE-DEPENDENT ANION-SELECTIVE CHANNEL 
PROTEIN 1  
HYEP EPOXIDE HYDROLASE 1  
 
VDAC2 
VOLTAGE-DEPENDENT ANION-SELECTIVE CHANNEL 
PROTEIN 2  
HYOU1 HYPOXIA UP-REGULATED PROTEIN 1   VTDB VITAMIN D-BINDING PROTEIN  
IFM3 INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 3  
 
VTI1B 
VESICLE TRANSPORT THROUGH INTERACTION WITH T-
SNARES HOMOLOG 1B  
ITB1 INTEGRIN BETA-1   YBOX1 NUCLEASE-SENSITIVE ELEMENT-BINDING PROTEIN 1  
   YIPF3 PROTEIN YIPF3  
   ZA2G ZINC-ALPHA-2-GLYCOPROTEIN  
 
Table 3.1 B. Proteins identified in MITO +CYTO preparation only 
Gene ID Protein Name  Gene ID Protein Name 





RAB8A RAS-RELATED PROTEIN RAB-8A  
CDC42 CELL DIVISION CONTROL PROTEIN 42 HOMOLOG   RARR2 RETINOIC ACID RECEPTOR RESPONDER PROTEIN 2  
CH60 60 KDA HEAT SHOCK PROTEIN, MITOCHONDRIAL   ROBO2 ROUNDABOUT HOMOLOG 2  
CLC4F C-TYPE LECTIN DOMAIN FAMILY 4 MEMBER F  
 
RTF1 
RNA POLYMERASE-ASSOCIATED PROTEIN RTF1 
HOMOLOG  
COPA COATOMER SUBUNIT ALPHA   S22A1 SOLUTE CARRIER FAMILY 22 MEMBER 1  
DHSO SORBITOL DEHYDROGENASE   SAP3 GANGLIOSIDE GM2 ACTIVATOR  
EGFR EPIDERMAL GROWTH FACTOR RECEPTOR   SNX25 SORTING NEXIN-25  
ESTD S-FORMYLGLUTATHIONE HYDROLASE   SPA3M SERINE PROTEASE INHIBITOR A3A-RELATED 
FAAH1 FATTY-ACID AMIDE HYDROLASE 1   SPA3N SERINE PROTEASE INHIBITOR A3N  
FAM3C PROTEIN FAM3C   STBD1 STARCH-BINDING DOMAIN-CONTAINING PROTEIN 1  
GNAI2 
GUANINE NUCLEOTIDE-BINDING PROTEIN G(I) SUBUNIT 
ALPHA-2  
 
STX12 SYNTAXIN-12  
GRP75 STRESS-70 PROTEIN, MITOCHONDRIAL   TBA1B TUBULIN ALPHA-1B CHAIN  
IC1 PLASMA PROTEASE C1 INHIBITOR   TBB2A TUBULIN BETA-2A CHAIN  
ITIH4 INTER-ALPHA-TRYPSIN INHIBITOR HEAVY CHAIN H4   TERA TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE  
MA2B1 LYSOSOMAL ALPHA-MANNOSIDASE   THRB PROTHROMBIN  
MK07 MITOGEN-ACTIVATED PROTEIN KINASE 7   TIGD2 TIGGER TRANSPOSABLE ELEMENT-DERIVED PROTEIN 2  
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Table 3.1 B (cont.). Proteins identified in MITO +CYTO preparation only 
NEUR1 SIALIDASE-1   TOIP2 TORSIN-1A-INTERACTING PROTEIN 2  
OBSCN OBSCURIN   ULA1 NEDD8-ACTIVATING ENZYME E1 REGULATORY SUBUNIT  
PH4H PHENYLALANINE-4-HYDROXYLASE   UN45B PROTEIN UNC-45 HOMOLOG B  
PON3 SERUM PARAOXONASE/LACTONASE 3   VATG1 V-TYPE PROTON ATPASE SUBUNIT G 1  
PYGL GLYCOGEN PHOSPHORYLASE, LIVER FORM   VIGLN VIGILIN  
 
Table 3.1 C. Proteins identified in MITO + VACA preparation only 
Gene ID Protein Name  Gene ID Protein Name 
AIF1 ALLOGRAFT INFLAMMATORY FACTOR 1  
 
KCNH8 
POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY H 
MEMBER 8  
ALPK2 ALPHA-PROTEIN KINASE 2   LMBD1 LYSOSOMAL COBALAMIN TRANSPORTER-RELATED  
AWAT1 ACYL-COA WAX ALCOHOL ACYLTRANSFERASE 1  
 
MCFD2 
MULTIPLE COAGULATION FACTOR DEFICIENCY PROTEIN 
2  
B2MG BETA-2-MICROGLOBULIN   P20D1 CARBOXYPEPTIDASE PM20D1-RELATED  
CE052 SUBFAMILY NOT NAMED  
 
PGRC2 
MEMBRANE-ASSOCIATED PROGESTERONE RECEPTOR 
COMPONENT 2  
CFAB COMPLEMENT FACTOR B  
 
QCR2 




CONTAINING PROTEIN 2-RELATED  
 
RAB43 RAS-RELATED PROTEIN RAB-43  
CNTP4 CONTACTIN-ASSOCIATED PROTEIN-LIKE 4   RL10A 60S RIBOSOMAL PROTEIN L10A  
CO4B COMPLEMENT C4-A-RELATED   RL23A 60S RIBOSOMAL PROTEIN L23A  
COPG1 COATOMER SUBUNIT GAMMA-1   RL24 60S RIBOSOMAL PROTEIN L24  
CP2J5 CYTOCHROME P450 2J5-RELATED   RL4 60S RIBOSOMAL PROTEIN L4  
DPP2 DIPEPTIDYL PEPTIDASE 2   RL5 60S RIBOSOMAL PROTEIN L5  
DYH5 DYNEIN HEAVY CHAIN 5, AXONEMAL   RN213 E3 UBIQUITIN-PROTEIN LIGASE RNF213  
ECHP PEROXISOMAL BIFUNCTIONAL ENZYME   RS16 40S RIBOSOMAL PROTEIN S16  
ERG24 DELTA(14)-STEROL REDUCTASE   RS4X 40S RIBOSOMAL PROTEIN S4-RELATED  
FRM4A FERM DOMAIN-CONTAINING PROTEIN 4A   SCFD1 SEC1 FAMILY DOMAIN-CONTAINING PROTEIN 1  
GOSR1 GOLGI SNAP RECEPTOR COMPLEX MEMBER 1   STXB2 SYNTAXIN-BINDING PROTEIN 2  
H17B6 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 6   T106B TRANSMEMBRANE PROTEIN 106B  
HRG HISTIDINE-RICH GLYCOPROTEIN   TFR1 TRANSFERRIN RECEPTOR PROTEIN 1  
INT1 INTEGRATOR COMPLEX SUBUNIT 1  
 
TNR19 
TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY 
MEMBER 19  
IRGM1 IMMUNITY-RELATED GTPASE FAMILY M PROTEIN 1   TTBK1 TAU-TUBULIN KINASE 1  
K2C1 KERATIN, TYPE II CYTOSKELETAL 1   UBTD2 UBIQUITIN DOMAIN-CONTAINING PROTEIN 2  
 
Table 3.1 D. Proteins identified in MITO + CYTO + VACA preparation only 
Gene ID Protein Name  Gene ID Protein Name 
ACOD1 ACYL-COA DESATURASE   MAAI MALEYLACETOACETATE ISOMERASE  
ANXA5 ANNEXIN A5   MIF MACROPHAGE MIGRATION INHIBITORY FACTOR  
BAP31 B-CELL RECEPTOR-ASSOCIATED PROTEIN 31  
 
NUA4L 
NADH DEHYDROGENASE [UBIQUINONE] 1 ALPHA 
SUBCOMPLEX SUBUNIT 4-LIKE 2  
BTBD3 BTB/POZ DOMAIN-CONTAINING PROTEIN 3   PGAM1 PHOSPHOGLYCERATE MUTASE 1  
CDC5L CELL DIVISION CYCLE 5-LIKE PROTEIN   PRDX5 PEROXIREDOXIN-5, MITOCHONDRIAL  
CNPY3 PROTEIN CANOPY HOMOLOG 3  
 
QCR1 
CYTOCHROME B-C1 COMPLEX SUBUNIT 1, 
MITOCHONDRIAL  
CP2A5 CYTOCHROME P450 2A13   RL19 60S RIBOSOMAL PROTEIN L19  
CP2BJ CYTOCHROME P450 2B6   RPH3L RAB EFFECTOR NOC2  
CPSM 
CARBAMOYL-PHOSPHATE SYNTHASE [AMMONIA], 
MITOCHONDRIAL  
 
RRBP1 RIBOSOME-BINDING PROTEIN 1  
CT2NL CTTNBP2 N-TERMINAL-LIKE PROTEIN   RS15 40S RIBOSOMAL PROTEIN S15  
DOPD D-DOPACHROME DECARBOXYLASE   SNP23 SYNAPTOSOMAL-ASSOCIATED PROTEIN 23  
EF2 ELONGATION FACTOR 2   SOX10 TRANSCRIPTION FACTOR SOX-10  
ERP29 ENDOPLASMIC RETICULUM RESIDENT PROTEIN 29   STOM ERYTHROCYTE BAND 7 INTEGRAL MEMBRANE PROTEIN 
FOLH1 GLUTAMATE CARBOXYPEPTIDASE 2-RELATED   TBA1A TUBULIN ALPHA-1A CHAIN  
GOGA2 GOLGIN SUBFAMILY A MEMBER 2   TBB5 TUBULIN BETA-5 CHAIN  
GT2D2 
GENERAL TRANSCRIPTION FACTOR II-I REPEAT DOMAIN-
CONTAINING PROTEIN 2A-RELATED  
 
TM14C TRANSMEMBRANE PROTEIN 14C  
LAMA1 LAMININ SUBUNIT ALPHA-1   TMM53 TRANSMEMBRANE PROTEIN 53  
LEG9 GALECTIN-9   TPST1 PROTEIN-TYROSINE SULFOTRANSFERASE 1  




VESICLE TRANSPORT THROUGH INTERACTION WITH T-
SNARES HOMOLOG 1A  
 
Table 3.1: MDV proteomics.  Proteins identified by the MASCOT server and SwissProt database 
were annotated using the PANTHER protein annotation software. Protein names identified by 




Table 3.2 Vesicle-mediated transport proteins 
MITO + CYTO Proteins 
Gene ID Protein Name  Gene ID Protein Name 
CLH1 CLATHRIN HEAVY CHAIN 1  RAB6A RAS-RELATED PROTEIN RAB-6A 
COPA COATOMER SUBUNIT ALPHA  SX22B VESICLE-TRAFFICKING PROTEIN SEC22B 
HYOU1 HYPOXIA UP-REGULATED PROTEIN 1  STX12 SYNTAXIN-12 
LMAN1 PROTEIN ERGIC-53  STX16 SYNTAXIN-16 
MIA3 MELANOMA INHIBITORY ACTIVITY PROTEIN 3  STX8 SYNTAXIN-8 
RAB10 RAS-RELATED PROTEIN RAB-10  TERA TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE 
RAB1A RAS-RELATED PROTEIN RAB-1A 
 
TMEDA 
TRANSMEMBRANE EMP24 DOMAIN-CONTAINING 
PROTEIN 10 
RAB1B RAS-RELATED PROTEIN RAB-1B-RELATED  VAMP8 VESICLE-ASSOCIATED MEMBRANE PROTEIN 8 
RAB2A RAS-RELATED PROTEIN RAB-2A 
 
VTI1B 
VESICLE TRANSPORT THROUGH INTERACTION WITH T-
SNARES HOMOLOG 1B 
     
MITO + VACA Proteins 
Gene ID Protein Name  Gene ID Protein Name 
CLH1 CLATHRIN HEAVY CHAIN 1  RAB2A RAS-RELATED PROTEIN RAB-2A 
COPG1 COATOMER SUBUNIT GAMMA-1  RAB6A RAS-RELATED PROTEIN RAB-6A 
GOSR1 GOLGI SNAP RECEPTOR COMPLEX MEMBER 1  SC22B VESICLE-TRAFFICKING PROTEIN SEC22B 
HYOU1 HYPOXIA UP-REGULATED PROTEIN 1  SCFD1 SEC1 FAMILY DOMAIN-CONTAINING PROTEIN 1 
LMAN1 PROTEIN ERGIC-53  STX16 SYNTAXIN-16 
LMAN2 VESICULAR INTEGRAL-MEMBRANE PROTEIN VIP36  STX8 SYNTAXIN-8 
MCFD2 MULTIPLE COAGULATION FACTOR DEICIENCY PROTEIN 2  STXB2 SYNTAXIN-BINDING PROTEIN 2 
MIA3 MELANOMA INHIBITORY ACTIVITY PROTEIN 3 
 
TMEDA 
TRANSMEMBRANE EMP24 DOMAIN-CONTAINING 
PROTEIN 10 
RAB10 RAS-RELATED PROTEIN-10  VAMP8 VESICLE-ASSOCIATED MEMBRANE PROTEIN 8 
RAB1A RAS-RELATED PROTEIN-1A 
 
VTI1B 
VESICLE TRANSPORT THROUGH INTERACTION WITH T-
SNARES HOMOLOG 1B 
RAB1B RAS-RELATED PROTEIN RAB-1B-RELATED    
     
MITO + VACA + CYTO Proteins 
Gene ID Protein Name  Gene ID Protein Name 
BAP31 B-CELL RECEPTOR-ASSOCIATED PROTEIN 31  RAB6A RAS-RELATED PROTEIN RAB-6A 
CLH1 CLATHRIN HEAVY CHAIN 1  SX22B VESICLE-TRAFFICKING PROTEIN SEC22B 
ERP29 ENDOPLASMIC RETICULUM RESIDENT PROTEIN 29  SNP23 SYNAPTOSOMAL-ASSOCIATED PROTEIN 23 
GOGA2 GOLGIN SUBFAMILY A MEMBER 2  STX8 SYNTAXIN-8 
HYOU1 HYPOXIA UP-REGULATED PROTEIN 1  TMM53 TRANSMEMBRANE PROTEIN 53 
LMAN1 PROTEIN ERGIC-53  VAMP8 VESICLE-ASSOCIATED MEMBRANE PROTEIN 8 
LMAN2 VESICULAR INTEGRAL-MEMBRANE PROTEIN VIP36 
 
VTI1A 
VESICLE TRANSPORT THROUGH INTERACTION WITH T-
SNARES HOMOLOG 1A 
MIA3 MELANOMA INHIBITORY ACTIVITY PROTEIN 3 
 
VTI1B 
VESICLE TRANSPORT THROUGH INTERACTION WITH T-
SNARES HOMOLOG 1B 
RAB10 RAS-RELATED PROTEIN RAB-10    
RAB1A RAS-RELATED PROTEIN RAB-1A    
RAB1B RAS-RELATED PROTEIN RAB-1B RELATED    
     
 
Table 3.2: MDV proteome: Vesicle-mediated transport proteins.  Proteins from all datasets 
were characterized by molecular function and proteins specifically identified functioning in 
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Chapter 4: Intragastric infusion of VacA  
4.1 Introduction 
In order to colonize a host niche and establish an infection, pathogenic bacteria secrete 
effectors that directly modulate host cell physiology. Although the consequences of an infection 
are often well described, the necessity and sufficiency of individual pathogenic effectors, and the 
roles those effectors play for the pathogenesis of a microorganism, remains poorly understood. 
Often, the challenge of investigating the role of an individual pathogenic effector lies in the ability 
to expose tissue in vivo to an effector by a methodology that accurately reciprocates that of a 
natural infection, as often the immediate source of a pathogenic effector is a group of bacteria 
that colonized a given host environment. Frequently, a multitude of studies are conducting in in 
vitro cell culture systems using immortalized animal or human derived cells. Although the cells 
are most certainly not a perfect model of in vivo biology, the importance of these systems cannot 
be understated, and full utilization of cell culture allows for large scale, multi-dimensional studies 
to be completed and thoroughly tested in order to develop a model of the physiological role of a 
given system of study. Furthermore, use of cell culture certainly limits unnecessary 
experimentation on animal models and even human patients. However, in nearly all areas of study 
of basic cell biology and host-pathogen interactions, in vivo studies must be completed in order 
to evaluate the relevance of previous findings established in cell culture. Immortalized cells are 
notorious for having severe heterogeneity in phenotypes between different lines and even in 
slightly different cell culture media and incubation conditions, also with perturbed signal 
transduction pathways, metabolic profiles, and gene transcription regulation. Therefore, there is 
a need to transition from in vitro to in vivo, especially in regards to studying the individual effects 
of a given pathogenic effector in the context of a given infection. Elucidation of the direct effects 
of a pathogenic effector provides a greater understanding of the mechanisms of pathogenesis for 
a given microbe, as well as the dynamics of host-microbe interactions and potential strategies to 
counter and limit an infection and subsequent disease. 
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The human gastric pathogen Helicobacter pylori chronically infects humans by colonizing 
the stomach at the level of the gastric epithelial barrier1-3. A major pathogenic effector of H. pylori 
is the vacuolating cytotoxin (VacA)4, which is a Type 5 secreted toxin that contacts gastric 
epithelial cells5, is internalized into early endocytic compartments6,7, and ultimately localizes to 
the mitochondria and induces mitochondrial dysfunction8-11 and cellular vacuolation12. 
Furthermore, all biological activity of VacA is attributed to its ability to form ion conducting 
channels in the membranes of host cells13-17. Although VacA has been extensively studied in cell 
culture models, the direct contributions that VacA provides to H. pylori pathogenesis in vivo 
remains poorly understood.  
Previous studies have evaluated the role of VacA in vivo by either infecting animal models 
with VacA deficient H. pylori or H. pylori expressing different alleles of VacA, or administering 
purified VacA or VacA containing H. pylori culture supernatants to animals via oral gavage. For 
animal infection experiments, given H. pylori is a human specific pathogen, a considerable 
challenge has arisen in finding an animal model by which not only is H. pylori able to colonize, 
but also where the disease manifestation is similar to that of human infections. By and large, the 
predominant animal used in H. pylori infection experiments is the Mongolian gerbil, as those 
animals best reciprocate the gastric pathology observed in H. pylori infection, including gastric 
ulceration, gastritis, gastric adenocarcinoma, and intestinal metaplasia18-21. In addition, other 
groups have shown promise in using specific germ free CD1, C3H/He, C57BL/6, DBA/2 and 
BALB/c mice22,23. However, in order to achieve colonization after infection, H. pylori used often 
goes through an “adaptation” process, which consists of serial passage of human culture isolates 
of bacteria through an animal, selecting only for those bacteria that were able to colonize, then 
using the same isolated bacteria to infect other animals of the same species23. However, given 
the genetic plasticity and natural competence of H. pylori24,25, even if colonization is achieved in 
a non-human model, a major gap in knowledge and potential confounding variable is how the 
bacteria changed in order to allow them to colonize in a non-human animal model. It is essential 
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that extensive confirmatory studies are conducted in order to evaluate gene expression profiles, 
and to identify whether or not the different virulence factors of H. pylori, including VacA, are 
secreted. Otherwise, studies evaluating the importance of various virulence factors and H. pylori 
as a whole are invalidated, as it is unknown whether or not those factors are present, or if they 
were mutated, differentially regulated, suppressed, inactivated, or absent during infection of a 
non-native host. Nevertheless, during infection experiments of C57BL/6 mice, wild-type (WT) H. 
pylori was able to outcompete H. pylori lacking VacA, suggesting that VacA is important for 
colonization26. However, infection of Mongolian gerbils with either WT or VacA deficient H. pylori 
neither affected colonization nor induction of gastric inflammation20, but it was observed that loss 
of VacA resulted in higher body weights of infected animals compared to infection with wild-type 
H. pylori, and a reduction in gastric ulceration and slight reduction in intestinal metaplasia20. 
Interestingly, loss of VacA also resulted in an elevation of detected carcinoids in the gastric fundus 
glands20, supporting previous indications that VacA is important in mediating the effects of other 
H. pylori toxins. Indeed, one major challenge in the study of the specific effects of VacA are the 
other H. pylori pathogenic effectors and toxins, with the most notable of which being CagA. Most 
of the strains of H. pylori that produce VacA also have the intact Cag pathogencity island, although 
one factor is not necessary for the expression of the other27,28. Therefore, deciphering the 
individual role of a single pathogenic effector by eliminating its expression while in the background 
of other pathogenic effectors poses a considerable challenge to attribute specific functionality to 
a given toxin. Thus, studies are certainly warranted and essential to expose intact tissue to a 
purified toxin. 
For studies that have attempted to evaluate the specific effects of VacA in vivo, an oral 
gavage approach has been utilized. To that end, BALB/c mice were administered 0.25 – 0.5 ml 
of purified VacA, H. pylori culture supernatants, or bacterial lysates following a 24 hour fasting29-
32. Treatments were often re-administered every 24-48 hours for up to 72-96 hours29-32. Under 
these conditions, several histopathological observations were noted, including cellular 
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vacuolation, edema, necrosis, erosion, gastric ulceration, and loss of the gastric gland structure, 
with infiltration of mononuclear cells and mast cells29,31,32. Interestingly, although infection with H. 
pylori is well known to induce robust gastric inflammation, exposure to purified VacA was never 
detected to induce inflammation31. Altogether, in vivo studies of VacA are suggestive that the toxin 
is important for H. pylori colonization and is capable of inducing changes to the gastric mucosa, 
although the nature of how these effects are observed are uncertain.  
Although previous in vivo studies provide essential evidence that VacA is an important 
virulence factor for H. pylori colonization and persistence, the direct effects of VacA in vivo, and 
the necessity and sufficiency of VacA for gastric disease are poorly understood. Although 
promising, the results of the oral gavage in vivo approach must be interpreted under the guise of 
two significant biological limitations, that being the rate by which material transits through the 
stomach, and the gastric mucosal barrier. The gastrointestinal (GI) system is effectively a long 
series of chambers that facilitates the digestion of ingesta. As ingesta is biochemically broken 
down and its composition changes, it moves down the GI tract. GI motility is not a passive process, 
but rather a highly regulated series of muscle contractions coupled with neuroendocrine and 
neurohumoral inputs that respond to not only the size and composition GI contents, but also the 
physiological status of an organism overall33,34. For example, in regards to oral gavage of a liquid 
to a mouse, if 0.25 ml were administered, that volume will not remain in the stomach indefinitely. 
Rather, through an integrated series of inputs, the liquid will pass through the stomach and into 
the duodenum, then subsequently the rest of the GI tract. And indeed, given the importance of 
understanding gastric emptying time, precise measurements and studies have been conducted 
using advanced imaging and tracing modalities, including nuclear magnetic resonance and MRI, 
and nuclear scintigraphy, coupled with the gold standard of tracing phenol red35-38. From this work, 
it was determined that ~50% of solid gastric contents in a mouse remain after 30 min of 
introduction, decreasing to <25% after 60 min35. Liquid contents, however, were much faster in 
passing through the stomach, with ~30% of liquid gastric contents remaining in the stomach after 
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15 min of administration, ~25% remaining after 30 min, and decreasing further to <10% after 60 
min35. Even with repeated gavages every 24-48 hours, it is to be expected that ~75% of orally 
administered VacA will pass out of the stomach within 30 min, with <10% remaining after 1 hour. 
Although fasting of the animals would ensure that the majority of the gastric content after gavage 
is VacA (and not a mix of VacA and ingesta), this approach may hamper exposure time as pure 
liquid content passes through the stomach at a faster rate than if the contents were a mixture of 
gavaged VacA in solution with solid ingesta. Regardless, it is possible that either the <10% of 
initially administered VacA is sufficient to induce severe gastric pathology after 60 min of 
introduction, or the initial higher concentration of VacA is capable of bypassing the gastric mucus 
layer and contacting the gastric epithelium within 15 min before passing into the lower GI tract. 
While these explanations are certainly possible, given a basic understanding of gastric 
physiology, fluid dynamics, and solute diffusion equilibria, it seems reasonable to ascertain that 
during oral gavage, a substantial proportion of administered VacA is not in contact with the gastric 
epithelium, and that the gastric pathology observed may be a simple artifact of biological 
variability.  
In addition to the potential confounding variable of gastric emptying time, the gastric 
mucus layer provides an additional challenge. The gastric mucosa and thus the gastric epithelial 
cells are not in direct contact with the gastric contents. Given the predominant physiological 
function of the stomach is to initiate the digestion of ingested foods through secretion of different 
proteases as well as gastric hydrochloric acid, epithelial cells are protected from the degradative 
gastric lumenal contents through a mucus barrier39-41. The human gastric mucus layer is ~0.7 mm 
in thickness, and is primarily comprised of the MUC1, MUC5AC, MUC6, and MUC16 mucins, as 
well as β–defensins, IgG, IgM, and sIgA41-43. Throughout the GI tract, the mucus layers functions 
as a physical and an immunological barrier to protect the underlying GI epithelial cells from 
environmental exposures, whether it be ingesta, chemicals, or various pathogens42,43. In regards 
to H. pylori, the bacterium is not an acidophile free-living within the gastric contents, but rather a 
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neutrophile that burrows through the gastric mucus layer in order to gain access to the underlying 
gastric mucosa in a relatively higher, more neutral pH44-47, that also being the predominant site of 
VacA secretion. Therefore, the mucus layer in and of itself is a major barrier to the diffusion of 
orally administered VacA to reach the underlying gastric epithelial cells. Conceivably, one would 
ascertain that higher concentrations of VacA, maintained for prolonged periods of time, would be 
required in order to drive the diffusion equilibrium and concentration gradient of VacA from the 
gastric lumen through the mucus layer before achieving biologically relevant concentrations at 
the gastric epithelial cells. Coupling the kinetics of the transit time of gastric contents with the 
barrier of gastric mucus, it is near astonishing that other groups observed severe gastric pathology 
with a limited number of gavages and a relatively short exposure time after treatment. Perhaps 
VacA is more potent in vivo than initially anticipated based on extensive cell culture experiments, 
or perhaps the biologically relevant concentration of VacA in gastric tissue is much lower than 
expected. Or perhaps VacA avidly binds to gastric mucus and is not rapidly passed through the 
stomach. Or perhaps a previously unidentified mechanism facilitates the transport of purified 
VacA through the gastric mucus to the gastric epithelial cells. Regardless of possible 
explanations, based on well-established parameters of fundamental gastric physiology, the oral 
gavage approach raises more questions than answers provided, and poses numerous technical 
and biological concerns regarding the findings observed. Therefore, in order to best evaluate the 
physiological role of VacA in vivo, VacA must be administered via a modality that mimics natural 
infection with H. pylori, with essential factors being a continual, constant, and long-term exposure 
to VacA.  
Here, I report the implementation of an intragastric toxin infusion model48 for evaluating 
the effects of a bacterial toxin in vivo. As H. pylori establishes chronic infections within the human 
stomach, and VacA is continuously secreted into the extracellular space, this modality sought to 
provide a constant, long term exposure to the purified VacA toxin. In order to evaluate the direct 
effects of VacA in vivo by a methodology most representative of natural infection, an intragastric 
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catheter was surgically implanted into the stomachs of mice with an externalized port connected 
to a peristaltic pump, which maintained a constant level of purified VacA within the stomachs of 
mice for prolonged periods of time by direct infusion. Histologically, a collapse of gastric pit 
structure with epithelial degeneration, parietal cell vacuolation, lymphocytic infiltration into the 
gastric mucosa, and depletion of apical gastric mucus were observed, all phenotypes identified 
previously in H. pylori infected stomachs. Furthermore, infusion of purified VacA into the mouse 
stomach resulted in detectable circulating IgM and IgG antibodies against VacA, indicating that 
VacA alone is sufficient to generate an immune response. Altogether, these data support a model 
that during H. pylori infection, VacA contributes to H. pylori pathogenesis by remodeling the host 
gastric environment to create a niche that is suitable for H. pylori colonization and persistence 
within the human stomach.  
 
4.2 Materials and methods 
Bacterial strains. Helicobacter pylori 60190 (cag PAI+, vacA s1/m1; 49503; ATCC) was 
cultured in biphasic media (3 ml of liquid media on top of solid agar media) in bisulfite- and sulfite-
free Brucella broth (BSFB) on Ham’s F-12 (Sigma) agar plates supplemented with 5 µg/ml 
vancomycin (Sigma) and 10% fetal bovine serum (Sigma) for 48 h at 37ºC under microaerophilic 
conditions (5% CO2, 10% O2). Plate supernatants were collected as a starter culture inoculum 
and diluted 1:100 in fresh BSFB supplemented with 5 µg/ml vancomycin and incubated on a 
shaker platform for 48 h at 37ºC under microaerophilic conditions. 
Mammalian cells. AZ-521 (HuTu-80) human duodenal adenocarcinoma derived cells 
were obtained from Riken Japan Health Science Foundation (3940) and were maintained in MEM 
(Fisher Scientific), supplemented with glutamine (2 mM, Fisher Scientific), fetal bovine serum 
(FBS) (10%, Sigma-Aldrich), penicillin (100 U/ml, Fisher Scientific), and streptomycin sulfate (1 
mg/ml, Fisher-scientific). Cells were maintained at 37ºC, 5% CO2, in humidified atmosphere, and 
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passaged with trypsin (0.05%, Corning) for 5 min at 37ºC after cells reached approximately 80% 
confluency.  
Chemicals, reagents and primary antibodies. Unless otherwise noted, all chemicals 
and reagents were purchased from Sigma-Aldrich. The anti-VacA primary antibody was raised in 
lab from New Zealand White rabbits immunized with purified VacA.  
Animal Care. All experiments involving the use of live vertebrate animals were conducted 
with the approval of the University of Illinois at Urbana-Champaign Institutional Animal Care and 
Use Committee. Animal populations were composed of C57BL/6J mice (Jackson Laboratory, Bar 
Harbor ME) bred in-house, and BALB/C mice (Jackson Laboratory, Bar Harbor ME). Animals 
were housed in a climate-controlled (23ºC, 55% humidity) University of Illinois at Urbana-
Champaign animal care unit with a 12h/12h light:dark cycle. Animals were fed a standard 
commercial rodent diet (Envigo, Indianapolis, IN) and allowed access to food and water ab libitum. 
Animals were sib-mated in trios (2 females and 1 male) and were weaned at 22 days of age. At 
the time of all experimental procedures, animals were 5-6 weeks old. Following surgical 
procedures and placement of the intragastric catheter, animals were housed singly for the 
duration of studies.  
Purification of VacA. (Figure 4.1) Culture supernatants were obtained by centrifuging 48 
h H. pylori bacterial cultures (8, 2 liter Erlenmeyer flasks each containing 200 ml of culture) at 
7,000 x g for 30 min at 4ºC. Culture supernatants were precipitated at 90% ammonium sulfate 
(Fisher Scientific) at room temperature for 1 h, then centrifuged at 7,000 x g for 30 min. 
Precipitated protein pellets were resuspended in phosphate buffer (10 mM Na2HPO4 (Sigma), pH 
7.0), then dialyzed in 50,000 MWCO dialysis membrane (Spectrum Laboratories) 1:200 in 
phosphate buffer at 4ºC for 5 h with 4 buffer changes. Dialyzed culture extracts were filter 
sterilized through 0.22 µm pore PES filters (Millipore), and loaded onto a 35 ml bed volume 
diethylaminoethyl (DEAE)-sephacel anion exchange column (GE, Sigma-Aldrich) pre-equilibrated 
with 2 bed volume washes phosphate buffer. The culture extract bound column was washed with 
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2 bed volumes of phosphate buffer, then eluted with phosphate buffer containing elution salt (10 
mM Na2HPO4, 200 mM NaCl (Fisher scientific), pH 7.0). Column eluates were evaluated by SDS-
PAGE and Coomassie staining, and eluates containing pure VacA (as defined by the 88 kDa 
VacA band comprising >95% of total lane bands) were combined and dialyzed in a 50,000 MWCO 
dialysis membrane (Spectrum Laboratories) 1:200 in saline (0.9% NaCl in diH2O) at 4ºC for 5 h 
with 3 buffer changes. Saline dialyzed, purified VacA was filtered sterilized through a 0.22 µm 
pore syringe filter (Millipore), aliquoted into single use vials, and stored at -20ºC. The 
concentration of purified VacA was determined by the BCA protein concentration assay with 
bovine serum albumin (BSA) standards prepared in saline, VacA activity was determined by the 
neutral red vacuolation assay with only purified VacA batches yielding activity within one standard 
deviation of previously established Vac50 values (the concentration of VacA yielding vacuolation 
in 50% of intoxicated cells) being used for experimentation, and the identify of purified VacA was 
confirmed by immunoblotting purified VacA batches separated on a 10% gel by SDS-PAGE and 
transferred to PVDF with detection using rabbit anti-VacA antibodies. 
Protein concentration assay (Figure 4.1B). The concentration of saline dialyzed, filter 
sterilized, purified VacA was determined by the bicinchoninic acid (BCA) protein concentration 
assay kit (Thermo Fisher Scientific) by the manufacturer’s instructions. In brief, standards of 0, 
25, 125, 250, 500, 750, 1000, and 1500 μg/ml of bovine serum albumin (BSA) were prepared in 
saline (0.9% NaCl in diH2O) from 2 mg/ml BSA ampules provided by the kit provided. Standards 
and VacA samples were plated 25 μl per well in a 96 well non-tissue culture treated plate (Fisher 
Scientific) in triplicate. The BCA working reagent was prepared fresh for each concentration 
assay, consisting of a 50:1 dilution of Reagent A to Reagent B in a volume sufficient for 0.2 ml of 
working reagent for each well. After addition of the working reagent, plates were incubated in a 
37ºC incubator, followed by absorbance measurement at 562 nm on a plate reader (BioTek 
Synergy 2, Gen5 software version 1.02.8). A standard curve was plotted as absorbance at 562 
nm versus the concentration of BSA protein (μg/ml) and fitted as a 3rd order polynomial.  
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Acid activation of VacA. Immediately prior to experimentation, single use aliquots of 
saline dialyzed, filter sterilized, purified VacA was thawed and acid activated by incubating VacA 
10:1 in 0.3 M HCl (Fisher) for 30 min at 37ºC in a hot water bath, followed by neutralization with 
an equal volume of 0.3 M NaOH (Fisher) to the volume of 0.3 M HCl used. The acid activated 
VacA was diluted with either cell culture media for cell culture treatments, or saline for animal 
infusions, to the indicated final concentration and immediately used. 
Analysis of cellular vacuolation (Figure 4.1C, D). AZ-521 were cultured in 96 well plates 
at a density of 2.5 x 105 cells per ml of culture volume and allowed to adhere overnight at 37ºC, 
5% CO2, in humidified atmosphere. Cells received the designated experimental treatment in cell 
culture medium containing 5 mM NH4Cl (Sigma) with an experimental set (including technical 
replicates) being performed in duplicate on the same plate for total protein measurement. For 
routine quality control testing of purified VacA, neutral red vacuolation assays were performed for 
4 h. Following experimentation, cells were imaged for visual vacuole formation by light 
microscopy. Following imaging, all cells were washed twice at room temperature with PBS pH 
7.4. The plate was incubated at 37ºC for 4 min with experimental set for vacuolation measurement 
staining in 100 µl per well of Neutral Red solution (Sigma-Aldrich) (diluted 1:5 with PBS pH 7.4) 
and the experimental set for total protein measurement in 100 µl per well of PBS pH 7.4. Following 
staining, all cells were washed three times with PBS pH 7.4 to remove residual neutral red and 
control for washing and cell loss. The experimental set of cells for vacuolation measurement were 
lysed in 100 µl per well of acid alcohol (3.7% HCl, 70% ethanol, in diH2O), and the experimental 
set of cells for total protein measurement were lysed in 25 µl per well of RIPA buffer (Thermo 
Fisher). The plate was incubated for 10 min at room temperature on a shaker platform for cell 
lysis. Subsequently, 200 µl of BCA working reagent (Thermo Fisher) was added per well for the 
total protein measurement experimental set. The entire plate was incubated at 37ºC for 30 min 
for BCA development. For total protein measurement, a set of standards from 1500 µg/ml bovine 
serum albumin (BSA) in RIPA buffer to 25 µg/ml were prepared with 25 μl per well on a separate, 
319 
 
non-tissue culture treated 96 well plate (Fisher Scientific) in triplicate. Neutral red uptake was 
measured at 530 nm and 410 nm on a plate reader (Bio Tek Synergy 2, Gen5), and total protein 
was measured at 562 nm. Data from 3 independently performed biological replicates were 
compiled after the data from each independent biological replicate performed with 3 technical 
replicates were normalized to the respective total protein measurement under the same 
experimental treatment and relativized to the respective untreated control. 
Pure protein, cell culture lysate, and tissue lysate processing for SDS-PAGE and 
immunoblotting. Samples were prepared for immunoblotting using the appropriate denaturing 
buffer for the sample on hand. Purified VacA protein was diluted 1:2 using 2X Laemmli sample 
buffer (Bio-Rad) supplemented with β–mercaptoethanol (Sigma-Aldrich) 1:20 to the 2X sample 
buffer. Samples were boiled at 100ºC for 10 min on a heating block, then used immediately for 
electrophoresis. Cell culture lysates were prepared by washing adherent cells with PBS pH 7.4 
twice, then following removal of PBS, the lysates were collected in 25% of the culture volume of 
lysis buffer (100 mM Tris-Cl, 4% SDS, 0.2% Bromophenol Blue, 20% glycerol, 10% β-
mercaptoethanol, and 50 mM dithiothreitol). Samples were boiled at 100ºC for 10 min on a heating 
block, then aliquoted and stored at -20ºC, or used immediately for electrophoresis. Animal tissue 
lysates were prepared by first weighing pieces of tissue in an analytical balance. The tissue were 
then cut into ~5 mm cubes and placed in a porcelain crucible and overlaid with liquid nitrogen. 
After the liquid nitrogen evaporated and the tissue was frozen, the tissue was crushed using a 
porcelain pestle. To every 100 mg of tissue, 1 ml of RIPA buffer with HALT protease inhibitor 
cocktail (Fisher Scientific) was added and mixed using the pestle. Tissue lysates were collected 
from the porcelain crucible, transferred into a 1.5 ml microcentrifuge tube, and incubated on a 
rotary shaker for 3 h at 4ºC. After incubation, tissue lysates were centrifuged at 750 x g for 15 min 
at 4ºC to pellet heavy membranes and debris. Lysate supernatants were collected, aliquoted, and 
stored at -20ºC. For immunoblotting, samples were diluted 1:2 with 2X lysis buffer (200 mM Tris-
Cl, 8% SDS, 0.4% Bromophenol Blue, 40% glycerol, 20% β-mercaptoethanol, and 50 mM 
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dithiothreitol), boiled at 100ºC for 10 min on a heating block, then used immediately for 
electrophoresis. 
SDS-PAGE and immunoblotting. Following boiling of samples at 100ºC on a heating 
block for 10 min for denaturation, samples were centrifuged at 1000 x g for 15 sec to collect 
condensation. Depending on the molecular weight of the protein target, samples were separated 
on 6-12% polyacrylamide gels at 80-120V for 60-120 min at room temperature via SDS-PAGE. 
Following electrophoresis, samples were immunoblotted to polyvinylidene fluoride (PVDF) 
membranes activated with methanol by wet transfer at 60-80V for 30-60 min at 4ºC. PVDF 
membranes were blocked with 5% milk in Tris-Buffered Saline + Tween (TBS-T: 137 mM NaCl, 
100 mM Tris-base, 0.5% Tween-20, pH 7.6) at room temperature for 1 hour, then incubated in 
the given primary antibody in 1% milk in TBS-T overnight at 4ºC. Membranes were washed with 
TBS-T, then incubated in secondary antibodies conjugated to horseradish peroxidase (HRP) (Cell 
Signaling) at room temperature for 60 min. Membranes were washed with TBS-T, then developed 
with SuperSignal West Femto/Pico Maximum Sensitivity Substrate (ThermoFisher). Images were 
acquired using a ChemiDoc XRS+ system and data were processed with ImageLab software. 
Ex vivo VacA exposure (Figure 4.2, 4.3). Adult C57BL/6 mice aged 6-8 weeks were 
euthanized by CO2 asphyxiation and death confirmed by cervical dislocation. Intact stomachs 
were immediately dissected at the level of the esophagus and proximal duodenum and 
temporarily stored in PBS pH 7.4 on ice. Through the pyloric sphincter, the gastric contents were 
removed by gentle compression of the stomach, then the stomach was flushed twice with PBS 
pH 7.4. The pyloric sphincter was sutured closed with a single circumferential ligature and VacA 
(250 nM) or PBS pH 7.4 was directly injected into the stomach via a 30 G needle and syringe until 
full. Stomachs were submerged and incubated in DMEM at 37ºC, 5% CO2, humidified atm for 4 
h. Upon completion of the incubation, the stomachs were dissected, fixed, and processed for 
paraffin embedding. All experiments were conducted in accordance with the National Institutes of 
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Health Guide for the Care and Use of Laboratory Animals and were approved by the University 
of Illinois at Urbana-Champaign Institutional Animal Care and Use Committee. 
Oral gavage VacA exposure (Figure 4.2, 4.4). Adult C57BL/6 mice aged 6-8 weeks were 
orally administered 200 µl of VacA (250 nM) in PBS pH 7.4 or PBS pH 7.4 by gavage once every 
12 h for 24 h using a feeding needle and syringe (Fisher Scientific). After completion of the gavage 
exposure, mice were euthanized by CO2 asphyxiation and death confirmed by cervical dislocation. 
Stomachs were immediately dissected, fixed, and processed for paraffin embedding. All 
experiments were conducted in accordance with the National Institutes of Health Guide for the 
Care and Use of Laboratory Animals and were approved by the University of Illinois at Urbana-
Champaign Institutional Animal Care and Use Committee. 
Gastric ligature VacA exposure (Figure 4.2, 4.5). Adult C57BL/6 mice aged 6-8 weeks 
were withheld of food for 12 h prior to surgery. Mice were induced under anesthesia with 5% 
isoflurane (Henry Schein) in oxygen for 1 min until loss of righting reflex and nonresponsive to toe 
pinch, then maintained under 1.5% isoflurane throughout the procedure. The ventral abdomen 
was clipped to remove hair and cleaned with 4% chlorhexidine gluconate (Xttrium Laboratories) 
then 10% povidone-iodine (Medline). Mice were administered pre-operative analgesics of 
carprofen (Zoetis) (5mg/kg) and buprenorphine (Par Pharmaceuticals) (0.05 mg/kg) 
subcutaneously along the side of the animal. Using a #15 scalpel blade, a ventral midline 
abdominal incision no more than 1 cm in length was made approximately 0.5 cm caudal to the 
xyphoid process. The subcutaneous tissue and linea alba were similarly incised to open the 
abdominal cavity. The stomach was accessed using low-traumatic DuBakey forceps by gently 
pulling the stomach from under the liver, taking attention not to disturb any vasculature. A single 
circumferential ligature using 6-0 polydiaxanone suture (Ethicon) was placed approximately 0.5 
cm distal to the pyloric sphincter around the duodenum. Using a 30 gauge needle and syringe, 
0.3 ml of treatment solution (PBS pH 7.4 or VacA (250 nM) in PBS pH 7.4) was directly injected 
into the stomach along the greater curvature. The stomach was gently returned to the abdomen 
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using a sterile cotton swab moistened with PBS pH 7.4. The incision site was closed with 
interrupted cruciate sutures using 4-0 polydiaxanone suture (Ethicon) in the abdominal wall 
leaving no more than ~5-10 mm between sutures. Approximately 2-3 drops of bupivacaine 
(0.25%, Hospira) was applied to the abdominal suture as a local block analgesic. The skin was 
closed by approximating the skin edges of the initial incision together and sealing with external 
tissue adhesive (ethyl cyanoacrylate tissue glue; VetBond 3M). Animals were monitored at 2, 4, 
6, 12, and 24 h post-surgery. At 12 h post-surgery, animals received a second dose of 
buprenorphine (0.05 mg/kg, subcutaneously). After 24 h, mice were euthanized by CO2 
asphyxiation and death confirmed by cervical dislocation. Stomachs were immediately dissected, 
fixed, and processed for paraffin embedding. All experiments were conducted in accordance with 
the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were 
approved by the University of Illinois at Urbana-Champaign Institutional Animal Care and Use 
Committee. 
Intragastric catheter design. A polyurethane intragastric catheter was custom designed 
by Norfolk Medical (Access Technologies) (Figure 4.6). The catheter had a ~0.6 mm inner 
diameter with ~1.0 mm outer diameter and was 8 cm in length. The catheter was passed through 
a 0.75 cm diameter polyethylene terephthalate (Dacron®) suture disk for securing the catheter to 
both the stomach wall and the body wall. The suture disk was positioned 0.5 cm from the distal 
end of the catheter and 7.5 cm from the proximal end of the catheter. The distal catheter contained 
a slit valve for placement within the stomach. The assembled catheters were obtained pre-
sterilized with an unattached 23G, 0.5” blunt Luer needle. 
Surgical pack preparation. Sterile surgical instrument packs were prepared within 1 
week of surgery. An individual pack was prepared for every animal to prevent cross-contamination 
between animals and surgeries. All instruments were cleaned immediately following surgery using 
surgical instrument lubricant (JorVet) to remove tissue and bodily fluids, scrubbed, rinsed, and 
allowed to dry. All instruments were carefully evaluated for cleanliness before preparation. Any 
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instruments with debris or appeared rusted were re-cleaned. In a double-layered surgical drape 
were placed 1 pair of 4.5” blunt/sharp Iris scissors, 1 pair of DeBakey vasculary forceps, 1 pair of 
splinter 4.5” eye dressing forceps, 1 #3 scalpel handle, and 1 pair of 5” needle holders. 
Instruments were wrapped with surgical drape twice for an inner and outer layer, autoclaved, and 
allowed to dry and cool prior to use. Sterile surgical disposable packs were assembled for every 
animal to facilitate ease of surgery. Disposable, single use packs included 1 #15 scalpel blade, 1 
29G 3.5” spinal needle (BD Biosciences), 1 14G 1.16” IV catheter (BD Angiocath), 1 pack of 5-0 
RB-1, taper vicryl suture (Ethicon), 1 sterile intragastric catheter (Norfolk Medical, Access 
Technologies), 1 pack of 6.5 sterile surgical gloves (Triumph Medline), and 1 male Luer cap 
(Qosina).  
Surgeon and assistant preparation. All personnel in the surgical room wore a facemask 
and clean laboratory coat. Immediately prior to surgery, the surgeon scrubbed hands and 
forearms with a surgical scrub brush and chlorhexidine surgical scrub. Hands and arms were 
rinsed, dried, and the surgeon wore a clean laboratory coat. Sterile surgical gloves were used for 
each individual animal, with gloves being discarded between surgeries, if multiple surgeries were 
performed in one day. The surgical bench area was pre-cleaned and incorporated an air 
scavenger unit to prevent personnel exposure to isoflurane.   
Surgical placement of intragastric catheter (Figures 4.7, 4.8). Anesthesia was induced 
in adult 5-7 week old C57BL/6 or BALB/C mice in an induction chamber with 5% isoflurane (Henry 
Schein) in oxygen for 1 min until loss of righting reflex and lack of response to toe pinch were 
noted. Anesthesia was then maintained on a nose cone with 1.5% isoflurane, and animals were 
placed on a heating pad to maintain body temperature throughout the procedure. The ventral 
abdomen (caudal to the xiphoid process and cranial to the pelvis), left thorax and abdomen 
(caudal to the left scapula and cranial to the 13th rib), and cervical area (caudal to the occipital 
bone and cranial to the scapula) were clipped to remove larger hairs, and shaved to provide a 
clean surgical site. Clipped regions were cleansed with 4% chlorhexidine gluconate (Xttrium 
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Laboratories) followed by 10% povidone-iodine (Medline), each using sterile gauze. Mice were 
administered pre-operative analgesics of carprofen (Zoetis) (5 mg/kg) and buprenorphine (Par 
Pharmaceuticals) (0.05 mg/kg), and antibiotics of cefazolin (West-Ward Pharmaceutical) (20 
mg/kg) subcutaneously on the animal’s right side using a 23G needle and 1 ml syringe. The 
animal was placed in dorsal recumbency, and using a #15 scalpel blade, a ~1 cm midline 
celiotomy was performed beginning just caudal to the xiphoid process. Using DeBakey forceps, 
the skin was gently dissected from the underlying linea alba. Using blunt/sharp Iris scissors, a ~1 
cm incision was made in the body wall exposing the abdominal cavity. Using Debakey forceps, 
the stomach was gently exteriorized from the abdominal cavity. Sterile saline was applied to 
internal organs as needed to prevent desiccation. A 29G 3.5” spinal needle (BD Biosciences) was 
inserted into the intragastric catheter (Norfolk Medical, Access Technologies) primed with sterile 
saline, exposing the distal aspect of the needle through the distal end of the catheter. The stomach 
was manually stabilized with DeBakey forceps and punctured along the greater curvature of the 
forestomach ~3-5 mm proximal to the margo plicatus with the spinal needle, and the gastric 
catheter was inserted over the needle into the stomach, thus permitting minimally-invasive, 
intragastric placement of the catheter while also minimizing leakage of gastric contents into the 
abdominal cavity. The intragastric catheter was secured to the serosa of the forestomach by 
applying a ~10 µl drop of sterile internal cyanoacrylate tissue adhesive (GLUture, Norfolk Medical, 
Access Technologies) to one side of the suture disk and applying gentle pressure to distribute the 
adhesive across the disk to serosa interface. The catheter was held with gentle pressure to the 
stomach for 10-15 sec to allow adhesion. Secure placement of the catheter to the stomach was 
confirmed by gently pulling on the catheter and examining for areas of separation between the 
suture disk and the gastric serosa. If areas of separation were observed, ~2-5 µl of tissue 
adhesive was reapplied as needed. After the suture disk was fully adhered to the forestomach, 
the spinal needle was removed and the stomach with attached catheter were gently returned to 
the abdominal cavity using a sterile cotton swab moistened with sterile saline. The patency of the 
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intragastric catheter was checked by flushing the catheter from the free proximal end with sterile 
saline. The animal was rotated to right lateral recumbency, and using DeBakey forceps, the fascia 
between the skin and body wall was gently dissected along the entire left side of the animal to the 
cervical area just caudal to the ears. Approaching from the subcutaneous space, a 14G I.V. 
catheter (BD Biosciences) was used to puncture only the body wall approximately 1 cm left and 
dorsal to the ventral celiotomy. With the 14G I.V. catheter held in position passing through the 
body wall, the free proximal end of the intragastric catheter was then passed into the 14G I.V. 
catheter. Gently, the whole assembly of the intragastric catheter held within the 14G I.V. catheter 
was pulled through the body wall, effectively passing the intragastric catheter from the abdomen 
through the body wall and into the subcutaneous space while minimizing the opening through the 
body wall. The 14G I.V. catheter was removed, leaving the proximal free end of the intragastric 
catheter in the subcutaneous space. The positioning of the intragastric catheter was examined 
from the abdominal cavity, with particular care to avoid pinching of the liver between the suture 
disk and the body wall. After ensuring the attachment area was clear, a ~10 µl drop of internal 
cyanoacrylate tissue adhesive was placed on the free side of the suture disk, and the disk and 
stomach were brought into apposition with the body wall by gently pulling on the proximal free 
end of the intragastric catheter from the subcutaneous space and pressure was maintained for 
10-15 sec to allow for adhesion. The area surrounding the suture disk was examined to ensure 
portions of the liver were not attached, and that the suture disk to body wall interface was secure. 
After attachment of the stomach to the body wall via the suture disk, DeBakey forceps were placed 
within the previously opened subcutaneous space from the celiotomy to the prepared cervical 
surgical site. While holding the DeBakey forceps in place underneath the skin, the dorsal neck 
just caudal to the ears was punctured with a 14G I.V. catheter, and the I.V. catheter was advanced 
along the DeBakey forceps towards the celiotomy to minimize trauma to the underlying tissue. 
Upon visualization of the distal end of the 14G I.V. catheter from the animal’s ventral surface, the 
DeBakey forceps were removed from the subcutaneous space. While holding the 14G I.V. 
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catheter in position, the proximal end of the intragastric catheter was inserted into the 14G I.V. 
catheter, and the whole assembly of the intragastric catheter within the 14G I.V. catheter was 
pulled through the subcutaneous space and exteriorized through the dorsal skin puncture, thus 
positioning the free proximal end of the intragastric catheter at the dorsal external port of the 
animal. After evaluating proper positioning of all components of the intragastric catheter and 
evaluating for any trauma or hemorrhage due to the surgery, the abdominal wall incision was 
closed with an interrupted cruciate suture pattern with 5-0 vicryl suture with RB-1 taper point 
needle (Ethicon), leaving no more than 2-3 mm of space between sutures. Approximately 2-3 
drops of 0.25% bupivacaine (Hospira) were applied to the sutured incision as a local anesthetic. 
The abdominal skin was apposed by approximating the edges and applying external 
cyanoacrylate tissue adhesive (VetBond, 3M) and allowing 30-60 sec for adherence and drying. 
After confirming complete closure of the abdominal incision, the animal was rotated into sternal 
recumbency, and a 23G 0.5” blunt Luer needle primed with sterile saline was inserted into the 
proximal end of the exteriorized intragastric catheter and capped with a male Luer cap. The 
assembly was then secured to the mouse’s dorsum using a single 5-0 vicryl suture at the Luer 
needle hub. The dorsal skin puncture and sutured area were treated with topical application of 
0.25% bupivacaine as a local anesthetic, and the external port assembly was secured with 
external cyanoacrylate tissue adhesive and a light thoracic wrap. Animals were recovered from 
anesthesia on heating pads until active, then placed in a clean cage with cob bedding and 
monitored for at least 30 min and assessed for mobility and pain. If recovery was successful, 
animals were individually housed in cob bedding cages with 50% of the cage placed on a heating 
pad, and animals were provided ground level, moistened food daily to facilitate ease of access to 
fresh food and water with assisted thermoregulation. Immediately following surgery, animals were 
monitored every 2 h for the first 12 h, then every 12 h for the 2-3 week recovery period by the 
same individual to provide consistency in evaluation. Monitoring consisted of weighing the mouse 
for changes in body mass and food and water consumption, observing the incision site for 
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complications (dehiscence, inflammation, infection), and evaluating for pain and stress. Pain and 
stress was assessed by observing for normal mouse behavior, including decreased grooming, 
piloerection, hunched posture, and squinted eyes. A score from 0-10 was assigned at each 
monitoring session (0 = no pain or stress observed, 10 = severe pain or stress observed). If a 
score of 5-8 was observed, a licensed lab animal veterinarian was immediately consulted for the 
proper course of action. If a score of 9-10 was observed, the animal was immediately removed 
from the study and euthanized by CO2 asphyxiation with death confirmed by cervical dislocation. 
Monitoring consisted of 3 sub-scores to sum to the final pain score: pre-handling observation (0-
4) assessed unaltered mobility, grooming, posture, and breathing; handling observation (0-4) 
assessed responsiveness to being handled and natural exploring behavior; and weighing (0-2) 
assessed trends in body weight, with >5% loss of body weight between any monitoring sessions, 
or >10% loss of initial body weight being considered severe points of concern. Animals received 
a second and third dose of buprenorphine (0.05 mg/kg, subcutaneously) at 12 h and 24 h after 
surgery. Animals received additional analgesia, antibiotic, or hydration therapy at the discretion 
of a licensed lab animal veterinarian of the University of Illinois Division of Animal Research if 
monitoring scores detected any issues or trends of decline. Once a day during the monitoring 
period, the catheters were flushed with 50 μl of sterile saline in order to maintain patency of the 
catheter and to check for blockage. All experiments were conducted in accordance with the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved 
by the University of Illinois at Urbana-Champaign Institutional Animal Care and Use Committee. 
Infusion system design (Figure 4.9). The infusion system consisted of a custom built, 
six-chambered acrylic reservoir equipped with 0.22 µm filters and Luer adaptors, each chamber 
measuring 2 cm x 2 cm x 7 cm with a total volume capacity of ~28 ml. The reservoir was connected 
to silicone peristaltic pump tubing (inner diameter 1.0 mm, outer diameter 3.0 mm; Langer) using 
Luer fittings. The silicone tubing was passed through a 6-roller pump head connected to a 
peristaltic pump (BT100-2J, Langer Instruments). After passing through the pump, the silicone 
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tubing was connected to polyurethane tubing (inner diameter 1.6 mm, outer diameter 3.1 mm, 
Nordson), and the polyurethane tubing was passed through a cage swivel assembly (SAI infusion 
technologies) fixed atop the animal’s cage. The tubing was then attached to the blunt needle Luer 
port on the cervical area of the animal. The peristaltic pump was controlled locally by a laptop 
(Acer) with a custom written Python program. The program inputs include initial fill volume and 
time, and maintenance fill volume, time and interval. Two programs were designed, an acute 
exposure maintained the stomachs ~95% full for up to 3 days (initial infusion bolus of 200 µl over 
5 min, re-infuse with 50 µl over 1 min every 30 min) and a chronic exposure maintained the 
stomachs ~50% full for up to 30 days (initial infusion bolus of 100 µl over 1 min, then re-infuse 
with 50 µl over 1 min every 45 min). 
Intragastric infusion. The infusion chamber and lines were prepared by clearing with 
70% ethanol for 1 h at 2 RPM followed by sterile saline for 1 h at 2 RPM. All lines were primed 
with the designated infusion treatment prior to attaching the lines to an animal. Animals with patent 
catheters and no signs of distress that had recovered by 2-3 weeks after surgery were attached 
to the infusion line by connecting the primed infusion line to the Luer port on the neck of the 
animal. Animals were singly housed with 50% of the cage on a heating pad with ad libitum access 
to food and water during the infusion. Animals were monitored every 12 h for the duration of the 
infusion by the same parameters discussed for post-surgical monitoring. Upon completion of the 
infusion, animals were euthanized by CO2 asphyxiation and death was confirmed by cervical 
dislocation in accordance with the American Veterinary Medical Association and the National 
Institutes of Health Office of Laboratory Animal Welfare Euthanasia Guidelines. Tissues were 
immediately collected and processed for tissue lysates or histology. 
Paraffin embedded tissue processing. The stomach, intestines, esophagus, spleen, 
and liver were collected from euthanized animals. The forestomach was removed, and the gastric 
contents were collected for tissue lysate processing. The glandular portion of the stomach was 
cut along the greater curvature from the margo plicatus to the pyloric sphincter using blunt/sharp 
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Iris scissors. The stomach was opened flat and cut in half, and one half of the stomach was 
processed for cryo-embedding and tissue lysates. The remaining half of the stomach was placed 
flat between biopsy pads in an embedding cassette (Fisher scientific). The esophagus remained 
intact and was placed in an embedding cassette. The liver and spleen were cut in half, with one 
half being placed in an embedding cassette, and the other half cut into ~ 100 mg pieces for tissue 
lysates. The intestines, from the proximal duodenum to the caudal colon, were dissected from the 
mesentery and were cut open longitudinally along the antimesenteric surface. The tissue was 
fixed in Bouin’s fixative (15:5:1 saturated picric acid (Sigma) : 40% formalin (Sigma) in 0.1M 
phosphate buffer : glacial acetic acid (Fisher Scientific)) at room temperature for 4 h. The stomach 
was removed from the biopsy pad and the liver, spleen, and esophagus continued processing in 
embedding cassettes. All tissues were dehydrated in a series of 1 h washes with gentle shaking 
in 50%, 70%, 90%, 95%, and 100% ethanol twice, with dilutions prepared in PBS pH 7.4. After 
ethanol washes, the intestines were rolled by the “Swiss Roll” method49,50. In brief, the proximal 
end of the opened intestine was grasped with fine, smooth tipped forceps. Then with gentle 
rotation and the mucosal surface facing outwards, the intestines were slowly wrapped along the 
developing roll. The completed roll was secured by placement of one 30G needle longitudinally 
through the diameter of the roll. Following the ethanol dehydration series, the tissues were cleared 
by two incubations in 100% xylene washes at room temperature for 1 hr with gentle shaking. The 
tissue was infiltrated in 2, 30 min washes in molten paraffin (maintained at ~67°C in an incubator) 
(Fisher Scientific), and embedding in tissue blocks. Tissue sections were cut to 5 – 15 μm thick 
using a microtome (Leica RM 2255 rotary microtome) and applied to charged microscope slides 
(Globe Scientific). Cut tissue sections on slides were dried overnight at 37ºC then stored at room 
temperature. 
Cryo-embedded tissue processing. The stomach was collected from euthanized 
animals. The forestomach was removed from the glandular portion of the stomach, and the 
stomach was cut open along the greater curvature from the margo plicatus to the pyloric sphincter. 
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The gastric content was removed and the stomach was opened flat and cut in half, with one half 
of the stomach being processed for paraffin embedding. The remaining half of the stomach was 
placed in M1 embedding matrix (Thermo Fisher) in a cryo-embedding mold (Fisher Scientific). 
The tissue in embedding media was frozen by placing the embedding mold into 2-methylbutane 
chilled with dry ice. After the tissue became frozen, blocks were stored at -80°C. Sections were 
cut using a cryostat (Leica CM3050 S cryostat) and placed on charged microscope slides (Globe 
Scientific) and stored at -20ºC. 
H&E and PAS staining. Cut tissue sections embedded in paraffin were deparaffinized 
and hydrated through a series of 3 min washes from xylene (3 times), 1:1 xylene:ethanol, 100% 
ethanol (twice), 95% ethanol, 70% ethanol, and 3 dips in PBS pH 7.4. For H&E staining, hydrated 
tissue slides were stained in Gills 1 hematoxylin (Sigma) for 6 min, washed with tap water, dipped 
in acid alcohol (1% HCl, 70% ethanol) 3 times, washed with tap water, dipped in ammonia water 
(0.1% ammonium hydroxide) 5 times, washed, stained in Eosin for 1 min, and rinsed. For PAS 
staining, hydrated tissue slides were oxidized in 0.5% periodic acid for 5 min, washed with tap 
water, incubated in Schiff reagent (EM biosciences) for 15 min, washed, then counterstained in 
Mayer’s hematoxylin (Sigma) for 1 min, and washed. Stained slides were dehydrated and cleared 
through a series of 2 min washes from 95% ethanol (2 times), 100% ethanol (2 times), 1:1 
xylene:ethanol, and xylene (3 times). Slides were mounted in CytoSeal mounting media (Thermo 
Fisher), coverslipped, and allowed to dry. Slides were imaged by light microscopy and digitized 
by scanning (NanoZoomer, Hamamatsu) with image analysis using the NDP.view2 software 
(Hamamatsu). 
Fluorescence microscopy. All fluorescently stained tissues were imaged using a Nikon 
A1 laser confocal microscope with exposure conditions held constant between tissue imaging. 
Images were deconvoluted using AutoQuantX, with the fixed PSF (non-blind) theoretical PSF 




Statistical analysis. All infusions were performed with three independent replicate blocks with 
three replicate animals per block. Animals within one replicate block received surgeries on the 
same day as a surgical set and monitored collectively. For pairwise comparisons, significance 
was determined using a 2-tailed distribution, paired t test. For multiple comparisons, significance 
was determined using a one-way ANOVA with Tukey correction for multiple comparisons. Unless 
otherwise indicated, statistical significance was signified by an alpha level threshold of 0.05. Error 
bars from quantification datasets represent standard error of the mean (SEM). For all statistical 
analyses, Graphpad Prism (version 6.01) was used. 
 
4.3  Results 
4.3.1  In vivo evaluation of VacA function 
 The evaluation of the role a pathogenic effector plays in vivo poses a considerable 
challenge. The predominant hurdle to overcome is in reciprocating natural infection or exposure 
to a pathogenic effector while also in the absence of the pathogen and all other pathogenic 
effectors. Upfront this issue may not appear as stark. However, the approach would first and 
foremost require the ability to purify a given pathogenic effector in the absence of all other factors, 
ideally with the purification occurring from the actual pathogen and not a non-native, 
overexpression vector. Furthermore, pathogens establish infections where host tissue is exposed 
to toxins for relatively prolonged periods of time, which raises the question of how a toxin’s 
exposure levels could remain elevated without a pathogen being present to continually secrete 
the toxin. Often, the evaluation of the importance of a pathogenic effector in vivo is accomplished 
through the use of genetic mutants of a pathogen lacking the ability to express a pathogenic 
effector gene. However, unless a phenotype is known to be specific to a pathogenic effector, the 
use of genetic mutants is limited to the detection of a loss of phenotype, rather than the induction 
of a phenotype compared to an untreated control. Furthermore, biological complexity arises in 
that virulence factors may interact with one another either directly, or indirectly through 
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modulations of host cellular physiology, and some effectors exert similar effects to a host. 
Therefore, an important model system to develop in the study of host-pathogen interactions is the 
exposure of an animal model to only the purified pathogenic effector of interest via a modality that 
reciprocates natural infection.  
 In order to evaluate the importance of VacA in vivo, previous studies have utilized standard 
animal models. By oral gavage of purified VacA (2 gavages, 24 h apart) of BALB/c mice, it was 
observed that VacA treatment resulted in cellular vacuolation, immune cell infiltration, edema, and 
necrosis29. Oral gavage of crude H. pylori extracts from various toxigenic strains (1 gavage, 48 h 
exposure) indicated that VacA is important for inducing damage to the gastric mucosa, but was 
not involved in initiating inflammation30. By infection of C57BL/6 mice with wild-type or VacA 
deficient H. pylori, it was observed that wild-type H. pylori was able to outcompete mutant H. pylori 
deficient in VacA26,51. These data were interpreted that VacA is important for colonization, and 
potentially dissemination of H. pylori between hosts.  
Although an oral gavage of VacA yielded positive results, an issue lies in the transit time 
and structure of the stomach. As gastric contents become broken down into smaller components, 
the material passes into the intestines. The rate at which material moves through the stomach 
depends on the size and composition of the material, and the species of animal. For mice, it was 
observed that after 15 min, approximately 30% of liquid gastric material remained in the stomach, 
and approximately 65% of solid gastric material remained in the stomach35. Furthermore, after 1 
h <10% of liquid and solid material remained in the stomach35. In addition, the stomach contains 
a double-layered mucus protective barrier for epithelial cells from the acidic lumen of the 
stomach52. This mucus layer consists of an outer layer (towards gastric lumen) that is less dense 
and not attached to cells, and an inner layer that is more dense, attached to cells, and serves as 
a barrier to the diffusion of gastric HCl52. In regards to VacA, VacA is produced by the Type 5 
secretion system, and is easily purified in high yield with biological activity directly from H. pylori 
culture supernatants53,54 (Figure 4.1). Therefore, by an oral gavage approach, it is expected that 
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approximately 50% of the administered VacA is to remain in the stomach after 10-25 min, and the 
remaining VacA must then diffuse across the dense gastric mucus layer. Given H. pylori 
establishes a chronic infection within a human host, it is expected that the exposure of gastric 
tissue to VacA is a chronic exposure as well, as the expression of VacA does not appear to be 
differentially regulated, and thus the short term exposure of gastric tissue to VacA is unlikely to 
be representative of natural infection and toxin exposure.  
In order to evaluate the in vivo effects of VacA, four different approaches were attempted 
(Figure 4.2). First, an ex vivo approach (Figure 4.3) consisted of euthanizing an animal, 
harvesting the stomach, then directly exposing the gastric tissue to VacA by directly injecting 
purified VacA into the stomach lumen. This approach is attractive in that it provides a constant 
exposure to the toxin as well as the flexibility to treat the stomach tissue directly with compounds 
that may otherwise be toxic to a living animal. However, the ex vivo approach is limited in the 
length of time for incubation and the viability of the tissue, as once the animal is euthanized and 
the stomach is excised, the blood supply and nerve innervation is lost and the tissue begins to 
autolyze. As an alternative, the previously used oral gavage approach (Figure 4.4) was indeed 
attempted. Oral gavage consists of oral administration of the toxin, and allows for VacA exposure 
to occur while an animal is alive and thus the gastric tissue is viable and would respond similarly 
to an infection with H. pylori. However, as described previously, the oral gavage approach is 
limited by the relatively rapid transit time of the stomach and the gastric mucus barrier, resulting 
in a small percentage of toxin administered reaching the gastric mucosa. Although repeated 
gavages may be conducted, the procedure of gavage is traumatic to an animal as it involves 
forcing a feeding needle into the esophagus of an awake mouse. This process is stressful and 
risks trauma, tearing, or perforation of the esophagus or accidentally administering a treatment 
into the lungs. Therefore, oral gavages are only re-administered once every 12 h to minimize 
harm to an animal. Given this limitation of repeated exposures to maintain higher levels of VacA 
within the stomach, a gastric ligature approach (Figure 4.5) was also attempted. The gastric 
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ligature modality consisted of surgically blocking the passage of material through the stomach by 
placing a single circumferential suture around the proximal duodenum. VacA was then directly 
injected into the stomach lumen, and the mouse was allowed to recover from surgery and live 
with the blocked stomach for 24 h prior to tissue processing. Although this approach provided 
both of the benefits of the ex vivo approach by containing VacA within the stomach, as well as 
the oral gavage approach by allowing the stomach to remain in a living animal, this approach 
severely perturbed gastrointestinal physiology by blocking the passage of material through 
stomach. The final approach sought to combine the benefits of all approaches, whereby high 
levels of VacA are maintained within the stomach of a live animal with minimal disruption of normal 
gastrointestinal physiology. To accomplish these parameters, an intragastric toxin infusion model 
was utilized (Figures 4.6, 4.7, 4.8, 4.9), consisting of the surgical placement of a catheter into the 
stomach of an animal, where VacA is continually infused over time, constantly replenishing any 
VacA that passes through the stomach into the intestines. This approach provides a direct, 
continual exposure to the stomach in a live animal without negatively compromising the health 
and physiology of the animal.  
 
4.3.2  Ex vivo exposure of gastric tissue to VacA  
 The evaluation of a toxin or particular compound of interest is often limited in animal 
models given concerns of toxicity. In addition, it is difficult to develop a system that maintains a 
constant exposure to a given agent, due to the transit or clearance through a particular tissue or 
organ. Therefore, ex vivo approaches have been developed, whereby an animal is euthanized 
and a given tissue of interest is collected and maintained in culture55-57. Given the tissue of interest 
is removed from an organism, the blood supply and nerve innervation are removed, and thus 
tissue begins to degrade if not maintained properly. For the stomach, an oxygenated Earle’s 
Hepes buffer has been used, with the stomach being continually flushed with oxygenated solution 
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(95% O2, 5% CO2)55. However, for relatively shorter conditions, standard cell culture media and 
incubation conditions may be utilized. 
In order to evaluate the effects of VacA in an ex vivo model, stomachs from adult C57BL/6 
mice were obtained following euthanasia. The gastric contents were removed by applying gentle 
pressure to the gastric mucosa, followed by flushing of the stomach with sterile PBS pH 7.4 
(Figure 4.3). The stomach was sutured closed at the pyloric sphincter, and 0.3 ml of purified VacA 
or control PBS pH 7.4 was directly injected into the stomach. The stomach was then incubated at 
37ºC, 5% CO2, humidified atm for up to 4 h. Stomach tissue was then fixed, embedded in paraffin, 
and processed for histology. Hematoxylin and Eosin (H&E) staining indicated significant damage 
to the gastric mucosa upon exposure to VacA (Figure 4.10A). Gastric pit structure was 
degenerated upon VacA treatment, with significant shortening of the gastric mucosa. However, it 
is to be noted that the control, untreated tissue lacked healthy gastric pit structure, as the gastric 
mucosa appeared disorganized with numerous areas clearance, indicating autolysis. Upon 
staining tissue by anti-VacA immunohistochemistry and metal-enhanced diaminobenzidine (DAB) 
reaction, immune-reactive material was detected in the VacA treated tissue, as indicated by dark 
staining aggregates (Figure 4.10B). Given the heterogeneity and depth by which VacA was 
detected within the gastric mucosa, as well as the severe disruption of the gastric mucosa, it 
stands to reason that the tissue become autolytic may provide an artifact by which VacA is able 
to non-specifically interact with the dying gastric tissue. Furthermore, the thickness of the gastric 
mucosa appears relatively thinned, indicating that perhaps the stomachs were overfilled when 
VacA or PBS was administered, resulting in stretching of the gastric mucosa and rendering any 
reliable interpretation of tissue that underwent this treatment inconclusive. Regardless of 
background autolysis within the ex vivo gastric tissue, upon examination of the gastric tissue by 
phase contrast microscopy and H&E staining, it was observed that the gastric acid secreting 
parietal cells were vacuolated in the VacA treated stomachs (Figure 4.10C). Vacuolar change is 
a common phenomenon observed in severely stressed cells, so it remains to be determined from 
336 
 
a relatively small set of ex vivo gastric tissue treatments whether or not the vacuolation is VacA 
specific, or indicative of greater cellular stresses within that given tissue, either due to VacA, or 
due to the experimental modality. 
In summation, these data support previous findings that VacA induces damage to the 
gastric mucosa29. However, the H&E staining also revealed that the control gastric mucosa was 
severely damaged, albeit to a lesser extent compared to VacA treatment. Given tissue autolysis 
initiates soon after euthanasia, especially within gastrointestinal tissues given the robust digestive 
environment with extensive microbiota, a background level of damage and degeneration was 
expected. However, it remains to be determined whether or not the severity of background gastric 
mucosal damage and autolysis is a major confounding variable for the application and further 
implementation of this model system. In order to address any potential limitation due to time, 
shorter incubations may be utilized (less than 4 h). Given VacA localizes to the mitochondria 
within 0.5-1 h and may induce visible vacuolation within 2-4 h, shorter incubation times may 
certainly yield insight into the initial responses of gastric tissue to VacA exposure. If longer 
exposures are warranted and the flexibility of an ex vivo approach is needed (for treatments that 
cannot occur in a living animal), alternative ex vivo modalities have been utilized, including 
isolation of gastric primary cells58,59 or the relatively newer methodology of gastric organoids60-62. 
Given a fundamental goal in the study of VacA and H. pylori infection is to understand the effects 
VacA exerts on gastric tissue and the role of VacA in H. pylori pathogenesis, longer timepoints of 
exposure are required, as H. pylori does not establish <4 h infections, but rather, chronic, lifelong 
infections in the absence of medical intervention. Therefore, a true in vivo approach was sought 
whereby tissue is not extracted from an animal.  
 
4.3.3  Oral gavage of VacA to mice  
 For the administration of agents targeting the gastrointestinal tract, an oral gavage is a 
simple and effective method. Oral gavages are routinely used for the administration of bacteria to 
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colonize the gastrointestinal tract, such as Salmonella enterica or Escherichia coli63,64, or various 
medications, such as antibiotics, nutritional supplementation, or anti-inflammatory agents that are 
easily absorbed65-67. Previous studies have used an oral gavage approach to evaluate the effect 
of VacA on gastric tissue in vivo29, where it was observed that administration of VacA alone is 
sufficient to induce gastric mucosal damage as indicated by ulceration, mononuclear cell 
infiltration, and erosion.  
Given the incubation considerations and issues of autolysis in an ex vivo approach, the 
oral gavage method was next tested as a means to evaluate the effect of VacA in vivo (Figure 
4.4). Adult, C57BL/6 mice were orally administered 0.1 ml of purified VacA (250 nM) or PBS pH 
7.4 control, with a second gavage 12 h later. The volume of 0.1 ml was used as it is estimated to 
be ~50% of the mouse stomach volume, and has been previously reported by other groups. At 
24 h after the first gavage, animals were euthanized and the stomachs were collected, fixed, and 
embedded in paraffin and processed for histology. By H&E staining, no significant abnormalities 
were observed (Figure 4.11). With the VacA gavage, possible mononuclear cell infiltration may 
be observed as darkened nuclei throughout the gastric mucosa, however, the same material is 
observed within the control mucosa, although the distribution appears more localized to the mid-
gastric pit region. Given the tissues obtained from the oral gavage method were fixed in Carnoy’s 
fixative instead of formalin, it is possible that the dark staining material is simply precipitated debris 
within the tissue.  
If the mononuclear cell infiltration is a true phenotype, then this finding supports previous 
reports of VacA oral gavage29. However, given the known transit time of the stomach, as well as 
the physical barrier of VacA bypassing the gastric mucus, a major and significant concern 
remained whether the exposure of gastric tissue to VacA is not only occurring, but whether or not 
it is representative of exposure conditions during H. pylori infection. If an oral gavage approach is 
required for a given experimental setup, then increased dosages and repeated gavages should 
be warranted in order to maintain higher levels and constant exposures to VacA. However, care 
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must be taken to ensure damage is not induced due to repeated gavages. In order to better 
evaluate the in vivo effects of a gastric toxin, not only are exposures within a living animal model 
warranted, but the amount of toxin being exposed to the tissue should remain constant in order 
to mimic a natural infection exposure of VacA. 
 
4.3.4  Gastric ligature and VacA exposure 
 The ex vivo approach is beneficial in that the stomach is sealed to form a closed structure 
whereby administered VacA is able to exert its toxic effects, while the oral gavage approach is 
beneficial in that the toxin is being administered to a live, healthy animal. Therefore, an ideal 
model is one where toxin levels are maintained within the stomach of a live animal for prolonged 
periods of time. In order to increase the exposure and contact time of gastric tissue to 
administered VacA, the passage of material through the stomach was blocked by performing a 
modification to the classic ileal loop assay68, which is here termed the gastric ligature approach 
(Figure 4.5). The gastric ligature involves placing a single suture around a portion of the GI tract 
distal to a site of interest, with a treatment being administered proximal to the ligature. Although 
this approach provides an in vivo modality to study an intragastric toxin, the approach severely 
hampers basic GI physiology as food and water are not being absorbed, and therefore the 
maximum time allowed for exposure is 24 h. Regardless, for even relatively short exposures, this 
gastric ligature approach provides a simple and direct means localize the treatment of interest to 
a specific organ within the body of a living animal. 
In the gastric ligature approach, a survival surgery was performed, whereby the passing 
of material through the stomach was blocked by placing a single circumferential suture around 
the proximal duodenum, thus creating a constriction point (Figure 4.5). VacA or control PBS pH 
7.4 was then directly injected into the stomach, and the stomach was returned to the abdominal 
cavity. The animal was sutured closed, and allowed to recover from the surgery and survive for 
no more than 24 h, as given the passage of material through the stomach was blocked, animals 
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were not receiving proper nutrition after the surgery, and thus ethically exposure times are 
minimized. In initial control experiments, different combinations of the procedure were performed, 
whereby an animal either received or did not receive a ligature around the proximal duodenum, 
and either received or did not receive an injection of PBS pH 7.4. After 24 h from surgery 
completion, animals were euthanized and stomachs were collected and observed grossly for 
signs of pathology, including hemorrhage, necrosis, torsion, and tears (Figure 4.12A). For the 
animal only undergoing surgery and tissue manipulation with neither ligature placement nor 
injection, the stomach appeared healthy with no overt signs of pathology, and the gastric contents 
contained expected yellow-brown colored ingesta, indicating that the general surgical approach 
was not traumatic (Figure 4.12A, animal #1). For the animal undergoing surgery with only 
injection of PBS pH 7.4 but without ligature placement, the stomach also displayed no overt signs 
of pathology, indicating that the injection itself and the volume of injection solution was not 
excessive to cause distension trauma or rupture to the stomach (Figure 4.12A, animal #3). For 
the animal that underwent surgery and received only the gastric ligature but without injection, the 
stomach appeared massively distended, approximately 5 times the size of a normal healthy 
stomach, and the gastric contents displayed a slight reddish tint, indicating potential hemorrhage. 
Given this animal did not receive an injection, the stomach was returned to the abdominal cavity 
undistended during surgery, and thus the drastic increase in stomach volume is what would be 
expected for simple background if the experiments were to continue with full treatments. This 
significant distension of the stomach indicated that material was continuing to fill the stomach, 
either through ingestion by the mouse, or through secretion of material into the stomach lumen 
via the gastric mucosa, and overall, the severity of distension and gastric mucosal hemorrhage 
provides a major confounding variable to study the in vivo effects of any treatment with the 
stomach (Figure 4.12A, animal #2). For the animal that received the full procedure, including 
surgery, gastric ligature, and injection, the animal was moribund within 12 h after surgery, and 
was humanely removed from the study. For this initial control set, only one animal was used for 
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each set of conditions, and thus it is possible that the animal became moribund due to another 
surgical complication. Regardless, the stomach was collected, and although the stomach did not 
appear as distended as the ligature only control animal, the gastric tissue was severely inflamed 
as indicated by a reddened tissue, and the gastric contents appeared red tinted. No signs of 
gastric rupture were observed and the gastric ligature was intact, although it is possible the 
contents leaked retrograde into the esophagus, even though mice are not able to regurgitate 
under normal physiological conditions. (Figure 4.12A, animal #4). Altogether, the gross 
pathology indicates that the gastric ligature approach in and of itself is causing significant 
distension and thus damage to the gastric mucosa, providing a major confounding variable for 
the study of the in vivo effects of VacA.  
For initial experimental setup, two animals were used for a pilot exposure to VacA. Both 
animals underwent the gastric ligature surgery, with one animal being exposed to PBS pH 7.4 as 
a control, and the other being exposed to 250 nM VacA with tissue processing 24 h after surgery 
for histopathology and H&E staining (Figure 4.12B). Although slight differences might be 
appreciated between the two experimental animals, a profound phenotype observed in both of 
the tissues stained is massive dilation of blood vessels within the gastric submucosa. In normal 
healthy tissue, venules and arterioles are observed as small circular structures with a well 
delineated endothelium and the presence of some erythrocytes may be observed. However, in 
the gastric ligature tissue, the blood vessels were massively distended and engorged with blood, 
nearly 5-10 times the expected diameter. Further damage was observed in the gastric mucosa 
itself, as indicated by a loss of gastric mucosa architecture, erosion, edema, necrosis, and space 
separation of gastric epithelial cells from one another (Figure 4.12B). Although VacA exposure 
might have an effect on the gastric mucosa, those effects are not only masked by the severe 
submucosa vascular congestion and dilation of the gastric mucosa, but the effects and any 
interpretation are also irrelevant as the gastric physiology is severely disrupted and thus cannot 
be interpreted with confidence. 
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The gastric ligature approach provides a useful modality to limit the passage of material 
from the stomach, thus increased contact time between injected gastric contents and the gastric 
mucosa. However, the significant pathology cannot be understated as it provides a profound 
confounding variable to the interpretation of any effects that VacA is exerting on gastric tissue in 
vivo. If this modality were to be used in future work, care should be made to ensure that the 
proximal duodenal ligature is not occluding and blood vasculature leading to or coming from the 
stomach. In addition, perhaps an alternative is to physically block the passage of material through 
the stomach by placing a non-constrictive “plug” within the proximal duodenum or pyloric sphincter 
to avoid the crushing of vasculature. In addition, the esophagus should be ligated to prevent filling 
and severe distension of the stomach from ingested food and water. Finally, shorter exposure 
times should be used, such as no more than 12 h, to limit the accumulation of gastric damage 
occurring and to minimize any trauma or discomfort that may be inflicted upon the animal. Given 
the significant issues observed with the gastric ligature approach, as well as the oral gavage and 
ex vivo modalities, the implementation of an in vivo approach to evaluate the effects of VacA on 
gastric tissue was still warranted, with the major factors to consider being prolonged and continual 
exposure of viable gastric tissue to VacA with minimal disruption of gastric physiology. 
 
4.3.5.  Intragastric infusion setup 
 In order to best reciprocate natural exposure of VacA to viable gastric tissue in H. pylori 
infection without the presence of the bacterium and other secreted effectors, an in vivo model is 
needed which maintains a constant exposure to purified VacA. The ex vivo and gastric ligature 
approaches are beneficial in that they constrain VacA exposure to only the stomach, while the 
oral gavage and gastric ligature approaches are beneficial as they allow VacA exposure to occur 
in viable tissue within a living animal. However, given several substantial issues noted with each 
of the three previously discussed approaches, a model that takes advantage of all of the benefits 
while limiting the confounding variables was designed. To that end, an intragastric infusion was 
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pursued, consisting of the surgical placement of an intragastric catheter to continually infuse 
purified VacA into the stomach. Although this approach is limiting in that it requires a surgery, and 
thus some perturbations to the animal’s health is expected, by allowing animals to fully recover 
from surgery and only infusing treatments at volumes that should not result in severe gastric 
distension, the baseline perturbations to gastric physiology should be minimized. Overall, this 
approach provides the least invasive, most consistent, and most representative exposure of 
purified VacA to a viable stomach within a living animal model. 
 The intragastric infusion model consists of surgically implanting a custom designed 
intragastric catheter (Figure 4.6) into the stomachs of mice. The catheter then provided a direct 
connection from an external port to a custom designed reservoir containing the treatment solution 
(either saline dialyzed, filter sterilized, purified VacA, or sterile saline alone) (Figure 4.9). The 
administration of treatment solution was controlled by a peristaltic pump run locally off of computer 
with a custom designed program allowing for input parameters of initial fill volume and fill time, 
maintenance fill volume and fill time, and refilling interval (Figure 4.9). Two different models of 
infusion were used: 1) an acute exposure, where the stomachs were maintained at approximately 
95% full by providing an initial bolus of 0.2 ml over 5 min, then refilling the stomach every 30 min 
with 0.05 ml of treatment over the course of 1 min for up to 3 days, and 2) a chronic exposure, 
where the stomachs were maintained at approximately 50% full by providing an initial bolus of 0.1 
ml over 1 min, then refilling the stomach every 45 min with 0.05 ml of treatment over the course 
of 1 min for up to 30 days. The volume of solution to infuse was based on stomach volume 
measurements performed from cadaver C57BL/6 mouse stomachs so that the stomachs were 
full, but not distended, with the average mouse stomach volume being 0.2 ml. The frequency and 
volume to refill the stomach were based on previous reports of the mouse gastric emptying time35, 
that of which being the stomach becomes approximately 75% empty every 30 min. Given the 
mice were continually allowed free access to food and water, it was anticipated that the gastric 
contents would be a mixture of solid and liquid material, and thus estimates of gastric refilling 
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rates were conservative to make sure that the stomachs would not become overly distended. For 
the acute exposure program, the stomachs were maintained at 95% capacity, and thus it was 
expected that food and water consumption would lessen in the infused mice; therefore, a 
maximum of 3 days was used for humane and ethical reasons. It is to be noted that for the duration 
of the 3 day acute infusions, the feeding behavior of the mice was not appeared to be affected, 
and the contents of the mouse stomachs always contained solid material, indicating that the 
animals were not experiencing food aversion due to a continually full stomach. For the chronic 
exposure program, it was predicted that maintaining the stomachs at 50% capacity would not 
affect food and water consumption. 
 
4.3.6  Intragastric infusion catheter placement 
The placement of a custom designed intragastric catheter (Figure 4.6) was modified from 
a previously reported procedure for an intragastric infusion model48. In brief, a catheter was 
surgically placed through the forestomach of a mouse. As the forestomach of mice is a 
nonglandular tissue consisting of stratified squamous epithelium with a muscularis mucosa and 
serosal surface, whereas the glandular stomach contains the functional gastric mucosal cells of 
interest to VacA exposure, the forestomach was chosen as the site of catheter placement. In 
order to minimize the number of punctures to the stomach, the catheter was adhered to the gastric 
serosa by use of internal tissue adhesive between the gastric serosa and a suture disk by which 
the catheter was passed through (Figure 4.6), rather than through placement of multiple sutures 
through the wall of the stomach. In addition, the puncture and entry port of the catheter into the 
stomach was minimized to limit not only damage to the stomach, but also potential leakage of 
gastric contents into the abdominal cavity. To accomplish this goal, a spinal needle was placed 
within the intragastric catheter, which served as the source of puncturing the stomach wall (Figure 
4.7, Panel 4). In initial surgical procedure control animals, the forestomach was collected and 
processed for histology with the catheter situated in place within the forestomach, with the site of 
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catheter entry into the stomach being imaged (Figure 4.13). Near the port insertion site for the 
catheter, the keratinized layers appeared thickened, as well as the stratified squamous epithelium 
(~5-6 layers thick), whereas the adjacent forestomach tissue distal to the port of catheter insertion 
was thinned (~2-3 layers of stratified squamous epithelium). In addition, an increase in 
lymphocytes was observed in the submucosa of the forestomach near the port insertion site, 
indicating irritation of tissue by the internal tissue adhesive used to secure the catheter to the 
stomach serosa. Given the lymphocytic infiltration appeared lessened in adjacent forestomach 
submucosa, it is anticipated that the lymphocytic response was localized to the port insertion site, 
and should not affect the glandular portion of the stomach. 
In order to ensure that the intragastic catheter is not pinched or twisted due to normal 
movement of internal organs, the stomach was attached to the body wall. This attachment was 
accomplished by use of internal tissue adhesive between the anti-serosal surface of the suture 
disk adhered to the stomach, and the body wall (Figure 4.7, Panel 9). An organ within direct 
contact to the stomach is the liver, and during surgery, care was taken to avoid incidentally 
damaging the liver either through manipulation of the stomach, or by attaching the stomach to the 
intragastric catheter or body wall via the internal tissue adhesive. However, it is to be noted that 
in some animals an idiopathic hepatonecrosis was observed (Figure 4.14). Although the necrosis 
cannot be directly attributed to the surgical procedure or to the internal tissue adhesive, it is 
currently hypothesized that the necrosis is indeed a response to incidental exposure to the tissue 
adhesive from the intragastric catheter port. Varying degrees of hepatonecrosis, ranging from 
small focal regions <50 μm in diameter, to large regions >1000 μm were observed. The necrosis 
was identified as regions of pale, eosin positive material with pyknotic nuclei and borders of 
granulomatous infiltration (Figure 4.14). Of the animals with tissue processed for H&E staining, 
some degree of hepatonecrosis was observed in approximately 20% of sampled liver sections 
from animals that underwent surgery, with no detectable necrosis in control animals that did not 
undergo surgery. Of the animals receiving surgery, 50% of the hepatonecrosis cases occurred in 
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animals receiving VacA infusions (at varying concentrations), and 50% in animals receiving 
control saline infusions. No trend was observed regarding length of time post-surgery, or 
concentration of VacA to the degree of hepatonecrosis. In addition, the degree of hepatonecrosis 
was not correlated with how well the animals recovered from surgery. This lack of association 
was most notable in an animal that underwent a 30 day infusion with no detectable pain scores 
or changes in behavior, yet held a larger degree of hepatonecrosis. Sentinel animals housed 
within the same animal facility as the intragastric infusion mice were routinely tested for infection 
with mouse hepatitis virus (murine coronavirus), and throughout the duration of the infusion study, 
animals were confirmed to test negative. Upon examination of the regions of necrosis, at the level 
of the portal triads, recanalization was observed, with bile ductules, portal veins, and hepatic 
arteries forming multiple, disorganized pathways in order to maintain patency (Figure 4.14A). 
This hepatic response indicates that the insult inducing the hepatonecrosis was not maintained 
or worsening, but rather a single, initial insult that the liver was able to respond to and begin to 
repair. Furthermore, at the borders of the necrotic regions, little to no neutrophils, histiocytes, or 
lymphocytes were observed (Figure 4.14B), indicating that the lesions were not due to infection 
or contamination introduced into the abdominal cavity during the surgery, either from leakage of 
the gastric contents, or through the external environment itself. This finding supports an 
interpretation that the necrosis is due to a sterile insult, such as ischemia induced by blockage of 
hepatic vasculature, and/or direct damage due to a chemical agent (such as internal tissue 
adhesive). As the liver holds a ~80% regenerative capacity, the detected hepatonecrosis would 
need to be severe (encompassing >80% of the liver mass itself) before the animal would display 
clinical signs of hepatic failure. Therefore, although the hepatonecrosis is an important point to 
discuss in regards to proper surgical technique, there is little concern that it would introduce a 
complicating factor to the interpretation of the intragastric infusion results. Furthermore, for future 
use of this intragastric infusion model, care must be taken to ensure that the minimal amount of 
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internal tissue adhesive is being used to connect the catheter to the stomach and body wall, and 
that there is no incidental exposure to the liver. 
After attachment of the stomach to the body wall, the intragastric catheter was passed 
under the skin through the subcutaneous space to an external port on the back of the animal in 
the cervical region (Figure 4.7, Panel 10-14). The port was positioned on the dorsal aspect of the 
animal in order to facilitate ease of mobility of the animal after the surgery and during the infusion. 
A Luer adaptor was attached to the intragastric catheter and capped, so that the catheter line was 
sealed and the mouse was able to freely move within the cage, while also providing an easy and 
quick attachment point to the infusion lines. The catheters were flushed daily with sterile saline in 
order to check for and maintain patency of the catheter line. Given the surgery in and of itself is 
an invasive and traumatic process, it was imperative to allow animals to fully recover from the 
surgery before beginning the infusion experiment. If infusion were to begin immediately after 
surgery and an animal were to become moribund within 24-48 h, it would be uncertain whether 
or not the issue was due to post-surgical complications, or due to the infusion treatment. 
Therefore, animals were carefully monitored every 12 h for 2 weeks for signs of health decline. 
Because placement of the catheter port and thoracic wrap may limit the ability of a mouse to reach 
its food and water, moistened food was provided fresh daily at ground level to help provide easy 
access to food and water. During the 2 week post-surgery monitoring period, each animal was 
weighed twice a day, as weight is an easy and reliable indicator of an animal’s health. If an animal 
stops eating and drinking, it will be reflected by a substantial loss of body mass. As animals were 
recovering from surgery, body mass decreased by approximately 15% from immediately following 
surgery to 5 days post-surgery (Figure 4.15A), then within one week after surgery weights began 
to return to normal. Likewise, animals were initially lethargic or displayed hunched body posture 
after surgery, but within one week all animals were mobile, bright, alert, and responsive (Figure 
4.15B). If at any point an animal’s body mass dropped substantially between measurements or 
never recovered from the initial weight loss, or if pain scores were elevated, a board-certified lab 
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animal veterinarian was immediately contacted and consulted regarding proper course of action. 
The monitoring data illustrate the value in allowing animals to fully recover for 2 weeks from 
surgery. If experimental treatments were to be performed prior to 8-10 days after surgery, animals 
may be showing signs of pain or distress, and have not fully regained their normal body weight, 
and thus any interpretation of experimental outcomes could be confounded by issues associated 
with surgery alone.  
 
4.3.7  Peristaltic pump conditions 
 In order to infuse a precise volume of solution over a given time, and to ensure that error 
does not accumulate over time, optimizations were completed in order to develop programs to 
run the peristaltic pump. The low volume peristaltic pump used for the infusion studies may only 
be programed in revolutions per minute (RPM), but in order to determine flow rates, additional 
studies were performed to obtain μl/min measurements. By running PBS pH 7.4 through the pump 
at various RPMs, a linear equation was determined for the flow rate of the pump in µl/ml, that 
being y = 0.01694x + 0.2242 (y = rpm, x = μl/min) (Figure 4.16A). The determined equation was 
used to program the pump for an infusion experimental setup. The infusion program was tested 
to ensure the proper volume was being infused over a given time by also running PBS pH 7.4 
through the system and measuring the mass of PBS pumped. By running the pump at a relative 
slow versus a fast rate, transferring a relatively low versus high volume, it was confirmed that the 
infusion rate equation was correct and matched expected transfer volumes calculated (Figure 
4.16). This quality control was necessary to ensure that over time the stomachs were not being 
over, or under filled. The equation determined was used to program the pump for the acute and 






4.3.8  VacA stability testing 
 Before running the intragastric infusion with live mice, it was important to evaluate the long 
term stability of VacA. Purified VacA from H. pylori needs to be acid activated prior to 
experimentation, as the ammonium sulfate precipitation renders the quaternary structure of VacA 
inactive. Simple incubation in acid protonates VacA residues to dissociate the oligomer, and 
subsequent neutralization results in the reassembly of the VacA oligomer into an active 
conformation69-71. However, for consistency between experiments, acid activated VacA is 
immediately used for experimentation after acid activation, as over time the activity of VacA 
diminishes due to the active conformation be less resistant to proteolytic cleavage. Although the 
infusion of mice seeks to provide a continual exposure to purified VacA, a technical limitation is 
that once acid activated, VacA will remain in the infusion reservoir and lines, as the dead volume 
between the reservoir and the mouse is approximately 2 ml. Therefore, a simple VacA activity 
assay was performed to evaluate the long term storage capacity of VacA at room temperature. 
As a quality control for VacA stability, VacA was acid activated then stored at room temperature 
for up to 1 week, then diluted to 250 nM with cell culture media and tested for vacuolation activity 
by the neutral red vacuolation assay (Figure 4.17). The data indicate that there is an initial drop 
in activity after 30 min following acid activation, then the activity slowly declines over the span of 
a week (Figure 4.17). Within 7 days after acid activation, the activity is approximately 50% of 
what could be obtained from freshly activated VacA. These data indicate that the infused VacA 
will be active throughout the duration of an infusion experiment. Furthermore, the VacA in the 
reservoir should be refilled frequently, at least every 24 h in order to maintain maximum biological 
activity. 
 
4.3.9  Detection of VacA in mouse tissue 
 Significant limitation in the standard in vivo VacA exposure approach of an oral gavage is 
whether or not VacA is reaching biologically relevant levels at the level of the gastric mucosa by 
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bypassing the gastric mucus, as well as gaining access before being passed into the lower GI 
tract. Therefore, in order to determine whether VacA associates with gastric tissue during 
intragastric infusion, and whether VacA gains access to other locations in the animal, various 
tissues were collected and immunoblotted for VacA from animals that received a 24 h infusion of 
35 nM or 100 nM VacA (Figure 4.18). VacA within the infusion reservoir was sampled as a 
baseline for comparison, in which full length VacA was detected in both the 35 nM and 100 nM 
VacA infused animals. Anti-VacA immuno-reactive material was detected in the gastric contents 
in both infusions in a similar profile, indicating that VacA was indeed present, but within the 
lumenal content the toxin was being degraded. Within the stomach tissue itself, protein was 
detected in the 100 nM VacA infused tissue, but the predominant band was also less than the 
expected molecular weight of 88 kDa, indicating that perhaps the toxin was being degraded to a 
mostly 50-60 kDa fragment. In addition, a faint band was observed in the 100 nM VacA infused 
mouse spleen. This observation may be indicative of non-specific binding, or it may represent 
VacA being transported to the spleen via immune cells as part of a host response to the VacA 
toxin. Finally, two bands were detected within the blood cell sample, with an upper band at 
approximately the same molecular weight as what was detected in the stomach (50-60 kDa), and  
lower, more diffuse band (25-30 kDa). Interestingly, these data may indicate that VacA is being 
degraded within the gastric tissue, then that larger fragment of VacA is being recognized by 
circulating immune cells and further degraded in transit to the spleen. These data are indicating 
that perhaps the immune system is able to recognize and transport VacA, either intact or as 
fragments, within a host organism. 
 In order to visualize the localization of VacA within infused gastric tissue, anti-VacA 
immunohistochemistry was performed on stomachs infused with either saline or 500 nM VacA for 
12 h, and co-stained with wheat germ agglutinin (WGA) and DAPI (Figure 4.19). Within the gastric 
mucosa, immuno-reactive VacA material was detected in the upper 30% of the gastric mucosa, 
and appeared to be localized on the surface of cells within the gastric pits, with no detectable anti-
350 
 
VacA immuno-reactive material in the control animal. This observation indicates that VacA is able 
to diffuse through the gastric mucus and gain access to the underlying gastric mucosal tissue. 
Furthermore, H. pylori colonizes within the gastric pit, often approximately 50% into the pit at the 
level of gastric parietal cells. Although from the 12 h infusion VacA does not appear to diffuse 
down to 50% of the gastric mucosa, it does appear to penetrate the gastric pits and access cells 
that are commonly affected by H. pylori. 
 
4.3.10  Histopathology of intragastric VacA infusion 
 Previous studies examining gastric histopathology after VacA exposure via oral gavage 
have reported damage to the gastric mucosa, indicated by apparent necrosis, vacuolation, 
ulceration, gastric mucosal degeneration, and immune cell infiltration29-32. However, as described 
previously, it was surprising that such severe gastric pathology was observed with only a relatively 
short exposure to VacA. In addition, although previous groups have indeed exposed live animals 
to VacA, the only tissue examined for, or at least reported for, histopathology, was the stomach. 
Although the justification for only examining gastric histology is certainly warranted, the response 
of an organism to an exogenous material, whether it be a drug, chemical, biological toxin, or 
infectious agent, is rarely localized to one specific organ. In addition, in order to confirm whether 
or not a given experimental intervention in and of itself is inducing a confounding effect, full 
examination of organ systems pathology is necessary for a complete evaluation of a biological 
system. For the intragastric infusion of VacA, the stomach, stomach contents, blood, liver, spleen, 
esophagus, intestines (from proximal duodenum to distal colon), heart, kidneys, and lungs were 
collected. In addition, although difficult to dissect in a mouse specimen, attempts to collect the 
pancreas and gallbladder were also made. All tissues were processed for tissue lysates for 
immunoblotting, as well as paraffin embedding for histopathology and staining by Hematoxylin 
and Eosin Y (H&E), or Periodic acid-Schiff (PAS) and Alcian Blue. 
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 Esophageal histopathology. Although mice and other rodents cannot vomit or 
regurgitate gastric contents due to the anatomy of the stomach and constriction of the diaphragm 
surrounding the esophagus, as well as decreased neuronal input from emetic stimuli, the 
esophagus from intragastric infusion mice was collected to confirm that the stomachs were not 
becoming overfilled with infusion solution, resulting in pressure overload and forced retrograde 
leakage and passage of solution into the esophagus from the stomach. In comparison of the 
esophagus from animals undergoing infusions with saline or 500 nM VacA in saline for either 3 
days with the stomach maintained at 95% capacity, or 30 days with the stomachs maintained at 
50% capacity, no appreciable differences in esophageal histology were appreciated (Figure 
4.20). The esophagi did not appear distended in any treatment condition, the muscularis mucosa 
appeared intact and not stretched, the stratified squamous epithelium in all conditions were the 
expected 5-7 layers thick, and an appropriate layer of keratinized surface material was observed. 
Grossly, no abnormalities were appreciated in the esophageal serosa. Altogether, these 
observations indicate that the stomachs were not overfilled with infusion treatment, and that VacA 
was not being localized retrograde into the esophagus due to pressure overload and thus 
bypassing of the cardiac sphincter. If studies were to utilize the oral gavage approach for in vivo 
exposure to VacA, it is expected that the esophagus would be in contact with VacA; therefore, it 
is recommended that the esophagus is also evaluated histologically during oral gavage in order 
to identify any potential confounding effects of VacA outside of the stomach and in more proximal 
locations. 
 Gastrointestinal histopathology. After transiting through the stomach, VacA passes 
through the remaining gastrointestinal tract, including the small intestine (duodenum, jejunum, 
ileum), cecum, and colon. Rather that sectioning small portions of the intestines, the entire 
intestinal tract was collected by application of a “Swiss Roll” technique49,50, whereby the intestines 
are cut open longitudinally and rolled along a central point beginning at the proximal duodenum 
with the mucosa surface facing outwards of the roll, then after paraffin embedding, sections are 
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cut transverse to the roll. This approach allows for a complete evaluation of the intestinal tract in 
one section. In comparison of the intestinal tract from animals undergoing infusions with saline or 
500 nM VacA in saline for either 3 days with the stomach maintained at 95% capacity, or 30 days 
with the stomachs maintained at 50% capacity, no appreciable differences were observed (Figure 
4.21). Intestinal villi and crypt structure and length ratios appeared to coincide with the expected 
observations for healthy mouse intestines, with no blunting, degeneration, or widening of the 
intestinal villi. There were no appreciable changes to goblet cell number of distribution, which was 
more easily appreciated by PAS/Alcian blue staining. Altogether, these observations indicate that 
VacA passage through the GI did not yield detectable pathology. This is important to evaluate as 
damage to the intestinal tract, such as ulceration, degeneration, or necrosis, may manifest as a 
systemic inflammation with pathology observed in the liver and spleen, and thus may provide 
additional confounding variables in interpreting the in vivo effects of VacA. It is worthwhile to note 
however, that the conformation of VacA passing into the intestines is unknown. The mucus neck 
cells and chief cells of the stomach secrete the zymogen pepsinogen, which is activated to the 
protease pepsin upon exposure to the gastric environment. Therefore, it is anticipated that VacA 
within the gastric lumen is largely being degraded by pepsin and is further degraded by additional 
proteases within the intestinal tract. This interpretation is supported by the observation that by 
western blotting the gastric contents and gastric tissue of VacA intragastrically infused mice, the 
molecular weight of VacA detected was less than the 88 kDa band expected for VacA (Figure 
4.18). This trend highlights the importance of providing a continual source of fresh VacA within 
the stomach, as a substantial portion of VacA is expected to be degraded prior to passing through 
the gastric mucus. The degradation of VacA by gastrointestinal proteases further argues against 
an oral gavage approach, whereby far fewer molecules of VacA are being administered into the 
stomach.  
 Peyer’s patches. In addition to examining the intestinal villi and crypt structure, a major 
physiological structure to evaluate is the gut-associated lymphoid tissue (GALT), which may form 
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smaller, isolated structures, or larger follicles termed Peyer’s patches, which serve as major 
immune regulators within the gastrointestinal tract72,73. By using the rolling approach to visualize 
the entire intestinal tract, numerous Peyer’s patches were identified. In comparison of the 
intestinal tract from animals undergoing infusions with saline or 500 nM VacA in saline for 3 days 
with the stomach maintained at 95% capacity, no appreciable differences in Peyer’s patches were 
observed (Figure 4.22). Some Peyer’s patches appeared smaller, while others were multi-
nodular. Germinal centers were observed within the submucosa of the intestines, and there were 
no appreciable differences in regards to reactivity of the patches between the saline and VacA 
infused animals. These findings also indicate that VacA was not highly antigenic and was not 
exerting damaging effects to the gastrointestinal tract.  
 Hepatic histopathology. For material passing through the gastrointestinal tract, 
substances are often absorbed through the portal vein in order to gain access to the systemic 
circulation after passing through the liver. Material enters the liver via the portal vein in a structure 
known as the portal triad, which consists of a portal vein from the intestines, a bile duct, and a 
hepatic artery. These portal triad structures are arranged in a hexaganol pattern around a central 
vein, whereby hepatocytes filter incoming material through hepatic sinusoids as the material 
passes to the central vein for systemic circulation. As hepatocytes in closer proximity to the portal 
triad, designated Zone 1, are also exposed to higher concentrations of oxygen in the blood via 
the hepatic arteries, cells closer to the central vein, designated at Zone 3, are exposed to lower 
concentrations of oxygenated blood as the direction of blood flow is from the portal triad to the 
central vein, and thus Zone 3 hepatocytes are often more sensitive to hypoxia or other organism 
stressors. Often, under conditions of hypoxia or other hepatic stresses, Zone 3 cells display signs 
of vacuolar change or cellular damage. In comparison of the livers from animals undergoing 
infusions with saline or 500 nM VacA in saline for either 3 days with the stomach maintained at 
95% capacity, or 30 days with the stomachs maintained at 50% capacity, no appreciable 
differences were observed in hepatic architecture (Figure 4.23). Zone 3 hepatocytes near the 
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central vein were slightly more pale in appearance in all tissues observed, with no observable 
pathology throughout the liver samples. Altogether, these observations indicate that VacA is not 
absorbed via the portal circulation from the intestinal tract as an active toxin, as pathology would 
be expected, especially in Zone 1 hepatocytes, if VacA were to be transported from the GI tract 
to throughout the animal’s body systemically. This is an important observation to note as 
pathogens, or their secreted factors, such as siderophores, may become invasive and gain 
access to systemic sites throughout an organism. For the study of VacA, no reports have indicated 
absorption or transport of VacA systemically, and the hepatic histological analysis does not 
indicate that active VacA molecules are exerting toxic activity beyond the level of the stomach in 
other organs within a host. 
 Splenic histopathology. A major organ for regulating immune responses as well as the 
filtering and generation of erythrocytes is the spleen. Histologically, two predominant regions of 
the spleen are observed: the red pulp which is primarily comprised of erythrocytes and appears 
light pink to pale by H&E staining, and the white pulp which is comprised of germinal centers of 
maturing T and B lymphocytes and appears dark blue to purple in follicle shapes by H&E staining. 
Depending on physiological stresses, the distribution of the red and white pulp may change, to 
either compensate for losses and increase production of, or storage of either the erythrocytes or 
leukocytes. In comparison of the spleens from animals undergoing infusions with saline or 500 
nM VacA in saline for either 3 days with the stomach maintained at 95% capacity, or 30 days with 
the stomachs maintained at 50% capacity, VacA infused animals appeared to have more immune-
reactive spleens, as indicated by increased presence of dark staining nuclei (Figure 4.24). The 
spleens of VacA infused animals appeared to not only have a greater number of lymphoid follicles 
in comparison to the red pulp, but within the red pulp a greater number of lymphocytes were 
appreciated. Altogether, these observations indicate that mice being intragastrically infused with 
purified VacA may be generating an immune response. Given the nature of the exogenous 
material is a protein toxin, and not an infectious organism, it is predicted that a humoral response 
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would predominate, with the generation of plasma and memory B cells. Given no pathology was 
observed in other tissues that would suggest an infection was introduced by either the surgical 
procedure itself, or through gastrointestinal ulceration by VacA damaging the gastrointestinal 
barrier, it stands to reason that the infused VacA is being recognized by the innate immune system 
with the generation of a humoral, B cell response. 
 Renal histopathology. In addition to the spleen, liver, esophagus, intestines, and 
stomach collected from each animal, the kidneys, pancreas, and lungs were also evaluated 
histologically. Kidneys are important for assess for histopathology for if VacA were to gain access 
to the systemic circulation, it is expected that the toxin would potentially be filtered in the kidney 
and would collect in the renal glomeruli. Given the size of VacA, it is unexpected that it would 
pass through the glomeruli and would gain access to the urinary system, however, if VacA is 
inducing a robust immune response, it is possible that elevated levels of circulating antibodies 
could be present in the renal tubules or renal glomeruli as amyloid casts. In addition, if any 
infections were established either due to introduction during surgery or by VacA causing severe 
ulceration or damage to the gastrointestinal tract, possible infarctions may be observed in the 
kidneys with additional amyloid filling the renal tubules. In comparison of the kidneys from animals 
undergoing infusions with either saline or VacA, some differences in renal structure were 
observed (Figure 4.25). The proximal convoluted tubules of the renal cortex appeared to contain 
more eosinophilic material, indicative of protein casts. Furthermore, the glomerular mesangium 
appeared more eosinophilic, also indicative of increased protein accumulation, and the Bowman’s 
capsules were not well defined. These observations indicate that animals intragastrically infused 
with VacA had elevated levels of circulating proteins. It is, however, uncertain whether or not the 
protein would be antibodies, or inflammatory cytokines. But given the histological findings in other 
tissues, it is reasonable to ascertain that the differences might be due to a humoral response, 
rather than the establishment of an infection. Regardless, value would be found in measuring total 
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protein from either the circulating blood or the urine collected from mice undergoing infusion with 
VacA.  
Pancreatic histopathology. In addition to evaluating the kidneys, the pancreas was also 
observed. In cases of severe stress or inflammation, or if there was an increase of input from the 
gastrointestinal tract for severe changes in diet, the pancreas may show signs of inflammation. In 
comparison of the pancreas from animals undergoing infusion with either saline or VacA, no 
appreciable differences were observed (Figure 4.25), indicating that VacA alone was not causing 
severe damage to the GI tract or to the animal systemically. Often, severe GI inflammation may 
be manifested by disruptions in the pancreas and distribution of pancreatic islets, but in the 
exposure to VacA, no pathologies were observed within the pancreas. 
Pulmonary histopathology. Finally, the lungs were collected from animals undergoing 
infusion in order to evaluate not only potential systemic issues induced by VacA, but also 
retrograde movement of VacA from the stomach to the esophagus in the event of overfilling the 
stomach via the infusion. As described previously when discussing the esophagus, rodents are 
not physically capable of vomiting, and thus passage of gastric contents retrograde into the 
esophagus is not expected. However, although careful estimates and measurements were made 
to ensure that the stomachs of mice were not being overfilled and reaching high pressure levels, 
it was uncertain whether or not those estimates from previous groups or measurements based on 
cadavers would translate to a live animal, and thus there was uncertainty. If the infusion solution 
were too great for the limitations of the stomach and the distal GI tract, it is anticipated that 
pressure overload could drive VacA into the esophagus. If levels were high enough in the 
esophagus, gastric contents could be aspirated from the esophagus into the trachea with 
subsequent passage into the lungs and induce an aspirational pneumonia. Alternatively, if a 
systemic infection were to be introduced either by surgery or through VacA severely damaging 
the gastrointestinal tract, signs of infection would manifest in the lungs, as the pulmonary 
vasculature is within a single cell separation to the alveoli, and thus severe infections may results 
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in pulmonary pathology. In comparison of the lungs from animals undergoing infusion of either 
saline or VacA, no appreciable differences in pulmonary architecture were observed (Figure 
4.25). This findings are important as it supports the interpretations that the infusion in and of itself 
is not overloading the stomach, and that VacA is not inducing severe systemic issues. It is to be 
noted that careful examination of the lungs is important for any work conducted using an oral 
gavage approach. Accidental exposure of the lungs to orally gavaged material may occur by 
placing the gavage needle into the incorrect opening (trachea versus the esophagus), or if the 
esophagus is punctured via the feeding needle material may pass into the thoracic cavity or the 
trachea directly, or if material is placed in the esophagus but not passed into the stomach, material 
may move retrograde into the lungs and induce an aspirational pneumonia. It is therefore 
imperative that lungs are collected and examined histologically for signs of pathology during not 
only intragastric infusion of solutions, but administration of other solutions via oral gavage as well 
in order to confirm proper technique and administration. 
 Gastric histology. As H. pylori establishes chronic infections within the stomach, the main 
tissue of interest for the intragastric infusion of VacA was most certainly the stomach. Previously, 
it has been reported that exposure to purified VacA by oral gavage resulted in cellular vacuolation, 
edema, necrosis, erosion, gastric ulceration, and loss of the gastric gland structure, with infiltration 
of mononuclear cells and mast cells within the gastric mucosa29,31,32. As described previously, the 
significant limitations of the oral gavage approach rendered caution in interpreting the 
histopathological results of the gastric mucosa, given relatively small quantities of orally 
administered VacA would need to survive gastric protease degradation, penetrate the diffusion 
barrier of the gastric mucus while also being relatively rapidly transited from the stomach with the 
gastric contents. Intragastric infusion of VacA provides the most representative modality of natural 
H. pylori infection to evaluate the role of VacA in vivo, and the effects that VacA alone exerts on 
gastric tissue and the health of an animal overall. Upon examination of the stomachs of mice 
infused with either saline or VacA in saline for either 3 days with the stomachs maintained at 95% 
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capacity, or 30 days with the stomachs maintained at 50% capacity, changes to the gastric 
mucosa were observed. First, it was observed the gastric parietal cells were vacuolated in VacA 
infused tissues (Figure 4.26), as indicated by pale staining cytoplasm with distinct vacuolar 
structures observed encompassing the cytoplasm. This observation may be indicative any of at 
least three potential explanations, that being a phenomenon that is generalized, specific to VacA, 
or specific to the gastric cells. First, cellular vacuolation and vacuolar change is a phenomenon 
observed in tissues that are undergoing various stressors. For example, vacuolation of cells is 
observed during muscle fatigue74, lysosomal disorders or storage abnormalities75, neoplasms76, 
leukodystrophy diseases77, liver disease (including fatty liver disease and fibrosis)78, and may 
even be an artifact due to a delay in tissue processing79. Therefore, it is possible that infusion of 
VacA is inducing generalized gastric stress that may even be manifested through extra-gastric 
effects. If this explanation is supported, this finding would suggest that VacA is either being 
absorbed systemically and inducing a more widespread effect on the health of a host, or that 
localized dysfunction is inducing a more systemic effect. Second, VacA has indeed been well 
reported to induce cellular vacuolation, as VacA was identified as a vacuolating cytotoxin80-85. 
Therefore, it is possible that the observed vacuoles are a direct effect of VacA activity and are the 
manifestation of vacuoles that have been observed and characterized in in vitro cell culture 
systems. If this explanation is supported, this finding would directly support in vitro observations 
with the in vivo model, and illustrate that VacA is indeed gaining access to gastric mucosal cells, 
and is being internalized to exert biological activity by inducing the formation of vacuoles. Finally, 
gastric parietal cells are dynamic cells that respond to various inputs, including histamine, gastrin, 
and acetylcholine, in order to regulate the secretion of gastric hydrochloric acid to aid in the 
digestion of ingesta, as well as the secretion of intrinsic factor to aid in the absorption of vitamin 
B86-88. The regulation of parietal cell function is controlled by parietal cells existing in an active 
versus an inactive state. When parietal cells are in a resting state, acid secreting H,K-ATPases 
are sequestered within tubulovesicles within the cytoplasm, and when parietal cells are activated, 
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the vesicles are transported to the cell surface to secrete acid89-91. Interestingly, H. pylori has been 
shown to have direct effects on gastric parietal cells, both in in vivo infection experiments as well 
as VacA exposure to isolated primary gastric parietal cells, including disruption of apical 
recruitment of tubulovesicles by VacA and thus inhibition of parietal cell mediated acid secretion92, 
vacuolation and inactivation of parietal cells in patients infected with H. pylori93, and induction of 
cell death by infection of isolated cells with H. pylori94. Therefore, it is possible that the observed 
vacuolation in gastric parietal cells is a manifestation of parietal cells being inactivated, with the 
vacuoles themselves being derivatives of sequestered tubulovesicles within the cytoplasm. If this 
explanation is supported, it would indicate that VacA alone is sufficient to inhibit parietal cell 
activity, explaining the observation that H. pylori infection results in hypochlohydria and parietal 
cell hyperplasia in infected patients.  
In addition to the parietal cell vacuolation, it was also observed that infusion with VacA 
resulted in a decrease in gastric mucus (Figure 4.27). By staining tissue with periodic acid-Schiff 
(PAS), substances such as polysaccharides and mucosubstances are visualized as a pink to 
purple material, and is often used to observe mucin. Previous reports have indeed indicated that 
mice orally gavaged with crude H. pylori extracts resulted in a loss of PAS staining material in the 
stomach30; therefore, changes to gastric mucus were evaluated upon intragastric infusion with 
VacA. In order to indirectly quantify gastric mucus production, measurements of PAS positively 
staining material from the gastric apical surface were taken and compiled from multiple fields of 
view, in multiple tissue sections, and in multiple animals (Figure 4.27A). In order to normalize the 
amount of PAS staining material to the size of the different regions of the stomach, each 
measurement was normalized to the depth of the gastric mucosa at the PAS measured location 
(Figure 4.27A). First, measurement of the various tissue sections yielded no significant difference 
in gastric mucosa depth, indicating that VacA infusion alone does not result in a loss of the gastric 
mucosa over time (Figure 4.27B). Upon measurement of the relative PAS staining distance, a 
significant decrease in the ratio of PAS staining material to the total gastric mucosa was observed 
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(Figure 4.27C), indicating that infusion of VacA results in less gastric mucus production. 
Altogether, these findings indicate exposure to VacA negatively impacts the ability of gastric 
mucus cells to function properly and produce mucus, but does not do so by inducing massive cell 
death at the level of the gastric mucosa. In addition, by imaging the apical regions of infused 
stomachs stained with H&E under phase contrast light microscopy, it was observed that in VacA 
infused stomachs, there was a marked decrease in cells staining with dark vacuolar structures 
(Figure 4.28). Given mucus is primarily comprised of mucin, and mucin is a heavy glycosylated 
protein, reports indicate that mucins can be detected by eosin, or hematoxylin if acidic95. Given 
gastric mucus secreting cells are primarily located on the apical level of the gastric mucosa, a 
possibility is that the vacuolar structures observed are contained within mucus secreting cells. 
The loss of these dark staining structures in VacA infused stomachs supports the interpretation 
that VacA is inhibiting the ability of mucus secreting cells to function properly by limiting the 
production of mucus. 
Altogether, the changes in the gastric mucosa upon intragastric infusion with VacA 
suggest that VacA alone is sufficient to induce gastric parietal cell and mucus cell function. 
Whether the effect of VacA on gastric epithelial cells is direct or not remains to be fully understood. 
However, given the biological function of VacA elucidated in vitro in cell culture experiments, a 
possible explanation is that both phenotypes of gastric parietal cell vacuolation and disruption of 
gastric mucus secretion are dependent upon functional mitochondria. As VacA targets 
mitochondria and induces mitochondrial dysfunction, it is reasonable to ascertain that if 
mitochondria with parietal and mucus cells are not functioning properly, the cells are not able to 
secrete gastric acid or mucus, respectively, effectively. It may further be hypothesized that by 
disrupting gastric acid and mucus production, VacA functions to aid in the ability of H. pylori to 
establish chronic infections within the gastric mucosa.  




4.3.11 Immune response to intragastric VacA infusion 
Histological analysis of the spleen indicated that animals receiving an intragastric infusion 
of VacA may be undergoing an immune response, and given no significant pathology indicative 
of an infection was observed in the liver or gastrointestinal tract, it was hypothesized that the 
immune response may be directed against the infused VacA itself. Therefore, serum was 
collected from experimental animals that underwent either a 15 or 30 day infusion and the serum 
was used as a primary antibody against purified VacA that was immunoblotted. Secondary 
antibodies targeting IgG and IgM were used in order to evaluate whether VacA infused animals 
were generating detectable IgG or IgM levels against VacA. Upon examination of anti-VacA 
western blots, immuno-reactive material was detected in the serum of 30 day infusion animals, 
with IgG levels yielding a stronger signal than IgM (Figure 4.29). The molecular weight of the 
detected material was ~ 30-50 kDa, indicating that the IgG and IgM antibodies produced during 
VacA intragastric infusion are not directed against full length VacA, but rather VacA fragments. 
This finding further indicates that the antibodies produced during VacA infusion, and potentially 
during H. pylori infection, are not protective, as the full length toxin is not recognized. These 
findings also illustrate the conformation of VacA upon interaction with the immune system, with 
two potential explanations for the generation of anti-VacA circulating antibodies. First, it is 
possible that as VacA passes through the gastrointestinal tract, VacA is being subsequently 
digested by proteases, with the VacA fragments being detected at the level of the gut-associated 
lymphoid tissue, with further processing and presentation by antigen presenting cells and 
generation of a B-cell humoral response to VacA. An alternative, albeit less likely explanation, 
incorporates a recent finding that mitochondrial derived vesicles (MDVs) are involved in a process 
known as mitochondrial antigen presentation96. If the hypothesis is supported that VacA is 
selectively removed via MDVs upon induction of mitochondrial stress, it is possible that the MDVs 
are functioning to present VacA fragments to the immune system via major histocompatibility 
complex I (MHC-1) in gastric epithelial cells. Although the phenotypes of mitochondrial derived 
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vesicle activation and immune response remain to be fully understood, this explanation unites the 
observations of an immune response to VacA coupled with VacA mediated mitochondrial 
dysfunction and a host cellular response. Regardless, altogether the results indicate that the 
immune system of animals intragastrically infused with VacA is recognizing VacA fragments, 
resulting in the generation of anti-VacA antibodies. 
 
4.4 Discussion 
 Elucidation of the specific role that a pathogenic effector fulfills in the context of a 
pathogenic infection is a major goal in the study of host-pathogen and host-microbe interactions. 
Pathogens engage clever strategies to usurp host cell physiology in order to establish and 
infection and cause disease. Some pathogens may directly mimic host cell factors in order to 
evade host detection and responses, while other pathogens may recruit and take full advantage 
of host physiological processes in order to replicate and establish an infection. The mechanism 
by which most pathogens interact with and remodel the host cell environment is mediated through 
the production of pathogenic effectors and bacterial toxins. In many situations, the various 
effectors may be isolated or purified from a pathogen and extensive studies may be conducted in 
in vitro cell culture systems, and those studies yield fundamental insights into the activity of the 
effectors and how host cells are manipulated to the pathogen’s benefit. However, although cell 
culture systems are immensely powerful, considerable limitations exist within the isolated system 
of cell culture, and without a transition to in vivo systems, it remains unknown whether the 
phenotypes observed in vitro are biologically relevant. In order to evaluate the function of a 
pathogenic effector in vivo, often, infection experiments are employed, whereby animals are 
infected with pathogens that are either secreting or not secreting an effector of interest, and the 
lack of phenotype in the mutant is thus the phenotype that is attributed to the effector of interest. 
However, this approach only addresses the necessity of a particular factor in vivo, but does not 
address whether or not the factor is sufficient to induce the phenotype alone. Often the 
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predominant limiting factor in evaluating the role of a pathogenic effector in vivo is the ability to 
expose host tissue to the factor by a means that best reciprocates an exposure during a natural 
infection. The development of proper experimental models for the determination of the importance 
of a pathogenic effector in vivo poses a considerable challenge. Not only does an ideal model 
system require reciprocation of phenotypes as seen in a natural infection with the native host, but 
the administration and exposure conditions of the factor need to be matched. Often, this necessity 
requires the application of clever modalities in order circumvent the biological limitations imposed 
by standard models of toxin exposure. It is only through the development of advanced animal 
models is the field of host-pathogen interactions going to progress to a level where fundamental 
new insights into the mechanisms of microbial pathogenesis will be made. Here, I report the 
adaptation of an intragastric infusion model, whereby a purified bacterial toxin is directly infused 
into the natural site of toxin exposure. Furthermore, as the bacterial pathogen secreting the 
effector establishes chronic, lifelong infections, the model was developed in order to best mimic 
natural toxin exposure, with the target organ being continually exposed to the effector at 
maintained levels for biological activity. Such an approach yielded observations without making 
assumptions that potentially confounded the interpretations of any major findings of a study, as 
other exposure modalities have demonstrated. In the study of host-pathogen interactions, and 
any field for that matter, considerable care must be taken to understand the biological system 
being employed, and which assumptions are being made when a model is being engaged. If more 
questions are raised concerning the validity of a study, then those in the field must pause and 
critically evaluate whether or not the best modality is being broached for their system of interest. 
However, if a study answers major gaps in knowledge in the study of the system, and further 
raises addition questions that had not previously been comprehended in regards to the nature of 
a particular host-pathogen interaction, then that study has contributed to moving the field forward, 
if even to a relatively small degree.  
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In the study of the vacuolating cytoxin from Helicobacter pylori, a considerable challenge 
arises in maintaining a chronic exposure to the toxin in a live animal. Use of the ex vivo, oral 
gavage, and gastric ligature modalities of VacA exposure failed to fully address the development 
of an ideal in vivo model. Ex vivo experimentation requires that tissue is maintained viable and 
metabolically similar to tissues in a live animal, however, once an animal is euthanized, blood 
supply and nerve innervation are removed and the tissue becomes necrotic. Although oral gavage 
has been the most common modality used to evaluate VacA effects in vivo, oral gavage requires 
that the brief exposure to an agent is sufficient to detect a response. In the study of VacA, a 
protein toxin will only be present in the stomach for approximately 15-30 min before being cleared, 
and in that time it needs to penetrate the thick mucus layer and evade protease degradation in 
order to interact with the gastric mucosa. These issues of gastric clearance, mucus penetration, 
and gastric protease degradation severely limit the exposure to VacA occurring in an oral gavage. 
Finally, the gastric ligature approach requires that there are no severe perturbations in gastric 
physiology, however, ligating the proximal duodenum to limit the flow of gastric material was 
rather harmful to the stomach, and the animal overall. All three models failed in the listed 
requirements, and each provided a significant confounding variable in the assessment of gastric 
function and response to VacA intoxication. However, each model contributed an attribute to the 
development of an ideal model. The ex vivo and gastric ligature approaches emphasized the 
importance of containing VacA within the stomach to not only prolong the exposure of gastric 
tissue to the toxin, but to also maintain high levels of the toxin for the duration of a treatment. In 
addition, the gastric ligature and oral gavage approaches emphasized the importance of exposing 
intact gastric tissue to VacA within a living animal, as a biological system is most certainly complex 
and removal of an organ from the system significantly limits any physiological interpretation of the 
toxin effects in vivo. 
365 
 
The intragastric infusion model provides the best and most representative approach to 
evaluating the effects of VacA in vivo. The approach allows for a continuous and direct exposure 
of gastric tissue to VacA, as what would be expected in a H. pylori infection. The length of 
continual exposure to VacA allows for enough time for VacA to diffuse through the gastric mucus 
layer without harming gastric physiology through the procedure itself. Furthermore, placement of 
the intragastric catheter into the forestomach and allowance of full recovery after surgery ensures 
that stomachs are fully healed and have returned to normal function. This approach limits any 
potential confounding variables that might be associated with handling or other technical 
manipulations. The studies conducted with the intragastric infusion model have reciprocated 
previous findings that VacA and H. pylori induce damage at the level of the gastric mucosa, as 
evidence by vacuolation of parietal cells and inhibition of mucus production from gastric mucus 
cells. Furthermore, VacA was confirm to be detected within gastric tissue, indicating that indeed 
VacA was able to penetrate the mucus layer of the stomach during infusion. Through careful and 
thorough evaluation of organ systems pathology, the conclusion may be supported that neither 
the surgical approach itself, nor the infusion with VacA, introduced an infection into the 
experimental animals, thus illustrating the strength of the modality utilized. Interestingly, the 
observations made in the spleen and serum collected indicate intragastric infusion alone with 
VacA is sufficient to generate an immune response to VacA fragments. This finding illustrates the 
nature by which VacA is interacting with the immune system, and more importantly, how 
generated VacA antibody titers may contribute to the host response to H. pylori infection.  
Altogether, these data support a model that VacA functions to render gastric cells dysfunctional 
and might be involved in initiating an immune response. It is hypothesized that the importance of 
perturbing gastric cell function is to facilitate H. pylori colonization and persistence within the 
stomach of human hosts. The constant production of acid by parietal cells and mucus by mucus 
secreting cells limits H. pylori growth and is providing a physical force to move the bacteria from 
the surface of the gastric mucosa. If VacA is capable of limiting those processes, then the ability 
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of H. pylori to establish an infection within a human stomach is greatly enhanced. If these findings 
are supported, especially in the context of VacA targeting host mitochondria, this study will provide 
essential evidence into the role that VacA fulfills in H. pylori infection with a direct connection to a 
wealth of in vitro studies of VacA toxicity, and ultimately contributes to a major gap in knowledge 



















Figure 4.1: VacA purification. Purified VacA is test for purity, yield, and activity before 
experimental use. Following elution from ion exchange column chromatography, eluates are 
resolved via SDS-PAGE and stained with Coomassie Blue. Only eluates containing pure VacA 
are combined (eluates 2-11 in the example gel) (A). Yield of purified VacA is measured by BCA 
protein concentration assay with bovine serum albumin standards fitted to a 3rd order polynomial 
curve (B). The activity of VacA is determined by the neutral red vacuolation assay, consisting of 
a two-fold serial dilution of acid activated, purified VacA that is treated to cells in cell culture media 
containing 5 mM NH4Cl. The amount of vacuolation is observed visually, and quantified after 
staining of neutral red normalized to total protein (C, D). Images are representative of, and 
quantified data are compiled from three independent purifications with quality control 




Figure 4.2: Model of approaches to examine the effects of VacA in vivo. The ex vivo 
approach consists of harvesting stomachs from euthanized mice, removing gastric contents and 
washing with PBS pH 7.4, followed by direct injection of VacA into the stomach and incubating 
the stomachs under cell culture conditions (37ºC, 5% CO2, humidified atm, in DMEM) for up to 4 
h. The oral gavage approach consists or orally administering 100 - 200 µl of VacA every 12 h over 
24 h. The gastric ligature approach consists of surgically suturing the proximal duodenum (just 
distal to the pyloric sphincter) closed and directly injecting VacA into the stomach. The blocked 
stomachs were replaced into the body cavity and animals lived for up to 24 h. The intragastric 
infusion approach consists of surgically implanting an intragastric catheter, connecting the lumen 
of the stomach to an accessible port on the back of an animal. After recovery, animals were 





Figure 4.3: Ex vivo approach to expose gastric tissue to VacA. The stomach was dissected 
from a euthanized mouse by cutting the distal esophagus and proximal duodenum (1). A single 
circumferential ligature was placed distal to the pyloric spincter to close the stomach after 
removing the gastric contents by applying gentle pressure and washing with PBS pH 7.4. VacA 
was directly injected into the stomach via a 30G needle and syringe (2). Filled stomachs were 
incubated in DMEM at 37°C, 5% CO2, humidified atm for no more than 4 h (3) prior to processing 








Figure 4.4: Oral gavage approach to expose gastric tissue to VacA. Animals were orally 
gavaged with purified VacA by through a feeding needle and syringe by restraining a mouse with 
a gentle scruff, then passing a feeding needle and syringe into the esophagus via the oral cavity 
and administering the VacA solution. Animals were returned to their cages and allowed free 
access to food and water. Gavages were repeated every 24 h for 24-48 h, and upon completion 
of the timeseries the stomachs were dissected from euthanized animals and processed for 








Figure 4.5: Gastric ligature approach to expose gastric tissue to VacA. While under 
anesthesia, the abdominal cavity of a mouse was accessed by a ventral midline incision and the 
stomach was gently exteriorized (1-3). The proximal duodenum was ligated with a single 
circumferential ligature and VacA was directly injected into the stomach (4). The stomach was 
returned to the abdominal cavity and the incisions were closed with sutures (5). Animals were 
allowed to recover from anesthesia and lived for 24 h before euthanasia and processing of tissue 






Figure 4.6: Intragastric catheter design. The custom design intragastric catheter was 8 cm in 
length, with a 0.75 cm in diameter suture disk placed 0.5 cm from the distal end and 7.5 cm from 
the proximal end of the cathether. Slit valves were included on the distal end of the catheter to 
limit clogging or blockage of the catheter port. The inner diameter of the catheter was 0.6 mm, 
and the outer diameter 1.0 mm. The distal end of the catheter was inserted into the stomach, with 
the proximal end externalized on the back of an animal and the suture disk serving as an 






Figure 4.7: Surgical placement of intragastric catheter. While under anesthesia, the stomach 
of a mouse was accessed by a ventral midline incision (1-3). A spinal needle was placed within 
the lumen of a saline primed intragastric catheter, and the assembly was inserted into the 
forestomach of a mouse and secured with internal tissue adhesive (4-6). An I.V. catheter was 
used to puncture the body wall, and the intragastric catheter was inserted to the I.V. catheter, and 
thus passed through the body wall and secured with tissue adhesive (7-9). An I.V. catheter was 
passed through the subcutaneous space along the left side of the mouse and the intragastric 
catheter was placed into the I.V. catheter (10-11). The assembly was pulled through the 
subcutaneous space, thus positioning the intragastric catheter on the neck of the mouse (12). 
The ventral incisions were closed with sutures and external tissue adhesive (13). A blunt needle 
with Luer adaptor was inserted into the external intragastric catheter, and the assembly was 
secured to the animal with a suture and thoracic wrap (14-15). Animals recovered from anesthesia 




Figure 4.8: Intragastric catheter surgical placement. A custom designed intragastric catheter 
is surgically implanted into the forestomach of a mouse and is held in apposition between the 
stomach and body wall by internal surgical  glue and a suture disk. The catheter runs under the 
skin and out through the back. The externalized catheter is secured with a Luer port, for 
connection to a peristaltic pump after recovery from surgery. Artwork by Janet Sinn-Hanlon, 

























acute 95% 12 h 
1 day 
3 days 
200 5 min 50 1 min 30 min 
chronic 50% 5 days 
15 days 
30 days 
100 1 min 50 1 min 45 min 
 
Figure 4.9: Infusion system design. The intragastric infusion system consists of a 6-chambered 
reservoir holding treatments to be infused, a 6-line peristalic pump running locally off of a laptop, 
and 6 lines leading to 6 indiviually housed mouse cages, with each line directly connected to a 
port on the back of each animal. Two programs were used, an acute exposure maintaining the 
stomachs at 95% capacity for up to 3 days (initial infusion bolus of 200 µl over 5 min, re-infuse 
with 50 µl over 1 min every 30 min) and a chronic exposure maintained the stomachs ~50% 
capacity for up to 30 days (initial infusion bolus of 100 µl over 1 min, then re-infuse with 50 µl over 








Figure 4.10: Ex vivo VacA treated mouse stomachs. Stomachs were harvested from C57BL/6 
mice euthanized from CO2 asphyxiation. Gastric contents were removed and stomachs were 
washed with PBS pH 7.4. The pyloric sphincter was sutured closed and VacA (250 nM) or PBS 
pH 7.4 was directly injected into the stomach. Tissues were incubated in DMEM at 37ºC, 5% CO2, 
humidified atm for 4 h. Tissues were fixed and processed for histology with paraffin embedding 
and 10 μm thick sections. Stomachs were assessed by H&E staining with light microscopy (A), 
immunohistochemistry with metal enhanced DAB staining against VacA (B), and H&E staining 





Figure 4.11: Oral gavage of VacA to mice. C57BL/6 mice were orally gavaged with 100 µl of 
VacA (250 nM) or PBS pH 7.4 once every 12 h for 24 h. After 24 h of exposure, mice were 
euthanized by CO2 asphyxiation and tissue was fixed with Carnoy’s fixative and processed for 
histology. Stomachs were assessed by H&E staining on 15 μm thick paraffin embedded sections 





Figure 4.12: Gastric ligature and VacA exposure. C57BL/6 mice underwent a surgery where 
the proximal duodenum, just caudal to the pyloric sphincter, was sutured closed. A volume of 0.3 
ml PBS pH 7.4 was directly injected into the stomachs, then the blocked stomachs were returned 
to the body cavity, incisions were sutured closed, and mice were allowed to survive for up to 24 
h after the procedure. In order to assess the quality of the procedure, the surgery was performed 
with or without a ligature, and with or without an injection. Stomachs were examined for gross 
morphology (A). In order to assess the effects of VacA and histological changes to the tissue, the 
surgery was performed with a ligature and injection of 0.3 ml of 250 nM VacA or PBS pH 7.4, and 





Figure 4.13: Intragastric catheter insertion site. C57BL/6 mice underwent surgery whereby an 
intragastric catheter was surgically implanted into the forestomach and was adhered to the 
stomach serosa by use of internal tissue adhesive between the stomach serosa and a suture disk 
by which the intragastic catheter passed through. The site of entry of the intragastric catheter to 
the forestomach was collected and processed for histology with paraffin embedding and H&E 
staining. The lumen of the forestomach (inner surface) is facing towards the upper side of each 
image, with the serosa (outer surface) facing towards the bottom side of each image. Dotted 
regions on the left images are shown as magnified insets on the right images. Tissue immediatley 
adjacent to the port insertion site are shown in the upper images, and tissue distal to the port 






Figure 4.14: Idiopathic hepatonecrosis in intragastric infusion mice. C57BL/6 mice 
underwent surgery whereby an intragastric catheter was surgically implanted into the forestomach 
and was adhered to the stomach serosa by use of internal tissue adhesive between the stomach 
serosa and a suture disk by which the intragastic catheter passed through. The catheter-
implanted stomach was secured to the body wall by use of internal tissue adhesive between the 
suture disk attached to the stomach serosa and the body wall. For all animals in the intragastric 
infusion study, the livers were collected, with 3-4 separate regions of liver being collected, and 
processed for histology by paraffin embedding and H&E staining. In some animals, regions of 
hepatonecrosis were observed. A representative  tissue section is shown above, with magnified 
inset regions shown to the right being identified as region A and region B. Scale bars are either 







Figure 4.15: Post-surgical 2 week monitoring of mouse weight and pain indices. 
Immediately following completion of the surgical placement of an intragastric catheter, the weight 
of each mouse was measured (in grams) (A) and animals were assessed for pain (0-10) (B) every 
2 h for the first 12 h, then every 12 h for 2 weeks. Data are compiled from 9 sibling aged matched 
mice that received surgeries during the same surgical set (performed sequentially in one day). 
This data set are representative of all of other surgical sets performed. Error bars represent 




Figure 4.16: Optimization of peristaltic pump. The peristaltic pump was set for various RPMs 
(0.5 through 7 RPM) and run for 10 min to transfer PBS. The weight of PBS transferred was used 
to calculate mg/ml flow rate, then transferred to µg/min (A). The equation determined in (A) was 
used to program the peristaltic pump, which was set to transfer a relatively low (10 μl) or high 
(500 μl) volume, over relatively slow (5 min refill time) or fast (15 sec refill time) administration 
rates. The pump was run for 60 min with PBS being transferred and weighed (black bars). Based 
on pump parameters set and the equation obtained in (A), the expected volume transferred was 
calculated (white bars) (B). Data were compiled from six technical replicates, error bars represent 





Figure 4.17: VacA stability over time after acid activation. Saline dialyzed, filter sterilized, 
purified VacA was acid activated, then incubated at room temperature for 0.5 to 7 days. Acid 
activated VacA was then diluted to 250 nM with cell culture media supplemented with 5 mM 
NH4Cl. AZ-521 cells were treated with the VacA preparations for 4 h the processed for activity the 
neutral red uptake assay. Measurements of neutral red uptake were treatment matched to paired 
cells that were used for measurement of total protein by BCA assay for normalization. VacA 
activity of vacuolation was measured by neutral red uptake and normalized to total protein. Data 
are representative of a single replicate experiment performed with triplicate, with error bars 





Figure 4.18: VacA detection in mouse tissue. Tissue lysates of the stomach, spleen, and liver 
were collected from mice intragastrically infused with VacA (35 nM or 100 nM) for 24 h. In addition, 
VacA from the infusion reservoir was sampled, gastric contents were collected, and the blood was 
separated into cell and serum. Samples were immunoblotted with anti-VacA antibodies following 





Figure 4.19: VacA detection in infused mouse stomachs. Mouse stomachs were infused with 
VacA (500 nM) for 12 h. Tissue collected was fixed in Bouin’s fixative and embedded in paraffin. 
Sections 10 µm thick were processed for immunohistochemistry and stained with anti-VacA 
primary antibodies and Alexa Fluor 488 conjugated secondary antibodies, wheat germ agglutinin 





Figure 4.20: Esophageal histopathology. C57BL/6 mouse stomachs were intragastrically 
infused with saline or 500 nM VacA for 3 days with stomachs maintained at 95% capacity, or 30 
days with stomachs maintained at 50% capacity. Following euthanasia, the esophagus was 
collected and fixed in Bouin’s fixative, embedded in paraffin, and transverse cut 10 μm thick 
sections being stained with H&E. Magnified insets are shown to the right of each main image. 






Figure 4.21: Gastrointestinal histopathology. C57BL/6 mouse stomachs were intragastrically 
infused with saline or 500 nM VacA for 3 days with stomachs maintained at 95% capacity, or 30 
days with stomachs maintained at 50% capacity. Following euthanasia, the intestines from the 
proximal duodenum to the colon were collected and fixed in Bouin’s fixative, and orientated in a 
“Swiss Roll” approach with the proximal intestine within the center of roll distal intestines 
subsequently wrapped atop more proximal regions of the intestine. The entire roll was embedded 
in paraffin, with longitudinal cut 10 μm thick sections being stained with H&E. Representative 
regions of the duodenum (D), jejunum (J) and ileum (I) are shown as insets below each main 
image. Scale bars are either 1000 μm in length for the main intestinal roll images, or 100 μm in 






Figure 4.22: Peyer’s patches. C57BL/6 mouse stomachs were intragastrically infused with 
saline or 500 nM VacA for 3 days with stomachs maintained at 95% capacity. Following 
euthanasia, the intestines from the proximal duodenum to the colon were collected and fixed in 
Bouin’s fixative, and orientated in a “Swiss Roll” approach with the proximal intestine within the 
center of roll distal intestines subsequently wrapped atop more proximal regions of the intestine. 
The entire roll was embedded in paraffin and longitudinal cut 10 μm thick sections being stained 
with H&E. Representative regions of Peyer’s patches are shown as insets to the right of each 
main image. Scale bars are either 1000 μm in length for the main intestinal roll image, or 250 μm 






Figure 4.23: Hepatic histopathology. C57BL/6 mouse stomachs were intragastrically infused 
with saline or 500 nM VacA for 3 days with stomachs maintained at 95% capacity, or 30 days with 
stomachs maintained at 50% capacity. Following euthanasia, the liver was collected in 3-4 
segments and fixed in Bouin’s fixative, embedded in paraffin, and 10 μm thick sections being 
stained with H&E. Magnified insets are shown to the right of each main image. Scale bars are 






Figure 4.24: Splenic histopathology. C57BL/6 mouse stomachs were intragastrically infused 
with saline or 500 nM VacA for 3 days with stomachs maintained at 95% capacity, or 30 days with 
stomachs maintained at 50% capacity. Following euthanasia, the spleen was collected and fixed 
in Bouin’s fixative, embedded in paraffin, and transverse cut 10 μm thick sections being stained 
with H&E. Magnified insets are shown to the right of each main image. Scale bars are either 500 






Figure 4.25: Renal, pancreatic, and pulmonary histopathology. C57BL/6 mouse stomachs 
were intragastrically infused with saline or VacA. Following euthanasia, the kidney, pancreas, and 
lungs were collected and fixed in Bouin’s fixative, embedded in paraffin, and cut 10 μm thick 
sections were stained with H&E. Magnified insets are shown to the right of each main image. 
Scale bars are either 500 μm in length for the main renal, pancreatic, or pulmonary images, or 







Figure 4.26: Gastric histology: Gastric mucosa vacuolation. C57BL/6 mouse stomachs were 
intragastrically infused with saline or 500 nM VacA for 3 days with stomachs maintained at 95% 
capacity, or 30 days with stomachs maintained at 50% capacity. Following euthanasia, the 
stomach was collected and fixed in Bouin’s fixative, embedded in paraffin, and transverse cut 10 
μm thick sections were stained with PAS and Alcian Blue. Magnified insets are shown to the right 
of each main image. Scale bars are either 100 μm in length for the main gastric images, or 25 μm 







Figure 4.27: Gastric histology: Gastric mucus. C57BL/6 mouse stomachs were intragastrically 
infused with saline or 500 nM VacA for 3 days with stomachs maintained at 95% capacity. 
Following euthanasia, the stomach was collected and fixed in Bouin’s fixative, embedded in 
paraffin, and transverse cut 10 μm thick sections were stained with PAS. Quantitative data were 
collected by measuring the total gastric mucosa length and positive PAS staining in 9 different 
regions in 3 different tissue slices from 3 different animals receiving the same treatment. Relative 
positive PAS staining material was quantified by dividing the measured apical PAS staining 
material by the total gastric mucosa length in order to account for thickness differences in different 





Figure 4.28: Mucus cell vacuoles in infused mouse stomachs. C57BL/6 mouse stomachs 
were intragastrically infused with saline or 500 nM VacA for 24 h with stomachs maintained at 
95% capacity. Following euthanasia, the stomachs were collected and fixed in Bouin’s fixative, 
embedded in paraffin, and transverse cut 10 μm thick sections were stained with H&E with images 





Figure 4.29: Immune response to intragastric VacA infusion. C57BL/6 mouse stomachs were 
intragastrically infused with saline or 500 nM VacA for 15 or 30 days with stomachs maintained 
at 50% capacity. Following euthanasia, blood from animals was collected via cardiac puncture. 
Whole blood was allowed to clot by incubation at 4°C for 4 h. Whole cells were separated from 
serum by centrifugation at 1500 x g for 15 min at 4°C. Purified VacA was immunoblotted by using 
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Chapter 5: Conclusions and future work 
5.1  Introduction 
 The major gaps in knowledge sought to be addressed by this work included understanding 
the mechanisms governing mitochondrial targeting by VacA, whether a host cell is capable of 
detecting and responding to VacA mediated mitochondrial dysfunction, and to gain and 
understanding of the importance of VacA in vivo. The questions raised are central gaps in 
knowledge in not only the study of VacA, but other mitochondrial targeted pathogenic effectors 
as well. While the mechanisms of mitochondrial targeting and import have been identified for 
some pathogenic effectors, including PorB of N. gonorrhoeae1,2, LncP of L. pneumophila3,4, and 
MAP of E. coli3, the majority of mitochondrial targeted pathogenic effectors remain unknown how 
mitochondrial transport is achieved. Furthermore, while some reports exist characterizing 
mitochondrial quality control response to a pathogen, only the mitochondrial unfolded protein 
response and mitophagy have been described, but for the same pathogen (P. aeruginosa) and in 
C. elegans5-7. Given the large number of pathogens that have been described to target the 
mitochondria3, there is considerable need to understand the host cellular responses to pathogen 
mediated mitochondrial dysfunction. Finally, current studies used to evaluate the importance of 
VacA in vivo rely on an oral gavage approach, which has considerable limitations considering the 
transit time of the mouse stomach and need of VacA, a large protein toxin, to pass through the 
gastric mucus. The work presented in this dissertation addressed important questions in the study 
of VacA, H. pylori, and the interaction with host cells, as well as other mitochondrial targeted 
pathogenic effectors. Numerous avenues of research remain to fully investigate the interactions 
of VacA with host mitochondria. 
 
5.2 Major findings 
 The work addressed and presented address major gaps in knowledge in the study of 
VacA. From this work, additional questions were raising regarding the mechanism of the biological 
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activity of factors identified and pathways described. Continual elucidation of those processes is 
important to fully understand the importance of a bacterium producing a toxin that localizes to and 
disrupts the mitochondria. 
 
5.2.1  VacA intracellular trafficking 
 Given VacA is a membrane-embedded, pore-forming toxin8, and to date no mechanisms 
have been described vesicle transport to the mitochondria, in order to evaluate VacA trafficking 
to the mitochondria, intracellular compartments containing VacA were isolated using a magnetic 
based pulse-chase isolation approach. In addition to trafficking studies of fluorescence 
microscopy, the following major findings were made: 
 VacA associates with endosomal compartments prior to association with mitochondria 
 VacA association with mitochondria decreases over time 
 Isolated VacA enriched compartments (VECs) contained proteins previously identified to 
be important for VacA activity, or associated with VacA, namely RPTP, Rac1, Cdc42, 
EEA1, Bax, Rab7 and LAMP1 
 All subunits of the TOM complex, small TIM chaperone, and TIM23 complex were 
identified in VEC proteomics 
 Numerous membrane trafficking proteins were identified as potential candidates for VacA 
trafficking, namely Rab10, Rab1, Rab5C, Rab11, Rab14, Snp23, Stx4, Rab18, Rab6, 
Rab9, Snp20 and Stx6 
 14-3-3-G, VSP4B, Stx18, and Rab35 are important or VacA mediated vacuolation 
 14-3-3-G and Rab35 are important or VacA mediated mitochondrial fragmentation 
 Loss of 14-3-3-G increases the association of VacA with mitochondria 
 Loss of Rab35 decreases the association of VacA with mitochondria 
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Altogether, these findings support a model of VacA association with endosomes prior to 
association with mitochondria. Interestingly, the detection of all mitochondrial subunits of the TOM 
complex, TIM23 complex, and small TIM chaperones illustrate a potential model to explain VacA 
import into the mitochondria. The identification of numerous membrane trafficking proteins yield 
potential targets for future studies. Finally, 14-3-3-G, VSP4B, Stx18, and Rab35 were identified 
to be important for VacA mediated vacuolation, indicating a potential involvement in the trafficking 
of VacA to the mitochondria. 
 
5.2.2  VacA and mitochondrial quality control 
 Given VacA induces mitochondrial dysfunction, and the importance of maintaining 
mitochondrial homeostasis, it was predicted that a host cell should respond to pathogen insults 
at the level of the mitochondria as a quality control response. In the evaluation of mitochondrial 
quality control in response to VacA, the following findings were made: 
 VacA mediated mitochondrial fragmentation, depolarization, and ATP depletion recover 
over time 
 VacA treatment does not induce OPA1 cleavage 
 VacA treatment does not induce PINK1 or PARKIN mediated mitophagy or result in a 
decrease in mitochondrial mass 
 Recovery of VacA mediated mitochondrial dysfunction limits the induction of autophagy, 
cell mediated cell death, and conversion from mitochondrial oxidative phosphorylation to 
glycolysis 
 VacA is trafficked from mitochondria to LAMP1 enriched compartments 
 VacA treatment results in an increased association of mitochondrial proteins with the 
lysosomal marker LAMP1 
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 Vacuole formation and VacA association with LAMP1 is a downstream consequence of 
VacA intracellular activity 
 VacA mediated vacuole formation is dependent upon functional mitochondria 
 RAB32 and DRP1 are important for VacA mediated vacuolation, mitochondrial 
fragmentation, and vacuole formation 
 VacA induces the formation of TOM20 positive, cytochrome c negative mitochondrial 
derived vesicles (MDVs)  
 VacA associates with MDVs in vitro 
 Canonical MDV trafficking machinery, namely Stx17 and Snx9, are important for VacA 
mediated vacuolation 
 VacA induced MDVs are more enriched in inner mitochondrial membrane proteins than 
outer mitochondrial membrane proteins 
 Isolation and characterization of VacA mediated MDVs identified potential targets for MDV 
formation and transport, namely Rab10, Rab1, Rab2, Rab6, Stx12, Stx16, Stx8, Vamp8 
 Rab5C is important for VacA mediated vacuolation 
Altogether, these findings support a model that a host cell is capable of detecting and 
responding to VacA mediated mitochondrial dysfunction, and current evidence supporting a 
model of mitochondrial derived vesicles. Although a negative result cannot be proven, the 
preponderance of evidence does not support VacA induction of mitophagy. These findings 
illustrate that VacA mediated mitochondrial dysfunction is not irreversible, that a host cell can 







5.2.3  Intragastric infusion of VacA 
 Previous studies evaluating the importance of VacA in vivo have relied on an oral gavage 
model. However, given the transit time of the stomach, the presence of gastrointestinal proteases, 
and the need for VacA to penetrate the gastric mucus, there is significant concern that an oral 
gavage is far removed from reciprocating the exposure of VacA in an actual infection. To address 
this issue, several modalities of in vivo VacA exposure were attempted, with the final development 
of an intragastric infusion model being the most representative of what is expected of VacA 
exposure in a natural intoxication. By use of the intragastric infusion model, the following findings 
were made: 
 Surgical placement of an intragastric catheter does not negatively impact the health of an 
animal 
 VacA is detected within the stomach tissue, and stomach lumenal contents in VacA 
infused animals 
 VacA infusion does not induce appreciable esophageal, pulmonary, pancreatic or hepatic 
pathology 
 VacA infusion induces a humoral immune response  
 VacA infusion induces parietal cell vacuolation 
 VacA infusion inhibits gastric mucus production 
Altogether, these findings illustrate the successful development of an intragastric infusion 
model for VacA exposure in vivo. Pathology was only observed in the gastric mucosa and spleen, 
with no apparent perturbations in locations proximal or distal to the stomach, including the 
esophagus, lungs, liver, or intestines. Gastric pathology observed is consistent with previous 





5.3  Conclusion 
 The completion of the aforementioned studies have arrived at a unifying model (Figure 
5.1). The final model is that VacA binds to the cell surface and is internalized into endosomal 
compartments indicative of GEEC. VacA is then routed in the endosomal compartments, which 
are dynamically remodeled over time to become functionally competent to traffic to and deliver 
VacA to the mitochondria by recruiting proteins that are canonically involved in mediated 
membrane trafficking. Due to the pore-forming ability of VacA, when VacA achieves mitochondrial 
localization, the inner mitochondrial membrane becomes depolarized, leading to mitochondrial 
fragmentation and a loss of cellular ATP. As a response to VacA mediated mitochondrial 
dysfunction, a host detects and responds to mitochondrial dysfunction by activating a quality 
control response, whereby VacA is selectively removed into mitochondrial derived vesicles. These 
vesicles containing mitochondrial excised VacA and are transported to lysosomes for 
degradation. However, due to the pore-forming ability of VacA, the lysosomes swell into the 
vacuoles that allowed VacA to be initially discovered. This quality control response limits the 
severity of mitochondrial dysfunction induced by VacA, leaving the cells viable, with slightly 
dysfunctional mitochondria. Gastric cells exposed to VacA under this recovery condition limits 
their ability to produce gastric acid and mucus, and thus facilitates the persistence of H. pylori 
infection in a human stomach. 
 
5.4 Future work 
 In addition to addressing several important gaps in knowledge in the study of VacA and 
the mitochondria, this work identified numerous future studies to be pursued, while also providing 






5.4.1  VacA intracellular trafficking 
 Although VacA enriched intracellular compartments were isolated and characterized, the 
precise mechanism governing VacA trafficking to and import into the mitochondria remains 
unknown. For future work, host factors mediating VacA trafficking to the mitochondria need to be 
evaluated, and my proteomics work has identified several potential targets. Furthermore, the 
mechanism of VacA import into the mitochondria needs to be addressed. The proteomics finding 
indicating that the TOM complex, TIM23 complex, and small TIM chaperones were present in 
VacA enriched compartments lends a potential clue to addressing this mechanism. Finally, the 
mechanism by which RAB35 mediates VacA transport to mitochondria remains to be fully 
elucidated. 
 
5.4.2  VacA and mitochondrial quality control 
 Studies conducting provide strong evidence that mitochondrial dysfunction induced by 
VacA recovers over time, and supporting evidence that mitochondrial derived vesicles are 
mediating this repair process. However, it is unknown what signal is being detected by a host cell 
to activate MDV formation in response to VacA. Furthermore, the mechanisms governing the 
selective excision of VacA from the mitochondria is unknown. In addition, it is not clear whether 
one class of MDVs are being activated in response to VacA, and whether all are being trafficked 
to the lysosomes. Finally, the molecular machinery governing MDV formation and trafficking is 
unknown, although the proteomics data have provided potential targets for addressing this future 
work. 
 
5.4.3  Intragastric infusion of VacA 
 The studies conducted established a novel in vivo approach to study the importance of 
VacA. The findings collected support previous findings of the effect of VacA on gastric tissue. 
However, it is unknown whether major phenotypes of VacA intoxication in vitro are also observed 
414 
 
in the infusion model, including induction of autophagy, mitochondrial dysfunction, and 
vacuolation. In addition, the ability to intragastrically infuse one factor of interest would allow for 
the potential to perform a complementation experiment, whereby animals are infected with VacA 
deficient H. pylori, then intragastrically infused with VacA, in order to complement the expected 
phenotypes attributed to VacA. A final interesting avenue of potential future work is to use this 
infusion model system to evaluate whether gastric exposure of VacA alone is sufficient to drive 
an anti-VacA antibody response and how that response facilitates H. pylori colonization and 
persistence within a host. With the implementation of this model, potentially very long term 
exposures may be performed, with greater than 30 days being feasible. Finally, additional animal 
models may be used for an intragastric infusion approach. Considerable work in the study of H. 
pylori pathogenesis has utilized a Mongolian gerbil model of infection. For future work, other 
animal models may be evaluated for intragastric infusion of not only VacA, but other pathogenic 





5.5  Figure 
 
Figure 5.1: Model of VacA interactions with mitochondria. The final model posits that VacA 
binds to the cell surface and is internalized into GEEC compartments. VacA is then routed in the 
endosomal compartments, which are dynamically remodeled over time to become functionally 
competent to traffic to and deliver VacA to the mitochondria. Due to the pore-forming ability of 
VacA, when VacA achieves mitochondrial localization, the inner mitochondrial membrane 
becomes depolarized, leading to mitochondrial fragmentation and a loss of cellular ATP. As a 
response to VacA mediated mitochondrial dysfunction, a host detects and responds to 
mitochondrial dysfunction by activating a quality control response, whereby VacA is selectively 
removed into mitochondrial derived vesicles. These vesicles containing mitochondrial excised 
VacA and are transported to lysosomes for degradation. However, due to the pore-forming ability 
of VacA, the lysosomes swell into the vacuoles that allowed VacA to be initially discovered. This 
quality control response limits the severity of mitochondrial dysfunction induced by VacA, leaving 
the cells viable, with slightly dysfunctional mitochondria. Gastric cells exposed to VacA under this 
recovery condition limits their ability to produce gastric acid and mucus, and thus facilitates the 
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